

ACCESSION NUMBER:		0001052257-14-000003
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		12
CONFORMED PERIOD OF REPORT:	20131231
FILED AS OF DATE:		20140414
DATE AS OF CHANGE:		20140414
FILER:
	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Z TRIM HOLDINGS
 INC
		CENTRAL INDEX KEY:			0001052257
		STANDARD INDUSTRIAL CLASSIFICATION:	GRAIN MILL PRODUCTS [2040]
		IRS NUMBER:				364197173
		STATE OF INCORPORATION:			IL
		FISCAL YEAR END:			1231
	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32134
		FILM NUMBER:		14762472
	BUSINESS ADDRESS:	
		STREET 1:		1011 CAMPUS DRIVE
		CITY:			MUNDELEIN
		STATE:			IL
		ZIP:			60060
		BUSINESS PHONE:		847-549-6002
	MAIL ADDRESS:	
		STREET 1:		1011 CAMPUS DRIVE
		CITY:			MUNDELEIN
		STATE:			IL
		ZIP:			60060
	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CIRCLE GROUP HOLDINGS INC
		DATE OF NAME CHANGE:	20030313
	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CIRCLE GROUP INTERNET INC
		DATE OF NAME CHANGE:	19980512









    
















Washington
 D.C.&#160;&#160;20549





December 31
 2013







Z Trim Holdings
 Inc.























1011 Campus Drive
 Mundelein
 Illinois







Registrant&#8217;s telephone
 including area code:&#160;&#160;&#160;







Common Stock
 $0.00005 par value



Indicate by check mark if the registrant is a well-known seasoned issuer
 as defined in Rule 405 of the Securities Act.





Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports)
 and (2) has been subject to such filing requirements for the past 90 days.&#160;&#160;Yes&#160;&#160;

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site
 if any
 every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).&#160;&#160;&#160;Yes&#160;&#160;

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (229.405 of this chapter) is not contained herein
 and will not be contained
 to the best of registrant&#8217;s knowledge
 in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.&#160;&#160;&#160;

Indicate by check mark whether the registrant is a large accelerated filer
 an accelerated filer
 a non-accelerated filer
 or a smaller reporting company.&#160;&#160;See the definitions of &#8220;large accelerated filer
&#8221; &#8220;accelerated filer&#8221; and &#8220;smaller reporting company&#8221; in Rule 12b-2 of the Exchange Act.








$47
785
197.

The number of shares of our common stock outstanding as of April 15
 2014 was 39
734
854.
























































































&#160;Market for Registrant&#8217;s Common Equity
 Related Stockholder Matters and Issuer





















































&#160;Directors
 Executive Officers and Corporate Governance.














&#160;Certain Relationships and Related Transactions
 and Director Independence.























&#160;Exhibits
 Financial Statement Schedules.












































The statements contained in this Form 10-K that provide guidance or are not historical facts (such as statements in the future tense and statements including &#8220;believe
&#8221; &#8220;expect
&#8221; &#8220;intend
&#8221; &#8220;plan
&#8221; &#8220;anticipate
&#8221; &#8220;goal
&#8221; &#8220;target&#8221; and similar terms and concepts)
 including all discussions of periods which are not yet completed
 are forward-looking statements that involve risks and uncertainties
 including
 but not limited to:







- our product development efforts
 including risk that we will not be able to produce our products in a cost-effective manner;

- our ability to secure new customers
 maintain our current customer base and deliver product on a timely basis;

- possible issuances of common stock subject to options
 warrants and other securities that may dilute the interest of stockholders
 and/or future exercise of such options and warrants;



- competition from larger
 more established companies with far greater economic and human resources;



- possible product recalls due to adulteration of products or materials
 future regulatory action
 or other concerns;
- our ability to comply with all government regulation and retain favorable regulatory status
 such as GRAS status
 of our products and ingredients;




- our ability to successfully defend future litigation
 including possible claims related to products liability and infringement of intellectual property
 as well as the outcome of regulatory actions and inquiries;
- future sale of a substantial number of shares of our common stock that could depress the trading price of our common stock
 lower our value and make it more difficult for us to raise capital;
- our additional securities available for issuance
 which
 if issued
 could adversely affect the rights of the holders of our common stock;

- our stock price is likely to be highly volatile due to a number&#160;of factors
 including a relatively&#160;limited public float and potential for short sales of our stock.



In addition
 see Risk Factors in Part I
 Item 1A and Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations in Part II
 Item 7 for a further discussion of some of the factors that could affect future results.



























Z Trim Holdings
 Inc. was incorporated in the State of Illinois on May 5
 1994 under the original name Circle Group Entertainment Ltd.&#160;&#160;The Company has no operating subsidiaries.&#160;&#160;Z Trim Holdings
 Inc. is a bio-technology company that owns existing
 and develops new
 products and processes that transform agricultural by-products into multi-functional ingredients used in food manufacturing and other industries.&#160;&#160;&#160;The Company currently sells a line of products to the food industry that can help manufacturers reduce their costs
 improve the quality of finished goods
 and also help solve many production problems.&#160;&#160;The Company&#8217;s innovative technology provides value-added ingredients across virtually all food industry categories.&#160;&#160;These all-natural products offer a range of functional attributes
 including helping to reduce fat and calories
 adding fiber
 improving shelf-stability
 preventing oil migration
 and enhancing binding capacity &#8211; all without degrading the taste and texture of the final food products.&#160;&#160;Perhaps most significantly
 Z Trim&#8217;s ingredients can help extend the life of finished products
 potentially increasing its customers&#8217; gross margins.

The Company
 through an exclusive license to technology patented by the United States Department of Agriculture
 has developed products that manage moisture to help reduce production costs and improve nutritional value in finished foods
 while maintaining the essential taste and mouth-feel associated with full-fat products.&#160;&#160;The global market for Z Trim&#8217;s line of products spans the entire food and nutritional beverage industry
 including fat-free
 low-fat
 reduced-fat and full-fat
 across meats
 baked goods
 dairy and non-dairy products
 snacks
 beverages
 dressings
 sauces and dips.

We currently manufacture our products at a facility owned by our toll manufacturer
 Aveka Nutra Processing LLC (&#8220;ANP&#8221;). Our original facility
 which we phased out in the third quarter of 2013
 was a prototype plant
 the first of its kind to produce our innovative products.&#160;&#160;In 2011
 the Company and ANP entered into a tolling agreement
 providing that ANP would build a facility capable of producing a minimum of 40
000 pounds per month of Z Trim ingredients and average volumes of 100
000 pounds per month
 with the capability of scaling up to 1 million pounds per month.&#160;&#160;In late 2012
 the ANP facility began to make Z Trim products and
 although we experienced various start-up difficulties and issues with the relationship
 ANP is currently in the process of ramping up to achieve initial
 contracted-for capacity; however
 we cannot provide assurances that these production levels will continue or that issues may not affect production in the future.

In July 2012
 the Company opened an industrial products division focusing on the manufacture
 marketing and sales of products designed specifically for industrial applications
 including oil drilling fluids
 petroleum coke
 charcoal briquettes
 hydraulic fracturing
 and paper and wood adhesives.&#160;&#160;When used in industrial operations
 we believe that Z Trim&#8217;s products can reduce costs
 enhance supply-chain reliability
 limit environmental impact
 and improve finished product quality compared to current products such as guar gum
 xanthan gum
 CMC
 lignosulfonates and starches used as binders
 adhesives
 viscofiers or emulsifiers.

In January 2013
 the Company entered into a joint development agreement with Newpark Drilling Fluids LLC
 a subsidiary of Newpark Resources
 Inc.
 to develop new
 environmentally-friendly drilling fluids that incorporate Z Trim's proprietary industrial materials that could replace products such as guar and xanthan gums in drilling applications.



The Company&#8217;s core product portfolio of multifunctional food ingredients includes Corn Z Trim&#174; (both GMO and non-GMO) and Oat Z Trim&#174;. The superior water-holding capacity and amorphous structure of Z Trim ingredients are key to the exclusive multifunctional attributes they contribute to food product design
 including moisture management
 oil deflection
 texture and appearance quality
 fat and calorie reduction. Perhaps most significantly
 these attributes allow manufacturers using Z Trim to reduce costs of finished products by replacing more expensive ingredients with Z Trim fiber and water.&#160;&#160;Z Trim&#174; is now being used by food manufacturers world-wide
 across a multitude of food categories
 such as meats
 sauces
 soups
 dressings
 baked goods
 fillings
 toppings
 prepared meals
 dairy products
 frozen handheld snacks
 and pizza dough. Food formulators are seeking greater functionality and product performance than they can get from starches
 gums
 fats
 and other fibers &#8211; for both standard and lower fat content foods - and are increasingly discovering how Z Trim&#174; multifunctional ingredients can help to delight their consumers with finished products that the Company believes have enhanced eating quality
 outstanding product performance
 and frequently
 improved nutritional profiles.


Major market drivers such as greater nutrition awareness
 increasing obesity trends
 the economy
 rising costs and hectic lifestyles have triggered an evolution of the food industry and consumer expectations.&#160;&#160;The Company&#8217;s goal is to further enable food manufacturers to address the challenges and opportunities of this evolution by helping them to lower their costs
 differentiate their products
 achieve their growth objectives
 and delight their customers.&#160;&#160;Through ongoing product applications research
 the Company develops solutions that help food manufacturers solve formulation and product challenges and capture market opportunities with high quality
 innovative products that fulfill consumer demands.


The Company currently manufactures and markets Z Trim&#174; products as cost-competitive ingredients that help improve the food industry&#8217;s ability to deliver on its promises of quality
 taste
 and healthfulness. The Company&#8217;s primary goal is to establish Z Trim as an important ingredient in the evolution of the food industry and consumer expectations.

The Company began manufacturing non-GMO corn products in early 2013 with the intent to meet potentially expanding domestic and international demand.&#160;&#160;On February 6
 2013
 the Company announced that it had recorded its first sales of such products.

In 2012
 the Company opened an industrial division seeking to serve a variety of industries
 including
 but not limited to
 oil drilling
 hydraulic fracturing
 petroleum coking
 pharmaceuticals
 nutracuticals
 paper and corrugated box adhesives
 and others.&#160;&#160;The Company is developing products from its patented technologies to make value-added ingredients from low-cost agricultural sources to serve these industries.


In February 2013
 the Company announced its first sale of industrial grade Bio-Fiber Gum for use in the petroleum coke industry.


















The Company is developing its food ingredient market through (i) direct and brokered sales to major food manufacturers
 as well as small and mid size companies for packaged retail foods
 and (ii) direct and brokered sales to large and small foodservice manufacturers that supply to restaurants
 hospitals
 schools and cafeterias. In addition to direct sales
 we use a network of ingredient distributors
 both domestic and international
 to distribute our products.

As mentioned above
 in January 2013
 the Company entered into a joint development agreement with Newpark Drilling Fluids LLC
 a subsidiary of Newpark Resources
 Inc.
 to develop new
 environmentally-friendly drilling fluids that incorporate Z Trim's proprietary industrial materials that could replace products such as guar and xanthan gums in drilling applications.&#160;&#160;The Company cannot provide assurance that this relationship will be successful or result in improved sales results.




Z Trim&#174; ingredients compete with a wide variety of hydrocolloids and other fiber ingredients.&#160;&#160;Within the food industry
 depending on the food application
 required functional properties and product development objectives
 competitive ingredients might include gums (e.g.
 guar
 xanthan
 locust bean
 and Arabic)
 seaweed extracts (e.g.
 alginates
 carrageenan)
 starches (native
 modified and resistant)
 and fibers (e.g.
 oat bran
 corn bran
 pea fiber
 potato fiber).&#160;&#160;Most of these competitive ingredients are well-established in the food industry
 and many of the companies that supply them have substantially greater resources than we do.&#160;&#160;However
 we believe that the unique properties of Z Trim multifunctional fiber ingredients pose not only significant market opportunities for us
 but also provide differentiation and growth opportunities for food companies.&#160;&#160;We believe that no other single hydrocolloid or fiber has the combined water holding and binding capacity that is effective across as wide a pH and temperature range as Z Trim&#174;
 nor imparts as many superior attributes to the finished consumer food product.&#160;&#160;Furthermore
 we believe Z Trim&#174; ingredients can have synergistic effects with other hydrocolloids and fibers
 allowing food manufacturers to achieve even greater processing improvements
 cost efficiencies
 and finished product performance.&#160;&#160;Many of the same ingredients used in foods are also used for industrial applications
 where they compete with a similar complement of ingredients.&#160;&#160;We believe that our products&#8217; unique functionalities
 combined with the fact that they are produced domestically from abundant raw material sources (agricultural by-products)
 provide us with strengths that our competitors&#8217; products do not possess.



Raw materials used in Z Trim&#174; products are sourced principally in the United States.&#160;&#160;Approximately 70% of our raw materials consist of corn bran and oat hulls
 which are generally available from a variety of suppliers.&#160;&#160;Our major suppliers include Agricor
 Inc. and Hydrite Chemical. We seek to mitigate the risk of a shortage of raw materials through identification of alternative suppliers for the same or similar raw materials
 where available. We have purchasing staff with extensive knowledge of our products that work with marketing
 product research and development and quality control personnel to source raw materials for products and other items.



The Company&#8217;s customers are predominantly food manufacturers.&#160;&#160;There were three significant customers who accounted for 36%
 24% and 5%
 respectively
 of total sales for the year ended December 31
 2013.&#160;&#160;There were three significant customers who accounted for 36%
 24% and 9%
 respectively
 of total sales for the year ended December 31
 2012.



The Company protects intangible assets that include patents pending and issued
 as well as trade secrets and know how.&#160; Central to this portfolio is an exclusive license to US Patent No. 5
766
662
 including all related international patents
 issued to Dr. George Inglett of the USDA.&#160; The Company&#8217;s license expires upon the expiration of the underlying patent in 2015
 and we will therefore lose our patent protection at that time.&#160; Additionally
 the USDA patent was filed in several countries throughout the world.

Through the process of development and commercialization of&#160;its technology
 the Company has identified and sought patent protection for improvements to the manufacturing process
 product applications and is currently developing several spin-off technologies.&#160; On December 1
 2009
 we were issued U.S. Patent No. 7
625
591 B2; such will expire in 2026 and will continue until this time subject to the payment of maintenance fees.&#160;&#160;On July 27
 2010
 we were issued U.S. Patent No. 7
763
301; such will expire in 2027 and will continue until that time subject to payment of maintenance fees.&#160;&#160;These patents expand the raw material sources for the creation of Z Trim products as well as incorporate blends of ingredients combined with Z Trim.&#160;&#160;In July 2012 the Company
 jointly with the USDA
 filed a provisional patent for its Bio-Fiber Gum line of products
 seeking patent protection for the composition of matter
 process for making
 as well as applications for
 its proprietary soluble fibers.

The Company continues to work with the USDA to expand its intellectual property portfolio; however
 there can be no assurance that the Company will procure any additional intellectual property.


















We are subject to a broad range of federal
 state
 local and foreign laws and regulations intended to protect public health and the environment. Food production and marketing are highly regulated by a variety of federal
 state
 local
 and foreign agencies.&#160;&#160;However
 as Z Trim ingredients are made from natural raw material sources (corn and oat)
 they are considered Generally Recognized As Safe or &#8220;GRAS.&#8221;&#160;&#160;&#160;In October 2012
 the FDA approved the labeling of Z Trim products in meat applications. Specifically
 the FDA has approved the use of Z Trim ingredients in ground
 emulsified
 and processed meats and poultry.&#160;&#160;We believe this will create the potential for increased sales
 although there can be no assurances.




Our R&amp;D team
 in conjunction with our customers and strategic industry partners
 including the USDA
 continues to work on the development of additional products and applications.&#160;&#160;In June 2011
 the Company entered into a 3-year agreement with the USDA to conduct joint research for the development of additional products and processes relating to its current patented products.&#160;&#160;We require all employees and visitors to our plant to execute a non-disclosure agreement.&#160;&#160;Our success depends to a significant degree upon our ability to develop proprietary products and technologies and to obtain patent coverage for these products and technologies. We intend to continue to file patent applications covering any newly developed products and technologies. However
 there can be no guarantee that any of our pending or future filed applications will issue as patents.

The Company spent $65
867 in 2013 and $134
705 in 2012 for research and development expense
 and is still innovating toward developing value-added products to add to its core line.



The Company does not face any&#160;material environmental compliance issues as a result of its manufacturing process
 however there can be no assurances.




Presently
 the Company employs 21 full-time employees.
























The Company incurred a net loss of $13
432
261 for the twelve months ended December 31
 2013
 and had an accumulated deficit of $126
873
491.&#160;&#160;The Company incurred a net loss of $9
583
756 for the twelve months ended December 31
 2012.

If the Company continues to incur significant losses
 it may not be able to continue operations.&#160;&#160;Even if it can continue operations
 its cash reserves may be depleted earlier than currently anticipated
 and the Company may be required to limit its future growth objectives to levels corresponding with its then available cash reserves.

DUE TO OUR HISTORY OF LOSSES
 OUR ACCOUNTANTS HAVE RAISED SUBSTANTIAL DOUBT WITH RESPECT TO OUR ABILITY TO CONTINUE AS A GOING CONCERN


As noted in our financial statements
 we incurred a net loss of $13
432
261 for the year ended December 31
 2013 and had an accumulated deficit of $126
873
491.&#160;&#160;We incurred a net loss of $9
583
756 for the year ended December 31
 2012.&#160;&#160;Although we have generated revenue
 we are still operating at a significant net loss
 and may continue to incur significant losses for a period of time.&#160;&#160;We will be required to obtain additional financing in order to repay existing contractual obligations coming due in 2014
 and to continue to cover operating losses and working capital needs.&#160;&#160;We cannot assure you that we will be able to obtain sufficient funds from our operating or financing activities to support our continued operations.


The audit report of M&amp;K CPAS
 PLLC for the fiscal year ended December 31
 2013 contained a paragraph that emphasizes the substantial doubt as to our continuance as a going concern.&#160;&#160;This is a significant risk that we may not be able to generate or raise enough capital to remain operational for an indefinite period of time.

IF THE COMPANY DOES NOT OBTAIN ADDITIONAL FINANCING
 IT WILL BE REQUIRED TO DISCONTINUE OPERATIONS.

As of December 31
 2013
 the Company had cash in the amount of $443
472 and total liabilities in the amount of $699
937. We also had working capital of $805
195 as of December 31
 2013. Over the last several years
 the Company&#8217;s operations have been funded primarily through the sale of both equity and debt securities.&#160;&#160;However
 the Company still requires additional financing to implement its business plan for the next twelve months and beyond.&#160;&#160;The Company&#8217;s current cash on hand is insufficient for it to be able to maintain its operations at the current level through the end of the fiscal 2014.&#160;&#160;In order to continue to pursue its business plan
 the Company will require additional funding. If the Company is not able to secure additional funding
 the implementation of its business plan will be delayed and its ability to maintain or expand operations will be impaired. The Company intends to secure additional funding through debt or equity financing arrangements
 increased sales generated by its operations and reduced expenses.




On March 24
 2014
 Fordham Capital Partners
 LLC extended a $500
000 revolving loan to the Company.&#160;&#160;&#160;&#160;The Note requires monthly payments of principal of $10
417 plus interest
 commencing on April 24
 2014 and continuing until February 24
 2015
 followed by a final balloon payment of the entire unpaid principal balance of the Note and all accrued and unpaid interest on March 24
 2015.&#160;&#160;The amount of revenues generated by the business has been insufficient to support ongoing daily operations.&#160;&#160;Previously
 we had to rely on new equity or debt financing in order to satisfy other financing incurred by the Company.&#160;&#160;There are no assurances that the Company will grow sales sufficiently to generate the requisite positive cash flow or secure additional debt or equity financing in order to satisfy&#160;&#160;the Fordham loan without the liquidation of the assets securing the credit.



We have not conducted
 nor have others made available to us
 results of market research indicating how much market demand exists for Z Trim
 our functional food ingredient. We are relying on the current concerns over obesity
 weight-health issues
 and the rising cost of both foods and health care to drive demand for Z Trim&#8217;s line of products offered to the food and nutritional beverage industry. We have only recently begun exploring the use of our products for non-food usage (such as industrial products) and are also unable to determine whether there will be a viable non-food market going forward. We cannot assure you that we will be able to gain the market acceptance necessary to achieve profitability or that a significant market will exist for our products.

We make no projection with respect to our future income
 assets or business. No expert has reviewed our business plan for accuracy or reasonableness. It is likely that our actual business and results of operations will differ from those presented herein.



Our revenues and order bookings are concentrated with a small number of customers.&#160;&#160;The loss of one or more of our customers or material changes to the contracts with or payment terms of these customers may result in a significant business interruption through reduced revenues
 reduced cash flows
 delays in revenues or cash flows and such delays or reductions could have a material adverse impact on our future revenue growth and results of operations
 as well as our ability to continue operations.



Our original manufacturing facility was merely a pilot plant and our second facility
 owned an operated by our toll manufacturer
 is still ramping up.&#160;&#160;In order to fully implement our business plans we will need to successfully ramp up production at our second facility
 move the operations to larger facilities
 develop strategic partnerships or find other means to produce greater volumes of finished product
 and we cannot assure that we will be able to do so or to achieve positive gross margins and profitable operations.


















The new industrial products division will focus on the manufacture
 marketing and sale of products designed for industrial applications
 such as oil drilling fluids
 petroleum coke
 charcoal briquettes
 hydraulic fracturing
 and paper and wood adhesives.&#160;&#160;We have no prior experience in the manufacturing
 marketing or sale of industrial products.&#160;&#160;We may not be successful in these activities and may never generate significant revenues or profitability from our industrial products division.



All of our current products depend on our proprietary technology using agricultural products
 mainly corn bran and oat hull. Historically
 the costs of corn bran and oat hull are subject to fluctuations depending upon a number of factors which affect commodity prices in general and over which we have no control
 including crop conditions
 weather
 government programs and purchases by foreign governments. Commodity price changes may result in unexpected increases in raw material
 packaging
 and energy costs.&#160;&#160;We currently do not hedge against changes in commodity prices.&#160;&#160;If we are unable to increase productivity to offset these increased costs or increase our prices
 we may experience reduced margins and profitability.

WE ARE SUBSTANTIALLY DEPENDENT ON OUR MANUFACTURING FACILITY AND THE ABILITY OF OUR TOLL MANUFACTURER
 AVEKA NUTRA PROCESSING
 TO RAMP UP PRODUCTION; ANY OPERATIONAL DISRUPTION COULD RESULT IN A REDUCTION OF OUR SALES VOLUMES AND COULD CAUSE IT TO INCUR SUBSTANTIAL LOSSES.

Our revenues primarily are and are expected to continue to be derived from the sale of functional ingredients made from dietary fiber that we manufacture at ANP&#8217;s facility in Iowa.&#160;&#160;Our operations may be subject to significant interruption if the ANP facility experiences a major accident or is damaged by severe weather or other natural disasters.&#160;&#160;In addition
 the ANP operation may be subject to labor disruptions and unscheduled downtime
 or other operational hazards inherent in the industry
 such as equipment failures
 fires
 explosions
 abnormal pressures
 blowouts
 pipeline ruptures
 transportation accidents and natural disasters. Some of these operational hazards may cause personal injury or loss of life
 severe damage to or destruction of property and equipment or environmental damage
 and may result in suspension of operations and the imposition of civil or criminal penalties. Our insurance may not be adequate to fully cover the potential operational hazards described above; in addition
 we may not be able to renew this insurance on commercially reasonable terms or at all.

IF COMPETITION INCREASES
 OUR ABILITY TO ATTRACT AND RETAIN CUSTOMERS OR EXPAND OUR BUSINESS COULD BE IMPAIRED.

Competition is intense in our targeted industries
 including nutraceuticals
 functional food ingredients
 oils
 and gums.&#160;&#160;A large number of businesses are engaged in various fat replacement industries. Many of our competitors have established reputations for successfully developing and marketing their products
 including products that are widely recognized as providing similar calorie reduction. In addition
 many of our competitors have greater financial
 managerial
 and technical resources than we have.&#160;&#160;&#160;If we are not successful in competing in these markets
 we may not be able to attain our business objectives or continue operations.

OUR INTELLECTUAL PROPERTY RIGHTS ARE VALUABLE
 AND ANY INABILITY TO PROTECT THEM COULD REDUCE THE VALUE OF OUR PRODUCTS
 SERVICES AND BRAND.

Our patents
 trademarks
 trade secrets
 copyrights and other intellectual property rights are important assets for us.&#160;&#160;Various events outside of our control pose a threat to our intellectual property rights as well as to our products and services.&#160;&#160;For example
 effective intellectual property protection may not be available in every country in which our products and services are distributed.&#160;&#160;Also
 the efforts we have taken to protect our proprietary rights may not be sufficient or effective.&#160;&#160;Any significant impairment of our intellectual property rights could harm our business or our ability to compete.&#160;&#160;Also
 protecting our intellectual property rights is costly and time consuming.&#160;&#160;Any increase in the unauthorized use of our intellectual property could make it more expensive to do business and harm our operating results.

Although we seek to obtain patent protection for our innovations
 it is possible we may not be able to protect some of these innovations.&#160;&#160;In addition
 given the costs of obtaining patent protection
 we may choose not to protect certain innovations that later turn out to be important.&#160;&#160;Furthermore
 there is always the possibility
 despite our efforts
 that the scope of the protection gained will be insufficient or that an issued patent may be deemed invalid or unenforceable.


















We license or hold several patents as well as copyrights and trademarks with respect to our products and expect to continue to file applications in the future as a means of protecting our intellectual property. In addition
 we seek to protect our proprietary information and know-how through the use of trade secrets
 confidentiality agreements and other similar security measures. With respect to patents
 there can be no assurance that any applications for patent protection will be granted
 or
 if granted
 will offer meaningful protection.&#160;&#160;Some of the technology employed by Z Trim in its products is licensed to the Company by the USDA. The USDA patent expires 2015 and we will therefore lose our patent protection with respect to that patent at that time. Although the Company has additional process patents on file and
 in 2012
 jointly with the USDA
 filed a provisional patent for an insoluble fiber product
 there can be no assurance that new patents will in fact be issued or that they will provide effective protection.&#160;&#160;In addition
 we recently received two other patents in our own name:&#160;&#160;Patent Nos. 7
763
301 and 7
625
591.

Additionally
 there can be no assurance that competitors will not develop
 patent or gain access to similar know-how and technology
 or reverse engineer our products
 or that any confidentiality agreements upon which we rely to protect our trade secrets and other proprietary information will be adequate to protect our proprietary technology. The occurrence of any such events could have a material adverse effect on our results of operations and financial condition.




The patent for the technology we employ in manufacturing our products is licensed to us by the USDA.&#160;&#160;The USDA patent expires in 2015 and we will therefore lose our patent protection with respect to that patent at that time
 which will provide new opportunities to our competitors and significantly reduce barriers to entry.&#160;&#160;Although we have additional process patents on file and in 2012
 jointly with the USDA
 filed a provisional patent for an insoluble fiber product
 there can be no assurance that new patents will in fact be issued or that they will provide effective protection.



We rely on the legal protections of trade secrets to protect our technology
 especially where we do not believe patent protection is appropriate or obtainable. However
 trade secrets are difficult to protect. In order to protect our proprietary technology and processes
 we also rely in part on confidentiality and intellectual property assignment agreements with our corporate partners
 employees
 consultants
 outside scientific collaborators and sponsored researchers and other advisors. These agreements may not effectively prevent disclosure of confidential information nor result in the effective assignment to us of intellectual property
 and may not provide an adequate remedy in the event of unauthorized disclosure of confidential information or other breaches of the agreements. In addition
 others may independently discover our trade secrets and proprietary information
 and in such case we could not assert any trade secret rights against such party. Enforcing a claim that a party illegally obtained and is using our trade secrets is difficult
 expensive and time consuming
 and the outcome is unpredictable. In addition
 courts outside the United States may be less willing to protect trade secrets. Costly and time-consuming litigation could be necessary to seek to enforce and determine the scope of our proprietary rights
 and failure to obtain or maintain trade secret protection could adversely affect our competitive business position.



We hold an intellectual property portfolio
 including patent
 trademark
 copyright and trade secret protection.&#160;&#160;Our competitors
 however
 may design around our patent claims
 rendering our patent protection ineffective against such competitors.&#160;&#160;Similarly
 our competitors may independently develop technology similar to our trade secrets and technical know-how.&#160;&#160;Such occurrences could increase competitive pressure on our marketing and sales efforts
 and adversely affect our results of operation.



Any claim that we infringe a third party&#8217;s patents or other intellectual property rights
 whether meritorious or not
 could be time consuming and result in costly litigation.&#160;&#160;If any of our practices are found to be in violation of another party&#8217;s rights
 we may be required to pay monetary damages or licensing fees
 which could be substantial
 or cease making products which are deemed to be infringing.&#160;&#160;Any of those occurrences could substantially harm our business
 results and financial condition.

IF OUR FOOD PRODUCTS BECOME ADULTERATED
 MISBRANDED
 OR MISLABELED
 WE MIGHT NEED TO RECALL THOSE ITEMS AND MAY EXPERIENCE PRODUCT LIABILITY CLAIMS IF CONSUMERS ARE INJURED.

We may need to recall some of our products if they become adulterated
 misbranded
 or mislabeled. A widespread product recall could result in significant losses due to the costs of a recall
 the destruction of product inventory
 and lost sales due to the unavailability of product for a period of time. In such a case
 or in the event that injuries are determined to arise from our products
 we could also suffer losses from a significant product liability judgment against us. A significant product recall or product liability case could also result in adverse publicity
 damage to our reputation
 and a loss of consumer confidence in our food products
 which could have a material adverse effect on our business results and the value of our brands.

IF WE FAIL TO COMPLY WITH GOVERNMENT REGULATION IMPACTING OUR BUSINESS
 WE MAY BE SUBJECT TO A RANGE OF SANCTIONS THAT WILL ADVERSELY IMPACT OUR OPERATIONS.

We are subject to extensive regulation
 and compliance with existing or future laws and regulations may require us to incur substantial expenditures or require us to make product recalls.&#160;&#160;As such
 we are subject to a broad range of federal
 state
 local and foreign laws and regulations intended to protect public health and the environment.&#160;&#160;Food production and marketing are highly regulated by a variety of federal
 state
 local
 and foreign agencies.&#160;&#160;Changes in laws or regulations that impose additional or different regulatory requirements on us could increase our cost of doing business or restrict our actions
 causing our results of operations to be adversely affected.&#160;&#160;In addition
 we advertise our products.&#160;&#160;Our advertisements could be the target of claims relating to alleged false or deceptive advertising under federal
 state
 and foreign laws and regulations and of new laws or regulations restricting our right to advertise products.

Our operations are also subject to regulation by various federal agencies
 including the Alcohol and Tobacco Tax Trade Bureau
 the Occupational Safety and Health Administration
 the Food and Drug Administration and the Environmental Protection Agency
 and by various state and local authorities.&#160;&#160;Such regulation covers virtually every aspect of our operations
 including production facilities
 marketing
 pricing
 labeling
 packaging
 advertising
 water usage
 waste water discharge
 disposal of hazardous wastes and omissions and other matters.&#160;&#160;Violations of any of these laws and regulations may result in administrative
 civil or criminal penalties being levied against us
 permit revocation or modification
 performance of environmental investigatory or remedial activities
 voluntary or involuntary product recalls
 or a cease and desist order against operations that are not in compliance.&#160;&#160;These laws and regulations may change in the future and we may incur material costs in our efforts to comply with current or future laws and regulations or to affect any product recalls. These matters may have a material adverse effect on our business.
















IF OUR PRODUCTS DO&#160;NOT&#160;SATISFY CERTAIN GOVERNMENTAL REGULATIONS
&#160;WE&#160;MAY BE&#160;UNABLE TO OBTAIN&#160;REGULATORY&#160;APPROVAL&#160;OR MAY BE REQUIRED TO OBTAIN MULTIPLE LICENSES TO SELL OUR PRODUCTS.

Z Trim&#160;has&#160;self-certified&#160;that all&#160;components&#160;of its products are generally recognized as safe (&#8220;GRAS&#8221;) according to the U.S. Food and Drug&#160;Administration&#160;regulations.&#160; A GRAS&#160;designation&#160;exempts the products from the regulations of the U.S. Department of Agriculture
&#160;permitting the sale of the&#160;products anywhere&#160;in the United States&#160;without obtaining&#160;a&#160;license.&#160;&#160; Should&#160;the&#160;products&#160;lose&#160;their&#160;GRAS designation
&#160;Z Trim will be required to sell the&#160;products as food additives&#160;by&#160;obtaining a license to sell from each&#160;individual&#160;state in which sales&#160;would&#160;occur.&#160; There&#160;is no&#160;assurance&#160; that&#160;Z Trim&#160;&#160;would&#160; be&#160; able to successfully&#160; obtain or&#160; maintain&#160; licenses&#160; in all&#160; states&#160; in which&#160; sales are expected to be made or that the cost of obtaining and maintaining these licenses would not limit its ability to sell its products.

WE ARE SUBJECT TO PERIODIC LITIGATION AND OTHER REGULATORY PROCEEDINGS
 WHICH COULD RESULT IN UNEXPECTED EXPENSE OF TIME AND RESOURCES.

We are a defendant from time to time in lawsuits and regulatory actions relating to our business
 including litigation brought by former employees. Due to the inherent uncertainties of litigation and regulatory proceedings
 we cannot accurately predict the ultimate outcome of any such proceedings. An unfavorable outcome could have an adverse impact on our business
 financial condition and results of operations. In addition
 any significant litigation in the future
 regardless of its merits
 could divert management&#8217;s attention from our operations and result in substantial legal fees.

WE HAVE IDENTIFIED MATERIAL WEAKNESSES IN OUR INTERNAL CONTROL OVER FINANCIAL REPORTING
 WHICH COULD IMPACT NEGATIVELY OUR ABILITY TO REPORT OUR RESULTS OF OPERATIONS AND FINANCIAL CONDITION ACCURATELY AND IN A TIMELY MANNER.

Effective internal controls over financial reporting are necessary for us to provide reliable financial reports.&#160;&#160;We have identified material weaknesses in these controls.&#160;&#160;A material weakness is a deficiency
 or a combination of deficiencies
 in internal control over financial reporting
 such that there is a reasonable possibility that a material misstatement of the company&#8217;s annual or interim financial statements will not be prevented or detected on a timely basis.&#160;&#160;In our annual evaluation of the effectiveness of our internal control over financial reporting conducted by management as required by the Sarbanes-Oxley Act of 2002
 at December 31
 2013
 we identified material weaknesses in our internal control over financial reporting and concluded that
 as of December 31
 2013
 we did not maintain effective control over financial reporting based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. For a detailed description of these material weaknesses
 see Item 9A
 &#8220;Controls and Procedures
&#8221; herein.&#160;&#160;Each of our material weaknesses results in more than a remote likelihood that a material misstatement of the annual or interim financial statements that we prepare will not be prevented or detected. As a result
 we must perform additional work to obtain reasonable assurance regarding the reliability of our financial statements.&#160;&#160;

As of December 31
 2013
 we carried out an evaluation
 under the supervision and with the participation of our management
 including our principal executive officer and principal financial officer
 of the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rules 13a &#8211; 15(c) and 15d &#8211; 15(e)).&#160;&#160;Based upon that evaluation
 our principal executive officer and principal financial officer concluded that
 as of the end of the period covered in this report
 our disclosure controls and procedures were not effective to ensure that information required to be disclosed in reports filed under the Securities Exchange Act of 1934 is recorded
 processed
 summarized and reported within the required time periods and is accumulated and communicated to our management
 including our principal executive officer and principal financial officer
 as appropriate to allow timely decisions regarding required disclosure.

If we are unsuccessful in developing and implementing or following a remediation plan
 or fail to update our internal control over financial reporting as our business evolves
 we may not be able to timely or accurately report our financial condition
 results of operations or cash flows or to maintain effective disclosure controls and procedures. If we are unable to report financial information in a timely and accurate manner or to maintain effective disclosure controls and procedures
 we could be subject to
 among other things
 regulatory or enforcement actions by the SEC
 securities litigation and a general loss of investor confidence
 any one of which could adversely affect our business prospects and the market value of our common stock.



Our success depends
 in part
 on the efforts and abilities of our management team and other key employees. Their skills
 experience and industry contacts significantly benefit our operations and administration. The failure to attract and retain members of our management team and other key employees could have a negative effect on our operating results. In addition
 transitions of important responsibilities to new individuals inherently include the possibility of disruptions to our business and operations
 which could negatively affect our business
 financial condition
 results of operations and cash flow.

















OUR STOCK TRADES AT LOW PRICES PER SHARE AND TRADES ON THE OTC: PINK ELECTRONIC QUOTATION SYSTEM
 WHICH PROVIDES LIMITED LIQUIDITY AND SIGNIFICANT VOLATILITY.

Since our common stock is currently traded on the OTC Markets Group&#8217;s OTCQB electronic quotation system (the &#8220;OTCQB&#8221;)
 investors may find it difficult to obtain accurate quotations of our common stock and may experience a lack of buyers to purchase such stock or a lack of market makers to support the stock price.&#160;&#160;Being a penny stock also could limit the liquidity of our common stock and limit the coverage of our stock by analysts.&#160;&#160;The OTCQB generally provides less liquidity than stock exchanges like NYSE or NASDAQ.&#160;&#160;Stocks trading on the OTC markets may be very thinly traded and highly volatile.&#160;&#160;Therefore
 holders of the Company&#8217;s common stock may be unable to sell their shares at any price
 whether or not such shares have been registered for resale.&#160;&#160;A public trading market having the desired characteristics of depth
 liquidity and orderliness depends on the presence in the marketplace of willing buyers and sellers of our common shares at any given time.&#160;&#160;This presence depends on the individual decisions of investors and general economic and market conditions over which we have no control.&#160;&#160;Given the lower trading volume of our common shares
 significant sales of our common shares
 or the expectation of these sales
 could cause our share price to fall.



Our common stock currently does not meet all of the requirements for initial listing on a national securities exchange. Specifically
 the bid price of our common stock is less than the minimum bid price required to obtain a listing. Trading in our common stock continues to be conducted in the over-the-counter market. As a result
 an investor may find it difficult to dispose of or to obtain accurate quotations as to the market value of our common stock
 and our common stock may be less attractive for margin loans
 for investment by larger financial institutions
 as consideration in possible future acquisition transactions or other purposes.

THE FLUCTUATION IN OUR STOCK PRICE MAY RESULT IN A DECLINE IN
 OR THE LOSS OF
 THE VALUE OF YOUR INVESTMENT.

The price of our common stock has fluctuated widely in the past
 and may continue to do so.&#160;&#160;&#160;In 2013 our stock had high and low bid prices of $2.70 and $0.52
 respectively. In 2012
 our common stock had high and low bid prices of $3.50 and $0.07 per share
 respectively.&#160;&#160;This volatility is likely to continue for the foreseeable future. Factors affecting potential volatility include:














The occurrence of any of these events may cause the price of the common stock to fall.&#160;&#160;In addition
 the stock market in general has recently experienced volatility that often has been unrelated to the operating performance or financial condition of individual companies.&#160;&#160;Any broad market or industry fluctuations may adversely affect the trading price of our common stock
 regardless of operating performance or prospects.

Companies that experience volatility in the market price of their securities often are subject to securities class action litigation.&#160;&#160;This type of litigation
 if instituted against us
 could result in substantial costs and divert management&#8217;s attention and resources away from our business.


















From time to time
 certain of our stockholders may be eligible to sell all or some of their shares of common stock by means of ordinary brokerage transactions in the open market pursuant to Rule 144
)
 subject to certain limitations. In general
 pursuant to Rule 144
 a stockholder (or stockholders whose shares are aggregated) who has satisfied the required holding period may
 under certain circumstances
 sell within any three-month period a number of securities which does not exceed the greater of 1% of the then outstanding shares of common stock. Rule 144 also permits
 under certain circumstances
 the sale of securities
 without any limitations
 by a non-affiliate of our company that has satisfied a one-year holding period. Any substantial sale of common stock pursuant to Rule 144 or pursuant to any resale prospectus may have an adverse effect on the market price
 if any
 of our securities.

EXERCISES OF STOCK OPTIONS
 WARRANTS AND OTHER CONVERTIBLE SECURIIES WILL DILUTE YOUR PERCENTAGE OF OWNERSHIP AND COULD CAUSE OUR STOCK PRICE TO FALL.

As of April 15
 2014
 we had outstanding stock options to purchase 11
238
shares of common stock and outstanding warrants to purchase 16
688
265 shares of our common stock
 at prices ranging from $1.50 to $0.01 per share.&#160;&#160;Additionally
 we have reserved up to a total of 18
000
000 shares (inclusive of the 11
238
062 outstanding stock options) to be issued pursuant to equity awards under our Incentive Compensation Plan. The exercise
 conversion or exchange of stock options
 warrants or convertible securities will dilute the percentage ownership of our other stockholders. Sales of a substantial number of shares of our common stock could cause the price of our common stock to fall and could impair our ability to raise capital by selling additional securities.

WE HAVE ADDITIONAL SECURITIES AVAILABLE FOR ISSUANCE
 WHICH
 IF ISSUED
 COULD ADVERSELY AFFECT THE RIGHTS OF THE HOLDERS OF OUR COMMON STOCK.

Our Articles of Incorporation authorize the issuance of 200
000
000 shares of our common stock
 1
000
000 shares of Series I Preferred Stock and 1
000
000 shares of Series II Preferred Stock. The common stock and preferred stock
 as well as the awards available for issuance under the Incentive Compensation Plan
 can be issued by our board of directors without stockholder approval. We will not be required to seek
 and will generally not seek
 stockholder approval in connection with our equity offerings.&#160;&#160;Any future issuances of such stock would further dilute the percentage ownership of us held by public stockholders. Any preferred stock that is issued may rank ahead of our common stock in terms of dividends
 liquidation rights and voting rights and could adversely affect the voting power and the rights of our holders of common stock. In addition
 the issuance of the preferred stock may be used as an &#8220;anti-takeover&#8221; device without further action on the part of our stockholders
 and may adversely affect the holders of the common stock.



Brightline Ventures I
 LLC (&#8220;Brightline I&#8221;) Brightline Ventures I-B
 LLC (&#8220;Brightline I-B&#8221;) and Brightline Ventures I-C
 LLC ((&#8220;Brightline I-C&#8221;)
 and collectively with Brightline I and Brightline I-B
 &#8220;Brightline&#8221;) beneficially own approximately 61.1% of our common stock. As a result
 Brightline has a significant influence in determining the outcome of all corporate transactions or other matters which require approve of our stockholders
 including mergers
 consolidations and the sale of all or substantially all of our assets
 the power to elect directors to the board of directors
 and also the power to prevent or cause a change in control.&#160;&#160;Brightline may prevent or frustrate attempts to effect a transaction or series of transactions that is or are in the best interest of the Company or minority stockholders. The interests of Brightline may differ from the interests of the other stockholders.&#160;&#160;In addition
 this concentration of ownership may delay or prevent a change in our control
 even when a change in control may be in the best interest of the Company or the other stockholders
 and might affect the market price of our common stock. Furthermore
 the interests of this concentration of ownership may not always coincide with our interests or the interests of other stockholders.



We have experienced and may continue to experience unexpected declines in our stock price due to manipulation of the market by individuals who profit by short selling our common stock. Short selling occurs when an individual borrows shares from an investor through a broker and then sells those borrowed shares at the current market price. The short seller profits when the stock price falls because he or she can repurchase the stock at a lower price and pay back the person from whom he or she borrowed the stock
 thereby making a profit. We cannot assure you that short sellers will not drive the stock price down in the future
 causing decline in the value of your investment.


















We do not anticipate paying cash dividends to the holders of the Common Stock at any time.&#160;&#160;Accordingly
 investors in our Common Stock must rely upon subsequent sales after price appreciation as the sole method to realize a gain on investment. There are no assurances that the price of Common Stock will ever appreciate in value. Investors seeking cash dividends should not buy our securities.

BECAUSE THE SEC IMPOSES ADDITIONAL SALES PRACTICE REQUIREMENTS ON BROKERS WHO DEAL IN OUR SHARES
 WHICH ARE PENNY STOCKS
 SOME BROKERS MAY BE UNWILLING TO TRADE THEM.&#160;&#160;THIS MEANS THAT YOU MAY HAVE DIFFICULTY IN RESELLING YOUR SHARES AND MAY CAUSE THE PRICE OF THE SHARES TO DECLINE.

Our stock is a penny stock. The SEC generally defines &#8220;penny stock&#8221; to be any equity security that has a market price less than $5.00 per share or an exercise price of less than $5.00 per share
 subject to certain exceptions. Our securities are covered by the penny stock rules
 which impose additional sales practice requirements on broker-dealers who sell to persons other than established customers and &#8220;accredited investors&#8221;. The term &#8220;accredited investor&#8221; refers generally to institutions with assets in excess of $5
000
000 or individuals with a net worth in excess of $1
000
000 or annual income exceeding $200
000 or $300
000 jointly with their spouse. The penny stock rules require a broker-dealer
 prior to a transaction in a penny stock not otherwise exempt from the rules
 to deliver a standardized risk disclosure document in a form prepared by the SEC which provides information about penny stocks and the nature and level of risks in the penny stock market. The broker-dealer also must provide the customer with current bid and offer quotations for the penny stock
 the compensation of the broker-dealer and its salesperson in the transaction and monthly account statements showing the market value of each penny stock held in the customer&#8217;s account. The bid and offer quotations and the broker-dealer and salesperson compensation information must be given to the customer orally or in writing prior to effecting the transaction and must be given to the customer in writing before or with the customer&#8217;s confirmation. In addition
 the penny stock rules require that prior to a transaction in a penny stock not otherwise exempt from these rules
 the broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive the purchaser&#8217;s written agreement to the transaction. These disclosure requirements may have the effect of reducing the level of trading activity in the secondary market for the stock that is subject to these penny stock rules. Consequently
 these penny stock rules may affect the ability of broker-dealers to trade our securities. We believe that the penny stock rules discourage investor interest in
 and limit the marketability of
 our common stock.

In addition to the &#8220;penny stock&#8221; rules promulgated by the SEC
 FINRA has adopted rules that require that in recommending an investment to a customer
 a broker-dealer must have reasonable grounds for believing that the investment is suitable for that customer. Prior to recommending speculative
 low-priced securities to their non-institutional customers
 broker-dealers must make reasonable efforts to obtain information about the customer&#8217;s financial status
 tax status
 investment objectives and other information. Under interpretations of these rules
 FINRA believes that there is a high probability that speculative low-priced securities will not be suitable for at least some customers. The FINRA requirements make it more difficult for broker-dealers to recommend that their customers buy our common stock
 which may limit your ability to buy and sell our stock.



























We occupy approximately 44
000 square feet of leased space at 1011 Campus Drive
 Mundelein
 Illinois. This space is leased for $21
361 per month
 including property taxes
 pursuant to a cancelable operating lease.&#160;&#160;The current lease term is through May 14

 2014 the Company entered into an amendment to the original lease agreement for office space located in Mundelein
 Illinois.&#160;&#160;The amendment extended the term of the lease to May 14
 2015 upon the same terms and conditions contained in the lease as amended.




In July 2007
 Judicial Circuit Court
 St. Clair County
 Illinois by Joseph Sanfilippo and James Cluck for violation of the Consumer Fraud Act and is seeking damages in excess of $200
000.&#160;&#160;The trial court has issued a default order against the Company
 and has denied the Company&#8217;s motion to reconsider.&#160;&#160;Management believes that the trial court&#8217;s rulings were erroneous and that it has grounds for appeal
 and that the underlying allegations are frivolous and wholly without merit and the Company will vigorously defend the claim. The outcome of this matter is unknown as of the report date.&#160;&#160;However
 the Company has conservatively allocated a reserve of $102
000 to satisfy any liability it may incur as a result of this proceeding.


In December 2011
 the Company was sued in Circuit Court of the 17th Judicial District
 Winnebago County
 Illinois
 by LIBCO Industries
 Inc.
 alleging the Company breached a construction contract and tortiously interfered with a business relationship
 and is seeking damages in excess of $185
000.&#160;&#160;The case has subsequently been transferred to the 19th Judicial Circuit Court
 Lake County
 Illinois.&#160;&#160;Management believes that the allegations are frivolous and wholly without merit and will vigorously defend the claim.&#160;&#160;Related to this matter
 Process Piping
 LLC
 a sub-contractor for LIBCO Industries
 filed a mechanics lien on the property leased by the Company
 claiming it was owed in excess of $95
000 by LIBCO Industries.&#160;&#160;As of December 31
 2011
 the Company accrued as a settlement loss
 the $62
500 paid to Process Piping
 LLC on March 6
 2012 in exchange for a release of its lien as well as an assignment of all of its claims against LIBCO Industries.&#160;&#160;On January 31
 2013
 the Circuit Court granted the Company&#8217;s motion for partial summary judgment on the tortious interference claim.&#160;&#160;In the fourth quarter of 2013
 the parties settled all outstanding matters and the case has subsequently been dismissed. As part of the settlement
 the Company received $10
000 in cash and both parties provided releases of all respective claims.


Although there can be no assurances
 based on the information currently available
 management believes that it is probable that the ultimate outcome of each of these actions will not have a material adverse effect on the financial statements of the Company.&#160;&#160;However
 an adverse outcome in either of these actions could have a material adverse effect on the financial results of the Company in the period in which it is recorded.


In addition to the above actions
 in the first quarter of 2013
 the Company settled a dispute with one of its investors related to the anti-dilution adjustment provisions to the exercise price of certain warrants it holds.&#160;&#160;As part of the settlement agreement and release
 the Company issued the investor 875
000 shares of restricted stock
 and also agreed to modify terms of certain of the warrants at issue to provide for a cashless exercise feature.&#160;&#160;The parties also agreed to release certain claims against each other related to this dispute.&#160;&#160;At December 31
 2012
 the Company recorded a common stock payable and settlement loss in the amount of $1
881
250.












































Market for Registrant&#8217;s Common Equity
 Related Stockholder Matters and Issuer Purchases of Equity Securities.





Since October 6
 2010 the Company&#8217;s common stock has been quoted on the &#8220;OTCQB&#8221; electronic quotation system.


The market for our common stock is limited
 volatile and sporadic.&#160;&#160;The following table sets forth the range of high and low bid quotations for our common stock for each of the periods indicated as reported by the OTCQB.&#160;&#160;Where such information is not available
 the high and low closing bid quotations as reported by the OTCQB has been provided.&#160;&#160;These quotations below reflect inter-dealer prices
 without retail mark-up
 mark-down or commission and may not necessarily represent actual transactions.






Fiscal Year Ended December 31
 2013

























March 31
 2013











June 30
 2013











September 30
 2013











December 31
 2013

















Fiscal Year Ended December 31
 2012

























March 31
 2012











June 30
 2012











September 30
 2012











December 31
 2012

















As of March 31
 2014
 there were approximately 3
792 record holders of the common stock.&#160;&#160;This number does not include shareholders whose shares are held in securities position listings.



To date
 we have not declared or paid cash dividends on our shares of Common Stock.&#160;&#160;We do not anticipate paying cash dividends to the holders of Common Stock at any time.



The following table sets forth certain information regarding grants under the Company&#8217;s equity compensation plan as of December 31
 2013:














outstanding options










price of outstanding options


























9
583
762












8
416
238
































9
583
762












8
416
238




(1)&#160;&#160;All options or shares relate to the Company&#8217;s Incentive Compensation Plan
 which was approved by stockholders in 2012.




To date
 the Company has never repurchased any shares of its Common Stock.



On October 28
 2013
 the Company entered into a Consulting Agreement with Steeltown Consulting Group
 LLC
 pursuant to which Steeltown will assist in evaluating various business and financial matters.&#160;&#160;The Company issued 220
000 restricted shares of common stock as consideration for the services being rendered in this agreement.&#160;&#160;This agreement was scheduled to terminate on January 31
 2014.&#160;&#160;On December 3
 2013
 the Company and Steeltown entered into a new Consulting Agreement (which replaces the agreement dated October 28
 2013) in which both the Company and Steeltown substantially agreed to the same services being rendered as the previous agreement.&#160;&#160;The Company issued 550
000 shares of restricted common stock as consideration for the services being rendered under this new agreement.&#160;&#160;This agreement will terminate on January 31
 2015.


























This Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations contains forward-looking statements.&#160;&#160;Forward-looking statements are subject to risks
 uncertainties and assumptions which could cause actual results to differ materially from those projected
 including those described in Item 1A
 &#8220;Risk Factors
&#8221; in Part I of this report and in &#8220;&#8216;Cautionary Statement Regarding Forward Looking Statements&#8221; of this report.

The following discussion should be read in conjunction with our consolidated financial statements and the related notes to the consolidated financial statements in Item 8
 &#8220;Financial Statements and Supplementary Data
&#8221; in Part II of this report.







On October 17
 2011
 the Company entered into a Custom Processing Agreement (&#8220;CPA&#8221;) with AVEKA Nutra Processing
 LLC (&#8220;ANP&#8221;)
 part of the Aveka Group
 in order to provide the Company with a partner for future manufacturing initiatives.&#160;&#160;The CPA provides that ANP will perform certain services related to the Company&#8217;s dietary fiber product
 including manufacturing
 processing
 packaging and storage/warehousing for an initial term of three years.&#160;&#160;The CPA automatically renews at the end of the initial term for an additional two-year term unless either party provides written notice to the other within the specified time frame.&#160;&#160;Start-up activities began in the third quarter of 2012
 and production began in the fourth quarter of 2012.&#160;&#160;The CPA provides for minimum production volumes of 40
000 lbs. per month and average volumes of 100
000 lbs. per month with the ability to increase future production volume to potentially as much as 1
000
000 lbs. per month.&#160;&#160;However
 due to factors
 including potential start-up problems
 changes in customer demand
 inability of parties to perform their obligations and factors outside the Company&#8217;s control
 the Company cannot assure that production will grow as anticipated or that it will achieve these levels.

In 2012
 the FDA approved the labeling of Z Trim products in meat applications. Specifically
 the FDA has approved the use of Z Trim ingredients in ground
 emulsified
 and processed meats and poultry. We believe this will create the potential for increased sales
 although there can be no assurances.




Private Placements
 Warrant Programs
 Waivers
 Cashless Exercises and Anti-dilution Adjustments


In the first quarter of 2013
 we completed a warrant exercise program
 which resulted in the exercise of 1
756
088 warrants into 1
756
088 shares of the Company&#8217;s common stock.&#160;&#160;The warrant program
 which was open to all holders of $1.50 warrants
 allowed those warrant holders to exercise their warrants for a $1.25 strike price during February 2013; it also required a waiver of the anti-dilution provisions in these warrants until February 28
 2013 so that those provisions would not be triggered by the exercises. The conversion of these warrants raised approximately $2.2 million in additional capital for the Company

On August 20
 2013
 the Company entered into a private placement subscription agreement with Brightline Ventures I-C
 LLC (together with Brightline Ventures I
 LLC and Brightline Ventures I-B
 LLC
 referred to collectively herein as &#8220;Brightline&#8221; unless the context indicates otherwise) pursuant to which it sold 376
000 shares of common stock
 at a price of $1.25 per share (the &#8220;$1.25 Raise&#8221;)
 and received gross proceeds of $470
000.


Concurrent to the $1.25 Raise
 the Company (i) allowed the holders of the Company&#8217;s outstanding warrants with a $1.50 per share exercise price (the &#8220;$1.50 Warrants&#8221;) with certain anti-dilution provisions contained in the warrant agreements to choose to exercise their $1.50 Warrants on a cashless basis such that for every ten $1.50 warrants exercised
 the holder received 4.5 shares of common stock (fractional shares were rounded up) (the &#8220;Cashless Exercise Program&#8221;)
 (ii) sought a temporary waiver from the holders of the $1.50 Warrants of the anti-dilution provisions in the warrant agreements with respect to the Cashless Exercise Program and potential capital-raising activities (other than the $1.25 Raise) by the Company prior to December 31
 2013
 and (iii) asked the holders of the $1.50 Warrants to permanently amend the warrant agreements with respect to certain ratchet provisions so as to reduce the derivative liability the Company incurs as a result of those provisions in the agreement.


The Cashless Exercise Program resulted in 7
172
751 of the $1.50 Warrants being converted into 3
227
742 shares of common stock (including 5
718
750 $1.50 Warrants that were converted by Brightline Ventures I
 LLC into 2
573
438 shares of Common Stock).&#160;&#160;As a result of the Cashless Exercise Program
 the Company recognized a loss on equity modification of $990
656&#8212;the difference in value between the $1.50 Warrants exercised and the common stock issued&#8212;for the three months ended September 30
 2013.


As a result of the August 20
 2013 transaction with Brightline Ventures I
 pursuant to the anti-dilution provisions contained in the $1.50 Warrants that were not exercised as part of the Cashless Exercise Program
 the Company reduced the exercise price of the remaining warrants to $1.25 per share and adjusted the number of shares issuable upon the exercise of those warrants such that for every five warrants owned
 each remaining holder of $1.50 Warrants received one additional warrant with an exercise price of $1.25 per share.&#160;&#160;Thus
 the Company issued an additional 2
376
009 warrants at an exercise price of $1.25 per share to the holders of the $1.50 Warrants that were not exercised as part of the Cashless Exercise Program.


On September 18
 2013
 the Company entered into a private placement subscription agreement with Brightline Ventures I-C pursuant to which it sold 468
571 shares of common stock at a price of $1.05 per share
 along with warrants to purchase 234
286 shares of common stock at an exercise price of $1.50 per share (the &#8220;$1.05 Raise&#8221;)
 and received gross proceeds of $492
000.&#160;&#160;The waiver indicated above was effective for the $1.05 Raise; therefore
 no additional warrants were issued and no exercise price adjustments were made pursuant to anti-dilution and ratchet provisions as a result of the $1.05 Raise.



















On November 18
 2013
 the Company completed a public offering of 1
866
667 shares of common stock at $0.75 per share and warrants to purchase up to 1
400
000 shares of common stock.&#160;&#160;For every share of common stock purchased in the public offering
 the investor received a warrant to purchase three-quarters (3/4) of a share of common stock.&#160;&#160;The warrants have an exercise price of $1.00 per share and a term of exercise of five years from date of issuance.&#160;&#160;The Company realized net proceeds from this public offering of $1
210
165.&#160;&#160;These funds will be used to finance the Company&#8217;s working capital needs and other general corporate purposes.




In March 2013
plus accrued dividends into 3
859
697 shares of the Company&#8217;s Common Stock.&#160;&#160;&#160;Following the above conversions
 all outstanding shares of Series II Preferred Stock have been converted and none remain outstanding.


On August 13
 2012
 the Company entered into an agreement with Brightline Ventures I pursuant to which Brightline agreed to convert $7
721
worth of Series I and II Preferred Stock into 7
721
shares of the Company&#8217;s Common Stock at the earlier of either the maturity date of the security or the closing of any approved transaction with Maxim Group
 LLC.&#160;&#160;In consideration for the foregoing conversion of Preferred Stock by Brightline Ventures I on or before their respective maturity dates
 the Company modified the following warrants held by Brightline Ventures I to provide them with the ability to exercise such warrants on a cashless basis: (i) warrants to purchase an aggregate of&#160;&#160;11
582
shares of Common Stock with an exercise price of $1.50 per share
 which were issued to Brightline Ventures I in transactions where Brightline Ventures I acquired shares of the Company&#8217;s Series I and II Preferred Stock; and (ii) warrants to purchase an aggregate of&#160;&#160;2
859
375 shares of Common Stock with an exercise price of $1.50 per share
 which equals one half of the outstanding&#160;&#160;and unexercised warrants issued to Brightline Ventures I in other transactions where Brightline Ventures I provided financing to the Company. Prior to December 31
 2012
 all Series I Preferred shares held by Brightline Ventures I were converted to common shares consistent with the amendment. The remaining Series II Preferred shares held of 665
339 shares and $3
326
697 was reclassified to permanent equity based on the removal of the redemption feature associated with the preferred stock. The value reclassified was equal to the carrying value of the shares on the date the agreement was modified. This value was $2
157
238 based on a gross value of $3
326
697 and a remaining discount of $1
169
459. Furthermore
 the accrued dividends relating to the Series II Convertible Preferred Stock have also been reclassified to Stockholders&#8217; Equity.&#160;&#160;These reclassifications were necessary based on the preferred shares no longer being subject to potential cash redemption.


In the third quarter of 2012
 Brightline Ventures I converted $1
634
400 (including accrued dividends) of Series I Preferred Stock into 1
634
400 shares of Common Stock
 and Morris Garfinkle
 a director of the Company
 converted $34
800 (including accrued dividends) of Series I Preferred Stock into 34
800 shares of the Company&#8217;s Common Stock.


In addition
 during the fourth quarter of 2012
 Brightline Ventures I converted $3
465
100 (including accrued dividends) of Series I Preferred Stock into 3
465
100 shares of Common Stock.&#160;&#160;Further
 the non-executive directors of the Company
 Morris Garfinkle
 Mark Hershhorn
 Brian Israel and Ed Smith
 each converted $17
403 shares of Series I Preferred Stock (including accrued dividends) into 17
403 shares of Common Stock
 which resulted in issuing an aggregate of 69
612 shares to those individuals
 and another investor converted $290
000 (including accrued dividends) of the Series I Preferred Stock into 290
000 shares of Common Stock.

Following the above conversions
 all outstanding shares of Series I Preferred Stock have been converted and none remain outstanding.


In the first and second quarters of 2012
 Brightline Ventures I converted $1
420
000 in principal balance on notes it held
 plus $238
979 of interest accrued thereon into 1
658
979 shares of the Company&#8217;s Common Stock.



During the first quarter of 2012 we sold to three accredited investors (the &#8220;Investors&#8221;) senior secured convertible promissory notes (the &#8220;2012 Notes&#8221;) and warrants and received gross proceeds of $200
000.&#160;&#160;&#160;The 2012 Notes have a twenty-four month term and accrue interest at the rate of 8% per annum.&#160;&#160;The principal balance of the 2012 Notes is convertible at the rate of $1.00 per share into an aggregate of 200
000 shares of our Common Stock.&#160;&#160;The interest is payable either upon maturity or quarterly at the Investors&#8217; option in shares of our Common Stock.&#160;&#160;Any amount of principal or interest that is not paid when due shall bear interest at a rate of interest equal to the eighteen percent (18%) per annum.&#160;&#160;The Investors also received a five-year warrant
 to purchase an aggregate of 100
000 shares of Common Stock per unit with an exercise price of $1.50 per share.&#160;&#160;The warrants are also callable in the event that the ten-day trailing average closing price per share of Common Stock exceeds $2.99.


In the fourth quarter of 2012
 the holders of the 2012 Notes converted the principal balance of their notes outstanding and accrued interest of $12
056 into 212
056 shares of our Common Stock.&#160;&#160;After this conversion
 no other convertible notes remained outstanding.




















On January 23
 2013
 we entered into an agreement with Maxim
 pursuant to which Maxim agreed to act as the Company&#8217;s lead or managing placement agent in connection with a potential offering of common equity of the Company up to $20 million.&#160;&#160;This agreement expired on May 30
 2013.


On June 24
 2013
 an amendment to the above agreement was executed by the Company and Maxim
 whereas
 in exchange for Maxim&#8217;s services
 we agreed to pay Maxim a cash placement fee equal to 6.6% of the gross proceeds of any such offering
 as well as to reimburse its expenses in the offering up to $100
000.&#160;&#160;In addition
 we agreed to issue to Maxim warrants exercisable for a number of shares of common stock equal to 5% of the aggregate number of shares sold in any offering specified in the agreement (excluding any shares of common stock issuable upon exercise of any warrants included in such offering).&#160;&#160;At the closing of the public offering on November 18
 2013 the Company and Maxim agreed to compensation for Maxim of the 6.6% placement fee and a 2% (of gross proceeds) expense allowance adjusted for certain expenses incurred.&#160;&#160;The total fees paid to Maxim as a result of the public offering were $95
900.


On October 21
 2013
 the Company issued warrants to purchase up to 30
000 shares of common stock in a private placement transaction to a business consultant who will be assisting the Company in various product placement matters.&#160;&#160;The per share exercise prices of those warrants will be determined based on the market price of the Common Stock if and when certain sales targets are met; the warrants are exercisable through October 21
 2018.&#160;&#160;In addition
 on October 28
 2013
 the Company issued 220
000 shares of restricted stock in a private placement transaction to a business-consulting firm that will be assisting the Company in evaluating various business and financial matters.&#160;&#160;Then again on December 3
 2013
 the Company issued another 550
000 shares of restricted stock to the same business consultant as compensation for assisting the Company in evaluating various business and financial matte

On February 17
 2012
 we entered into an Investment Banking Agreement (&#8220;Investment Banking Agreement&#8221;) with Legend Securities
 Inc. (&#8220;Legend&#8221;)
 pursuant to which Legend agreed to provide business advisory services to us for a period of up to eighteen months with our ability to further extend the term of the Investment Banking Agreement for an additional six months.

In exchange for Legend&#8217;s services
 we agreed to pay Legend the sum of $10
000 per month and to issue Legend a warrant for the purchase of 550
000 shares of the Company&#8217;s Common Stock (the &#8220;Legend Warrants&#8221;) at an exercise price of $0.71 per share.&#160;&#160;The Legend Warrants vest as follows: 91
666 of the Legend Warrants vest on the date of the agreement and then 91
666 of the Legend Warrants vest each ninety (90) day period thereafter.&#160;&#160;The Legend Warrants have a term of five years.&#160;&#160;The Legend Warrants contain a cashless exercise provision and certain &#8220;piggy-back&#8221; registration rights
 pursuant to which the Company is obligated to register the shares underlying the Legend Warrants under the Securities Act of 1933 (the &#8220;Securities Act&#8221;)
 in any future registration statement that is filed by the Company with the U.S. Securities and Exchange Commission.


In July 2012
 we entered into a private placement of securities and advisory services agreement with Maxim Group LLC (&#8220;Maxim&#8221;)
 pursuant to which Maxim agreed to act as the Company&#8217;s exclusive placement agent in a proposed private placement of equity
 convertible
 debt and/or linked securities (the &#8220;Securities&#8221;) of the Company up to $10 million.&#160;&#160;In connection with that agreement
 we paid Maxim $10
000 per month and issued 150
000 shares of Common Stock to Maxim.&#160;&#160;The July 2012 agreement with Maxim expired on December 31
 2012.




During the first nine months of 2012
 we entered into various private placement subscription agreements with Brightline Ventures I-B
 pursuant to which we sold an aggregate of 1
985
488 shares of Common Stock
 for a price of $1.50 per share
 and received aggregate gross proceeds of $2
978
172.


During the fourth quarter of 2012
 we entered into private placement subscription agreements with several accredited investors
 pursuant to which we sold an aggregate of 360
780 shares of Common Stock
 for a price of $2.25 per share
 and received aggregate gross proceeds of $811
756.




On October 1
 2013
 the Office of Fraud Detection and Market Intelligence of the Financial Industry Regulatory Authority (&#8220;FINRA&#8221;) informed the Company that it had concluded its review of the trading activity in the Company&#8217;s common stock surrounding the Company&#8217;s January 22
 2013 announcement of the joint development agreement with Newpark Drilling Fluids LLC to develop new
 environmentally-friendly drilling fluids that incorporate Z Trim's proprietary industrial materials
 and referred their findings to the SEC.&#160;&#160;The SEC has not contacted the Company with respect to this matter.




















Revenue for the year ended December 31
 2013 was $1
429
419
 as compared to revenue of $1
274
649 for the year ended December 31
 2012
 an increase of 12.1%.&#160;&#160;Our revenue for both years was entirely attributable to product sales.&#160;&#160;The increase in sales was due to increased demand for our products.&#160;&#160;We are in the process of improving our production process so we can meet increasing demand for our products.&#160;&#160;In making changes to our production process
 we have worked with industry specialists to improve our separation technology
 as well as with scientists from the Aveka Group
 to assist in finding ways to improve our capacity and reduce our costs.&#160;&#160;We can provide no assurance that increased demand for our products will be sustained or that we will be successful in implementing changes to our production process to improve our capacity and reduce costs.


Our revenues
 by quarter
 for 2013
 were as follows:


&#160;&#160;&#160;$363
831
&#160;&#160;$382
126
&#160;$296
286
&#160;&#160;$387
176



Cost of revenues for products sold for the year ended December 31
 2013 and 2012 was $3
600
115 and $2
609
892
 respectively
 an increase of $990
223 or 37.9%.&#160;&#160;The increase in costs of revenues was primarily attributable to an increase in overhead costs and the recognition of an inventory valuation reserve of $742
168 for slow moving inventory within the industrial products division.&#160;&#160;The increase in overhead costs was a result of manufacturing finished product in our facility prior to the end of the third quarter 2013.&#160;&#160;Since this time
 all production has been moved to the ANP facility where we anticipate lower costs as a result of improvements in the production process and increasing production volume.&#160;&#160;We believe that this will enable us to allocate our fixed costs over a greater number of finished goods and help reduce the costs of revenues in the future to improve margins.&#160;&#160;As we ramp-up production pursuant to the CPA with ANP
 we expect that this will result in greater efficiencies in our production process and also result in improved margins.&#160;&#160;However
 there can be no assurance that greater efficiencies or improved margins can be achieved.



Gross loss for the year ended December 31
 2013 was $2
170
696
 or approximately 152% of revenues
 as compared to a gross loss of $1
335
243
 or approximately 105% of revenues for the year ended December 31
 2012.&#160;&#160;Gross loss reflects a number of factors that can vary from period to period
 including those described above.




Total operating expenses for the year ended December 31
 2013 increased by $1
772
353
 or 37.7%
 to $6
480
031 from $4
707
678 for the year ended December 31
 2012. The increase in operating expenses was primarily due to increases in stock-based compensation expense of $770
529 (non-cash)
 stock promotion of $569
800 relating to the value of the restricted stock issued to a business consulting firm during the fourth quarter (non-cash)
 and legal fees expense of $365
588 due to work related to capital raising activities.

The significant components of selling
 general and administrative expenses in the years indicated were as follows:







Year Ended December 31
















&#160;$2
318
355



&#160;$1
547
826






&#160;1
259
796



&#160;1
138
297






&#160;663
108



&#160;282
064






&#160;3
947



&#160;23
978






&#160;1
084



&#160;16
047






&#160;208
153



&#160;355
173









&#160;$4
454
443



&#160;$3
363
385





The increase in stock-based compensation expenses was the result of an increase in market price for our stock on the dates issued.&#160;&#160;In 2013
 professional fees increased as a result of capital raising activities offset by a decrease in investor relations expense due to less stock-based compensation given to our investor relations consultants




Operating loss for the year ended December 31
 2013 increased to $8
650
727 compared to $6
042
921 for the year ended December 31
 2012 due to the reasons described above.


















Other expense was $4
781
534 for the year ended December 31
 2013 as compared to $3
540
835 for the year ended December 31
 2012.&#160;&#160;The increased expense for 2013 was primarily due to the recognition of $5
780
457 of expense relating to the modification of warrants in connection with the warrant exercise program discussed above offset by a gain on derviative of $966
736 in the derivative liability as a result of the decrease in the valuation of our derivative securities during the year and the recognition in 2012 of aggregate settlement losses of $2
005
218 with a former provider of investment services and a former employee.




As a result of the foregoing
 the Company incurred a net loss of $13
432
261 for the year ended December 31
 2013
 or $0.41 per share
 compared to $9
583
756 for the year ended December 31
 2012
 or $0.53 per share.

After inclusion of charges for preferred dividends payable
 the Company incurred a net loss attributable to common stockholders of $13
488
405 for the year ended December 31
 2013
 or $0.41 per share.&#160;&#160;For the year ended December 31
 2012
 after inclusion of charges for preferred dividends payable and accretion of discount on preferred stock
 the Company incurred a net loss attributable to common stockholders of $13
852
208
 or $0.76 per share.

The decrease in the basic and diluted net loss per share for the year ended December 31
 2013
 as compared to the year ended December 31
 2012 was due to the effect of the results described above as well as the offset of additional shares outstanding in 2013 due to the conversion of preferred stock
 warrants and options into shares of common stock and the sales of common stock.




As of December 31
 2013
 we had a cash balance of $443
472
 a decrease from a balance of $644
804 at December 31
 2012.&#160;&#160;At December 31
 2013
 we had working capital of $805
195
 an improvement from the working capital deficit of $7
013
791 as of December 31
 2012.&#160;&#160;The difference in working capital was primarily because of an increase in inventory and a decrease in the derivative liability resulting from the conversion of derivative securities into common stock during fiscal 2013.&#160;&#160;As of April 4
 2014
 we had a cash balance of $80
275.


On March 24
 2014
 Fordham Capital Partners
 LLC (&#8220;Fordham&#8221;) extended a $500
000 revolving loan (the &#8220;Equipment Loan&#8221;) to Z Trim Holdings
 Inc. (the &#8220;Company&#8221;) evidenced by an Equipment Revolving Note (the &#8220;Note&#8221;) issued by the Company to Fordham.&#160; The Note requires monthly payments of principal of $10
416.66 plus interest
 commencing on April 24
 2014 and continuing until February 24
 2015
 followed by a final balloon payment of the entire unpaid principal balance of the Note and all accrued and unpaid interest on March 24
 2015.&#160; The interest on the Note is calculated at a fixed rate of 20% per annum.&#160; If the Note may be prepaid in full at any time; provided that if the Company prepays the Note prior to September 24
 2014 (such six-month period
 the &#8220;Guaranteed Interest Period&#8221;)
 it must pay a prepayment penalty equal to the amount by which (i) the aggregate interest that Fordham would have received on the Note during the Guaranteed Interest Period had there been no prepayment exceeds (ii) the aggregate interest paid by the Company prior to the date of prepayment.


Pursuant to the Security Agreement
 dated March 24
 2014
 between the Company and Fordham (the &#8220;Security Agreement&#8221;)
 the Equipment Loan is secured by all of the Company&#8217;s equipment (as more specifically defined in the Security Agreement
 the &#8220;Collateral&#8221;).&#160; The Security Agreement also contains customary restrictive covenants
 including without limitation
 covenants prohibiting the Company from (i) granting additional liens in the Collateral
 (ii) selling
 leasing or transferring the Collateral
 (iii) entering into certain merger
 consolidation or other reorganization transactions
 and (iv) creating
 incurring or assuming additional indebtedness
 in each case subject to certain exceptions.&#160; The Security Agreement also contains customary events of default.&#160; If an event of default under the Security Agreement occurs and is continuing
 Fordham may declare any outstanding obligations under the Credit Agreement immediately due and payable.&#160; After an event of default
 interest on the Note would accrue at a&#160;rate of 25% per annum.


Additionally
 pursuant to the Factoring Agreement
 dated March 24
 2014
 between the Company and Fordham
 Fordham may purchase any Accounts of the Company (the &#8220;Factoring Agreement&#8221;).&#160; To secure payment and performance of the Company&#8217;s liabilities and obligations to Fordham
 including obligations under the Factoring Agreement
 the Company granted Fordham a security interest in all of the Company&#8217;s (i) Accounts
 (ii) Inventory
 (iii) Chattel Paper
 Deposit Accounts
 Documents
 Equipment
 Financial Assets
 Fixtures
 General Intangibles
 Instruments
 Investment Property
 Letter-of-Credit Rights
 Securities
 Software and Supporting Obligations
 (iv) books and records of Seller which relate to Accounts
 (v) all amounts owing to the Company under the Factoring Agreement
 and (vi) Proceeds of the foregoing.&#160; The Factoring Agreement terminates at any time that the Equipment Loan is paid in full.


 the Company&#8217;s operations have been funded primarily through the sale of both equity and debt securities.&#160;&#160;During 2013
 the Company raised a total of $2
172
165 in net proceeds from the sale of common stock
 $77
734 from the exercise of stock options
 and $2
489
846 from the exercise of warrants.&#160;&#160;In 2012
 the Company raised a total of $3
789
928 in proceeds from the sale of common stock
 $9
526 from the exercise of stock options
 $304
225 from the exercise of warrants and $200
000 from the sale and issuance of convertible notes.&#160;&#160;In addition
 the Company is exploring additional equity and debt funding however
 there can be no assurance that the Company will be successful in raising all of the additional funding that it is seeking or that such amount will be sufficient for its needs.

To successfully grow our business
 our management believes it must improve our cash position through greater and sustainable sales of our product lines and increase the productivity and efficiency of the production process. However
 such an increase would depend on sustained or increased levels of purchases by existing and new customers and actual realization of our customers&#8217; current demand levels
 as well as the completion of changes in our production process
 all of which cannot be assured.

Under the terms of the CPA with ANP
 the Company agreed to make available to ANP a $500
000 line of credit (which includes $10
000 that the Company loaned ANP to assist ANP with the purchase of its Waukon
 Iowa facility) at an interest rate of 5.5%.&#160;&#160;The line of credit was only permitted to be used by ANP for operating costs
 which excludes capital expenditures of equipment in excess of $5
000.&#160;&#160;The loan is to be paid back to the Company in the form of discounts on production pricing commencing either two years after the first draw by ANP on the line of credit (other than the $10
000 the Company loaned ANP to assist it with the purchase of its Waukon
 Iowa facility) or the first month after the Company has ordered 80
000 pounds of product for three consecutive months
 whichever shall occur first.&#160;&#160;All of ANP&#8217;s obligations under the line of credit
 as well as the CPA
 are specifically guaranteed by its parent company
 Aveka Inc.&#160;&#160;As of December 31
 2013
 all $500
000 to ANP under the line of credit is outstanding.&#160;&#160;This extension of credit to ANP had a material adverse impact on the Company&#8217;s cash resources
 which has required the Company to seek additional capital resources to fund its operations.&#160;&#160;ANP
 in April of 2014
 has begun repaying the line of credit at a rate of $5
000 per month.

Certain of the Company&#8217;s warrants and its Convertible 8% Senior Secured Notes issued in 2008
 2009 and 2010 have reset provisions to the exercise price and conversion price if the Company issues equity or other derivatives at a price less than the exercise price set forth in such warrants and notes. This ratchet provision results in a derivative liability in our financial statements.&#160;&#160;Our derivative liabilities decreased to $95
049 at December 31
 2013 from $8
025
381 at December 31
 2012. The change in derivative fair value during the year ended December 31
 2013 resulted in other income of $2
480
892.&#160;&#160;Fair values for exchange traded securities and derivatives are based on quoted market prices. Where market prices are not readily available
 fair values are determined using market based pricing models incorporating readily observable market data and requiring judgment and estimates.
















The following discussion focuses on information in more detail on the main elements of the $201
332 net decrease in cash during the year ended December 31
 2013 included in the accompanying Statements of Cash Flow. The table below sets forth a summary of the significant sources and uses of cash for the years ended December 31:


















&#160;$(4
941
827)



&#160;$(4
081
948)










&#160;110
000






&#160;4
739
745



&#160;4
303
679











&#160;$(201
332)



&#160;$331
731










Net cash used by operating activities increased by $859
879
 or 21%
 to $4
941
827 for the year ended December 31
 2013
 as compared to $4
081
948 for the year ended December 31
 2012.&#160;&#160;&#160;&#160;This increase was attributable to the increase of $3
848
505 in the net loss for the year and an increase in the change in the derivative liability of $2
480
892 offset by an increase in stock-based compensation of $770
529 and the recognition of the loss on equity modification of $5
780
457.

Net cash provided by investing activities was $750 for the year ended December 31
 2013 as compared to $110
000 for the year ended December 31
 2012. During both 2013 and 2012
 cash provided by investing activities was a result of proceeds received from the sales of equipment.

Net cash provided by financing activities was $4
739
745 for the year ended December 31
 2013
 as compared to $4
303
679 for the year ended December 31
 2012.&#160;&#160;Net cash provided by financing activities for the year ended December 31
 2013 included $2
172
165 from the sale of common stock
 $77
734 from the exercise of stock options and $2
489
846 from the exercise of warrants. Net cash provided by financing activities for the year ended December 31
 2012 included proceeds of $3
789
928 from the sale of common stock
 $304
225 in proceeds from the exercise of warrants and $200
000 in proceeds from the sale of convertible notes.



AVEKA Nutra Processing

 under the terms of the CPA with ANP
 the Company agreed to make available to ANP a $500
000 line of credit (which includes $10
000 that the Company loaned ANP to assist ANP with the purchase of its Waukon
 Iowa facility) at an interest rate of 5.5%.&#160;&#160;As of December 31
 2013
 all $500
000 to ANP under the line of credit is outstanding.&#160;&#160;ANP
 in April of 2014
 has begun repaying the line of credit at a rate of $5
000 per month.

.&#160;&#160;As of December 31
 2013
 no shares of Series I and Series II Preferred Stock and no convertible notes remained outstanding.&#160;&#160;See &#8220;Recent Developments Affecting the Company &#8211; Funding Initiatives&#8221; above.


On March 24
 2014
 Fordham Capital Partners
 LLC (&#8220;Fordham&#8221;) extended a $500
000 revolving loan (the &#8220;Equipment Loan&#8221;) to Z Trim Holdings
 Inc. (the &#8220;Company&#8221;) evidenced by an Equipment Revolving Note (the &#8220;Note&#8221;) issued by the Company to Fordham.&#160; The Note requires monthly payments of principal of $10
416.66 plus interest
 commencing on April 24
 2014 and continuing until February 24
 2015
 followed by a final balloon payment of the entire unpaid principal balance of the Note and all accrued and unpaid interest on March 24
 2015.&#160; The interest on the Note is calculated at a fixed rate of 20% per annum.&#160; If the Note may be prepaid in full at any time; provided that if the Company prepays the Note prior to September 24
 2014 (such six-month period
 the &#8220;Guaranteed Interest Period&#8221;)
 it must pay a prepayment penalty equal to the amount by which (i) the aggregate interest that Fordham would have received on the Note during the Guaranteed Interest Period had there been no prepayment exceeds (ii) the aggregate interest paid by the Company prior to the date of prepayment.


&#160;&#160;At December 31
 2013
 the Company had no material commitments for capital expenditures.

&#160;&#160;The Company leases a combined production and office facility located in Mundelein
 Illinois.&#160;&#160;The lease was renewed in the first quarter of 2012 and expires in May 2014; monthly rental payments are $21
361
 inclusive of property taxes.&#160;&#160;On March 14
 2014 the Company entered into an amendment to the original lease agreement for office space located in Mundelein
 Illinois.&#160;&#160;The amendment extended the term of the lease to May 14
 2015 upon the same terms and conditions contained in the lease as amended.

.&#160;&#160;In July 2007
 Judicial Circuit Court
 St. Clair County
 Illinois by Joseph Sanfilippo and James Cluck for violation of the Consumer Fraud Act and is seeking damages in excess of $200
000.&#160;&#160;The trial court has issued a default order against the Company
 and has denied the Company&#8217;s motion to reconsider.&#160;&#160;Management believes that the trial court&#8217;s rulings were erroneous and that it has grounds for appeal
 and that the underlying allegations are frivolous and wholly without merit and the Company will vigorously defend the claim. The outcome of this matter is unknown as of the report date.&#160;&#160;However
 the Company has conservatively allocated a reserve of $102
000 to satisfy any liability it may incur as a result of this proceeding.

In December 2011
 the Company was sued in Circuit Court of the 17th Judicial District
 Winnebago County
 Illinois
 by LIBCO Industries
 Inc.
 alleging the Company breached a construction contract and tortuously interfered with a business relationship
 and is seeking damages in excess of $185
000.&#160;&#160;The case has subsequently been transferred to the 19th Judicial Circuit Court
 Lake County
 Illinois.&#160;&#160;Management believes that the allegations are frivolous and wholly without merit and will vigorously defend the claim.&#160;&#160;Related to this matter
 Process Piping
 LLC
 a sub-contractor for LIBCO Industries
 filed a mechanics lien on the property leased by the Company
 claiming it was owed in excess of $95
000 by LIBCO Industries.&#160;&#160;On March 6
 2012
 the Company paid $62
500 to Process Piping
 LLC in exchange for a release of its lien as well as an assignment of all of its claims against LIBCO Industries.&#160;&#160;On January 31
 2013
 the Circuit Court granted the Company&#8217;s motion for partial summary judgment on the tortious interference claim.&#160;&#160;In the fourth quarter of 2013
 the parties settled all outstanding matters and the case has subsequently been dismissed. As part of the settlement
 the Company received $10
000 in cash and both parties provided releases of all respective claims.


Although there can be no assurances
 based on the information currently available
 management believes that it is probable that the ultimate outcome of each of these actions will not have a material adverse effect on the consolidated financial statements of the Company.&#160;&#160;However
 an adverse outcome in either of these actions could have a material adverse effect on the financial results of the Company in the period in which it is recorded.



















As of December 31
 2013
 we had no off-balance sheet arrangements.




As of the date of our most recent audit
 which included the fiscal year ended December 31
 2013
 we had not generated sufficient revenues to meet our cash flow needs.&#160;&#160;As a result
 our auditors have expressed substantial doubt about our ability to continue as a going concern.&#160;&#160;Although we have generated revenue
 we are still operating at a net loss
 and may continue to incur losses for a period of time.&#160;&#160;We cannot assure you that we will be able to obtain sufficient funds from our operating or financing activities to support our continued operations.&#160;&#160;If we cannot continue as a going concern
 we may need to substantially revise our business plan or cease operations
 which may reduce or negate the value of your investment.




The Financial Statements and related notes contain information that is pertinent to management&#8217;s discussion and analysis. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities
 the disclosure of contingent assets and liabilities at the date of the financial statements
 and the reported amounts of revenues and expenses during the reporting period. These estimates are generally based on historical experience
 current conditions and on various other assumptions that are believed to be reasonable under the circumstances
 the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily available from other sources
 as well as identifying and assessing our accounting treatment with respect to commitments and contingencies. Actual results could differ from those estimates.



The Company considers the following policies and estimates to be the most critical in understanding the judgments that are involved in the preparation of the company&#8217;s financial statements and the uncertainties that could impact the company&#8217;s financial position
 results of operations and cash flows.

 - The Company generally recognizes product revenue when persuasive evidence of an arrangement exists
 delivery has occurred
 the fee is fixed or determinable
 and collectability is probable. In instances where the final acceptance of the product is specified by the customer
 revenue is deferred until all acceptance criteria have been met. No provisions were established for estimated product returns and allowances based on the Company&#8217;s historical experience.

 -&#160;&#160;All derivatives have been recorded on the balance sheet at fair value based on the lattice model calculation. These derivatives
 including embedded derivatives in the Company&#8217;s warrants
 convertible preferred stock
 and its Convertible 8% Senior Secured Notes issued in 2008
 2009
 and 2010
 which have reset provisions to the exercise price and conversion price if the Company issues equity or other notes at a price less than the exercise price set forth in such warrants and notes
 are separately valued and accounted for on the Company&#8217;s balance sheet. Fair values for exchange traded securities and derivatives are based on quoted market prices. Where market prices are not readily available
 fair values are determined using market based pricing models incorporating readily observable market data and requiring judgment and estimates.

 - The Company&#8217;s financial instruments consist of cash and cash equivalents
 accounts receivable
 inventory
 accounts payable
 accrued liabilities and long-term debt. The estimated fair value of cash
 accounts receivable
 accounts payable and accrued liabilities approximate their carrying amounts due to the short-term nature of these instruments. The carrying value of long-term debt also approximates fair value since their terms are similar to those in the lending market for comparable loans with comparable risks. None of these instruments are held for trading purposes.

The Company utilizes various types of financing to fund its business needs
 including convertible debt with warrants attached. The Company reviews its warrants and conversion features of securities issued as to whether they are freestanding or contain an embedded derivative and
 if so
 whether they are classified as a liability at each reporting period until the amount is settled and reclassified into equity with changes in fair value recognized in current earnings.







&#160;Level three &#8212; Unobservable inputs developed using estimates and assumptions
 which are developed by the reporting entity and reflect those assumptions that a market participant would use.

Determining which category an asset or liability falls within the hierarchy requires significant judgment. The Company evaluates its hierarchy disclosures each quarter. The Company&#8217;s only asset or liability measured at fair value on a recurring basis is its derivative liability associated with the units consisting of convertible debt and warrants to purchase common stock (discussed above). The Company classifies the fair value of these warrants under level three. The fair value of the derivative liability at December 31
 2013 and 2012 was $95
049 and $8
025
381
 respectively
 and the gain due to valuation for the twelve months ended December 31
 2013 was $966
736 as compared to an expense of $1
514
156 at December 31
 2012.

 - The Company estimates the fair value of share-based payment awards made to employees and directors
 including stock options
 restricted stock and employee stock purchases related to employee stock purchase plans
 on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense ratably over the requisite service periods.&#160;&#160;We estimate the fair value of each share-based award using the Black-Scholes option pricing model. The Black-Scholes model is highly complex and dependent on key estimates by management. The estimates with the greatest degree of subjective judgment are the estimated lives of the stock-based awards and the estimated volatility of our stock price. The Company recognized pre-tax compensation expense related to stock options of $2
318
355 and $1
547
826 for the year ended December 31
 2013 and 2012
 respectively.



























See the F-Pages contained herein
 which include our audited financial statements and are incorporated by reference in this Item 8.










We carried out an evaluation
 under the supervision and with the participation of our management
 including our principal executive officer and principal financial officer
 in Exchange Act Rules 13a &#8211; 15(e) and 15d &#8211; 15(e)).&#160;&#160;Based upon that evaluation
 our chief executive officer and chief financial officer concluded that
 as of the end of the period ended December 31
 2013
 our disclosure controls and procedures were not effective (1) to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded
 processed
 summarized and reported
 within the time periods specified in the SEC&#8217;s rules and forms and (2) to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to us
 including our chief executive and chief financial officers
 as appropriate to allow timely decisions regarding required disclosure. Our conclusion is based primarily on the material weakness in internal control over financial reporting which was disclosed in our Annual Report on Form 10-K for the year ended December 31
 2012 and our failure to complete the process of remediating these weaknesses by the end of the period covered by this Annual Report.



Our Principal Executive Officer and Principal Financial Officer do not expect that our disclosure controls or internal controls will prevent all error and all fraud. Although our disclosure controls and procedures were designed to provide reasonable assurance of achieving their objectives
 a control system
 no matter how well conceived and operated
 can provide only reasonable


 the design of a control system must reflect the fact that there are resource constraints
 and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems
 no evaluation of controls can provide absolute assurance that all control issues and instances of fraud
 if any
 within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty
 and that breakdowns can occur because of a simple error or mistake. Additionally
 controls can be circumvented if there exists in an individual a desire to do so. There can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Furthermore
 smaller reporting companies face additional limitations. Smaller reporting companies employ fewer individuals and find it difficult to properly segregate duties. Often
 one or two individuals control every aspect of the Company's operation and are in a position to override any system of internal control. Additionally
 smaller reporting companies tend to utilize general accounting software packages that lack a rigorous set of software controls.



as a process designed by
 or under the supervision of
 our Chief Executive Officer and Chief Financial Officer
 and effected by our board of directors
 management and other personnel
 to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles in the United States and includes those policies and procedures that:



- Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles
 and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and

- Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition
 use or disposition of our assets that could have a material effect on the financial statements.
















erial weakness is a deficiency
 or a combination of deficiencies
 in internal control over financial reporting
 such that there is a reasonable possibility that a material misstatement of the company&#8217;s annual or interim financial statements will not be prevented or detected on a timely basis. Our management assessed the effectiveness of our internal control over financial reporting as of December 31
 2013. In making this assessment
 our management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control-Integrated Framework.&#160;&#160;Based on this assessment
 Management has identified the following three material weaknesses that have caused management to conclude that
 as of December 31
 2013
 our disclosure controls and procedures
 and our internal control over financial reporting
 were not effective at the reasonable assurance level:









As of December 31
 2013
 we did not maintain effective controls over the control environment.&#160;&#160;Specifically we have not developed and effectively communicated to our employees our accounting policies and procedures.&#160;&#160;This has resulted in inconsistent practices.&#160;&#160;&#160;Since these entity level programs have a pervasive effect across the organization
 management has determined that these circumstances constitute a material weakness.













As of December 31
 2013
 we did not maintain effective controls over financial statement disclosure. Specifically
 controls were not designed and in place to ensure that all disclosures required were originally addressed in our financial statements.&#160;&#160;&#160;Accordingly
 management has determined that this control deficiency constitutes a material weakness.













As of December 31
 2013
 we did not maintain effective controls over financial reporting. Specifically controls were not designed and in place to ensure that the financial impact of certain complex equity and derivative liability transactions were appropriately and correctly reported. The transactions were identified by the auditors and calculated and reported correctly as of December 31
 2013.








There have been no changes in the Company&#8217;s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the Company&#8217;s most recent fiscal quarter that have materially affected
 or are reasonably likely to materially affect
 the Company&#8217;s internal control over financial reporting.
































ITEM 10.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Directors
 Executive Officers and Corporate Governance.



The following information sets forth the names of our current directors
 their ages
 period of service and description of their business experience:










Principal Occupation





Steven J. Cohen
 57




Mr. Cohen
 the Company's President
 has been employed by Z Trim since 2002 when he was hired as its director of investor relations.&#160;&#160;He was promoted to Vice President of Corporate Development in 2003 and to President in 2006 when he also began serving on the Board of Directors.&#160;&#160;In 2007
 Mr. Cohen assumed the role of Chief Executive Officer.&#160;&#160;Prior to joining Z Trim
 Mr. Cohen had 25 years' experience at the Chicago Mercantile Exchange where he worked in various brokerage house positions as well as a trader. Mr. Cohen attended college at the University of Illinois and Oakton Community College.&#160;&#160;Mr. Cohen was a member of the U.S. Olympic Team at the 1988 Olympics in Seoul and was a coach for the U.S. Olympic Team at the 2000 Olympics in Sydney Australia. Mr. Cohen&#8217;s&#160;&#160;understanding of the Company&#8217;s products and market has proven to be valuable to the Board in understanding that market and in evaluating and approving the Company&#8217;s strategic initiatives in that market. Mr. Cohen&#8217;s insights have been valuable in identifying and evaluating economic and market challenges faced by the Company
 which has been of particular benefit to the Board when reviewing and evaluating marketing and strategic initiatives.




Morris Garfinkle
 65




presently serves as Chairman of the Audit Committee.&#160;&#160;Mr. Garfinkle is the Founder
 President and CEO of GCW Consulting
 a consulting firm based out of Arlington
 Virginia
 and has operated as such since 2001.&#160;&#160;He received his Juris Doctor from Georgetown University and his B.S. in Economics (Cum Laude) from the Wharton School of Finance &amp; Commerce
 University of Pennsylvania.&#160;&#160;Mr. Garfinkle has over 35 years of experience in restructuring
 mergers and acquisitions
 investment assessment
 competitive positioning
 strategic planning and capital raising.&#160;&#160;His clients have included United Airlines Creditors' Committee
 Pension Benefit Guaranty Corporation
 Air China and Dallas-Fort Worth International Airport
 among many others.&#160;&#160;He also served on the Board of Directors of HMSHost from 2000 - 2006. The Company believes that Mr. Garfinkle&#8217; s financial
 business and legal expertise
 combined with his experience as an executive and director of other companies
 as well as his years of experience providing strategic advisory services
 qualifies him to serve as a member of the Board and an effective member of Audit Committee
 of which he is the Chairman.







































Principal Occupation





Brian S. Israel
 55




presently serves as Chairman of the Compensation and Nominating Committees.&#160;&#160;Mr. Israel spent more than 20 years in the real estate finance industry
 during which he managed teams responsible for production; operations; risk management; product development; and technology. In his most recent position
 he served from 1989 to 2004 as Vice President and Division Administrator for the Residential Mortgage Division of Harris Trust and Savings Bank.&#160;&#160;He is a former Member of the Federal National Mortgage Association's Regional Lender and Affordable Housing Advisory Boards
 and in 2000
 served as the 80th President of the Illinois Mortgage Banker's Association.

Since retiring from the corporate world in 2004
 he has dedicated much of his time and energy to consulting and community service.

- November 2012-present:&#160;&#160;President &#8211; Illinois Jump$tart Coalition for Personal Financial Literacy
 a non-profit organization working to enhance the financial capabilities of young people; Board Member from June 2011-present.
- May 2010-present: Advisory Board Member &#8211; StepOut USA
 a non-profit organization creating social
 cultural
 recreational and educational connections for adults with learning disabilities.
- April 2009-present: Partner &#8211; Money Smart Week
 a Midwest financial literacy education program coordinated by the 7
- May 2007-present: External Director and Compensation and Nominating Committee Chair &#8211; Z Trim Holdings
 Inc.
- January 2006-present: Principal &#8211; Future State Consulting
 a sole proprietorship providing strategic planning
 training and project management services to businesses and non-profit organizations.
- January 2005-present: Executive Committee Member &#8211; River North Residents&#8217; Association
 a non-profit community advocacy organization representing nearly 10
000 residents.
- June 2004-present: Partner &#8211; North Shore Custom Homes
 Ltd.
 a residential real estate development firm.
Since 2008
 Mr. Israel has also been a Member of the Ely Chapter of Lambda Alpha International
 an honorary society working to advance the study and practice of land economics. His experience in finance and human resource management
 especially as it relates to operational and structural issues
 has added substantial value to the deliberations of the Board.&#160;&#160;Mr. Israel&#8217;s experience in finance and management
 especially as it relates to operational and structural issues
 has added substantial value to the deliberations of the Board.





































Principal Occupation





Mark Hershhorn
 63




Mr. Hershhorn has a background in the marketing and operations of nutrition systems
 food industry marketing and transactional television. From 1998 to present
 he has served as President and co-owner of CKS &amp; Associates Management LLC; President and CEO of CKS &amp; Associates; CEO of Midwest Real Estate Investment LLC; General Partner of New Horizons West LLP
 and CEO of New Horizons Real Estate Holdings LLC.&#160;&#160;During much of the 1990&#8217;s
 Mark served as President
 CEO and director of National Media Corporation (NYSE-NMC) and as Chairman of the company&#8217;s international subsidiary
 Quantum International Ltd.&#160;&#160;Prior to that
 Mark served as Senior Vice President of food operations and joint ventures for Nutri/System
 Inc.&#160;&#160;During the 1980&#8217;s
 Mark was Chief Financial Officer
 Treasurer
 Vice President and director of the Franklin Mint.&#160;&#160;Mark has also held positions with companies such as Price-Waterhouse
 Pfizer Diagnostics
 and Wallace and Wampole Laboratories.&#160;&#160;Mark received his BS Degree in Economics from Rutgers University and an MBA from the Wharton School of Finance
 University of Pennsylvania. We believe that Mr. Hershhorn&#8217; s past experience as CEO of publicly traded companies
 as well as in the management of a food company
 brings valuable insight to the Board&#8217;s strategic planning.




Edward Smith III
 38




Mr. Smith is Managing Partner of Brightline Capital Management
 LLC (&#8220;BCM&#8221;)
 a New York-based investment firm founded in 2005. BCM is the investment manager of Brightline Ventures I
 LLC
 Brightline Ventures I-B
 LLC and Brightline Ventures I-C
 LLC (collectively
 &#8220;Brightline Ventures&#8221;) and Brightline Capital Partners
 LP. Prior to founding BCM
 Mr. Smith worked at Gracie Capital
 GTCR Golder Rauner and Credit Suisse First Boston.&#160;&#160;Mr. Smith holds a Bachelor of Arts in Social Studies from Harvard College and a Masters in Business Administration from Harvard Business School. He is currently a Director of Heat Biologics
 Inc. (Nasdaq:HTBX)
 a North Carolina based company focused on the development of novel therapeutics to prime the immune system against a variety of disorders. We believe that
 as a result of his past experience
 including managing an investment fund
 and his many contacts in the food industry
 Mr. Smith adds valuable managerial experience on the Board and an understanding of investor expectations
 both of which are important to the Board&#8217;s strategic planning and risk management responsibilities.






Other than with Edward Smith III
 there are/were no arrangements with any director or executive officer regarding their election or appointment.&#160;&#160;The Company agreed to nominate Mr. Smith as a director as part of Brightline Ventures I
 LLC&#8217;s investment in 2009.&#160;&#160;&#160;There are no family relationships between any director
 executive officer
 or person nominated or chosen by the Company to become a director or executive officer.


















The following information sets forth the names of our sole executive officer that is not serving as a director
 his age
 period of service and description of his business experience:










Principal Occupation





Brian Chaiken
 43





Mr. Chaiken was hired by the Company to serve as General Counsel and Vice President of Business Development in 2006.&#160;&#160;In 2008
 Mr. Chaiken was appointed to be the Company&#8217;s Chief Financial Officer.&#160;&#160;He received his Bachelor of Science in Accountancy from the University of Illinois
 from DePaul University
 and is a member of the Illinois and Florida Bars
 as well as those of the Northern District Court of Illinois
 United States Court of Appeals of the 11th Circuit and the Southern District Court of Florida.&#160;&#160;Prior to joining Z Trim
 Mr. Chaiken spent five years as the Executive Vice-President of Legal Affairs for Supra Telecommunications and Information Systems
 Inc.
 a Competitive Local Exchange Carrier (telecommunications provider) in South Florida.&#160;&#160;There
 Mr. Chaiken was a senior executive for a company with more than 300 employees in Florida
 Costa Rica and the Dominican Republic.&#160;&#160;He was instrumental in helping the company grow annual revenues from $10 million to approximately $150 million over an 18 month period.&#160;&#160;He successfully litigated and arbitrated multi-million dollar disputes involving trademark
 anti-trust
 fraud
 bankruptcy and complex commercial transactions.








Pursuant to Section 16(a) of the Exchange Act and the rules promulgated there under
 officers and directors of the company and persons who beneficially own more than 10% of our common shares are required to file with the SEC and furnish to the Company reports of ownership and change in ownership with respect to all equity securities of the company.&#160;&#160;Based solely on our review of the copies of such reports received by us during or with respect to the fiscal year ended December 31
 2013 and all prior years
 and written representations from such reporting persons
 we believe that those persons who were our officers
 directors and 10% shareholders during any portion of the fiscal year ended December 31
 2013
 complied with all Section 16(a) filing requirements applicable to such individuals.



We have adopted a Code of Ethics and Business Conduct (the &#8220;Code&#8221;).&#160;&#160;The Code applies to all directors
 officers
 and employees of the Company.&#160;&#160;Among other things
 the Code is intended to focus the board of directors and the individual directors on areas of ethical risk
 help directors recognize and deal with ethical issues
 provide mechanisms to report unethical conduct
 and foster a culture of honesty and accountability. The Code covers all areas of professional conduct relating to service on the Z Trim Board
 including conflicts of interest
 unfair or unethical use of corporate opportunities
 strict protection of confidential information
 compliance with all applicable laws and regulations and oversight of ethics and compliance by employees of the Company.

.&#160;&#160;We will disclose any future amendments to
 or waivers from
 provisions of these ethical policies and standards for Officers and Directors on our website within two business days following the date of such amendment or waiver.



















The Company&#8217;s Board of Directors established a Nominating Committee in 2008.&#160;&#160;The related provisions set forth in the Bylaws serve as the charter for the Nominating Committee.&#160;&#160;The Board Nominating Committee
 composed of two directors of the Company
 identifies candidates for director nominees through recommendations solicited from other directors
 the Company&#8217;s executive officers
 search firms or other advisors
 shareholders pursuant to the procedures set forth below
 and through such other methods as the independent directors deem to be helpful.&#160;&#160;Based upon an evaluation of the candidates by the Board Nominating Committee
 it recommends to the full Board candidates it has determined to be qualified for serving on the Board.&#160;&#160;Effective in 2008
 Brian Israel and Mark Hershhorn were appointed as members of the Nominating Committee
 with Brian Israel serving as chairman.&#160;&#160;During 2013
 the Nominating Committee held 1 meeting.

Our Bylaws provide that shareholders
 in submitting recommendations to the Nominating Committee for director candidates
 shall follow the following procedures:







The Company requires its directors to possess certain minimum qualifications
 including the following:

. Nominees should have demonstrated business acumen
 experience and ability to exercise sound judgments in matters that relate to the current and long-term objectives of the corporation and should be willing and able to contribute positively to the decision-making process of the corporation.

. Nominees must be free from any relationship that
 in the opinion of the Board
 would interfere with
 or have the appearance of interfering with
 the exercise of his or her independent judgment as a member of the Board
 including any conflicts of interest stemming from his or her institutional or other affiliations
 and candidates should be able to act in the interests of all shareholders.

. Nominees shall not have been convicted of any criminal offense or been subject to any adverse civil judgment in any jurisdiction involving financial crimes
 acts involving monies or breach of trust
 moral turpitude
 misfeasance or malfeasance
 or been convicted in any jurisdiction of a crime that is a felony
 or been deemed by the Board to have violated company policy







the diversity of viewpoints
 backgrounds
 or experiences of the Board as a whole; and


A director candidate recommended by our stockholders will be considered in the same manner as a nominee recommended by a Board member
 management or other sources.

While the Board does not have a separate formal diversity policy
 it is the Company&#8217;s and the Board&#8217;s policy to identify qualified potential candidates without regard to any candidate&#8217;s race
 color
 disability
 gender
 national origin
 religion or creed
 and the Company seeks to ensure the fair representation of shareholder interests on the Board through the criteria set forth above. The Company
 in selecting its directors
 considers the potential to contribute to the diversity of viewpoints
 backgrounds
 or experiences of the Board as a whole.&#160;&#160;The Board believes that the use of the Nominating Committee&#8217;s general criteria
 along with non-discriminatory policies
 will best result in a Board that shows diversity in many respects. The Board believes that it currently maintains that diversity





The Audit Committee met four times in fiscal 2013.&#160;&#160;The function of the Audit Committee is to assist the Board of Directors in preserving the integrity of the financial information published by the Company through the review of financial and accounting controls and policies
 financial reporting systems
 alternative accounting principles that could be applied and the quality and effectiveness of the independent public accountants.&#160;&#160;Among its other responsibilities
 the Committee also is responsible for the receipt
 retention and treatment of complaints received by the Company relating to accounting
 internal accounting controls or auditing matters and confidential
 anonymous submission by employees of concerns regarding questionable accounting or auditing matters.&#160;&#160;See also &#8220;Report of the Audit Committee.&#8221;
























Z Trim&#8217;s compensation philosophy has been
 and continues to be
 that compensation should drive long-term value creation for our stockholders. Total compensation for each employee should be based on individual and Company performance
 market practice
 and the value of the employee&#8217;s position at Z Trim. Our compensation programs should not encourage unnecessary or excessive risk taking.

Compensation to our named executive officers (&#8220;NEOs&#8221;) consists solely of cash compensation and the issuance of stock options pursuant to our Incentive Compensation Plan.&#160;&#160;We pay base salary in order to provide a predictable level of compensation that is competitive in the marketplace for the position responsibilities and individual skills
 knowledge
 and experience of each executive.&#160;&#160;We provide our NEOs with stock options that are generally available to all of our employees in order to further our goal of attracting and retaining senior executives of outstanding ability.&#160;&#160;The Company does not believe that its employee compensation policies are reasonably likely to have a material adverse effect on the Company.




The following table summarizes the compensation earned in the fiscal years ended December 31
 2013 and 2012 by our Chief Executive Officer and the most highly paid executive officers whose total salary and bonus awards exceeded $100
000 for the fiscal years ended December 31
 2013 and 2012 (collectively
 the &#8220;named executive officers&#8221;).
































150
000


301
155


451
155






150
000


129
410


279
410




Chief Financial Officer
 Chief Legal Officer and Secretary





136
000


237
021


373
021






136
000


119
455


255
455











The amounts in the table reflect the grant date fair value of options awards to the named executive officer in accordance with Accounting Standards Codification Topic 718.&#160;&#160;The ultimate values of the options awards to the executives generally will depend on the future market price of our common stock
 which cannot be forecasted with reasonable accuracy. The actual value
 if any
 which an optionee will realize upon exercise of an option
 will depend on the excess of the market value of the common stock over the exercise price on the date the option is exercised.&#160;&#160;See the &#8220;Outstanding Equity Awards at Fiscal Year-End&#8221; table below for information regarding all outstanding awards.

The amounts in this column reflect the dollar amount recognized as expense with respect to stock options for financial statement reporting purposes during the twelve months ended December 31
 2013 and 2012 in accordance with applicable accounting standards.&#160;&#160;In 2013
 Steven Cohen received 288
000 options at a strike price of $1.67 that have an option expiration date of January 4
 2018.&#160;&#160;In 2012
 Steven Cohen received 343
980 options at a strike price of $0.65 that have an option expiration date of January 25
 2017.&#160;&#160;In 2013
 Brian Chaiken received 226
667 options at a strike price of $1.67 that have an option expiration date of January 4
 2018.&#160;&#160;In 2012
 Brian Chaiken received 317
520 options at a strike price of $0.65 that have an option expiration date of January 25
 2017.



In 2006
 the Company entered into an employment agreement with Steven J. Cohen setting forth the terms of his employment as Z Trim&#8217;s President.&#160;&#160;Mr. Cohen&#8217;s employment under the employment agreement was for an initial term of three years and is now renewable on an annual basis for a one year term based on the mutual desire of the parties.&#160;&#160;Either Mr. Cohen or Z Trim can terminate the employment agreement without cause on thirty days written notice.&#160;&#160;If Mr. Cohen is terminated for any reason other than disability or death
 Z Trim is not required to make any further payments to Mr. Cohen other than with respect to obligations accrued on the date of termination.&#160;&#160;In the event that Mr. Cohen is terminated by reason of disability or death
 Z Trim is required to provide Mr. Cohen or his estate any benefits set forth in any of the Company&#8217;s benefit programs or plans on the date of termination.

Under Mr. Cohen&#8217;s employment agreement
 Z Trim is also protected from competition by Mr. Cohen after his employment with Z Trim would cease. Upon termination
 Mr. Cohen agrees to not interfere with the relationships between the suppliers
 customers or agents of Z Trim for six months
 and that he will not compete with Z Trim over the same period in any county of any state in which Z Trim is providing service at the time of termination.&#160;&#160;Further
 Mr. Cohen has agreed to related confidentiality requirements after the termination of his employment.

In 2007
 the Company entered into an employment agreement with Brian Chaiken setting forth the terms of his employment as Z Trim&#8217;s General Counsel and Vice President of Business Development.&#160;&#160;Mr. Chaiken&#8217; s employment under the employment agreement is at will.&#160;&#160;If Mr. Chaiken is terminated for cause
 Z Trim is not required to make any further payments to Mr. Chaiken other than with respect to obligations accrued on the date of termination.&#160;&#160;If Z Trim terminates Mr. Chaiken without cause
 Mr. Chaiken is entitled to receive a severance payment equal to his wages at the time he is terminated for a minimum of six months
 with an additional two months for each year of completed service on a pro-rata basis
 up to a maximum of two years.&#160;&#160;Under Mr. Chaiken&#8217; s employment agreement
 a termination for a &#8220;cause&#8221; would occur if&#160;&#160;Mr. Chaiken did any of the following: (i) committed or participated in an act of fraud
 gross neglect
 misrepresentation
 embezzlement or dishonesty against the Company; (ii) committed or participated in any other injurious act or omission wantonly
 willfully
against the Company
 monetarily or otherwise; (iii) engaged in a criminal enterprise involving moral turpitude; (iv) engaged in an act or acts constituting a felony under the laws of the United States or any state thereof or in any act or acts resulting in the loss of any state or federal license required for Mr. Chaiken to perform his material duties or responsibilities for the Company; or (v) Mr. Chaiken&#8217; s breach of any provision of the employment agreement.&#160;Mr. Chaiken would also be provided with COBRA expenses for family health insurance for 9 months following his separation from Z Trim.

&#160;Under Mr. Chaiken&#8217; s employment agreement
 Z Trim is also protected from competition by Mr. Chaiken after his employment with Z Trim would cease. Upon termination
 Mr. Chaiken agrees to not interfere with the relationships between the suppliers
 customers or agents of Z Trim for twelve months
 and that he will not compete with Z Trim over the same period in any target market in which it engages in or may engage in the future.



















December 31
 2013

The following table contains information regarding outstanding equity awards held at December 31
 2013
 by the named executive officers.







































288
000










343
980










245
700










315
000










210
000












226
667










317
520










245
700










315
000










210
000



















Employee directors do not receive any separate compensation for their activities on the board of directors.&#160;&#160;Non-employee directors receive 28
736 shares of common stock as an annual retainer as well as a maximum 35% tax gross up not to exceed $10
000 per board member.

Non-employee directors are reimbursed for travel expenses incurred in conjunction with their duties as directors. Furthermore
 the Company will provide the broadest form of indemnification under Illinois law under which liabilities may arise as a result of their role on the board of directors and payments for reimbursements for expenses incurred by a director in defending against claims in connection with their role
 and the director satisfies the statutory standard of care.



























10
000


50
000





60
000






10
000


50
000





60
000






10
000


50
000





60
000






10
000


50
000





60
000


























Each director received 28
736 shares of common stock on January 1
 2013.&#160;&#160;The amounts in the table reflect the grant date fair value of stock awards to the named directors in accordance with Accounting Standards Codification Topic 718
 which was $1.74 per share.&#160;&#160;The ultimate values of the stock awards to the directors generally will depend on the future market price of our common stock
 which cannot be forecasted with reasonable accuracy.






















The following table presents certain information as of April 4
 2014
 regarding the beneficial ownership of the Z Trim common stock held by each director or nominee for director
 each executive officer appearing in the &#8220;Summary Compensation Table&#8221; included in &#8220;Executive Compensation&#8221; and all directors and executive officers as a group.&#160;&#160;As of April 4
 2014
 the Company had 39
734
854 shares of common stock outstanding.
































1
631
483









&#160;&#160;599
426









&#160;&#160;328
045




















&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;303
692&#160;









1
512
887














&#160;&#160;&#160;&#160;5
194
410&#160;











The address for each stockholder listed in the table is c/o Z Trim Holdings
 Inc.
 1011 Campus Drive
 Mundelein
 Illinois 60060.




The specified persons have sole voting and sole dispositive powers as to all shares
 except as otherwise indicated.&#160;&#160;The amounts include the following shares as to which the person has the right to acquire subject to stock options or warrants within sixty days of April 4
 2014: Mr. Cohen (16
631
480)
&#160;&#160;Mr. Israel (13
500)
Mr. Smith (18
077) and Mr. Chaiken (1
512
887)
 and all current executive officers and directors as a group (3
175
944).




&#160;&#160;This figure excludes the 32
919
021 shares beneficially owned by Brightline Ventures I
 LLC
 which is described in the table below setting forth persons known to us to be owners of more than 5% of our common stock.&#160;&#160;Mr. Smith is the Managing Partner of Brightline Capital Management
 LLC
 an investment management firm that serves as the investment manager of Brightline Ventures I
 LLC
 Brightline Ventures I-B
 LLC and Brightline Ventures I-C
 LLC.


























The following table presents certain information as of April 4
 2014 regarding the beneficial ownership of the Z Trim common stock held by each known 5%-or-greater shareholder of Z Trim.





















Brightline Ventures I
 LLC and
Brightline Ventures I-B
 LLC and Brightline Ventures I-C
 LLC
1120 Avenue of the Americas
 Suite 1505
New York
 NY 10036



32
919
021


















&#160;&#160;Brightline Capital Management
 LLC (Brightline Capital)
 together with Brightline Ventures I
 LLC and Brightline Ventures I-B
 LLC and Brightline Ventures I-C
 LLC (collectively Brightline Ventures)
 Nick Khera and Edward B. Smith
 III filed a report on Schedule&#160;13D/A dated January 14
 2014
 reporting shared voting power as to 32
919
021 shares of common stock and shared dispositive power as to 32
919
021 shares.&#160;&#160;Messrs. Khera and Smith are the managing members of Brightline Capital
 an investment management firm that serves as the investment manager of Brightline Ventures.&#160;&#160;The amounts exclude Mr. Smith&#8217;s beneficial ownership of 303
692 shares set forth in the table above.























ITEM 13.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Certain Relationships and Related Transactions
 and Director Independence.



Director Edward Smith III is a Managing Member of Brightline Ventures I
 LLC and Brightline Ventures I-B
 LLC and Brightline Ventures I-C
 LLC (collectively
 &#8220;Brightline&#8221;)
 which is the beneficial owner of 61.1% of the Company&#8217;s voting securities
 as set forth in the Beneficial Ownership Table above.&#160;&#160;In fiscal 2012
 and subsequently
 we engaged in several transactions with Brightline.

On March 18
 2011
 we entered into a private placement subscription agreement with Brightline Ventures I pursuant to which we sold 332.6697 units
 consisting of Preferred Stock and warrants
 for an aggregate offering price of $3
326
697.&#160;&#160;Each of the units (individually
 a &#8220;Unit&#8221; and collectively
 the &#8220;Units&#8221;) consists of 2
000 shares of Series II 8% Convertible Preferred Stock (&#8220;Series II Preferred Stock&#8221;) and one warrant (a &#8220;Warrant&#8221;) at an Original Issue Price of $10
000 per Unit.&#160;&#160;The Series II Preferred Stock was issued with rights to: (i) a dividend which accrues cumulatively on a daily basis at the rate of 8% per annum of the Original Issue Price payable in shares of the Common Stock; (ii) conversion into such a number of shares of Common Stock determined by dividing the Original Issue Price by the Conversion Price
 initially
 $1.00; (iii) a liquidation preference equal to the sum of the Original Issue Price and an amount equal to 8% of the Original Issue Price for each 12 months that passed since the date of issuance of any of the Series II Preferred Stock; and (iv) mandatory redemption
 by the Company
 24 months from the date of issuance of the Series II Preferred Stock at a redemption price equal to the Original Issue Price plus any accrued but unpaid dividends. The dividend component on liquidation and redemption is payable in shares of the Common Stock of the Company. Payment of the dividend
 mandatory redemption and any provisions requiring payment on the Series II Preferred Stock are deferred until the 2008 Notes due in 2010 and the 2009 8% Senior Secured Convertible Notes due in 2011 and 2012 (the 2009 Notes)&#160;&#160;are paid in full or until any such restrictions are waived. Such deferral
 even if the maturity dates on the Notes are extended
 will not constitute a default under the Series II Preferred Stock terms. The Series II Preferred Stock terms may be amended by the Company and the consent of the holders of the majority of the outstanding shares of Preferred Stock and such majority may also waive an adjustment to the Conversion Price.&#160;&#160;The Series II Preferred Stock is convertible into a total of 3
326
697 shares of Common Stock
 exclusive of the shares of Common Stock issuable in connection with the 8% dividend.

Brightline Ventures I also received one five-year Warrant as part of each Unit purchased
 pursuant to which the holder may purchase 15
000 shares of Common Stock per Unit with an exercise price of $1.50 per share (&#8220;Warrants&#8221;). A total of 4
990
046 shares of Common Stock are issuable upon exercise of the Warrants.

We also entered into a registration rights agreement with Brightline Ventures I pursuant to which we agreed to file with the Securities and Exchange Commission a registration statement covering the resale of the Common Stock underlying the Series II Preferred Stock and Warrants.&#160;&#160;In connection with the offering
 Brightline Ventures I
 as the holder of a majority of the warrants issued in connection with the Company&#8217;s 2009 Notes (the 2009 Warrants) waived any price adjustment with respect to the 2009 Warrants.&#160;&#160;Brightline Ventures I also waived any price adjustment with respect to the warrants issued in connection with the Series I 8% Convertible Preferred Stock (the Series I Preferred Stock Warrants) it purchased from the Company.&#160;&#160;The Company obtained similar waivers from the other holders of the Series I Preferred Stock Warrants and the 2009 Warrants.

On January 15
 2012
 the Company received notice from Brightline Ventures I electing to convert an aggregate principal balance of $1
300
000 on outstanding convertible notes
 plus $208
000 of interest accrued thereon
 into 1
508
000&#160;shares of the Company&#8217;s Common Stock.&#160; This is equivalent to a conversion price of $1.00 per share of Common Stock.&#160; The shares issued in connection with foregoing conversion of convertible notes were on the same terms and conditions as offered to other non-affiliated debt holders.

On February 23
 2012
 we entered into a private placement subscription agreement with Brightline Ventures I-B
 pursuant to which we sold 311
545 shares of common stock
 for a price of $1.50 per share and received gross proceeds of $467
318.

On March 29
 2012
 we entered into a private placement subscription agreement with Brightline Ventures I-B pursuant to which we sold 437
380 shares of common stock
 for a price of $1.50 per share and received gross proceeds of $656
070.

On May 8
 2012
 we entered into a private placement subscription agreement with Brightline Ventures I-B
 pursuant to which we sold 744
711 shares of common stock
 for a price of $1.50 per share and received gross proceeds of $1
117
067.

On August 1
 2012
 we entered into a private placement subscription agreement with Brightline Ventures I-B
 pursuant to which we sold 417
612 shares of common stock
 for a price of $1.50 per share and received gross proceeds of $626
417.

On August 13
 2012
 the Company entered into an agreement with Brightline Ventures I pursuant to which Brightline Ventures I agreed to convert $7
721
worth of Series I and II Preferred Stock into 7
721
shares of the Company&#8217;s Common Stock at the earlier of either the maturity date of the security or the closing of any approved transaction with Maxim Group
 LLC.&#160;&#160;In consideration for the foregoing conversion of Preferred Stock by Brightline Ventures I on or before their respective maturity dates
 the Company modified the following warrants held by Brightline Ventures I to provide them with the ability to exercise such warrants on a cashless basis: (i) warrants to purchase an aggregate of&#160;&#160;11
582
shares of Common Stock with an exercise price of $1.50 per share
 which were issued to Brightline Ventures I in transactions where Brightline Ventures I acquired shares of the Company&#8217;s Series I and II Preferred Stock; and (ii) warrants to purchase an aggregate of&#160;&#160;2
859
375 shares of Common Stock with an exercise price of $1.50 per share
 which equals one half of the outstanding&#160;&#160;and unexercised warrants issued to Brightline Ventures I in other transactions where Brightline Ventures I provided financing to the Company. Prior to December 31
 2012
 all Series I Preferred shares held by Brightline Ventures I were converted to common shares consistent with the amendment. The remaining Series II Preferred shares held of 665
339 shares and $3
326
697 was reclassified to permanent equity based on the removal of the redemption feature associated with the preferred stock. The value reclassified was equal to the carrying value of the shares on the date the agreement was modified. This value was $2
157
238 based on a gross value of $3
326
697 and a remaining discount of $1
169
459. Furthermore
 the accrued dividends relating to the Series II Convertible Preferred Stock have also been reclassified to Stockholders&#8217; Equity.&#160;&#160;These reclassifications were necessary based on the preferred shares no longer being subject to potential cash redemption.

















On September 10
 2012
 we entered into a private placement subscription agreement with Brightline Ventures I-B
 pursuant to which we sold 74
200 shares of common stock
 for a price of $1.50 per share and received gross proceeds of $111
300.

In the third quarter of 2012
 Brightline Ventures I converted $1
634
400 (including accrued dividends) of Series I Preferred Stock into 1
634
400 shares of Common Stock.

During the fourth quarter of 2012
 Brightline Ventures I converted $3
465
100 (including accrued dividends) of Series I Preferred Stock into 3
465
100 shares of Common Stock.

In the third quarter of 2012
 Morris Garfinkle
 a Director of the Company
 converted $34
800 (including accrued dividends) of Series I Preferred Stock into 34
800 shares of the Company&#8217;s Common Stock.

During the fourth quarter of 2012
 the non-executive directors of the Company
 Morris Garfinkle
 Mark Hershhorn
 Brian Israel and Ed Smith
 each converted $17
403 shares of Series I Preferred Stock (including accrued dividends) into 17
403 shares of Common Stock
 for an aggregate of 69
612 shares of Common Stock.

During March 2013
 Brightline Ventures I converted its outstanding Series II Preferred Stock (including accrued dividends) into 3
859
697 shares of Common Stock.

In the first quarter of 2013
 we completed a warrant exercise program
 which resulted in the exercise of 1
756
088 warrants into 1
756
088 shares of the Company&#8217;s common stock.&#160;&#160;The warrant program
 which was open to all holders of $1.50 warrants
 allowed those warrant holders to exercise their warrants for a $1.25 strike price during February 2013; it also required a waiver of the anti-dilution provisions in these warrants until February 28
 2013 so that those provisions would not be triggered by the exercises. The conversion of these warrants raised approximately $2.2 million in additional capital for the Company

On August 20
 2013
 the Company entered into a private placement subscription agreement with Brightline Ventures I-C
 LLC (together with Brightline Ventures I
 LLC and Brightline Ventures I-B
 LLC
 referred to collectively herein as &#8220;Brightline&#8221; unless the context indicates otherwise) pursuant to which it sold 376
000 shares of common stock
 at a price of $1.25 per share (the &#8220;$1.25 Raise&#8221;)
 and received gross proceeds of $470
000.


Concurrent to the $1.25 Raise
 the Company (i) allowed the holders of the Company&#8217;s outstanding warrants with a $1.50 per share exercise price (the &#8220;$1.50 Warrants&#8221;) with certain anti-dilution provisions contained in the warrant agreements to choose to exercise their $1.50 Warrants on a cashless basis such that for every ten $1.50 warrants exercised
 the holder received 4.5 shares of common stock (fractional shares were rounded up) (the &#8220;Cashless Exercise Program&#8221;)
 (ii) sought a temporary waiver from the holders of the $1.50 Warrants of the anti-dilution provisions in the warrant agreements with respect to the Cashless Exercise Program and potential capital-raising activities (other than the $1.25 Raise) by the Company prior to December 31
 2013
 and (iii) asked the holders of the $1.50 Warrants to permanently amend the warrant agreements with respect to certain ratchet provisions so as to reduce the derivative liability the Company incurs as a result of those provisions in the agreement.


The Cashless Exercise Program resulted in 7
172
751 of the $1.50 Warrants being converted into 3
227
742 shares of common stock (including 5
718
750 $1.50 Warrants that were converted by Brightline Ventures I into 2
573
438 shares of Common Stock).&#160;&#160;As a result of the Cashless Exercise Program
 the Company recognized a loss on equity modification of $990
656&#8212;the difference in value between the $1.50 Warrants exercised and the common stock issued&#8212;for the three months ended September 30
 2013.


As a result of the August 20
 2013 transaction with Brightline Ventures I
 pursuant to the anti-dilution provisions contained in the $1.50 Warrants that were not exercised as part of the Cashless Exercise Program
 the Company reduced the exercise price of the remaining warrants to $1.25 per share and adjusted the number of shares issuable upon the exercise of those warrants such that for every five warrants owned
 each remaining holder of $1.50 Warrants received one additional warrant with an exercise price of $1.25 per share.&#160;&#160;Thus
 the Company issued an additional 2
376
009 warrants at an exercise price of $1.25 per share to the holders of the $1.50 Warrants that were not exercised as part of the Cashless Exercise Program.


On September 18
 2013
 the Company entered into a private placement subscription agreement with Brightline Ventures I-C pursuant to which it sold 468
571 shares of common stock at a price of $1.05 per share
 along with warrants to purchase 234
286 shares of common stock at an exercise price of $1.50 per share (the &#8220;$1.05 Raise&#8221;)
 and received gross proceeds of $492
000.&#160;&#160;The waiver indicated above was effective for the $1.05 Raise; therefore
 no additional warrants were issued and no exercise price adjustments were made pursuant to anti-dilution and ratchet provisions as a result of the $1.05 Raise.

The Company does not have a written policy with respect to related party transactions.&#160;&#160;However
 all such transactions are reviewed and approved by the Board of Directors prior to finalization.




Under the Company&#8217;s bylaws
 the composition of the Board must meet the independence requirements promulgated by the NYSE Amex (now known as NYSE MKT) or such other requirements as may be adopted by the Company.&#160;&#160;Based on these standards
 the Board of Directors has determined that Messrs.&#160;Garfinkle
 Hershhorn and Israel are each &#8220;independent&#8221; under applicable rules and guidelines. Mr.&#160;Cohen
 as chief executive officer of the Company
 and Mr.&#160;Smith
 as Managing Partner of Brightline Capital Management
 LLC (our controlling shareholder)
 are not considered to be &#8220;independent.&#8221;

In determining that Messrs. Garfinkle
 Hershhorn and Israel are each &#8220;independent&#8221; under applicable rules and guidelines used by the Company to determine independence
 the Board of Directors took into consideration that each of these directors has purchased convertible notes and/or preferred stock in private offerings on the same terms and conditions as was offered to persons not affiliated with the Company.

&#160;Our independent directors have the opportunity to meet in executive session
 without the other directors or management
 as part of each regular Board meeting.




















The following table is a summary of the fees billed to us by M&amp;K CPAS
 PLLC for professional services for the fiscal year ended December 31
 2013 and December 31
 2012
 respectively:



















$66
200



$63
600






$18
650















$84
850



$63
600












Our&#160;&#160;Audit&#160;&#160;Committee&#160;&#160;Charter&#160;&#160;provides&#160;&#160;that the&#160;&#160;Audit&#160;&#160;Committee&#160;&#160;shall pre-approve&#160;&#160;all&#160;&#160;auditing&#160;&#160;services
&#160;&#160;&#160;internal&#160;&#160;control-related&#160;&#160;services&#160;&#160;and permitted&#160;&#160;non-audit services&#160;&#160;(including the terms thereof) to be performed for us by&#160;&#160;our&#160;&#160;independent&#160;&#160;auditor
&#160;&#160;subject&#160;&#160;to&#160;&#160;the de&#160;&#160;minimis&#160;&#160;exceptions&#160;&#160;for non-audit services described in Section&#160;&#160;10A(i)(1)(B) of the Securities Exchange Act of 1934
&#160;&#160;as&#160;&#160;amended
&#160;&#160;which are&#160;&#160;approved&#160;&#160;by the&#160;&#160;Audit Committee&#160;&#160;prior to the completion of the service. The Audit Committee may also form and delegate authority to sub-committees consisting of one or more members when appropriate
 including the authority to grant&#160;&#160;pre-approvals&#160;&#160;of audit and&#160;&#160;permitted&#160;&#160;non-audit&#160;&#160;services
 provided that decisions of such&#160;&#160;subcommittee&#160;&#160;to grant&#160;&#160;pre-approvals&#160;&#160;shall be presented to the full&#160;&#160;Committee at its next&#160;&#160;scheduled&#160;&#160;meeting.&#160;&#160;In accordance with the pre-approval policy
 the Audit Committee has approved certain specified audit and non-audit services to be provided by M&amp;K CPAS
 PLLC for up to twelve (12) months from the date of the pre-approval. Any additional services to be provided by our independent auditors following such pre-approval require the additional pre-approval of the Audit Committee.



























ITEM 15.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exhibits
 Financial Statement Schedules.






































Balance Sheets as of December 31
 2013 and 2012













Statements of Operations for the Years Ended December 31
 2013 and December 31
 2012













Statement of Stockholders&#8217; Equity (Deficit) for the Years Ended December 31
 2013 and December 31
 2012













Statements of Cash Flows for the Years Ended December 31
 2013 and December 31
 2012





























See the Exhibit Index following the signature page of this report
 which is incorporated herein by reference.


























Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934
 the registrant has duly caused this report on Form 10-K to be signed on its behalf by the undersigned
 thereunto duly authorized.

Z TRIM HOLDINGS
 INC.
















Date:&#160;&#160;April 14
 2014




Steven J. Cohen
 Chief Executive Officer








Pursuant to the requirements of the Securities Exchange Act of 1934
 as amended
 this report has been signed below by following persons on behalf of the Registrant and in the capacities and on the dates indicated.











Steven J. Cohen
 Chief Executive Officer and Director (Principal Executive Officer)


Date:&#160;&#160;April 14
 2014












Date:&#160;&#160;April 14
 2014



Brian Chaiken
 Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

















Date:&#160;&#160;April 14
 2014



Mark Hershhorn
 Director


















Date:&#160;&#160;April 14
 2014



Brian Israel
 Director


















Date:&#160;&#160;April 14
 2014



Edward Smith III
 Director


















Date:&#160;&#160;April 14
 2014



Morris Garfinkle
 Director








































Z TRIM HOLDINGS
 INC.




Form 10-K for Fiscal Year Ended December 31
 2013


























Restated Articles of Incorporation (Filed as Exhibit 3(i) to the Annual Report on form 10-K for the fiscal year ended December 31
 2009;&#160;&#160;Illinois Statement of Resolution Establishing the Series I Preferred Stock filed as Exhibit 3.1 (a) in the Current Report on Form 8-K filed June 7
 2010; and Illinois Statement of Resolution Establishing the Series II Preferred Stock filed as Exhibit 3.1 (a) in the Current Report on Form 8-K filed March 21
 2011
 and incorporated herein by reference)







Bylaws
 as amended
 of Z Trim Holdings
 Inc. (filed as Exhibit 4.2 to the Company&#8217;s registration statement on Form S-8 filed on December 17
 2012 (File No. 333-185517)
 and incorporated herein by reference).







Form of Amended and Restated Warrant to Purchase Common Stock (filed as Exhibit 4.3 to the Company&#8217;s Form 8-K dated October 19
 2009 and incorporated herein by reference).








Form of Warrant to Purchase Common Stock (filed as Exhibit 4.3 to the Company&#8217;s Form 8-K dated April 21
 2009 and incorporated herein by reference).








Form of Warrant to Purchase Common Stock (filed as Exhibit 4.3 to the Company&#8217;s Form 8-K dated November 18
 2008 and incorporated herein by reference).








Form of Warrant to Purchase Common Stock (filed as Exhibit 4.3 to the Company&#8217;s Form 8-K dated September 3
 2008 and incorporated herein by reference).








Form of Amendment to the Warrant (filed as Exhibit 4.32 to the Company&#8217;s Form S-3 dated December 14
 2009 and incorporated herein by reference).








Form of Warrant to Purchase Common Stock (filed as Exhibit 4.3 to the Company&#8217;s Form 8-K dated June 24
 2008 and incorporated herein by reference).








Form of Warrant issued on February 9
 2009 for shares of Common Stock at $0.01 per share (filed as Exhibit 4.33 to the Company&#8217;s Form S-1 dated May 25
 2010 and incorporated herein by reference).








Form of Warrant to Purchase Common Stock (filed as Exhibit 4.2 to the Company&#8217;s Form 8-K dated June 7
 2010 and incorporated herein by reference).








Form of Warrant to Purchase Common Stock (filed as Exhibit 4.2 to the Company&#8217;s Form 8-K dated March 21
 2011 and incorporated herein by reference).








Form of Warrant (filed as Exhibit 4.2 to the Company&#8217;s Form 8-K dated February 17
 2012 and incorporated herein by reference).




Form of Equipment Revovling Note
 dated March 24
 2014 (filed as Exhibit 10.1 to the Company's Form 8-K dated March 28
 2014 and incorporated herein by reference).



Form of Security Agreement 
 dated March 24
 2014 (filed as Exhibit 10.2 to the Company's Form 8-K dated March 28
 2014 and incorporated herein by reference).



&#160;Form of Factoring Agreement
 dated March 24
 2014 (filed as Exhibit 10.3 to the Company's Form 8-K dated March 28
 2014 and incorporated herein by reference).










Form of Subscription Agreement (filed as Exhibit 10.1 to the Company&#8217;s Form 8-K dated February 17
 2012 and incorporated herein by reference).











Investment Banking Agreement with Legend Securities
 Inc. (filed as Exhibit 10.2 to the Company&#8217;s Form 8-K dated February 17
 2012 and incorporated herein by reference).











Custom Processing Agreement
 dated as of October 17
 2011
 by and between Z Trim Holdings
 Inc. and AVEKA Nutra Processing
 (filed as Exhibit 10.1 to the Company&#8217;s Form 8-K/A dated October 17
 2011 and incorporated herein by reference).











Cooperative Research and Development Agreement with the United States Department of Agriculture's Agricultural Research Service dated June 14
 2011 (filed as Exhibit 10.1 to the Company&#8217;s Form 10-Q for the quarter ending June 30
 2011 and incorporated herein by reference).











Steve Cohen Employment Agreement (filed as Exhibit 10.12 to the Company&#8217;s Form 10-QSB for the quarter ending June 20
 2006 and incorporated herein by reference).











Brian Chaiken Employment Agreement
 dated October 17
 2007 (filed as Exhibit 10.2 to the Company&#8217;s Form 10-KSB filed on April 14
 2008 and incorporated herein by reference).























































Z Trim Holdings
 Inc. Incentive Compensation Plan (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K dated December 5
 2012
 and incorporated herein by reference).*







Code of Ethics and Business Conduct (filed as Exhibit 14.1 to the Company&#8217;s Form 10-K for the year ended December 31
 2011
 and incorporated herein by reference)







Consent of M&amp;K CPAS
 PLLC.























Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350
 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002







Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350
 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002







The following materials from Z Trim Holdings
 Inc.'s Annual Report on Form 10-K for the year ended December 31
 2012
 formatted in XBRL (eXtensible Business Reporting Language): (i) the Balance Sheets
 (ii) the Statements of Operations
 (iii) the Statements of Stockholders Equity
 (iv) the Statements of Cash Flows and (v) the Notes to Financial Statements
 tagged as blocks of text
 furnished herewith.**




























































**&#160;&#160;Pursuant to Rule 406T of Regulation S-T
 this interactive data file is deemed not filed or part of a registration statement or prospectus for purposes of Section 11 or 12 of the Securities Act of 1933
 as amended
 is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934
 as amended
 and otherwise is not subject to liability under these sections.




























Stockholders of Z Trim Holdings
 Inc.

We have audited the accompanying balance sheets of Z Trim Holdings
 Inc. as of December 31
 2013 and 2012
 and the related statements of operations
 changes in stockholders' equity (deficit) and cash flows for the years then ended. These financial statements are the responsibility of the company's management. Our responsibility is to express an opinion on these financial statements based on our audits.


We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The company is not required to have
 nor were we engaged to perform
 an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances
 but not for the purpose of expressing an opinion on the effectiveness of the company's internal control over financial reporting. Accordingly
 we express no such opinion. An audit also includes examining
 on a test basis
 evidence supporting the amounts and disclosures in the financial statements
 assessing the accounting principles used and significant estimates made by management
 as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.


In our opinion
 the financial statements referred to above present fairly
 in all material respects
 the financial position of Z Trim Holdings
 Inc. as of December 31
 2013 and 2012
 and the results of its operations and its cash flows for the years then ended in conformity with accounting principles generally accepted in the Unites States of America.


The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements
 the Company does not have enough cash on hand to meet its current liabilities and has had reoccurring losses as of December 31
 2013. These conditions raise substantial doubt about its ability to continue as a going concern. Management's plans regarding those matters also are described in Note 2. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.








/s/ M&amp;K CPAS
 PLLC
Houston
 Texas
April 11
 2014
































Z TRIM HOLDINGS
 INC.





































































&#160;$443
472



&#160;$644
804







&#160;380
238



&#160;299
256







&#160;544
535



&#160;469
302







&#160;136
887



&#160;136
827













&#160;1
505
132



&#160;1
550
189





















&#160;$550
650



&#160;$523
150







&#160;11
892



&#160;11
892



&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Property and equipment
 net



&#160;1
800
306



&#160;2
445
965













&#160;2
362
848



&#160;2
981
007













&#160;$3
867
980



&#160;$4
531
196

























































&#160;$374
566



&#160;$328
887







&#160;194
144



&#160;173
534







&#160;36
178



&#160;36
178







&#160;95
049



&#160;8
025
381







&#160;699
937



&#160;8
563
980



















&#160;699
937



&#160;8
563
980

















Common stock
 $0.00005 par value; authorized 200
000
000 shares; issued and outstanding 39
449
138 and 25
032
444 shares
 December 31
 2013 and 2012
 respectively


&#160;1
973



&#160;1
252



Convertible Preferred Stock Series II
 $0.01 par value; authorized 1
000
000 shares
 issued and outstanding 0 and 665
339 shares
 December 31
 2013 and 2012
 respectively






&#160;2
157
238











&#160;2
358
107







&#160;130
039
561



&#160;104
891
849







&#160;(126
873
491)



&#160;(113
441
230)













&#160;3
168
043



&#160;(4
032
784)













&#160;$3
867
980



&#160;$4
531
196



































Z TRIM HOLDINGS
 INC.





























December 31




























&#160;$1
429
419



&#160;$1
274
649







&#160;1
429
419



&#160;1
274
649





















&#160;2
857
947



&#160;2
609
892







&#160;742
168











&#160;3
600
115



&#160;2
609
892













&#160;(2
170
696)



&#160;(1
335
243)

















Selling
 general and administrative



&#160;6
480
031



&#160;4
707
678







&#160;6
480
031



&#160;4
707
678













&#160;(8
650
727)



&#160;(6
042
921)

























&#160;4
225







&#160;27
558



&#160;23
411







&#160;(2
037)















&#160;(97
363)







&#160;966
736



&#160;(1
514
156)



Gain (loss) on asset disposals
 net



&#160;(1
334)



&#160;49
101







&#160;(5
780
457)























&#160;8
000



&#160;(2
005
218)







&#160;(4
781
534)



&#160;(3
540
835)













&#160;$(13
432
261)



&#160;$(9
583
756)













&#160;56
144



&#160;584
135











&#160;3
684
317













&#160;$(13
488
405)



&#160;$(13
852
208)

























&#160;32
862
216



&#160;18
216
576

































Z TRIM HOLDINGS
 INC.




































































































































Balance at December 31
 2011


&#160;14
139
621











&#160;$91
262
428





&#160;$(103
857
474)


&#160;$(12
594
339)
















&#160;238
800











&#160;159
988








&#160;160
000






&#160;150
000











&#160;149
992








&#160;150
000






&#160;2
346
228











&#160;3
789
812








&#160;3
789
928






&#160;(42
000)



























&#160;1
871
035











&#160;1
870
940








&#160;1
871
034






&#160;490
424











&#160;304
200








&#160;304
225






&#160;198
663



























&#160;14
600











&#160;9
525








&#160;9
526






&#160;131
161







































&#160;5
493
912











&#160;5
493
640








&#160;5
493
914


















&#160;1
547
826








&#160;1
547
826


















&#160;40
508








&#160;40
508


















&#160;4
520
207








&#160;4
520
207


















&#160;(584
135)








&#160;(584
135)


















&#160;(3
684
317)








&#160;(3
684
317)


















&#160;11
250








&#160;11
250





















&#160;1
881
250





&#160;1
881
250



&#160;&#160;Reclass convertible
 redeemable preferred stock











&#160;&#160;&#160;&#160;&#160;&#160;&#160;to convertible preferred stock
 net of discount








&#160;665
339


&#160;2
157
238





&#160;476
857





&#160;2
634
095
























&#160;(9
583
756)


&#160;(9
583
756)













Balance at December 31
 2012


&#160;25
032
444


&#160;$1
252


&#160;665
339


&#160;$2
157
238


&#160;$104
891
849


&#160;$2
358
107


&#160;$(113
441
230)


&#160;$(4
032
784)
















&#160;114
944











&#160;199
997








&#160;200
002






&#160;770
000











&#160;630
894








&#160;630
933



&#160;&#160;Stock issued for cash
 net of offering costs


&#160;2
711
238











&#160;2
172
029








&#160;2
172
165






&#160;2
287
730











&#160;2
489
732








&#160;2
489
846






&#160;3
606
157



























&#160;91
400











&#160;77
729








&#160;77
734






&#160;100
528







































&#160;3
859
697





&#160;(665
339)


&#160;(2
157
238)


&#160;2
690
046


&#160;(533
001)
























&#160;2
318
355








&#160;2
318
355










&#160;5
780
457




&#160;5
780
457


















&#160;6
963
596








&#160;6
963
596


















&#160;(56
144)


&#160;56
144












&#160;875
000











&#160;1
881
206


&#160;(1
881
250)






























&#160;(13
432
261)


&#160;(13
432
261)













Balance at December 31
 2013


&#160;39
449
138


&#160;$1
973








&#160;$130
039
561





&#160;$(126
873
491)


&#160;$3
168
043






























Z TRIM HOLDINGS
 INC.











































&#160;$(13
432
261)



&#160;$(9
583
756)




















&#160;2
318
355



&#160;1
547
826






&#160;200
002



&#160;160
000






&#160;630
933



&#160;161
250






&#160;5
780
457














&#160;78
819






&#160;643
575



&#160;682
134






&#160;1
334



&#160;(49
101)






&#160;742
168







Change in derivative liability
 net of bifurcation


&#160;(966
736)



&#160;1
514
156





















&#160;1
881
250






&#160;(8
000)



&#160;110
000













&#160;(80
982)



&#160;16
021






&#160;(817
401)



&#160;(212
460)










&#160;(28
244)






&#160;(27
500)



&#160;(437
935)






&#160;74
289



&#160;77
364






&#160;(4
941
827)



&#160;(4
081
948)






















&#160;110
000










&#160;110
000















Proceeds from sale of common stock
 net


&#160;2
172
165



&#160;3
789
928






&#160;77
734



&#160;9
526






&#160;2
489
846



&#160;304
225










&#160;200
000






&#160;4
739
745



&#160;4
303
679






&#160;(201
332)



&#160;331
731











&#160;644
804



&#160;313
073






&#160;$443
472



&#160;$644
804








































&#160;$1
881
250














&#160;$1
871
034






&#160;$2
690
056



&#160;$5
493
914










&#160;$3
684
317










&#160;$48
619






&#160;$4
201
908



&#160;$2
864
275






&#160;$2
761
688



&#160;$1
607
313






&#160;$56
144



&#160;$584
135





















&#160;$40
508










&#160;$476
857










&#160;$2
157
238




























Z Trim Holdings
 Inc.








Z Trim Holdings
 Inc. (the &#8220;Company&#8221;) is an agricultural ingredient technology company that owns existing
 and has developed new
 products and processes to make use of biomass for uses in the food and industrial markets.&#160;&#160;The Company&#8217;s food division currently sells a line of products to the food industry that can help food manufacturers reduce their costs and help them solve many production problems.&#160; The Company&#8217;s technology provides value-added ingredients across virtually all food industry categories.&#160; The Company&#8217;s all-natural products
 among other things
 help to reduce fat and calories
 add fiber
 provide shelf-stability
 prevent oil migration
 and add binding capacity &#8211; all without degrading the taste and texture of the final food products.&#160; Perhaps most significantly
 Z Trim&#8217;s products can help extend finished products
 and thereby increase its customers&#8217; gross margins.&#160;&#160;The Company&#8217;s industrial division
 opened in 2012
 plans to sell eco-friendly ingredients to oil drilling
 hydraulic fracturing
 petroleum coke
 steel/aluminum
 paper and other industries.&#160; The Company&#8217;s industrial ingredients are highly functional in applications for adhesives
 binders
 viscofiers and emulsifiers.




The financial statements have been prepared assuming that the Company will continue as a going concern.&#160;&#160;As of April 11
 2014
 the date that the independent registered public accountant issued its report on the audited financial statements as of and for the year ended December 31
 2013
 the Company did not have enough cash on hand to meet its current liabilities or to fund on-going operations beyond one year.&#160;&#160;The Company had reoccurring losses as of December 31
 2013.&#160;&#160;As a result
 the independent registered public accountant&#8217;s audit report included an explanatory paragraph in respect of our ability to continue as a going concern. The Company intends to secure additional funding through debt or equity financing arrangements
 increased sales generated by its operations and reduced expenses.











The Company generally recognizes product revenue when persuasive evidence of an arrangement exists
 delivery has occurred
 the fee is fixed or determinable
 and collectability is probable. In instances where the final acceptance of the product is specified by the customer
 revenue is deferred until all acceptance criteria have been met. No provisions were established for estimated product returns and allowances based on the Company&#8217;s historical experience.




Management of the Company makes judgments as to its ability to collect outstanding receivables and provide allowances for the portion of receivables when collection becomes doubtful. Provisions are made based upon a specific review of all significant outstanding invoices. For those invoices not specifically reviewed
 provisions are provided at differing rates
 based upon the age of the receivable. In determining these percentages
 management analyzes its historical collection experience and current economic trends. If the historical data the Company uses to calculate the allowance for doubtful accounts does not reflect the future ability to collect outstanding receivables
 additional provisions for doubtful accounts may be needed and the future results of operations could be materially affected. As of December 31
 2013 and 2012
 the allowance for doubtful accounts was $0.




For purposes of the statement of cash flows
 the Company considers all highly liquid investments with a maturity of three months or less to be cash equivalents.&#160;&#160;There were no cash equivalents as of December 31
 2013 and 2012.




Inventory is stated at the lower of cost or market
 using the first-in
 first-out method.&#160;&#160;The Company follows standard costing methods for manufactured products.



Property and equipment are stated at cost less accumulated depreciation and amortization.&#160;&#160;Maintenance and repair costs are expensed as incurred.&#160;&#160;Depreciation is calculated using the straight-line method over the estimated useful lives of the assets.&#160;&#160;Estimated useful lives of five to ten years are used for machinery and equipment
 office equipment and furniture
 and automobile. Estimated useful lives of up to five years are used for computer equipment and related software. Depreciation and amortization of leasehold improvements are computed using the term of the lease.



















Intangible assets are carried at the purchased cost less accumulated amortization. Amortization is computed over the estimated useful lives of the respective assets
 generally from fifteen to twenty years.








The amount of current and deferred taxes payable or refundable is recognized as of the date of the financial statements
 utilizing currently enacted tax laws and rates.&#160;&#160;Deferred tax expenses or benefits are recognized in the financial statements for the changes in deferred tax liabilities or assets between years.




All derivatives have been recorded on the balance sheet at fair value based on the lattice model calculation. These derivatives
 including embedded derivatives in the Company&#8217;s warrants
 convertible preferred stock
 and its Convertible 8% Senior Secured Notes issued in 2008
 2009
 and 2010
 which have reset provisions to the exercise price and conversion price if the Company issues equity or other notes at a price less than the exercise price set forth in such warrants and notes
 are separately valued and accounted for on the Company&#8217;s balance sheet. Fair values for exchange traded securities and derivatives are based on quoted market prices. Where market prices are not readily available
 fair values are determined using market based pricing models incorporating readily observable market data and requiring judgment and estimates.



The Company valued the warrants and conversion features in their convertible notes and preferred stock using a lattice valuation model
 with the assistance of a valuation consultant. The lattice model values these instruments based on a probability weighted discounted cash flow model. The Company uses the model to develop a set of potential scenarios. Probabilities of each scenario occurring during the remaining term of the instruments are determined based on management's projections and the expert&#8217;s calculations. These probabilities are used to create a cash flow projection over the term of the instruments and determine the probability that the projected cash flow will be achieved. A discounted weighted average cash flow for each scenario is then calculated and compared to the discounted cash flow of the instruments without the compound embedded derivative in order to determine a value for the compound embedded derivative.



The Company&#8217;s financial instruments consist of cash and cash equivalents
 accounts receivable
 inventory
 accounts payable and accrued liabilities. The estimated fair value of cash
 accounts receivable
 accounts payable and accrued liabilities approximate their carrying amounts due to the short-term nature of these instruments.&#160;&#160;None of these instruments are held for trading purposes.

The Company utilizes various types of financing to fund its business needs
 including convertible debt with warrants attached. The Company reviews its warrants and conversion features of securities issued as to whether they are freestanding or contain an embedded derivative and
 if so
 whether they are classified as a liability at each reporting period until the amount is settled and reclassified into equity with changes in fair value recognized in current earnings. At December 31
 2013 and 2012
 the Company had warrants to purchase common stock
 the fair values of which are classified as a liability.





















- Level three &#8212; Unobservable inputs developed using estimates and assumptions
 which are developed by the reporting entity and reflect those assumptions that a market participant would use.


Determining which category an asset or liability falls within the hierarchy requires significant judgment. The Company evaluates its hierarchy disclosures each quarter. The Company&#8217;s only asset or liability measured at fair value on a recurring basis is its derivative liability associated with warrants to purchase common stock and preferred stock. The fair value of the derivative liability at December 31
 2013 and 2012 was $95
049 and $8
025
381
 respectively.&#160;&#160;The gain on derivative liability for the twelve months ended December 31
 2013 was $966
736 compared to a loss on derivative liability of $1
514
156 for the twelve months ended December 31
 2012.&#160;&#160;Below is a hierarchy table of the components of the derivative liability:






































































&#160;$11
031
432











&#160;$11
031
432



&#160;$11
031
432

































&#160;(4
520
207)











&#160;(4
520
207)



&#160;(4
520
207)






&#160;1
514
156











&#160;1
514
156



&#160;1
514
156





&#160;(3
006
051)











&#160;(3
006
051)



&#160;(3
006
051)

































&#160;$8
025
381











&#160;$8
025
381



&#160;$8
025
381

































&#160;(6
963
596)











&#160;(6
963
596)



&#160;(6
963
596)






&#160;(966
736)











&#160;(966
736)



&#160;(966
736)





&#160;(7
930
332)











&#160;(7
930
332)



&#160;(7
930
332)

































&#160;$95
049











&#160;$95
049



&#160;$95
049







Accounting for Convertible
 Redeemable Preferred Stock

The Company accounts for convertible and redeemable preferred stock according to its stated redemption value net of any discounts related to attached warrants or beneficial conversions features. The Company classifies these instruments on the balance sheet according to the nature of the redemption feature. Preferred shares with redemption features that are solely within the control of the Company are accounted for within permanent equity. Preferred shares that are considered mandatorily redeemable due to a fixed redemption date and amount are accounted for as liabilities. Preferred shares that are conditionally redeemable based on conditions that are outside of the Company&#8217;s control are classified within temporary equity. Discounts on instruments classified as liabilities are amortized to interest expense
 and discounts on instruments classified within permanent or temporary equity are amortized to retained earnings or additional paid in capital when there is an accumulated deficit. Amortization of discounts on preferred shares classified within equity or temporary equity is deducted from net income to common shareholders on the income statement.



The Company expenses all advertising costs as incurred.&#160;&#160;The amount for the year ended December 31
 2013 and 2012 was $250 and $18
425 respectively.



Basic net income (loss) per share includes no dilution and is computed by dividing net income (loss) available to common stockholders by the weighted average number of common stock outstanding for the period. Diluted earnings per share is computed by dividing net income by the weighted average number of shares outstanding and
 when diluted
 potential shares from options and warrants to purchase common stock using the treasury stock method. Diluted net loss per common share does not differ from basic net loss per common share since potential shares of common stock are anti-dilutive for all periods presented.








The Company estimates the fair value of share-based payment awards made to employees and directors
 including stock options
 restricted stock and employee stock purchases related to employee stock purchase plans
 on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense ratably over the requisite service periods.&#160;&#160;We estimate the fair value of each share-based award using the Black-Scholes option pricing model. The Black-Scholes model is highly complex and dependent on key estimates by management. The estimates with the greatest degree of subjective judgment are the estimated lives of the stock-based awards and the estimated volatility of our stock price. The Company recognized pre-tax compensation expense related to stock options of $2
318
355 and $1
547
826 for the years ended December 31
 2013 and 2012
 respectively.



The Company has entered into a custom processing agreement with a vendor in order to provide the Company with a partner for future manufacturing initiatives. The Company has agreed to make available a $500
000 line of credit to the vendor at a 5.5% interest rate. The vendor may not draw down more than $75
000 during any thirty day period. The Company will be re-paid for these advances with future discounts on products manufactured by the vendor.

The Company capitalizes distributions to the vendor related to this agreement upon disbursement based on this value to be applied towards discounts on future product purchases. Interest on the outstanding advances are recorded to interest income and capitalized to the letter of credit account
 and will be realized with future discounts as well.

On March 28
 2014 the Company agreed to an amendment to the custom processing agreement relating to the repayment of the line of credit advances plus interest.&#160;&#160;Commencing on April 1
 2014
 Aveka Nutra Processing will begin paying the Company $5
000 per month to be applied to advances and accrued interest.





In February 2013
 the FASB issued an accounting standards update which requires an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component and to present either on the face of the statement where net income is presented
 or in the notes
 significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income
 but only if the amount reclassified is required to be reclassified to net income in its entirety in the same reporting period provides
 subject to certain conditions
 the option to perform a qualitative
 rather than quantitative
 assessment to determine whether it is more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying amount. The update will be effective in the first quarter of 2013
 although early adoption is permitted
 the Company has not elected early adoption of this pronouncement. The update did not have a material impact on the Company&#8217;s financial position
 results of operations or cash flows.

Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward
 a Similar Tax Loss
 or a Tax Credit Carryforward Exists

In July 2013
 the FASB issued an accounting standards update which requires an entity to present an unrecognized tax benefit
 or portion thereof
 in the statement of financial position as a reduction to a deferred tax asset for a net operating loss carryforward or a tax credit carryforward
 with certain exceptions related to availability. The update will be effective in the first quarter of 2014
 although early adoption is permitted
 the Company has not elected early adoption of this pronouncement. The update is not expected to have a material impact on the Company&#8217;s financial position
 results of operations or cash flows.



In July 2012
 the FASB issued an accounting standards update which provides
 subject to certain conditions
 the option to perform a qualitative
 rather than quantitative
 assessment to determine whether it is more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying amount. The update will be effective in the first quarter of 2013
 although early adoption is permitted
 the Company has not elected early adoption of this pronouncement. The update may
 under certain circumstances
 reduce the complexity and costs of testing indefinite-lived intangible assets for impairment
 but&#160;did not&#160;have a material impact on the Company&#8217;s financial position
 results of operations or cash flows.




















At December 31
 inventory consists of the following:


















&#160;$27
575



&#160;$42
831






&#160;8
178



&#160;1
873






&#160;33
527



&#160;64
170






&#160;475
255



&#160;360
428









&#160;$544
535



&#160;$469
302






At December 31 the Company recognized an inventory valuation reserve of $742
168 as a result of slow moving inventory within the Industrial Products Division.


NOTE 5 &#8211; PROPERTY AND EQUIPMENT
 NET

At December 31
 property and equipment
 net consists of the following:
















Production
 engineering and other equipment



$6
422
110



$6
426
432







2
904
188



2
904
188







603
182



603
182







140
238



140
238





$10
069
718



$10
074
040







($8
269
412)



($7
628
075)



Property and equipment
 net



$1
800
306



$2
445
965






Depreciation expense was $643
575 and $682
134 for the years ended December 31
 2013 and 2012
 respectively. During the year ended December 31
 2013
 the Company sold a fixed asset with a net book value of $2
084 in exchange for cash of $750 and recorded a loss on the sale of $1
334.&#160;&#160;For the twelve months ended December 31
 2012
 the Company sold equipment with a net book value of $60
899 for a total of $110
000 and recorded a gain on the sale of $49
101.





On October 17
 2011
 Z Trim Holdings
 Inc. (the &#8220;Company&#8221;) entered into a Custom Processing Agreement (the &#8220;Agreement&#8221;) with AVEKA Nutra Processing
 LLC (&#8220;ANP&#8221;)
 part of the Aveka Group
 in order to provide the Company with a partner for future manufacturing initiatives.


The Agreement provides that ANP will perform certain services related to the Company&#8217;s dietary fiber product
 including manufacturing
 processing
 packaging and storage/warehousing for an initial term of three years.&#160;&#160;The Agreement automatically renews at the end of the initial term for an additional two year term unless either party provides written notice to the other within the specified time frame.&#160;&#160;&#160;&#160;Production began during the third quarter of 2012.&#160;&#160;The Agreement provides for minimum production volumes of 40
000 lbs per month and average volumes of 100
000 lbs. per month with the ability to increase future production volume to potentially as much as 1
000
000 lbs. per month.


In addition
 the Company has agreed to make available to ANP a $500
000 line of credit (which includes $10
000 that the Company loaned ANP to assist it with the purchase of its Waukon
 Iowa facility) at an interest rate of 5.5%.&#160;&#160;The line of credit is only permitted to be used by ANP for operating costs which excludes capital expenditures of equipment in excess of $5
000.&#160;&#160;ANP may not draw down on the line of credit more than $75
000 in any given thirty day period.&#160;&#160;The loan is to be paid back to the Company in the form of discounts on production pricing commencing either two years after the first draw by ANP on the line of credit (other than the $10
000 the Company loaned ANP to assist it with the purchase of its Waukon
 Iowa facility) or the first month after the Company has ordered 80
000 lbs. of product for three consecutive months
 whichever shall occur first.&#160;&#160;All of ANP&#8217;s obligations under the line of credit
 as well as the Agreement
 are specifically guaranteed by its parent company
 Aveka Inc.&#160;&#160;As of December 31
 2013 we advanced a total of $500
000 and accrued interest on the advance was $50
650. On March 28
 2014 the Company agreed to an amendment to the custom processing agreement relating to the repayment of the line of credit advances plus interest.&#160;&#160;Commencing on April 1
 2014
 Aveka Nutra Processing will begin paying the Company $5
000 per month to be applied to advances and accrued interest.




At December 31
 accrued expenses consist of the following:

















&#160;$51
566



&#160;$32
021






&#160;102
000



&#160;110
000






&#160;40
578



&#160;31
513









&#160;$194
144



&#160;$173
534





























During the first quarter of fiscal 2012
 we secured financing from three accredited investors (the &#8220;Investors&#8221;) pursuant to which we sold senior secured convertible promissory notes (each a &#8220;Note&#8221; and collectively the &#8220;Notes&#8221;) and warrants and received gross proceeds of $200
000.&#160;&#160;&#160;The Notes have a twenty-four month term and accrue interest at the rate of 8% per annum.&#160;&#160;The principal balance of the Notes is convertible at the rate of $1.00 per share into an aggregate of 200
000 shares of our common stock
 $.00005 par value (the &#8220;Common Stock&#8221;).&#160;&#160;The interest is payable either upon maturity of the Notes or quarterly at the Investors&#8217; option in shares of our Common Stock.&#160;&#160;Any amount of principal or interest which is not paid when due shall bear interest at a rate of interest equal to the eighteen percent (18%) per annum.&#160;&#160;Attached to the Notes are warrants that entitle the Investor to purchase a specified number of shares of common stock of the Company at a price of $1.50 per share within five years.&#160;&#160;The warrants value is discounted against the Notes and is being amortized as interest expense using the effective interest method over the term of the Notes. The valuation of the related discount for the warrants was calculated using the Black Scholes model and was equal to $40
508. The key inputs to the model were the number of warrants of 100
000
 share prices on the grant dates of $0.59 and $0.70
 exercise price of $1.50
 terms of 5 years
 volatilities of 98.16% and 103.66%
 and discount rates of 0.91% and 0.88%.&#160;&#160;During 2012
 the Company recorded amortization of the debt discount in the amount of $40
608.

On November 5
 2012
 the $200
000 principal balance together with accrued and unpaid interest was converted into common stock.&#160;&#160;As of December 31
 2012
 the Company did not have any convertible notes payable outstanding.




For the twelve months ended December 31
 2012
 the Company recognized debt discount amortization in the amount of&#160;$78
819.





During 2012
 the Company entered into an agreement with its largest stockholder
 Brightline Ventures I
 LLC (&#8220;Brightline Ventures I&#8221;)
 pursuant to which Brightline Ventures I agreed to convert $3
326
worth of Series II Preferred Stock into 3
326
shares of the Company&#8217;s common stock at the earlier of either the maturity date of the security or the closing of any approved transaction with Maxim Group LLC.&#160;&#160;In consideration for the foregoing conversion of Series II Preferred Stock by Brightline Ventures I on or before their respective maturity dates
 the Company modified the following warrants held by Brightline Ventures I to provide them with the ability to exercise such warrants on a cashless basis: (i) warrants to purchase an aggregate of&#160;&#160;11
582
shares of common stock with an exercise price of $1.50 per share
 which were issued to Brightline Ventures I in transactions where Brightline Ventures I acquired shares of the Company&#8217;s Series I and II Preferred Stock; and (ii) warrants to purchase an aggregate of&#160;&#160;2
859
375 shares of common stock with an exercise price of $1.50 per share
 which equaled one half of the outstanding&#160;&#160;and unexercised warrants issued to Brightline Ventures I in other transactions where Brightline Ventures I provided financing to the Company at that time (see Note 12 for a discussion of matters related to these warrants that occurring during&#160;&#160;2013).&#160;&#160;As a result of this modification
 the Series II Convertible
 Redeemable Preferred Stock was reclassified on the balance sheet as permanent Stockholders&#8217; Equity and identified as Series II Convertible Preferred Stock at December 31
 2012. The value reclassified to permanent equity was equal to the carrying value of the shares on the date the agreement was modified. This value was $2
157
238 based on a gross value of $3
326
697 and a remaining discount of $1
169
459. Furthermore
 the accrued dividends relating to the Series II Convertible Preferred Stock were also reclassified to Stockholders&#8217; Equity as of December 31
 2012.&#160;&#160;These reclassifications were necessary based on the preferred shares no longer being subject to potential cash redemption.

On March 18
 2013
 Brightline Ventures I converted the Series II Convertible Preferred Stock of $3
326
697 together with $533
000 of accrued dividends thereon into 3
859
697 shares of the Company&#8217;s Common Stock.&#160;&#160;As of March 31
 2013 there was no Series II Convertible Preferred Stock outstanding.&#160;&#160;The value of the Series II Preferred Stock and dividends converted was equal to the total value recorded to common stock and additional paid in capital with no gain or loss recorded as the conversion was consistent with the original agreement.&#160;&#160;As a result of the preferred stock conversion
 $2
690
239 was recorded to common stock and additional paid-in capital.&#160;&#160;&#160;Accrued dividends were $476
857 as of December 31
 2012.

As of December 31
 2013
 no shares of Series II Preferred Stock remained outstanding.

















On August 15
 2012
 Brightline Ventures I converted $907
120 (including accrued dividends) of Series I Convertible
 Redeemable Preferred Stock into 907
120 shares of the Company&#8217;s Common Stock.&#160;&#160;In conjunction with this conversion
&#160;&#160;Morris Garfinkle
 a Director of the Company
 also converted $34
800 (including accrued dividends) of Series I Convertible
&#160;&#160;Redeemable Preferred Stock into 34
800 shares of the Company&#8217;s Common Stock.

On September 7
 2012
 Brightline Ventures I converted $727
280 (including accrued dividends) of Series I Convertible
 Redeemable Preferred Stock into 727
280 shares of the Company&#8217;s Common Stock.

On December 7
 2012
 Brightline Ventures I converted $2
559
752 (including accrued dividends) of Series I Convertible
 Redeemable Preferred Stock into 2
559
752 shares of the Company&#8217;s Common Stock.&#160;&#160;Again on December 29
 2012
 Brightline Ventures I converted $905
348 (including accrued dividends) of Series I Convertible
 Redeemable Preferred Stock into 905
348 shares of the Company&#8217;s Common Stock.

On December 11
 2012
 the Company&#8217;s external Directors
 Mark Hershhorn
 Morris Garfinkle
 Brian Israel and Edward Smith each agreed to convert $17
403 (including accrued dividends) of Series I Convertible
 Redeemable Preferred Stock into 17
403 shares of the Company&#8217;s Common Stock prior to its maturity.&#160;&#160;The aggregate conversion by the directors was $69
612.&#160;&#160;As a result of this early conversion the Company recorded a loss of $728 for the twelve months ended December 31
 2012.

On December 15
 2012
 an Investor converted $290
000 (including accrued dividends) of Series I Convertible
 Redeemable Preferred Stock into 290
000 shares of the Company&#8217;s Common Stock.

On August 13
 2012
 the Company entered into an agreement with Brightline Ventures I pursuant to which Brightline agreed to convert $7
721
worth of Series I and II Preferred Stock into 7
721
shares of the Company&#8217;s Common Stock at the earlier of either the maturity date of the security or the closing of any approved transaction with Maxim Group
 LLC.&#160;&#160;In consideration for the foregoing conversion of Preferred Stock by Brightline Ventures I on or before their respective maturity dates
 the Company modified the following warrants held by Brightline Ventures I to provide them with the ability to exercise such warrants on a cashless basis: (i) warrants to purchase an aggregate of&#160;&#160;11
582
shares of Common Stock with an exercise price of $1.50 per share
 which were issued to Brightline Ventures I in transactions where Brightline Ventures I acquired shares of the Company&#8217;s Series I and II Preferred Stock; and (ii) warrants to purchase an aggregate of&#160;&#160;2
859
375 shares of Common Stock with an exercise price of $1.50 per share
 which equals one half of the outstanding&#160;&#160;and unexercised warrants issued to Brightline Ventures I in other transactions where Brightline Ventures I provided financing to the Company. Prior to December 31
 2012
 all Series I Preferred shares held by Brightline Ventures I were converted to common shares consistent with the amendment. The remaining Series II Preferred shares held of 665
339 shares and $3
326
697 was reclassified to permanent equity based on the removal of the redemption feature associated with the preferred stock. The value reclassified was equal to the carrying value of the shares on the date the agreement was modified. This value was $2
157
238 based on a gross value of $3
326
697 and a remaining discount of $1
169
459. Furthermore
 the accrued dividends relating to the Series II Convertible Preferred Stock have also been reclassified to Stockholders&#8217; Equity.&#160;&#160;These reclassifications were necessary based on the preferred shares no longer being subject to potential cash redemption.


At December 31
 2012
 the Company has no outstanding Series I Convertible
 Redeemable Preferred Stock.&#160;&#160;All of the shares of Series II Convertible Preferred Stock outstanding as of December 31
 2012 were owned by related parties.



In connection with certain private placements of the Company&#8217;s securities (the &#8220;Registrable Securities&#8221;) effected in 2008 the Company entered into registration rights agreements (the &#8220;RRA&#8221;) that required the Company to file a registration statement covering the Registrable Securities with the Securities and Exchange Commission no later than thirty days after the final closing as contemplated in the Private Placement Memorandum for the 2008 offering (the &#8220;Filing Deadline&#8221;).&#160;&#160;The Company filed a registration statement on December 14
 2009. However
 the statement had not been declared effective as the Company was not Form S-3 eligible.&#160;&#160;A Form S-1 registration statement was filed on June 2
 2011
 and went effective on June 3
 2011.&#160;&#160;Under the terms of the registration rights agreement
 as partial compensation
 the Company would be required to make pro rata payments to each Investor in an amount equal to 1.5% of the aggregate amount invested by such Investor for each 30-day period or pro rata for any portion thereof following the Filing Deadline for which no registration statement was filed.&#160;&#160;We obtained a release and waiver of the amounts due from 74 of the 2008 investors.&#160;&#160;As of December 31
 2013
 there are 3 investors who have yet to sign the release and waiver.&#160;&#160;Under the terms of the RRA
 as of that date we potentially owe
 and recognized as liquidated damages
 the amount of $36
178.&#160;&#160;During 2011
 two investors did sign a release and waiver of any such claims
 and therefore we recognized a gain of $74
850 related to the reduction of these potential claims.





















Our derivative liabilities decreased to $95
049 at December 31
 2013 from $8
025
381 at December 31
 2012.&#160;&#160;The gain recognized during the twelve months ended December 31
 2013 was $966
736 as compared to a loss of $1
514
156 for the twelve months ended December 31
 2012.

During the twelve months ended December 31
 2013
 additional paid in capital increased by $6
963
596 as a result of the March 2013 conversion of the Series II Convertible Preferred Stock by Brightline Ventures I and the exercise of warrants in 2013.&#160;&#160;The change attributable to the conversion of the preferred stock was $2
761
688 and the change associated with the exercise of warrants was $4
201
908

The assumptions used to value the derivative liabilities in the lattice model for the year ended December 31
 2013 included the closing stock price of $0.56 per share
 the total market capitalization of $28
625
236
 and the projected volatility based on a historical value used of 93% and assuming the probability for an event of default occurring 5% of the time and increasing by 0.10% per month.&#160;&#160;For the year ended December 31
 2012
 the assumptions included the closing stock price of $1.74 per share
 the total market capitalization of $71
338
556
 and the projected volatility based on a historical value used of 182% and assuming the probability for an event of default occurring 5% of the time and increasing by 0.10% per month.

The following tabular presentation reflects the components of derivative financial instruments on the Company&#8217;s balance sheet at December 31
 2013 and December 31
 2012:






























&#160;$95
049



&#160;$6
626
255

















&#160;1
399
126











&#160;$95
049



&#160;$8
025
381











&#160;$8
025
381



&#160;$11
031
432






&#160;(966
736)



&#160;1
514
156






&#160;(6
963
596)



&#160;(4
520
207)











&#160;$95
049



&#160;$8
025
381






For the twelve months ended December 31
 2013
 the Company issued 5
893
887 shares of common stock as a result of the exercise of warrants both on a cash and cashless basis. The impact of these issuances to the related embedded derivative liabilities was a decrease to the derivative liability and increase to additional paid in capital for $2
489
552 on the exercise dates.&#160;&#160;Finally
 the Company issued 3
859
697 shares of common stock as a result of the conversion of Series II Convertible Preferred Stock and accrued dividends.&#160;&#160;The impact of these conversions to the related embedded derivative liabilities was a decrease to the derivative liability and increase to additional paid in capital for $2
761
688 on the conversion dates.

As a result of the August 20
 2013 transaction with Brightline Ventures I
 pursuant to the anti-dilution provisions in the $1.50 Warrants that were not exercised as part of the Cashless Exercise Program
 the Company reduced the exercise price of those warrants to $1.25 per share and adjusted the number of shares issuable upon the exercise of those warrants such that for every five warrants owned
 each remaining holder of $1.50 Warrants received one additional warrant with an exercise price of $1.25.&#160;&#160;There were a total of 11
880
047 warrants that were not exercised as part of the Cashless Exercise Program.&#160;&#160;In addition
 the warrant holders agreed to permanently waive the full reset feature contained in the original warrant.&#160;&#160;As a result
 the Company issued an aggregate of 2
376
009 additional warrants at an exercise price of $1.25 per share (including 2
316
597 additional warrants that were issued to Brightline Ventures I) to the holders of $1.50 Warrants that were not exercised as part of the Cashless Exercise Program and recognized a settlement to additional paid in capital for the related derivative liability of $1
712
356.

On November 18
 2013
 the Company completed a public offering of 1
866
667 shares of Common Stock at a price of $0.75 per share along with warrants to purchase 1
400
000 shares of Common Stock at an exercise price of $1.00 per share.&#160;&#160;The warrants were issued with a full reset feature which was valued at $57
729 at issuance and netted with the $966
736 gain recognized on the derivative liability for the year ended December 31
 2013.

During 2012
 the Company issued 689
087 shares of common stock as a result of the exercise of warrants both on a cash and cashless basis.&#160;&#160;The impact of these issuances to the related embedded derivative liabilities was a decrease to the derivative liability and increase to additional paid in capital for $1
021
913 on the exercise dates.&#160;&#160;Also during 2012
 the Company issued 1
658
979 shares of common stock as a result of the conversion of the remaining 2008 and 2010 notes payable
 including accrued interest.&#160;&#160;The impact of these conversions to the related embedded derivative liabilities was a decrease to the derivative liability and increase to additional paid in capital for $48
619 on the conversion dates.&#160;&#160;Finally
 the Company issued 5
493
912 shares of common stock as a result of the conversion of Series I Preferred Stock and accrued dividends.&#160;&#160;The impact of these conversions to the related embedded derivative liabilities was a decrease to the derivative liability and increase to additional paid in capital for $3
449
675 on the conversion dates.






















On February 6
 2012 the Company issued 238
800 shares of common stock to its four non-executive directors (59
700 each) &#8211; Mark Hershhorn
 Brian Israel
 Morris Garfinkle and Edward Smith III. The Company recognized a total of expense of $160
000 related to these issuances.&#160;&#160;These shares were valued based on the closing price of the grant date.


On July 2
 2012
 we entered into a Private Placement of Securities &amp; Advisory Services Agreement with Maxim Group LLC
 pursuant to which Maxim agreed to act as the Company&#8217;s exclusive placement agent in a proposed private placement of equity
 convertible
 debt and/or linked securities of the Company up to $10 million.&#160;&#160;This agreement terminated on December 31
 2012.

In exchange for Maxim&#8217;s services
 we agreed to pay Maxim with 150
000 shares of the Company&#8217;s Common Stock&#160;&#160;valued at $150
000 for purposes of the agreement
 as well as $10
000 per month for the duration of this agreement.&#160;&#160;An additional 350
000 shares of Common Stock would have been issued to Maxim upon the completion of a closing that resulted in the Company receiving a minimum of $10 million.&#160;&#160;No such transaction occurred prior to the termination of the agreement.

We determined that all of the securities issued pursuant to the agreement were exempt from registration under the Securities Act of 1933
 as amended (the Act) pursuant to Section 4(2) of the Act and Rule 506 of Regulation D promulgated under the Act. We based this determination on the non-public manner in which we offered the securities and on the representations of the persons purchasing such securities
 which included
 in pertinent part
 that such persons were accredited investors within the meaning of Rule 501 of Regulation D promulgated under the Act
 and that such persons were acquiring such securities for investment purposes for their own respective accounts and not as nominees or agents
 and not with a view to resale or distribution
 and that each such person understood such securities may not be sold or otherwise disposed of without registration under the Act or an applicable exemption therefrom.





On January 22
 2013 the Company issued 114
944 shares of common stock to its four non-executive directors
 Mark Hershhorn
 Morris Garfinkle
 Brian Israel and Edward Smith (28
736 shares each). The Company recognized a total of expense of $200
002 related to these issuances.&#160;&#160;These shares were valued based on the closing price on the grant date.

On October 28
 2013
 the Company entered into a Consulting Agreement with Steeltown Consulting Group
 LLC
 pursuant to which Steeltown will assist in evaluating various business and financial matters.&#160;&#160;The Company issued 220
000 restricted shares of common stock as consideration for the services being rendered in this agreement.&#160;&#160;This agreement was scheduled to terminate on January 31
 2014.&#160;&#160;On December 3
 2013
 the Company and Steeltown entered into a new Consulting Agreement (which replaces the agreement dated October 28
 2013) in which both the Company and Steeltown substantially agreed to the same services being rendered as the previous agreement.&#160;&#160;The Company issued 550
000 shares of restricted common stock as consideration for the services being rendered under this new agreement.&#160;&#160;This agreement will terminate on January 31
 2015.&#160;&#160;The Common Stock was valued at $569
800 based on the closing prices of the stock on the dates the agreements were executed.






On January 15
 2012
 the Company issued 1
508
000 shares of its Common Stock
 $.00005 par value per share
 upon conversion to common stock of&#160;&#160;its 8% Convertible Secured Notes due in 2012 (the Notes)
 representing principal of $1
300
000 and interest of $208
000.&#160;&#160;The conversion was in accordance with the agreement
 and therefore no gain or loss was recorded.

On April 19
 2012
 the Company issued 150
979 shares of its Common Stock
 $.00005 par value per share
 upon conversion to common stock of its Notes
 representing principal of $120
000 and interest of $30
979.&#160;&#160;The conversion was in accordance with the agreement
 and therefore no gain or loss was recorded.

On November 5
 2012
 the Company issued 212
056 shares of its Common Stock
 $.00005 par value per share
 upon conversion to common stock of its Notes
 representing principal of $200
000 and interest of $12
056.&#160;&#160;The conversion was in accordance with the agreement
 and therefore no gain or loss was recorded.





During the first quarter of 2013
 several investors participated in a warrant exercise program that resulted in the exercise of 1
756
088 warrants into 1
756
088 shares of the Company&#8217;s common stock.&#160;&#160;The warrant program
 which was open to all holders of $1.50 warrants
 allowed those warrant holders to exercise their warrants for a $1.25 strike price during February 2013; it also required a waiver of the anti-dilution provisions in these warrants until February 28
 2013 so that those provisions would not be triggered by the exercises. The conversion of these warrants raised $2
195
110 of cash for the Company.&#160;&#160;&#160;As a result of this warrant modification the Company recognized $4
789
801 of additional expense for previously issued warrants during the period ended March 31
 2013.&#160;&#160;The value of the additional expense was based on the fair value of the warrant modification at the date the offer was made to the warrant holders calculated by using the Black-Scholes Model.&#160;&#160;The key inputs utilized in this model include the Company&#8217;s stock price on the date of the modification of $2.30
 the computed volatility of the Company&#8217;s stock price at 109.96% and the discount rate used based on a U.S. Treasury security for a comparable period to the remaining term of the warrants of .06%.

Also during 2013
 in addition to the warrant exercise program described above
 other investors exercised 531
642 warrants and the Company received proceeds of $294
736.


During 2012
 490
424 stock warrants were exercised for cash of $304
225.




















Beginning August 20
 2013 and in conjunction with the private placement subscription agreement entered into between the Company and Brightline Ventures I-C
 LLC (indicated below and referred to as the &#8220;1.25 Raise&#8221;)
 the Company (i) allowed the holders of the Company&#8217;s outstanding warrants with a $1.50 per share exercise price (the &#8220;$1.50 Warrants&#8221;) with certain anti-dilution provisions contained in the related warrant agreements to choose to exercise their $1.50 Warrants on a cashless basis such that for every ten $1.50 Warrants exercised
 the holder received 4.5 shares of Common Stock (fractional shares were rounded up) (the &#8220;Cashless Exercise Program&#8221;)
 (ii) sought a temporary waiver from the holders of the $1.50 Warrants of the anti-dilution provisions in the warrant agreements with respect to the Cashless Exercise Program and potential capital-raising activities (other than the $1.25 Raise) by the Company by December 31
 2013
 and (iii) asked the holders of the $1.50 Warrants to permanently amend the warrant agreements with respect to certain ratchet provisions so as to reduce the derivative liability the Company incurs as a result of those provisions in the agreements.

The Cashless Exercise Program resulted in 7
172
751 of the $1.50 Warrants being converted into 3
227
742 shares of the Company&#8217;s common stock (including 5
718
750 $1.50 Warrants that were converted by Brightline Ventures I into 2
573
438 shares of common stock).&#160;&#160;As a result of the Cashless Exercise Program
 the Company recognized a loss on equity modification of $990
656&#8212;the difference in value between the $1.50 Warrants exercised and the common stock issued&#8212; for the three months ended September 30
 2013.


As a result of the August 20
 2013 transaction with Brightline Ventures I
 pursuant to the anti-dilution provisions in the $1.50 Warrants that were not exercised as part of the Cashless Exercise Program
 the Company reduced the exercise price of those warrants to $1.25 per share and adjusted the number of shares issuable upon the exercise of those warrants such that for every five warrants owned
 each remaining holder of $1.50 Warrants received one additional warrant with an exercise price of $1.25.&#160;&#160;There were a total of 11
880
047 warrants that were not exercised as part of the Cashless Exercise Program.&#160;&#160;In addition
 the warrant holders agreed to permanently waive the full reset feature contained in the original warrant.&#160;&#160;As a result
 the Company issued an aggregate of 2
376
009 additional warrants at an exercise price of $1.25 per share (including 2
316
597 additional warrants that were issued to Brightline Ventures I) to the holders of $1.50 Warrants that were not exercised as part of the Cashless Exercise Program and recognized a settlement to additional paid in capital for the related derivative liability of $1
712
356.

Also during 2013
 in addition to the warrant exercise program described above
 other investors exercised 909
784 warrants on a cashless basis and received 378
415 shares of common stock.

During 2012
 the Company issued 198
663 shares of common stock on the cashless exercise of warrants.




During 2013
 two former employees exercised 91
400 stock options and the Company received proceeds of $77
734.

During 2012
 14
600 stock options were exercised for cash of $9
526.




During 2013
 the Company issued 100
528 shares of common stock on the cashless exercise of 202
250 stock options.

During 2012
 the Company issued 131
161 shares of common stock on the cashless exercise of options.




On August 20
 2013
 the Company raised additional capital by entering into a private placement subscription agreement with Brightline Ventures I-C
 LLC
 an affiliate of its controlling stockholder
 pursuant to which it sold 376
000 shares of common stock
 for a price of $1.25 per share (the &#8220;1.25 Raise&#8221;)
 and received gross proceeds of $470
000.

On September 18
 2013
 the Company entered into another private placement subscription agreement with Brightline Ventures I-C
 LLC
 pursuant to which it sold 468
571 shares of Common Stock for a price of $1.05 per share
 along with warrants to purchase 234
286 shares of common stock at an exercise price of $1.50 per share (the &#8220;1.05 Raise&#8221;)
 and received gross proceeds of $492
000.&#160;&#160;The waiver discussed above was effective for the $1.05 Raise; therefore
 no additional warrants were issued and no exercise price adjustments were made pursuant to anti-dilution and ratchet provisions as a result of the $1.05 Raise.




On November 18
 2013
 the Company completed the sale of 1
866
667 shares of Common Stock at a price of $0.75 per share along with warrants to purchase 1
400
000 shares of Common Stock at an exercise price of $1.00 per share.&#160;&#160;The Company received after deducting various transaction expenses
 net proceeds of $1
210
165.




On February 12
 2013
 we entered into a settlement agreement with a former provider of investment services over compensation provided in a prior period for services in the raising of equity capital for the Company.&#160;&#160;As a result of this agreement
 the Company issued 875
000 shares of Common Stock to this party.&#160;&#160;As of December 31
 2012
 the Company has recorded a common stock payable in the amount of $1
881
250 which is equal to the value of the shares on the settlement date.




As indicated previously
 the Company entered into a modification with Brightline Ventures I pursuant to which Brightline Ventures I agreed to convert preferred stock into common stock on or before the respective maturity.&#160;&#160;As a result of this modification the Convertible
 Redeemable Preferred Stock Series II was reclassified to equity as Convertible Preferred Stock Series II as of December 31
 2012 as the shares are no longer redeemable.&#160;&#160;On March 18
 2013
 Brightline Ventures I converted the Series II Convertible Preferred Stock of $3
326
697 together with $533
000 of accrued dividends thereon into 3
859
697 shares of the Company&#8217;s Common Stock.






















For the twelve months ended December 31
 2013
 there were 2
287
730 stock warrants were exercised for cash and the Company issued 3
606
157 shares of Common Stock on the cashless exercise of warrants.&#160;&#160;Also during 2013
 91
400 stock options were exercised for cash while the Company issued 100
528 shares of common stock on the cashless exercise of stock options.&#160;&#160;&#160;&#160;In 2012
 490
424 stock warrants were exercised for cash and the Company issued 198
663 shares of Common Stock for the cashless exercise of warrants.&#160;&#160;Also during 2012
 14
600 stock options were exercised for cash while the Company issued 131
161 shares of Common Stock on the cashless exercise of options.

A summary of the status of the warrants issued by the Company as of December 31
 2013 and 2012 are as follows:









































&#160;23
392
811







&#160;23
752
669











&#160;4
010
295







&#160;650
000











&#160;(2
287
730)







&#160;(490
424)











&#160;(8
082
535)







&#160;(335
541)











&#160;(344
576)







&#160;(183
893)









&#160;16
688
265





&#160;23
392
811















Outstanding
 end of period



&#160;16
688
265







&#160;23
392
811





















&#160;16
688
265







&#160;23
392
811








As of December 31
 2013 and 2012
 the Company had warrants outstanding to purchase 16
688
265 and 23
736
811 shares of the Company&#8217;s common stock
 respectively
 at prices ranging from $0.01 to $1.50 per share.&#160;&#160;These warrants expire at various dates through November 2018.

There were 4
010
295 warrants issued in 2013.&#160;&#160;As part of the August 20
 2013 transaction with Brightline Ventures I discussed above
 the Company issued one additional warrant equal for every five warrants owned and not exercised as part of the Cashless Exercise Program.&#160;&#160;Thus
 the Company issued an aggregate of 2
376
009 additional warrants at an exercise price of $1.25 per share (including 2
316
597 additional warrants that were issued to Brightline Ventures I) to the holders of $1.50 Warrants. On September 18
 2013
 the Company entered into a private placement subscription agreement with Brightline Ventures I-C
 LLC
 pursuant to which it issued warrants to purchase 234
286 shares of common stock at an exercise price of $1.50 per share.&#160;&#160;Finally
 On November 18
 2013
 the Company completed a public offering of its Common Stock in which it issued warrants to purchase 1
400
000 shares of Common Stock at an exercise price of $1.00 per share.

On October 21
 2013
 the Company issued warrants to purchase up to 30
000 shares of common stock in a private placement transaction to a business consultant who will be assisting the Company in various product placement matters as partial consideration for services being rendered.&#160;&#160;The per share exercise prices of the warrants will be determined based on the market price of the Company&#8217;s common stock if and when certain targets are met; the warrants are exercisable through October 21
 2018.

During 2012
 there were 650
000 warrants issued to investors and for services rendered. The fair value of the warrants issued in 2012 did not have any reset provisions and were valued at $273
641 using the Black Scholes model. A portion of these warrants equal to 100
000
 were valued at $40
508 and were attached to debt. These warrants were recorded as a debt discount upon issuance and were fully amortized upon conversion of the related notes in 2012. The other portion of warrants equal to 550
000
 were valued at $233
133 using the Black Scholes model on the grant date. These warrants were issued for investor relations services. The fair value is being amortized straight line over the related requisite service period which resulted in $172
000 of expense during the year ended December 31
 2012.


















The Company&#8217;s Incentive Compensation Plan (the &#8220;Plan&#8221;) provides for the issuance of qualified options to all employees and non-qualified options to directors
 consultants and other service providers.

A summary of the status of stock options issued by the Company as of December 31
 2013 and 2012 are as follows:






































&#160;7
728
877







&#160;5
645
202











&#160;2
176
535







&#160;2
354
275











&#160;(293
650)







&#160;(230
600)











&#160;(28
000)







&#160;(40
000)









&#160;9
583
762





&#160;7
728
877















Outstanding
 end of period



&#160;9
583
762







&#160;7
728
877































&#160;9
536
262







&#160;7
582
022












At December 31
 2013
 the aggregate intrinsic value of all outstanding options was $0 of which 9
536
262 outstanding options are currently exercisable at a weighted average exercise price of $1.17 and a weighted average remaining contractual term of 3.3 years.












































































During 2013
 the Company granted 2
176
535 options to employees and recognized a total of $2
318
355 in stock compensation expense.&#160;&#160;During 2012
 the Company granted 2
324
275 options to employees or advisors and recognized a total of $96
599 in stock based compensation related to the options granted above.&#160;&#160;The options granted to employees are 25% vested at the date of grant and 25% every 90
 180 and 270 days subsequent to the grant date.&#160;&#160;The expiration date of the options granted in both 2013 and 2012 is five years from the grant date.

As of December 31
 2013
 the Company had reserved 8
416
238 shares of Common Stock to be issued upon the exercise of qualified options issued under the Plan.&#160;&#160;As of December 31
 2012 the Company had 10
271
123 shares available for grant under the Plan.

Stock options outstanding at December 31
 2013 are as follows:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;






















































































&#160;7
090
227











&#160;7
090
227







&#160;2
368
535











&#160;2
321
035







&#160;125
000











&#160;125
000





&#160;9
583
762











&#160;9
536
262

























Stock options outstanding at December 31
 2012 are as follows:
























































































&#160;5
435
202











&#160;5
107
003







&#160;210
000











&#160;210
000





&#160;5
645
202











&#160;5
317
003








As of December 31
 2013 and 2012 the Company had unrecognized stock based compensation to be recognized in the following year of $22
103 and $77
595
 respectively.




In December 2011
 the Company was sued in Circuit Court of the 17th Judicial District
 Winnebago County
 Illinois
 by LIBCO Industries
 Inc.
 alleging the Company breached a construction contract and tortuously interfered with a business relationship
 and is seeking damages in excess of $185
000.&#160;&#160;The case has subsequently been transferred to the 19th Judicial Circuit Court
 Lake County
 Illinois.&#160;&#160;Management believes that the allegations are frivolous and wholly without merit and will vigorously defend the claim.&#160;&#160;Related to this matter
 Process Piping
 LLC
 a sub-contractor for LIBCO Industries
 filed a mechanics lien on the property leased by the Company
 claiming it was owed in excess of $95
000 by LIBCO Industries.&#160;&#160;As of December 31
 2011
 the Company accrued as a settlement loss
 the $62
500 paid to Process Piping
 LLC on March 6
 2012 in exchange for a release of its lien as well as an assignment of all of its claims against LIBCO Industries.&#160;&#160;On January 31
 2013
 the Circuit Court granted the Company&#8217;s motion for partial summary judgment on the tortious interference claim.&#160;&#160;In the fourth quarter of 2013
 the parties settled all outstanding matters and the case has subsequently been dismissed. As part of the settlement
 the Company received $10
000 in cash and both parties provided releases of all respective claims.


During 2012
 the Company entered into a settlement agreement with a former employee who filed a Charge of Discrimination with the Equal Employment Opportunity Commission.&#160;&#160;The Company settled with a payment of $13
968 and the matter was resolved.


As of December 31
 2012
 the Company has recorded a liability in the amount of $102
000 relating to the complaint initiated by Joseph Sanfilippo and James Cluck as discussed in Note 18 below.&#160;&#160;The Company believes that it has good grounds to defend this suit
 and has only allocated this amount so as to be compliant with applicable accounting standards.


On February 12
 2013
 we entered into a settlement agreement with a former provider of investment services over compensation provided in a prior period for services in the raising of equity capital for the Company.&#160;&#160;As a result of this agreement
 the Company issued 875
000 shares of Common Stock to this party.&#160;&#160;As of December 31
 2012
 the Company has recorded a common stock payable and settlement loss in the amount of $1
881
250.




During 2013 and 2012
 the Company incurred net losses
 and therefore had no tax liability.&#160;&#160;The net deferred tax asset generated by the loss carry forward has been fully reserved.&#160;&#160;The cumulative net loss carry forward is approximately $96
624
455 and $91
147
205 for the years ended December 31
 2013 and 2012 respectively
 and will expire in the years 2021 through 2033.

At December 31
 2013
 the net deferred tax asset based on a 34% tax rate consisted of the following:




























&#160;$32
852
315



&#160;$30
990
050











&#160;(32
852
315)



&#160;(30
990
050)






















After evaluating our own potential tax uncertainties
 the Company has determined that there are no material uncertain tax positions that have a greater than 50% likelihood of reversal if the Company were to be audited.&#160;&#160;Our tax returns for the years ended December 31
 2013 and 2012 may be subject to IRS audit.


















The Company&#8217;s customers are food manufacturers
 school districts and the general public.&#160;&#160;There were three significant customers who accounted for 36%
 24% and 5% of total sales for the year ended December 31
 2013.&#160;&#160;There were three significant customers who accounted for 36%
 24% and 9% of total sales for the year ended December 31
 2012.&#160;&#160;Further
 two significant customers accounted for 61% and 11% of the total accounts receivable for the year ended December 31
 2013.&#160;&#160;Two significant customers accounted for 77% and 9% of the total accounts receivable for the year ended December 31
 2012.

The Company maintains cash deposits with major banks
 which from time to time may exceed federally insured limits.&#160;&#160;At December 31
 2013 and 2012
 $193
472 and $394
804
 respectively
 were in excess of federally insured limits.&#160;&#160;The Company periodically assesses the financial condition of the institutions and believes that the risk of any loss is minimal.






The Company leases a combined production and office facility located in Mundelein
 Illinois.&#160;&#160;The facility is approximately 44
000 square feet.&#160;&#160;The Company extended the lease in the first quarter of 2013 until May 2014 and the required monthly rental payments will be $21
361
 including property taxes.&#160;&#160;Insurance and maintenance are billed when due.&#160;&#160;If we were to lose this lease or not be able to extend our lease due to the specific requirements of our Company
 the effect on our operations could be substantial.





















&#160;256
332






&#160;85
444

























&#160;$341
776










The total rent expense for the years ended December 31
 2013 and 2012
 respectively
 was $280
696 and $324
397.


On March 14
 2014 the Company entered into an amendment to the original lease agreement for office space located in Mundelein
 Illinois.&#160;&#160;The amendment extended the term of the lease to May 14
 2015 upon the same terms and conditions contained in the lease as amended.





















On July 7
 2007
 the Company was served with a complaint by Joseph Sanfilippo and James Cluck for violation of the Consumer Fraud Act and is seeking damages in excess of $200
000.&#160;&#160;The trial court has issued a default order against the Company
 and has denied the Company&#8217;s Motion to reconsider.&#160;&#160;Management believes that the trial court&#8217;s rulings were erroneous and that it has grounds for appeal
 and that the underlying allegations are frivolous and wholly without merit and will vigorously defend the claim. The outcome of this matter is unknown as of the report date.&#160;&#160;However
 the Company has conservatively allocated a reserve of $102
000 to satisfy any liability it may incur as a result of this matter.


In December 2011
 the Company was sued in Circuit Court of the 17th Judicial District
 Winnebago County
 Illinois
 by LIBCO Industries
 Inc.
 alleging the Company breached a construction contract and tortuously interfered with a business relationship
 and is seeking damages in excess of $185
000.&#160;&#160;The case has subsequently been transferred to the 19th Judicial Circuit Court
 Lake County
 Illinois.&#160;&#160;Management believes that the allegations are frivolous and wholly without merit and will vigorously defend the claim.&#160;&#160;Related to this matter
 Process Piping
 LLC
 a sub-contractor for LIBCO Industries
 filed a mechanics lien on the property leased by the Company
 claiming it was owed in excess of $95
000 by LIBCO Industries.&#160;&#160;As of December 31
 2011
 the Company accrued as a settlement loss
 the $62
500 paid to Process Piping
 LLC on March 6
 2012 in exchange for a release of its lien as well as an assignment of all of its claims against LIBCO Industries.&#160;&#160;On January 31
 2013
 the Circuit Court granted the Company&#8217;s motion for partial summary judgment on the tortious interference claim.&#160;&#160;In the fourth quarter of 2013
 the parties settled all outstanding matters and the case has subsequently been dismissed. As part of the settlement
 the Company received $10
000 in cash and both parties provided releases of all respective claims.


During 2012
 the Company entered into a settlement agreement with a former employee who filed a Charge of Discrimination with the Equal Employment Opportunity Commission.&#160;&#160;The Company settled with a payment of $13
968 and the matter was resolved.





The Company from time to time enters into certain types of contracts that contingently require the Company to indemnify parties against third party claims. These contracts primarily relate to: (i) divestiture agreements
 under which the Company may provide customary indemnifications to purchasers of the Company&#8217;s businesses or assets; (ii) certain real estate leases
 under which the Company may be required to indemnify property owners for environmental and other liabilities
 and other claims arising from the Company&#8217;s use of the applicable premises; and (iii) certain agreements with the Company's officers
 directors and employees
 under which the Company may be required to indemnify such persons for liabilities arising out of their employment relationship.&#160;&#160;The terms of such obligations vary. Generally
 a maximum obligation is not explicitly stated. Because the obligated amounts of these types of agreements often are not explicitly stated
 the overall maximum amount of the obligations cannot be reasonably estimated. Historically
 the Company has not been obligated to make significant payments for these obligations
 and no liabilities have been recorded for these obligations on its balance sheet as of December 31
 2013.

In general
 the Company offers a one-year warranty for most of the products it sold.&#160;&#160;To date
 the Company has not incurred any material costs associated with these warranties.



















On February 6
 2012 the Company issued 238
800 shares of common stock to its four non-executive directors (59
700 each) &#8211; Mark Hershhorn
 Brian Israel
 Morris Garfinkle and Edward Smith III. The Company recognized a total expense of $160
000 related to these issuances.&#160;&#160;These shares were valued based on the closing price of the grant date.
On August 15
 2012
 Morris Garfinkle
 a Director of the Company
 converted $34
800 (including accrued dividends) of Series I Convertible
 Redeemable Preferred Stock into 34
800 shares of the Company&#8217;s Common Stock.

On December 11
 2012
 the Company&#8217;s external Directors
 Mark Hershhorn
 Morris Garfinkle
 Brian Israel and Edward Smith each agreed to convert $17
403 (including accrued dividends) of Series I Convertible
 Redeemable Preferred Stock into 17
403 shares of the Company&#8217;s Common Stock prior to its maturity.&#160;&#160;The aggregate conversion by the directors was $69
612.&#160;&#160;As a result of this early conversion the Company recorded a loss of $728 for the twelve months ended December 31
 2012.

On January 22
 2013 the Company issued 114
944 shares of common stock to its four non-executive directors
 Mark Hershhorn
 Morris Garfinkle
 Brian Israel and Edward Smith (28
736 shares each). The Company recognized a total of expense of $200
002 related to these issuances.&#160;&#160;These shares were valued based on the closing price on the grant date.

On February 27
 2013 Morris Garfinkle
 a Director of the Company
 participated in a warrant exercise program in which all holders of $1.50 warrants were allowed to exercise their warrants for a $1.25 strike price during February 2013.&#160;&#160;Mr. Garfinkle exercised 200
000 warrants and received 200
000 shares of Common Stock.&#160;&#160;As a result of this warrant modification the Company recognized $45
596 of additional expense during the quarter ended March 31
 2013 relating to Mr. Garfinkle&#8217; s warrants based on the fair value of the warrant modification at the date the offer was made to all warrant holders calculated by using the Black-Scholes Model.&#160;&#160;On March 6
 2013
 Mr. Garfinkle exercised other warrants
 with various exercise prices
 and received 26
571 shares of Common Stock. During August 2013
 Mark Hershhorn
 Edward Smith and Brian Israel
 Directors of the Company
 participated in a warrant exercised program offered to all holders of $1.50 warrants such that each warrant holder
 on a cashless basis
 can receive 4.5 shares of Common Stock for every ten warrants exercised.&#160;&#160;Messrs. Hershhorn
 Smith and Israel
 in the aggregate
 exercised 127
695 warrants and received 58
395 shares of Common Stock.&#160;&#160;As a result of the warrant modification the Company recognized $24
281 of additional expense during the quarter ended September 30
 2013 relating to the difference in value between the $1.50 warrants exercised by Messrs. Hershhorn
 Smith and Israel and the Common Stock issued.

See also Notes 9 and 12 with respect to transactions involving our largest shareholder
 Brightline Ventures I
 LLC.






On January 2
 2014 the Company issued 285
716 shares of common stock to its four non-executive directors (71
429 each) &#8211; Mark Hershhorn
 Brian Israel
 Morris Garfinkle and Edward Smith III.&#160;&#160;The Company recognized a total expense of $160
001 related to these issuances.&#160;&#160;These shares were valued based on the closing price on the grant date.


On February 11
 2014 the Company entered into an agreement with Edward Smith III
 a Director and Shareholder of the Company
 pursuant to which Mr. Smith agreed to lend the Company $200
000 in a convertible senior secured note.&#160;&#160;The note matures in two years (February 11
 2016) and bears interest at 12.5% computed based on a 365-day year.&#160;&#160;Accrued interest is payable either at maturity or quarterly at the option of Mr. Smith in shares of the Company&#8217;s Common Stock.&#160;&#160;The note is substantially secured by the assets of the Company.


On March 14
 2014 the Company entered into an amendment to the original lease agreement for office space located in Mundelein
 Illinois.&#160;&#160;The amendment extended the term of the lease from March 15
 2014 to May 14
 2015 upon the same terms and conditions contained in the lease as amended.


On March 24
 2014
 Fordham Capital Partners
 LLC (&#8220;Fordham&#8221;) extended a $500
000 revolving loan (the &#8220;Equipment Loan&#8221;) to Z Trim Holdings
&#160;Inc. (the &#8220;Company&#8221;) evidenced by an Equipment Revolving Note (the &#8220;Note&#8221;) issued by the Company to Fordham.&#160;&#160;The Note requires monthly payments of principal of $10
417 plus interest
 commencing on April 24
 2014 and continuing until February 24
 2015
 followed by a final balloon payment of the entire unpaid principal balance of the Note and all accrued and unpaid interest on March 24
 2015.&#160;&#160;The interest on the Note is calculated at a fixed rate of 20% per annum.&#160;&#160;The Note may be prepaid in full at any time; provided that if the Company prepays the Note prior to September 24
 2014 (such six-month period
 the &#8220;Guaranteed Interest Period&#8221;)
 it must pay a prepayment penalty equal to the amount by which (i) the aggregate interest that Fordham would have received on the Note during the Guaranteed Interest Period had there been no prepayment exceeds (ii) the aggregate interest paid by the Company prior to the date of prepayment.

Pursuant to the Security Agreement
 dated March 24
 2014
 between the Company and Fordham (the &#8220;Security Agreement&#8221;)
 the Equipment Loan is secured by all of the Company&#8217;s equipment (as more specifically defined in the Security Agreement
 the &#8220;Collateral&#8221;).&#160;&#160;The Security Agreement also contains customary restrictive covenants
 including without limitation
 covenants prohibiting the Company from (i) granting additional liens in the Collateral
 (ii) selling
 leasing or transferring the Collateral
 (iii) entering into certain merger
 consolidation or other reorganization transactions
 and (iv) creating
 incurring or assuming additional indebtedness
 in each case subject to certain exceptions.&#160;&#160;The Security Agreement also contains customary events of default.&#160;&#160;If an event of default under the Security Agreement occurs and is continuing
 Fordham may declare any outstanding obligations under the Credit Agreement immediately due and payable.&#160;&#160;After an event of default
 interest on the Note would accrue at a rate of 25% per annum.

Additionally
 pursuant to the Factoring Agreement
 dated March 24
 2014
 between the Company and Fordham
 Fordham may purchase any Accounts of the Company (the &#8220;Factoring Agreement&#8221;).&#160;&#160;To secure payment and performance of the Company&#8217;s liabilities and obligations to Fordham
 including obligations under the Factoring Agreement
 the Company granted Fordham a security interest in all of the Company&#8217;s (i) Accounts
 (ii) Inventory
 (iii) Chattel Paper
 Deposit Accounts
 Documents
 Equipment
 Financial Assets
 Fixtures
 General Intangibles
 Instruments
 Investment Property
 Letter-of-Credit Rights
 Securities
 Software and Supporting Obligations
 (iv) books and records of Seller which relate to Accounts
 (v) all amounts owing to the Company under the Factoring Agreement
 and (vi) Proceeds of the foregoing.&#160;&#160;The Factoring Agreement terminates at any time that the Equipment Loan is paid in full.

On March 28
 2014 the Company entered into an amendment to the custom processing agreement with Aveka Nutra Processing LLC relating to the repayment of the line of credit advances made by the Company plus interest.&#160;&#160;Commencing on April 1
 2014
 Aveka Nutra Processing agreed to begin paying the Company $5
000 per month to be applied to the advances made and accrued interest.















    










M&amp;K CPAS
 PLLC


Z Trim Holdings
 Inc.


We hereby consent to the inclusion in this annual report on Form 10-K of Z Trim Holdings
 Inc. of our report dated April 11
 2014
 relating to the Company's financial statements appearing in the Form 10-K for the years ended December 31
 2013 and 2012.


/s/ M&amp;K CPAS
 PLLC


Houston
 Texas


April 14
 2014













    











I
 Steven J. Cohen
 certify that:


1. I have reviewed this report on Form 10-K of Z Trim Holdings
 Inc.;


2. Based on my knowledge
 this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made
 in light of the circumstances under which such statements were made
 not misleading with respect to the period covered by this report;


3. Based on my knowledge
 the financial statements
 and other financial information included in this report
 fairly present in all material respects the financial condition
 results of operations and cash flows of the registrant as of
 and for
 the periods presented in this report;












a)&#160;&#160;Designed such disclosure controls and procedures
 or caused such disclosure controls and procedures to be designed under our supervision
 to ensure that material information relating to the registrant
 including its consolidated subsidiaries
 is made known to us by others within those entities
 particularly during the period in which this report is being prepared;












b)&#160;&#160;Designed such internal control over financial reporting
 or caused such internal control over financial reporting to be designed under our supervision
 to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;












c)&#160;&#160;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures
 as of the end of the period covered by this report based on such evaluation; and












d)&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected
 or is reasonably likely to materially affect
 the registrant&#8217;s internal control over financial reporting; and





5. The registrant's other certifying officer(s) and I have disclosed
 based on our most recent evaluation of internal control over financial reporting
 to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):









a)&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record
 process
 summarize and report financial information; and












b)&#160;&#160;&#160;Any fraud
 whether or not material
 that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.





Date:&#160;&#160;April 14
 2014

















    











I
 Brian Chaiken
 certify that:


1. I have reviewed this report on Form 10-K of Z Trim Holdings
 Inc.;


2. Based on my knowledge
 this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made
 in light of the circumstances under which such statements were made
 not misleading with respect to the period covered by this report;


3. Based on my knowledge
 the financial statements
 and other financial information included in this report
 fairly present in all material respects the financial condition
 results of operations and cash flows of the registrant as of
 and for
 the periods presented in this report;












a)&#160;&#160;Designed such disclosure controls and procedures
 or caused such disclosure controls and procedures to be designed under our supervision
 to ensure that material information relating to the registrant
 including its consolidated subsidiaries
 is made known to us by others within those entities
 particularly during the period in which this report is being prepared;












b)&#160;&#160;Designed such internal control over financial reporting
 or caused such internal control over financial reporting to be designed under our supervision
 to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;












c)&#160;&#160;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures
 as of the end of the period covered by this report based on such evaluation; and












d)&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected
 or is reasonably likely to materially affect
 the registrant&#8217;s internal control over financial reporting; and





5. The registrant's other certifying officer(s) and I have disclosed
 based on our most recent evaluation of internal control over financial reporting
 to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):









a)&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record
 process
 summarize and report financial information; and












b)&#160;&#160;&#160;Any fraud
 whether or not material
 that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.





Date:&#160;&#160;April 14
 2014

















    









18 U.S.C. SECTION 1350





In connection with the Annual Report of Z Trim Holdings
 Inc. (the &#8220;Company&#8221;) on Form 10-K for the period ended December 31
 2013
 as filed with the Securities and Exchange Commission on or about the date hereof (the &#8220;Report&#8221;)
 I
 Steven J. Cohen
 Chief Executive Officer of the Company
 certify
 pursuant to 18 U.S.C. &#167;1350
 as adopted pursuant to &#167;906 of the Sarbanes-Oxley Act of 2002
 that to the best of my knowledge:






















(2) The information contained in the Report fairly presents
 in all material respects
 the financial condition and results of operations of the Company.










April 14
 2014


A signed original of this written statement required by Section 906
 or other document authenticating
 acknowledging
 or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906
 has been provided to Z Trim Holdings
 Inc. and will be retained by Z Trim Holdings
 Inc. and furnished to the Securities and Exchange Commission or its staff upon request.












    









18 U.S.C. SECTION 1350





In connection with the Annual Report of Z Trim Holdings
 Inc. (the &#8220;Company&#8221;) on Form 10-K for the period ended December 31
 2013
 as filed with the Securities and Exchange Commission on or about the date hereof (the &#8220;Report&#8221;)
 I
 Brian Chaiken
 Chief Financial Officer of the Company
 certify
 pursuant to 18 U.S.C. &#167;1350
 as adopted pursuant to &#167;906 of the Sarbanes-Oxley Act of 2002
 that to the best of my knowledge:






















(2) The information contained in the Report fairly presents
 in all material respects
 the financial condition and results of operations of the Company.










April 14
 2014


A signed original of this written statement required by Section 906
 or other document authenticating
 acknowledging
 or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906
 has been provided to Z Trim Holdings
 Inc. and will be retained by Z Trim Holdings
 Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

















      


      
      




      


      




      


      




      


      




      


      




      

        



      




      

        



      




      


      
      




      

        



      




      

        



      




      


      




      

        



      




      

        



      




      

        



      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        



      
      




      

        



      
      




      

        
        



      




      

        
        
        



      




      

        
        
        



      




      

        
        
        



      




      

        
        
        



      
      




      

        
        
        



      
      




      

        
        
        



      
      




      

        
        



      
      




      

        
        
        



      
      




      

        
        
        



      
      




      

        
        



      
      




      

        
        
        



      
      




      

        
        
        



      




      

        
        
        



      




      

        
        



      




      

        
        



      




      

        
        
        



      




      

        
        
        



      




      

        
        
        



      




      

        
        
        



      




      

        
        



      




      

        
        



      
      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        
        



      




      

        
        



      
      




      

        



      
      




      

        



      
      




      

        



      




      

        



      
      




      

        
        



      




      

        
        



      




      

        
        



      
      




      

        
        



      
      




      

        



      
      




      

        
        



      
      




      

        
        



      




      

        



      




      

        
        



      




      

        
        



      
      




      

        
        



      




      

        
        



      
      




      

        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      




      

        
        



      




      

        
        



      




      

        
        



      




      

        



      




      

        
        



      




      


      




      

        
        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      
      




      

        



      
      




      

        
        



      
      




      

        



      
      




      

        
        



      
      




      

        



      
      




      

        



      
      




      

        



      




      

        



      




      

        



      




      

        



      
      




      

        



      
      




      

        



      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        
        



      
      




      

        



      
      




      

        



      
      




      

        



      




      

        



      




      

        
        



      




      

        



      
      




      

        



      




      

        



      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      




      

        



      




      

        



      




      

        



      
      




      

        



      
      




      

        
        



      
      




      

        



      
      




      

        



      




      

        



      




      

        



      




      


      




      

        



      




      

        



      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        
        



      
      




      

        
        



      
      




      

        



      
      




      

        
        



      




      

        



      




      

        
        



      




      


      
      




      

        



      




      

        



      
      




      

        



      
      




      

        
        



      
      




      

        



      
      




      

        



      
      




      

        



      




      

        



      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      
      




      

        



      




      

        



      




      

        
        



      
      




      

        



      
      




      

        
        



      
      




      

        



      
      




      

        



      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      




      

        
        



      
      




      

        
        



      
      




      

        



      
      




      

        



      
      




      

        



      




      


      
      




      

        



      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        
        



      
      




      

        
        
        



      
      




      

        
        
        



      
      




      

        
        
        



      
      




      

        
        
        



      
      




      

        
        
        



      
      




      

        
        
        



      
      




      

        
        
        



      
      




      

        
        
        



      
      




      

        
        
        



      
      




      

        



      




      

        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        



      




      


      
      




      

        



      
      




      


      
      




      


      
      




      

        



      




      

        



      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      




      

        
        



      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      



    


    




        


        




    


    


    




        


        




    


    


    


    


    


    


  

  

  

  

  

  

  

  




  


  

  

  

  

  


 accrued expenses consist of the following:&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&lt;table cellpadding=0 cellspacing=0 style=width: 100%; font-family: times new roman; font-size: 10pt;&gt;&lt;tr&gt;&lt;td valign=top style=width: 27%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;12/31/13&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;12/31/12&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 27%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Accrued payroll and taxes&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$51
566&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$32
021&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=top style=width: 27%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Accrued settlements&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;102
000&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;110
000&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 27%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Accrued expenses and other&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;40
578&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;31
513&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td valign=top style=width: 27%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td valign=top style=width: 27%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$194
144&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$173


  

  

  

  

  

  

 Depletion and Amortization
 Property
 Plant

  

 Depletion and Amortization
 Property
 Plant

  

  

  

 Share-based Compensation

  

 Share-based Compensation

  

 Share-based Compensation

  

 Share-based Compensation

  

 Share-based Compensation

  

 Share-based Compensation

  

 Share-based Compensation

  

 Share-based Compensation

  

 Share-based Compensation

  

 Share-based Compensation

  

 Share-based Compensation

  

 Share-based Compensation

  

  

  



 2013 and 2012 was $250 and $18



  


  

  

  

  


  


  


  


  

  

  

  

  

  

  

  



 the Company considers all highly liquid investments with a maturity of three months or less to be cash equivalents.&amp;#160;&amp;#160;There were no cash equivalents as of December 31



  


  


  


  


  

  


  

  

  

  

  

  

  

  

  

  

  

  

  

  


  


  


  


  


  


  


  


  


  


  


 Illinois.&amp;#160;&amp;#160;The facility is approximately 44
000 square feet.&amp;#160;&amp;#160;The Company extended the lease in the first quarter of 2013 until May 2014 and the required monthly rental payments will be $21
361
 including property taxes.&amp;#160;&amp;#160;Insurance and maintenance are billed when due.&amp;#160;&amp;#160;If we were to lose this lease or not be able to extend our lease due to the specific requirements of our Company

332&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=top style=width: 16%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;2015&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 20%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;85
444&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 16%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;2016&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 20%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=top style=width: 16%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;2017&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 20%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 16%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;2018&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 20%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td valign=top style=width: 16%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 20%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$341
776&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;The total rent expense for the years ended December 31
 2013 and 2012
 respectively
 was $280
696 and $324
397.&lt;/div&gt;&lt;div style=text-indent: 0pt; display: block;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;On March 14
 2014 the Company entered into an amendment to the original lease agreement for office space located in Mundelein
 Illinois.&amp;#160;&amp;#160;The amendment extended the term of the lease to May 14


  

 Value

  

 Value

  


  


  


  


  


  


  


  

 $0.00005 par value; authorized 200
000
000 shares; issued and outstanding 39
449
138 and 25
032
444 shares
 December 31
 2013 and 2012

  

 $0.00005 par value; authorized 200
000
000 shares; issued and outstanding 39
449
138 and 25
032
444 shares
 December 31
 2013 and 2012

  


  


  


  


  


  


  


  


  


  

 Goods

  

  

 Goods

  

  

  

 Goods

  

  

 Goods

  

 Goods

  

 Goods

  

  

  

  

  

  

  


 we secured financing from three accredited investors (the &amp;#8220;Investors&amp;#8221;) pursuant to which we sold senior secured convertible promissory notes (each a &amp;#8220;Note&amp;#8221; and collectively the &amp;#8220;Notes&amp;#8221;) and warrants and received gross proceeds of $200
000.&amp;#160;&amp;#160;&amp;#160;The Notes have a twenty-four month term and accrue interest at the rate of 8% per annum.&amp;#160;&amp;#160;The principal balance of the Notes is convertible at the rate of $1.00 per share into an aggregate of 200
000 shares of our common stock
 $.00005 par value (the &amp;#8220;Common Stock&amp;#8221;).&amp;#160;&amp;#160;The interest is payable either upon maturity of the Notes or quarterly at the Investors&amp;#8217; option in shares of our Common Stock.&amp;#160;&amp;#160;Any amount of principal or interest which is not paid when due shall bear interest at a rate of interest equal to the eighteen percent (18%) per annum.&amp;#160;&amp;#160;Attached to the Notes are warrants that entitle the Investor to purchase a specified number of shares of common stock of the Company at a price of $1.50 per share within five years.&amp;#160;&amp;#160;The warrants value is discounted against the Notes and is being amortized as interest expense using the effective interest method over the term of the Notes. The valuation of the related discount for the warrants was calculated using the Black Scholes model and was equal to $40
508. The key inputs to the model were the number of warrants of 100
000
 share prices on the grant dates of $0.59 and $0.70
 exercise price of $1.50
 terms of 5 years
 volatilities of 98.16% and 103.66%
 and discount rates of 0.91% and 0.88%.&amp;#160;&amp;#160;During 2012
 the Company recorded amortization of the debt discount in the amount of $40
608.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;On November 5
 2012
 the $200
000 principal balance together with accrued and unpaid interest was converted into common stock.&amp;#160;&amp;#160;As of December 31
 2012

 2012
 the Company recognized debt discount amortization in the amount of&amp;#160;$78


  

  


  


  

 net of amortization-Brightline Ventures I

  

  

  

  

  

  

  


  


  

  

  


  


  

  

  

  

  

  

  

  

  

  


049 at December 31
 2013 from $8
025
381 at December 31
 2012.&amp;#160;&amp;#160;The gain recognized during the twelve months ended December 31
 2013 was $966
736 as compared to a loss of $1
514
156 for the twelve months ended December 31
 2012.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;During the twelve months ended December 31
 2013
 additional paid in capital increased by $6
963
596 as a result of the March 2013 conversion of the Series II Convertible Preferred Stock by Brightline Ventures I and the exercise of warrants in 2013.&amp;#160;&amp;#160;The change attributable to the conversion of the preferred stock was $2
761
688 and the change associated with the exercise of warrants was $4
201

 2013 included the closing stock price of $0.56 per share
 the total market capitalization of $28
625
236
 and the projected volatility based on a historical value used of 93% and assuming the probability for an event of default occurring 5% of the time and increasing by 0.10% per month.&amp;#160;&amp;#160;For the year ended December 31
 2012
 the assumptions included the closing stock price of $1.74 per share
 the total market capitalization of $71
338
556
 and the projected volatility based on a historical value used of 182% and assuming the probability for an event of default occurring 5% of the time and increasing by 0.10% per month.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;The following tabular presentation reflects the components of derivative financial instruments on the Company&amp;#8217;s balance sheet at December 31
 2013 and December 31
 2012:&lt;/div&gt;&lt;/div&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&lt;table cellpadding=0 cellspacing=0 style=width: 100%; font-family: times new roman; font-size: 10pt;&gt;&lt;tr&gt;&lt;td colspan=2 valign=top style=border-bottom: black 2px solid; width: 41%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Components of derivative financial instruments&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 2%; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 11%; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=top style=width: 30%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=top style=width: 30%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;12/31/13&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;12/31/12&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 30%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Common stock warrants&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$95
049&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$6
626
255&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=top style=width: 30%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Embedded conversion features for&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 30%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;&amp;#160;convertible debt or preferred shares&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;1
399
126&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td valign=top style=width: 30%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 30%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Total&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$95
049&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$8
025
381&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td valign=top style=width: 30%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 30%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Beginning balance&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$8
025
381&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$11
031
432&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=top style=width: 30%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Change in derivative liability valuation&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(966
736)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;1
514
156&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 30%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Change in derivative liability - settlements&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(6
963
596)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(4
520
207)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td valign=top style=width: 30%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 30%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Total&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$95
049&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$8
025
381&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;For the twelve months ended December 31
 2013
 the Company issued 5
893
887 shares of common stock as a result of the exercise of warrants both on a cash and cashless basis. The impact of these issuances to the related embedded derivative liabilities was a decrease to the derivative liability and increase to additional paid in capital for $2
489
552 on the exercise dates.&amp;#160;&amp;#160;Finally
 the Company issued 3
859
697 shares of common stock as a result of the conversion of Series II Convertible Preferred Stock and accrued dividends.&amp;#160;&amp;#160;The impact of these conversions to the related embedded derivative liabilities was a decrease to the derivative liability and increase to additional paid in capital for $2
761
688 on the conversion dates.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;As a result of the August 20
 2013 transaction with Brightline Ventures I
 pursuant to the anti-dilution provisions in the $1.50 Warrants that were not exercised as part of the Cashless Exercise Program
 the Company reduced the exercise price of those warrants to $1.25 per share and adjusted the number of shares issuable upon the exercise of those warrants such that for every five warrants owned
 each remaining holder of $1.50 Warrants received one additional warrant with an exercise price of $1.25.&amp;#160;&amp;#160;There were a total of 11
880
047 warrants that were not exercised as part of the Cashless Exercise Program.&amp;#160;&amp;#160;In addition
 the warrant holders agreed to permanently waive the full reset feature contained in the original warrant.&amp;#160;&amp;#160;As a result
 the Company issued an aggregate of 2
376
009 additional warrants at an exercise price of $1.25 per share (including 2
316
597 additional warrants that were issued to Brightline Ventures I) to the holders of $1.50 Warrants that were not exercised as part of the Cashless Exercise Program and recognized a settlement to additional paid in capital for the related derivative liability of $1
712
356.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;On November 18
 2013
 the Company completed a public offering of 1
866
667 shares of Common Stock at a price of $0.75 per share along with warrants to purchase 1
400
000 shares of Common Stock at an exercise price of $1.00 per share.&amp;#160;&amp;#160;The warrants were issued with a full reset feature which was valued at $57
729 at issuance and netted with the $966
736 gain recognized on the derivative liability for the year ended December 31
 2013.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;During 2012
 the Company issued 689
087 shares of common stock as a result of the exercise of warrants both on a cash and cashless basis.&amp;#160;&amp;#160;The impact of these issuances to the related embedded derivative liabilities was a decrease to the derivative liability and increase to additional paid in capital for $1
021
913 on the exercise dates.&amp;#160;&amp;#160;Also during 2012
 the Company issued 1
658
979 shares of common stock as a result of the conversion of the remaining 2008 and 2010 notes payable
 including accrued interest.&amp;#160;&amp;#160;The impact of these conversions to the related embedded derivative liabilities was a decrease to the derivative liability and increase to additional paid in capital for $48
619 on the conversion dates.&amp;#160;&amp;#160;Finally
 the Company issued 5
493
912 shares of common stock as a result of the conversion of Series I Preferred Stock and accrued dividends.&amp;#160;&amp;#160;The impact of these conversions to the related embedded derivative liabilities was a decrease to the derivative liability and increase to additional paid in capital for $3
449



  


  


 including embedded derivatives in the Company&amp;#8217;s warrants
 convertible preferred stock
 and its Convertible 8% Senior Secured Notes issued in 2008
 2009
 and 2010
 which have reset provisions to the exercise price and conversion price if the Company issues equity or other notes at a price less than the exercise price set forth in such warrants and notes
 are separately valued and accounted for on the Company&amp;#8217;s balance sheet. Fair values for exchange traded securities and derivatives are based on quoted market prices. Where market prices are not readily available







 2013
 there were 2
287
730 stock warrants were exercised for cash and the Company issued 3
606
157 shares of Common Stock on the cashless exercise of warrants.&amp;#160;&amp;#160;Also during 2013
 91
400 stock options were exercised for cash while the Company issued 100
528 shares of common stock on the cashless exercise of stock options.&amp;#160;&amp;#160;&amp;#160;&amp;#160;In 2012
 490
424 stock warrants were exercised for cash and the Company issued 198
663 shares of Common Stock for the cashless exercise of warrants.&amp;#160;&amp;#160;Also during 2012
 14
600 stock options were exercised for cash while the Company issued 131
161 shares of Common Stock on the cashless exercise of options.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;A summary of the status of the warrants issued by the Company as of December 31
 2013 and 2012 are as follows:&lt;/div&gt;&lt;/div&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&lt;div&gt;&lt;table cellpadding=0 cellspacing=0 style=width: 100%; font-family: times new roman; font-size: 10pt;&gt;&lt;tr&gt;&lt;td valign=top style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 10%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;12/31/13&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 2%; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 9%; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;12/31/12&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 2%; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 9%; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=top style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td colspan=2 valign=top style=border-bottom: black 2px solid; width: 12%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Number of Warrants&lt;/div&gt;&lt;/td&gt;&lt;td colspan=2 valign=top style=border-bottom: black 2px solid; width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Weighted Average Exercise Price&lt;/div&gt;&lt;/td&gt;&lt;td colspan=2 valign=top style=border-bottom: black 2px solid; width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Number of Warrants&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Weighted Average Exercise Price&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 23%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Outstanding at beginning of year&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;23
392
811&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.46&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;23
752
669&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.55&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=top style=width: 23%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Granted&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;4
010
295&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.18&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;650
000&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$0.83&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 23%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Exercised&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(2
287
730)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.28&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(490
424)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$0.62&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=top style=width: 23%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Cashless Exercises&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(8
082
535)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.43&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(335
541)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$0.91&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 23%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Expired and Cancelled&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(344
576)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$0.88&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(183
893)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$14.73&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td valign=top style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;16
688
265&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;23
392
811&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td valign=top style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 10%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=top style=width: 23%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Outstanding
 end of period&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;16
688
265&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.44&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;23
392
811&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.46&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td valign=top style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 10%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=top style=width: 23%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Exercisable at end of period&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;16
688
265&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.44&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;23
392
811&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.46&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;br /&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;As of December 31
 2013 and 2012
 the Company had warrants outstanding to purchase 16
688
265 and 23
736
811 shares of the Company&amp;#8217;s common stock
 respectively
 at prices ranging from $0.01 to $1.50 per share.&amp;#160;&amp;#160;These warrants expire at various dates through November 2018.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;There were 4
010
295 warrants issued in 2013.&amp;#160;&amp;#160;As part of the August 20
 2013 transaction with Brightline Ventures I discussed above
 the Company issued one additional warrant equal for every five warrants owned and not exercised as part of the Cashless Exercise Program.&amp;#160;&amp;#160;Thus
 the Company issued an aggregate of 2
376
009 additional warrants at an exercise price of $1.25 per share (including 2
316
597 additional warrants that were issued to Brightline Ventures I) to the holders of $1.50 Warrants. On September 18
 2013
 the Company entered into a private placement subscription agreement with Brightline Ventures I-C
 LLC
 pursuant to which it issued warrants to purchase 234
286 shares of common stock at an exercise price of $1.50 per share.&amp;#160;&amp;#160;Finally
 On November 18
 2013
 the Company completed a public offering of its Common Stock in which it issued warrants to purchase 1
400
000 shares of Common Stock at an exercise price of $1.00 per share.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;On October 21
 2013
 the Company issued warrants to purchase up to 30
000 shares of common stock in a private placement transaction to a business consultant who will be assisting the Company in various product placement matters as partial consideration for services being rendered.&amp;#160;&amp;#160;The per share exercise prices of the warrants will be determined based on the market price of the Company&amp;#8217;s common stock if and when certain targets are met; the warrants are exercisable through October 21
 2018.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;During 2012
 there were 650
000 warrants issued to investors and for services rendered. The fair value of the warrants issued in 2012 did not have any reset provisions and were valued at $273
641 using the Black Scholes model. A portion of these warrants equal to 100
000
 were valued at $40
508 and were attached to debt. These warrants were recorded as a debt discount upon issuance and were fully amortized upon conversion of the related notes in 2012. The other portion of warrants equal to 550
000
 were valued at $233
133 using the Black Scholes model on the grant date. These warrants were issued for investor relations services. The fair value is being amortized straight line over the related requisite service period which resulted in $172
000 of expense during the year ended December 31
 2012.&lt;/div&gt;&lt;div style=text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;div&gt;STOCK OPTION PLAN&lt;/div&gt;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;The Company&amp;#8217;s Incentive Compensation Plan (the &amp;#8220;Plan&amp;#8221;) provides for the issuance of qualified options to all employees and non-qualified options to directors
 consultants and other service providers.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;A summary of the status of stock options issued by the Company as of December 31
 2013 and 2012 are as follows:&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&lt;table cellpadding=0 cellspacing=0 style=width: 100%; font-family: times new roman; font-size: 10pt;&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td colspan=3 valign=bottom style=border-bottom: black 2px solid; width: 21%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;12/31/13&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td colspan=3 valign=bottom style=border-bottom: black 2px solid; width: 21%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;12/31/12&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=border-bottom: black 2px solid; width: 10%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Number of Shares&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Weighted Average Exercise Price&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=border-bottom: black 2px solid; width: 10%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Number of Shares&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Weighted Average Exercise Price&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=bottom style=width: 23%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Outstanding at beginning of year&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;7
728
877&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.01&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;5
645
202&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.10&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=bottom style=width: 23%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Granted&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;2
176
535&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.67&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;2
354
275&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$0.80&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=bottom style=width: 23%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Exercised&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(293
650)&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$0.98&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(230
600)&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.09&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=bottom style=width: 23%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Expired and Cancelled&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(28
000)&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$2.18&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(40
000)&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$0.86&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td valign=bottom style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=border-bottom: black 4px double; width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;9
583
762&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=border-bottom: black 4px double; width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;7
728
877&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td valign=bottom style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 10%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 10%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=bottom style=width: 23%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Outstanding
 end of period&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=border-bottom: black 4px double; width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;9
583
762&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.16&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=border-bottom: black 4px double; width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;7
728
877&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.01&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td valign=bottom style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 10%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 10%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td valign=bottom style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 10%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 10%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=bottom style=width: 23%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Exercisable at end of period&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=border-bottom: black 4px double; width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;9
536
262&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.17&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=border-bottom: black 4px double; width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;7
582
022&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.03&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;At December 31
 2013
 the aggregate intrinsic value of all outstanding options was $0 of which 9
536

 the Company granted 2
176
535 options to employees and recognized a total of $2
318
355 in stock compensation expense.&amp;#160;&amp;#160;During 2012
 the Company granted 2
324
275 options to employees or advisors and recognized a total of $96
599 in stock based compensation related to the options granted above.&amp;#160;&amp;#160;The options granted to employees are 25% vested at the date of grant and 25% every 90
 180 and 270 days subsequent to the grant date.&amp;#160;&amp;#160;The expiration date of the options granted in both 2013 and 2012 is five years from the grant date.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;As of December 31
 2013
 the Company had reserved 8
416
238 shares of Common Stock to be issued upon the exercise of qualified options issued under the Plan.&amp;#160;&amp;#160;As of December 31
 2012 the Company had 10
271
123 shares available for grant under the Plan.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Stock options outstanding at December 31
 2013 are as follows:&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&lt;table cellpadding=0 cellspacing=0 style=width: 100%; font-family: times new roman; font-size: 10pt;&gt;&lt;tr&gt;&lt;td valign=top style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 8%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Weighted&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=top style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td colspan=2 valign=top style=width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Average&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Weighted&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=top style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 8%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Remaining&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Average&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=top style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Options&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 8%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Contractual&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Exercise&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Options&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 23%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Range of Exercise Prices&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Outstanding&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 8%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Life&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Price&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Exercisable&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td valign=top style=width: 23%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;$0.01-$1.50&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;7
090
227&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 8%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;2.8&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$0.97&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;7
090
227&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td valign=top style=width: 23%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;$1.51-$3.00&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;2
368
535&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 8%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;4.5&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.67&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;2
321
035&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td valign=top style=width: 23%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;$3.01-$5.00&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;125
000&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 8%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;4.6&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$3.11&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;125
000&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td valign=top style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 4px double; text-align: center; width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;9
583
762&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=text-align: center; width: 3%; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=text-align: center; width: 8%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;3.3&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=text-align: center; width: 3%; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=text-align: center; width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.17&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=text-align: center; width: 3%; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 4px double; text-align: center; width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;9
536
262&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: center;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Stock options outstanding at December 31
 2012 are as follows:&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&lt;table cellpadding=0 cellspacing=0 style=width: 100%; font-family: times new roman; font-size: 10pt;&gt;&lt;tr&gt;&lt;td valign=top style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 8%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Weighted&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=top style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 8%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Average&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Weighted&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=top style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 8%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Remaining&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Average&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=top style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Options&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 8%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Contractual&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Exercise&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Options&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 23%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Range of Exercise Prices&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Outstanding&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 8%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Life&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Price&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Exercisable&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td valign=top style=width: 23%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;$0.01-$1.50&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;5
435
202&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 8%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;3.9&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.18&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;5
107
003&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td valign=top style=width: 23%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;$1.51-$3.00&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;210
000&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 8%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;2.0&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.49&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;210
000&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td valign=top style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 4px double; text-align: center; width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;5
645
202&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=text-align: center; width: 8%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;4.0&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 4px double; text-align: center; width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;1.13&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 4px double; text-align: center; width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;5
317
003&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;div&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;As of December 31
 2013 and 2012 the Company had unrecognized stock based compensation to be recognized in the following year of $22
103 and $77
595


 Preferred Stock

  

 Preferred Stock

  

 Preferred Stock

  

 Preferred Stock

  

 Preferred Stock

  

 Preferred Stock

  

 Preferred Stock

  

 Preferred Stock

  

 Preferred Stock

  

 Preferred Stock

  

 Preferred Stock

  

 Preferred Stock

  

 Common Stock

  

 Common Stock

  

  

  

  


 when diluted


  

  

  

  

  

  

  

  


  


  


  


  


  


  

 Measurement with Unobservable Inputs Reconciliations
 Recurring Basis
 Liability Value-Derivative Financial Instruments
 Liabilities [Member]-Fair Value
 Measurements

  

 Measurement with Unobservable Inputs Reconciliations
 Recurring Basis
 Liability Value-Derivative Financial Instruments
 Liabilities [Member]-Fair Value
 Measurements
 Recurring [Member]-Fair Value
 Inputs

  

 Measurement with Unobservable Inputs Reconciliations
 Recurring Basis
 Liability Value-Fair Value
 Measurements
 Recurring [Member]-Fair Value
 Inputs
 Level 2 [Member]-Derivative Financial Instruments

  

 Measurement with Unobservable Inputs Reconciliations
 Recurring Basis
 Liability Value-Derivative Financial Instruments
 Liabilities [Member]-Fair Value
 Measurements
 Recurring [Member]-Fair Value
 Inputs

  

 Measurement with Unobservable Inputs Reconciliations
 Recurring Basis
 Liability Value-Fair Value
 Measurements
 Recurring [Member]-Derivative Financial Instruments
 Liabilities [Member]-Fair Value
 Inputs

  

 Measurement with Unobservable Inputs Reconciliations
 Recurring Basis
 Liability Value-Fair Value
 Measurements
 Recurring [Member]-Fair Value
 Inputs
 Level 2 [Member]-Derivative Financial Instruments

  

 Measurement with Unobservable Inputs Reconciliations
 Recurring Basis
 Liability Value-Derivative Financial Instruments
 Liabilities [Member]-Fair Value
 Measurements

  

 Measurement with Unobservable Inputs Reconciliations
 Recurring Basis
 Liability Value-Derivative Financial Instruments
 Liabilities [Member]-Fair Value
 Measurements

  

 Measurement with Unobservable Inputs Reconciliations
 Recurring Basis
 Liability Value-Derivative Financial Instruments
 Liabilities [Member]-Fair Value
 Inputs
 Level 3 [Member]-Fair Value
 Measurements

  

 Measurement with Unobservable Inputs Reconciliations
 Recurring Basis
 Liability Value-Derivative Financial Instruments
 Liabilities [Member]-Fair Value
 Inputs
 Level 2 [Member]-Fair Value
 Measurements

  

 Measurement with Unobservable Inputs Reconciliations
 Recurring Basis
 Liability Value-Fair Value
 Inputs
 Level 1 [Member]-Derivative Financial Instruments
 Liabilities [Member]-Fair Value
 Measurements

  

 Measurement with Unobservable Inputs Reconciliations
 Recurring Basis
 Liability Value-Derivative Financial Instruments
 Liabilities [Member]-Fair Value
 Inputs
 Level 3 [Member]-Fair Value
 Measurements

  


 accounts receivable
 inventory
 accounts payable and accrued liabilities. The estimated fair value of cash
 accounts receivable
 accounts payable and accrued liabilities approximate their carrying amounts due to the short-term nature of these instruments.&amp;#160;&amp;#160;None of these instruments are held for trading purposes.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;The Company utilizes various types of financing to fund its business needs
 including convertible debt with warrants attached. The Company reviews its warrants and conversion features of securities issued as to whether they are freestanding or contain an embedded derivative and
 if so
 whether they are classified as a liability at each reporting period until the amount is settled and reclassified into equity with changes in fair value recognized in current earnings. At December 31
 2013 and 2012
 the Company had warrants to purchase common stock

 which are developed by the reporting entity and reflect those assumptions that a market participant would use.&lt;/div&gt;&lt;div style=text-indent: 0pt; display: block;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Determining which category an asset or liability falls within the hierarchy requires significant judgment. The Company evaluates its hierarchy disclosures each quarter. The Company&amp;#8217;s only asset or liability measured at fair value on a recurring basis is its derivative liability associated with warrants to purchase common stock and preferred stock. The fair value of the derivative liability at December 31
 2013 and 2012 was $95
049 and $8
025
381
 respectively.&amp;#160;&amp;#160;The gain on derivative liability for the twelve months ended December 31
 2013 was $966
736 compared to a loss on derivative liability of $1
514
156 for the twelve months ended December 31
 2012.&amp;#160;&amp;#160;Below is a hierarchy table of the components of the derivative liability:&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;table cellpadding=0 cellspacing=0 style=width: 100%; font-family: times new roman; font-size: 10pt;&gt;&lt;tr&gt;&lt;td valign=top style=width: 25%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Carrying&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td colspan=4 valign=top style=border-bottom: black 2px solid; width: 22%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Fair Value Measurements Using&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 9%; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 1%; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 9%; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=top style=width: 25%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Value&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Level 1&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Level 2&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Level 3&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Total&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=top style=width: 25%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 25%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Derivative Liabilities&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=right valign=top style=width: 25%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;12/31/11&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; text-align: right; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$11
031
432&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$11
031
432&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$11
031
432&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td valign=top style=width: 25%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=top style=width: 25%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Change in derivative liabilities due to&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 25%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;settlements&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(4
520
207)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(4
520
207)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(4
520
207)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left colspan=2 valign=top style=width: 26%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Change in derivative liabilities valuation&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;1
514
156&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;1
514
156&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;1
514
156&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td valign=top style=width: 25%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(3
006
051)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(3
006
051)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(3
006
051)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td valign=top style=width: 25%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 25%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Derivative Liabilities&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=right valign=top style=width: 25%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;12/31/12&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; text-align: right; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$8
025
381&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$8
025
381&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$8
025
381&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td valign=top style=width: 25%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=top style=width: 25%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Change in derivative liabilities due to&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 25%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;settlements&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(6
963
596)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(6
963
596)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(6
963
596)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left colspan=2 valign=top style=width: 26%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Change in derivative liabilities valuation&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(966
736)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(966
736)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(966
736)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td valign=top style=width: 25%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(7
930
332)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(7
930
332)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(7
930
332)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td valign=top style=width: 25%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 25%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Derivative Liabilities&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=right valign=top style=width: 25%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;12/31/13&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$95
049&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$95
049&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$95


 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Period Increase (Decrease)-Derivative Financial Instruments
 Liabilities [Member]-Fair Value
 Measurements

  

 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Period Increase (Decrease)-Derivative Financial Instruments
 Liabilities [Member]-Fair Value
 Measurements
 Recurring [Member]-Fair Value
 Inputs

  

 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Period Increase (Decrease)-Fair Value
 Measurements
 Recurring [Member]-Derivative Financial Instruments
 Liabilities [Member]-Fair Value
 Inputs

  

 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Period Increase (Decrease)-Fair Value
 Inputs
 Level 2 [Member]-Fair Value
 Measurements
 Recurring [Member]-Derivative Financial Instruments

  

 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Period Increase (Decrease)-Derivative Financial Instruments
 Liabilities [Member]-Fair Value
 Measurements

  

 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Period Increase (Decrease)-Fair Value
 Inputs
 Level 1 [Member]-Fair Value
 Measurements
 Recurring [Member]-Derivative Financial Instruments

  

 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Period Increase (Decrease)-Fair Value
 Measurements
 Recurring [Member]-Fair Value
 Inputs
 Level 2 [Member]-Derivative Financial Instruments

  

 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Period Increase (Decrease)-Fair Value
 Measurements
 Recurring [Member]-Derivative Financial Instruments
 Liabilities [Member]-Fair Value
 Inputs

  


031
432&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$11
031
432&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$11
031
432&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td valign=top style=width: 25%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=top style=width: 25%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Change in derivative liabilities due to&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 25%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;settlements&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(4
520
207)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(4
520
207)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(4
520
207)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left colspan=2 valign=top style=width: 26%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Change in derivative liabilities valuation&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;1
514
156&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;1
514
156&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;1
514
156&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td valign=top style=width: 25%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(3
006
051)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(3
006
051)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(3
006
051)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td valign=top style=width: 25%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 25%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Derivative Liabilities&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=right valign=top style=width: 25%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;12/31/12&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; text-align: right; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$8
025
381&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$8
025
381&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$8
025
381&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td valign=top style=width: 25%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=top style=width: 25%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Change in derivative liabilities due to&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 25%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;settlements&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(6
963
596)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(6
963
596)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(6
963
596)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left colspan=2 valign=top style=width: 26%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Change in derivative liabilities valuation&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(966
736)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(966
736)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(966
736)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td valign=top style=width: 25%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(7
930
332)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(7
930
332)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(7
930
332)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td valign=top style=width: 25%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 25%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Derivative Liabilities&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=right valign=top style=width: 25%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;12/31/13&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$95
049&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$95
049&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$95


 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Purchases
 Sales
 Issues
 Settlements-Fair Value
 Inputs
 Level 2 [Member]-Fair Value
 Measurements
 Recurring [Member]-Derivative Financial Instruments

  

 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Purchases
 Sales
 Issues
 Settlements-Fair Value
 Measurements
 Recurring [Member]-Derivative Financial Instruments
 Liabilities [Member]-Fair Value
 Inputs

  

 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Purchases
 Sales
 Issues
 Settlements-Derivative Financial Instruments
 Liabilities [Member]-Fair Value
 Measurements
 Recurring [Member]-Fair Value
 Inputs

  

 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Purchases
 Sales
 Issues
 Settlements-Derivative Financial Instruments
 Liabilities [Member]-Fair Value
 Measurements

  

 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Purchases
 Sales
 Issues
 Settlements-Fair Value
 Inputs
 Level 1 [Member]-Fair Value
 Measurements
 Recurring [Member]-Derivative Financial Instruments

  

 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Purchases
 Sales
 Issues
 Settlements-Fair Value
 Measurements
 Recurring [Member]-Fair Value
 Inputs
 Level 2 [Member]-Derivative Financial Instruments

  

 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Purchases
 Sales
 Issues
 Settlements-Derivative Financial Instruments
 Liabilities [Member]-Fair Value
 Measurements

  

 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Purchases
 Sales
 Issues
 Settlements-Fair Value
 Measurements
 Recurring [Member]-Derivative Financial Instruments
 Liabilities [Member]-Fair Value
 Inputs

  


  


  

  

  

  

  

  

  

  

  


  


  

  

  


  


 under which the Company may provide customary indemnifications to purchasers of the Company&amp;#8217;s businesses or assets; (ii) certain real estate leases
 under which the Company may be required to indemnify property owners for environmental and other liabilities
 and other claims arising from the Company&amp;#8217;s use of the applicable premises; and (iii) certain agreements with the Company's officers
 directors and employees
 under which the Company may be required to indemnify such persons for liabilities arising out of their employment relationship.&amp;#160;&amp;#160;The terms of such obligations vary. Generally
 a maximum obligation is not explicitly stated. Because the obligated amounts of these types of agreements often are not explicitly stated
 the overall maximum amount of the obligations cannot be reasonably estimated. Historically
 the Company has not been obligated to make significant payments for these obligations
 and no liabilities have been recorded for these obligations on its balance sheet as of December 31
 2013.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;In general
 the Company offers a one-year warranty for most of the products it sold.&amp;#160;&amp;#160;To date


  


 the Company incurred net losses
 and therefore had no tax liability.&amp;#160;&amp;#160;The net deferred tax asset generated by the loss carry forward has been fully reserved.&amp;#160;&amp;#160;The cumulative net loss carry forward is approximately $96
624
455 and $91
147
205 for the years ended December 31
 2013 and 2012 respectively
 and will expire in the years 2021 through 2033.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;At December 31
 2013
 the net deferred tax asset based on a 34% tax rate consisted of the following:&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&lt;table cellpadding=0 cellspacing=0 style=width: 100%; font-family: times new roman; font-size: 10pt;&gt;&lt;tr&gt;&lt;td valign=top style=width: 25%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=top style=width: 25%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;12/31/13&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;12/31/12&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=top style=width: 25%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 25%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Net operating loss&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$32
852
315&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$30
990
050&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td valign=top style=width: 25%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 25%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Less: Valuation allowance&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(32
852
315)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(30
990
050)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td valign=top style=width: 25%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 25%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Net deferred tax asset&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$-&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;After evaluating our own potential tax uncertainties
 the Company has determined that there are no material uncertain tax positions that have a greater than 50% likelihood of reversal if the Company were to be audited.&amp;#160;&amp;#160;Our tax returns for the years ended December 31





  

  

  

  

  

  

  

  




  

  


  


  


  



 using the first-in


  

  

  

 Finished Goods

  

 Finished Goods

  

  

  


 inventory consists of the following:&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&lt;table cellpadding=0 cellspacing=0 style=width: 100%; font-family: times new roman; font-size: 10pt;&gt;&lt;tr&gt;&lt;td valign=top style=width: 27%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;12/31/13&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;12/31/12&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 27%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Raw materials&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$27
575&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$42
831&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=top style=width: 27%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Packaging&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;8
178&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;1
873&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 27%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Work-in-process&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;33
527&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;64
170&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=top style=width: 27%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Finished goods&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;475
255&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;360
428&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td valign=top style=width: 27%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td valign=top style=width: 27%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$544
535&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$469
302&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style=text-indent: 0pt; display: block;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;At December 31 the Company recognized an inventory valuation reserve of $742


  

  

  

  

  

  

  

  

  

  


 2007
 the Company was served with a complaint by Joseph Sanfilippo and James Cluck for violation of the Consumer Fraud Act and is seeking damages in excess of $200
000.&amp;#160;&amp;#160;The trial court has issued a default order against the Company
 and has denied the Company&amp;#8217;s Motion to reconsider.&amp;#160;&amp;#160;Management believes that the trial court&amp;#8217;s rulings were erroneous and that it has grounds for appeal
 and that the underlying allegations are frivolous and wholly without merit and will vigorously defend the claim. The outcome of this matter is unknown as of the report date.&amp;#160;&amp;#160;However
 the Company has conservatively allocated a reserve of $102
000 to satisfy any liability it may incur as a result of this matter.&lt;/div&gt;&lt;div style=text-indent: 0pt; display: block;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;In December 2011
 the Company was sued in Circuit Court of the 17th Judicial District
 Winnebago County
 Illinois
 by LIBCO Industries
 Inc.
 alleging the Company breached a construction contract and tortuously interfered with a business relationship
 and is seeking damages in excess of $185
000.&amp;#160;&amp;#160;The case has subsequently been transferred to the 19th Judicial Circuit Court
 Lake County
 Illinois.&amp;#160;&amp;#160;Management believes that the allegations are frivolous and wholly without merit and will vigorously defend the claim.&amp;#160;&amp;#160;Related to this matter
 Process Piping
 LLC
 a sub-contractor for LIBCO Industries
 filed a mechanics lien on the property leased by the Company
 claiming it was owed in excess of $95
000 by LIBCO Industries.&amp;#160;&amp;#160;As of December 31
 2011
 the Company accrued as a settlement loss
 the $62
500 paid to Process Piping
 LLC on March 6
 2012 in exchange for a release of its lien as well as an assignment of all of its claims against LIBCO Industries.&amp;#160;&amp;#160;On January 31
 2013
 the Circuit Court granted the Company&amp;#8217;s motion for partial summary judgment on the tortious interference claim.&amp;#160;&amp;#160;In the fourth quarter of 2013
 the parties settled all outstanding matters and the case has subsequently been dismissed. As part of the settlement
 the Company received $10
000 in cash and both parties provided releases of all respective claims.&lt;/div&gt;&lt;div style=text-indent: 0pt; display: block;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;During 2012
 the Company entered into a settlement agreement with a former employee who filed a Charge of Discrimination with the Equal Employment Opportunity Commission.&amp;#160;&amp;#160;The Company settled with a payment of $13



  


  

  

  

  

  

  

  

  

  

  

 Notes


 2011
 Z Trim Holdings
 Inc. (the &amp;#8220;Company&amp;#8221;) entered into a Custom Processing Agreement (the &amp;#8220;Agreement&amp;#8221;) with AVEKA Nutra Processing
 LLC (&amp;#8220;ANP&amp;#8221;)
 part of the Aveka Group
 in order to provide the Company with a partner for future manufacturing initiatives.&lt;/div&gt;&lt;div style=text-indent: 0pt; display: block;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;The Agreement provides that ANP will perform certain services related to the Company&amp;#8217;s dietary fiber product
 including manufacturing
 processing
 packaging and storage/warehousing for an initial term of three years.&amp;#160;&amp;#160;The Agreement automatically renews at the end of the initial term for an additional two year term unless either party provides written notice to the other within the specified time frame.&amp;#160;&amp;#160;&amp;#160;&amp;#160;Production began during the third quarter of 2012.&amp;#160;&amp;#160;The Agreement provides for minimum production volumes of 40
000 lbs per month and average volumes of 100
000 lbs. per month with the ability to increase future production volume to potentially as much as 1
000
000 lbs. per month.&lt;/div&gt;&lt;div style=text-indent: 0pt; display: block;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;In addition
 the Company has agreed to make available to ANP a $500
000 line of credit (which includes $10
000 that the Company loaned ANP to assist it with the purchase of its Waukon
 Iowa facility) at an interest rate of 5.5%.&amp;#160;&amp;#160;The line of credit is only permitted to be used by ANP for operating costs which excludes capital expenditures of equipment in excess of $5
000.&amp;#160;&amp;#160;ANP may not draw down on the line of credit more than $75
000 in any given thirty day period.&amp;#160;&amp;#160;The loan is to be paid back to the Company in the form of discounts on production pricing commencing either two years after the first draw by ANP on the line of credit (other than the $10
000 the Company loaned ANP to assist it with the purchase of its Waukon
 Iowa facility) or the first month after the Company has ordered 80
000 lbs. of product for three consecutive months
 whichever shall occur first.&amp;#160;&amp;#160;All of ANP&amp;#8217;s obligations under the line of credit
 as well as the Agreement
 are specifically guaranteed by its parent company
 Aveka Inc.&amp;#160;&amp;#160;As of December 31
 2013 we advanced a total of $500
000 and accrued interest on the advance was $50
650. On March 28
 2014 the Company agreed to an amendment to the custom processing agreement relating to the repayment of the line of credit advances plus interest.&amp;#160;&amp;#160;Commencing on April 1
 2014
 Aveka Nutra Processing will begin paying the Company $5


  

  

  

  

  

  

 Carrying Value

  

  


 Inc. (the &amp;#8220;Company&amp;#8221;) is an agricultural ingredient technology company that owns existing
 and has developed new
 products and processes to make use of biomass for uses in the food and industrial markets.&amp;#160;&amp;#160;The Company&amp;#8217;s food division currently sells a line of products to the food industry that can help food manufacturers reduce their costs and help them solve many production problems.&amp;#160; The Company&amp;#8217;s technology provides value-added ingredients across virtually all food industry categories.&amp;#160; The Company&amp;#8217;s all-natural products
 among other things
 help to reduce fat and calories
 add fiber
 provide shelf-stability
 prevent oil migration
 and add binding capacity &amp;#8211; all without degrading the taste and texture of the final food products.&amp;#160; Perhaps most significantly
 Z Trim&amp;#8217;s products can help extend finished products
 and thereby increase its customers&amp;#8217; gross margins.&amp;#160;&amp;#160;The Company&amp;#8217;s industrial division
 opened in 2012
 plans to sell eco-friendly ingredients to oil drilling
 hydraulic fracturing
 petroleum coke
 steel/aluminum
 paper and other industries.&amp;#160; The Company&amp;#8217;s industrial ingredients are highly functional in applications for adhesives
 binders



  


  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  


 the FASB issued an accounting standards update which requires an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component and to present either on the face of the statement where net income is presented
 or in the notes
 significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income
 but only if the amount reclassified is required to be reclassified to net income in its entirety in the same reporting period provides
 subject to certain conditions
 the option to perform a qualitative
 rather than quantitative
 assessment to determine whether it is more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying amount. The update will be effective in the first quarter of 2013
 although early adoption is permitted
 the Company has not elected early adoption of this pronouncement. The update did not have a material impact on the Company&amp;#8217;s financial position
 results of operations or cash flows.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; font-style: italic; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward
 a Similar Tax Loss
 or a Tax Credit Carryforward Exists&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;In July 2013
 the FASB issued an accounting standards update which requires an entity to present an unrecognized tax benefit
 or portion thereof
 in the statement of financial position as a reduction to a deferred tax asset for a net operating loss carryforward or a tax credit carryforward
 with certain exceptions related to availability. The update will be effective in the first quarter of 2014
 although early adoption is permitted
 the Company has not elected early adoption of this pronouncement. The update is not expected to have a material impact on the Company&amp;#8217;s financial position

 the FASB issued an accounting standards update which provides
 subject to certain conditions
 the option to perform a qualitative
 rather than quantitative
 assessment to determine whether it is more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying amount. The update will be effective in the first quarter of 2013
 although early adoption is permitted
 the Company has not elected early adoption of this pronouncement. The update may
 under certain circumstances
 reduce the complexity and costs of testing indefinite-lived intangible assets for impairment
 but&amp;#160;did not have a material impact on the Company&amp;#8217;s financial position


  

  

  


  


  

 Loans and Financing Receivable
 Net

  

 Loans and Financing Receivable
 Net

  


  

  

  

  

  

 Rent Expense

  

 Rent Expense

  

 Future Minimum Payments Receivable

  

  

  

  

  

  

  


  

  

  

  

  

  

  

  

  


  


  


  


  

 Including Additional Paid in Capital

  

 Including Additional Paid in Capital

  

  

  

  

  

  

  

  


 the Company entered into an agreement with its largest stockholder
 Brightline Ventures I
 LLC (&amp;#8220;Brightline Ventures I&amp;#8221;)
 pursuant to which Brightline Ventures I agreed to convert $3
326
697 (exclusive of dividends)&lt;font style=display: inline; font-weight: bold;&gt;&amp;#160;&lt;/font&gt;worth of Series II Preferred Stock into 3
326
697&lt;font style=display: inline; font-weight: bold;&gt;&amp;#160;&lt;/font&gt;shares of the Company&amp;#8217;s common stock at the earlier of either the maturity date of the security or the closing of any approved transaction with Maxim Group LLC.&amp;#160;&amp;#160;In consideration for the foregoing conversion of Series II Preferred Stock by Brightline Ventures I on or before their respective maturity dates
 the Company modified the following warrants held by Brightline Ventures I to provide them with the ability to exercise such warrants on a cashless basis: (i) warrants to purchase an aggregate of&amp;#160;&amp;#160;11
582
983&lt;font style=display: inline; font-weight: bold;&gt;&amp;#160;&lt;/font&gt;shares of common stock with an exercise price of $1.50 per share
 which were issued to Brightline Ventures I in transactions where Brightline Ventures I acquired shares of the Company&amp;#8217;s Series I and II Preferred Stock; and (ii) warrants to purchase an aggregate of&amp;#160;&amp;#160;2
859
375 shares of common stock with an exercise price of $1.50 per share
 which equaled one half of the outstanding&amp;#160;&amp;#160;and unexercised warrants issued to Brightline Ventures I in other transactions where Brightline Ventures I provided financing to the Company at that time (see Note 12 for a discussion of matters related to these warrants that occurring during&amp;#160;&amp;#160;2013).&amp;#160;&amp;#160;As a result of this modification
 the Series II Convertible
 Redeemable Preferred Stock was reclassified on the balance sheet as permanent Stockholders&amp;#8217; Equity and identified as Series II Convertible Preferred Stock at December 31
 2012. The value reclassified to permanent equity was equal to the carrying value of the shares on the date the agreement was modified. This value was $2
157
238 based on a gross value of $3
326
697 and a remaining discount of $1
169
459. Furthermore
 the accrued dividends relating to the Series II Convertible Preferred Stock were also reclassified to Stockholders&amp;#8217; Equity as of December 31
 2012.&amp;#160;&amp;#160;These reclassifications were necessary based on the preferred shares no longer being subject to potential cash redemption.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;On March 18
 2013
 Brightline Ventures I converted the Series II Convertible Preferred Stock of $3
326
697 together with $533
000 of accrued dividends thereon into 3
859
697 shares of the Company&amp;#8217;s Common Stock.&amp;#160;&amp;#160;As of March 31
 2013 there was no Series II Convertible Preferred Stock outstanding.&amp;#160;&amp;#160;The value of the Series II Preferred Stock and dividends converted was equal to the total value recorded to common stock and additional paid in capital with no gain or loss recorded as the conversion was consistent with the original agreement.&amp;#160;&amp;#160;As a result of the preferred stock conversion
 $2
690
239 was recorded to common stock and additional paid-in capital.&amp;#160;&amp;#160;&amp;#160;Accrued dividends were $476
857 as of December 31
 2012.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;As of December 31
 2013

 2012
 Brightline Ventures I converted $907
120 (including accrued dividends) of Series I Convertible
 Redeemable Preferred Stock into 907
120 shares of the Company&amp;#8217;s Common Stock.&amp;#160;&amp;#160;In conjunction with this conversion
&amp;#160;&amp;#160;Morris Garfinkle
 a Director of the Company
 also converted $34
800 (including accrued dividends) of Series I Convertible
&amp;#160;&amp;#160;Redeemable Preferred Stock into 34
800 shares of the Company&amp;#8217;s Common Stock.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;On September 7
 2012
 Brightline Ventures I converted $727
280 (including accrued dividends) of Series I Convertible
 Redeemable Preferred Stock into 727
280 shares of the Company&amp;#8217;s Common Stock.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;On December 7
 2012
 Brightline Ventures I converted $2
559
752 (including accrued dividends) of Series I Convertible
 Redeemable Preferred Stock into 2
559
752 shares of the Company&amp;#8217;s Common Stock.&amp;#160;&amp;#160;Again on December 29
 2012
 Brightline Ventures I converted $905
348 (including accrued dividends) of Series I Convertible
 Redeemable Preferred Stock into 905
348 shares of the Company&amp;#8217;s Common Stock.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;On December 11
 2012
 the Company&amp;#8217;s external Directors
 Mark Hershhorn
 Morris Garfinkle
 Brian Israel and Edward Smith each agreed to convert $17
403 (including accrued dividends) of Series I Convertible
 Redeemable Preferred Stock into 17
403 shares of the Company&amp;#8217;s Common Stock prior to its maturity.&amp;#160;&amp;#160;The aggregate conversion by the directors was $69
612.&amp;#160;&amp;#160;As a result of this early conversion the Company recorded a loss of $728 for the twelve months ended December 31
 2012.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;On December 15
 2012
 an Investor converted $290
000 (including accrued dividends) of Series I Convertible
 Redeemable Preferred Stock into 290
000 shares of the Company&amp;#8217;s Common Stock.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;On August 13
 2012
 the Company entered into an agreement with Brightline Ventures I pursuant to which Brightline agreed to convert $7
721
988 (exclusive of dividends)&lt;font style=display: inline; font-weight: bold;&gt;&amp;#160;&lt;/font&gt;worth of Series I and II Preferred Stock into 7
721
988&lt;font style=display: inline; font-weight: bold;&gt;&amp;#160;&lt;/font&gt;shares of the Company&amp;#8217;s Common Stock at the earlier of either the maturity date of the security or the closing of any approved transaction with Maxim Group
 LLC.&amp;#160;&amp;#160;In consideration for the foregoing conversion of Preferred Stock by Brightline Ventures I on or before their respective maturity dates
 the Company modified the following warrants held by Brightline Ventures I to provide them with the ability to exercise such warrants on a cashless basis: (i) warrants to purchase an aggregate of&amp;#160;&amp;#160;11
582
983&lt;font style=display: inline; font-weight: bold;&gt;&amp;#160;&lt;/font&gt;shares of Common Stock with an exercise price of $1.50 per share
 which were issued to Brightline Ventures I in transactions where Brightline Ventures I acquired shares of the Company&amp;#8217;s Series I and II Preferred Stock; and (ii) warrants to purchase an aggregate of&amp;#160;&amp;#160;2
859
375 shares of Common Stock with an exercise price of $1.50 per share
 which equals one half of the outstanding&amp;#160;&amp;#160;and unexercised warrants issued to Brightline Ventures I in other transactions where Brightline Ventures I provided financing to the Company. Prior to December 31
 2012
 all Series I Preferred shares held by Brightline Ventures I were converted to common shares consistent with the amendment. The remaining Series II Preferred shares held of 665
339 shares and $3
326
697 was reclassified to permanent equity based on the removal of the redemption feature associated with the preferred stock. The value reclassified was equal to the carrying value of the shares on the date the agreement was modified. This value was $2
157
238 based on a gross value of $3
326
697 and a remaining discount of $1
169
459. Furthermore
 the accrued dividends relating to the Series II Convertible Preferred Stock have also been reclassified to Stockholders&amp;#8217; Equity.&amp;#160;&amp;#160;These reclassifications were necessary based on the preferred shares no longer being subject to potential cash redemption.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;At December 31
 2012
 the Company has no outstanding Series I Convertible
 Redeemable Preferred Stock.&amp;#160;&amp;#160;All of the shares of Series II Convertible Preferred Stock outstanding as of December 31



  


  


  


  

  

  


  


  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  


 office equipment and furniture



  


  


  


  


  


  


  


  


  


  


  


  



 property and equipment
 net consists of the following:&lt;/div&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&lt;table cellpadding=0 cellspacing=0 style=width: 100%; font-family: times new roman; font-size: 10pt;&gt;&lt;tr&gt;&lt;td valign=top style=width: 34%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 4%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;12/31/13&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;12/31/12&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 34%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Production
 engineering and other equipment&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 4%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;$6
422
110&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;$6
426
432&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=top style=width: 34%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Leasehold improvements&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 4%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;2
904
188&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;2
904
188&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 34%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Office equipment and furniture&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 4%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;603
182&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;603
182&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=top style=width: 34%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Computer equipment and related software&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 4%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;140
238&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;140
238&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td valign=top style=width: 34%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 4%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;$10
069
718&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;$10
074
040&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=top style=width: 34%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Accumulated depreciation&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 4%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;($8
269
412)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;($7
628
075)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 34%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Property and equipment
 net&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 4%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;$1
800
306&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;$2
445




 NET&lt;/div&gt;&lt;div style=text-indent: 0pt; display: block;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;At December 31
 property and equipment
 net consists of the following:&lt;/div&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&lt;table cellpadding=0 cellspacing=0 style=width: 100%; font-family: times new roman; font-size: 10pt;&gt;&lt;tr&gt;&lt;td valign=top style=width: 34%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 4%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;12/31/13&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;12/31/12&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 34%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Production
 engineering and other equipment&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 4%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;$6
422
110&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;$6
426
432&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=top style=width: 34%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Leasehold improvements&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 4%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;2
904
188&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;2
904
188&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 34%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Office equipment and furniture&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 4%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;603
182&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;603
182&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=top style=width: 34%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Computer equipment and related software&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 4%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;140
238&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;140
238&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td valign=top style=width: 34%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 4%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;$10
069
718&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;$10
074
040&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=top style=width: 34%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Accumulated depreciation&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 4%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;($8
269
412)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;($7
628
075)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 34%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Property and equipment
 net&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 4%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;$1
800
306&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;$2
445
965&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&lt;div style=text-indent: 0pt; display: block;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Depreciation expense was $643
575 and $682
134 for the years ended December 31
 2013 and 2012
 respectively. During the year ended December 31
 2013
 the Company sold a fixed asset with a net book value of $2
084 in exchange for cash of $750 and recorded a loss on the sale of $1
334.&amp;#160;&amp;#160;For the twelve months ended December 31
 2012
 the Company sold equipment with a net book value of $60
899 for a total of $110
000 and recorded a gain on the sale of $49



  


  


 2012 the Company issued 238
800 shares of common stock to its four non-executive directors (59
700 each) &amp;#8211; Mark Hershhorn
 Brian Israel
 Morris Garfinkle and Edward Smith III. The Company recognized a total expense of $160
000 related to these issuances.&amp;#160;&amp;#160;These shares were valued based on the closing price of the grant date.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;On August 15
 2012
 Morris Garfinkle
 a Director of the Company
 converted $34
800 (including accrued dividends) of Series I Convertible
 Redeemable Preferred Stock into 34
800 shares of the Company&amp;#8217;s Common Stock.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;On December 11
 2012
 the Company&amp;#8217;s external Directors
 Mark Hershhorn
 Morris Garfinkle
 Brian Israel and Edward Smith each agreed to convert $17
403 (including accrued dividends) of Series I Convertible
 Redeemable Preferred Stock into 17
403 shares of the Company&amp;#8217;s Common Stock prior to its maturity.&amp;#160;&amp;#160;The aggregate conversion by the directors was $69
612.&amp;#160;&amp;#160;As a result of this early conversion the Company recorded a loss of $728 for the twelve months ended December 31
 2012.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;On January 22
 2013 the Company issued 114
944 shares of common stock to its four non-executive directors
 Mark Hershhorn
 Morris Garfinkle
 Brian Israel and Edward Smith (28
736 shares each). The Company recognized a total of expense of $200
002 related to these issuances.&amp;#160;&amp;#160;These shares were valued based on the closing price on the grant date.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;On February 27
 2013 Morris Garfinkle
 a Director of the Company
 participated in a warrant exercise program in which all holders of $1.50 warrants were allowed to exercise their warrants for a $1.25 strike price during February 2013.&amp;#160;&amp;#160;Mr. Garfinkle exercised 200
000 warrants and received 200
000 shares of Common Stock.&amp;#160;&amp;#160;As a result of this warrant modification the Company recognized $45
596 of additional expense during the quarter ended March 31
 2013 relating to Mr. Garfinkle&amp;#8217; s warrants based on the fair value of the warrant modification at the date the offer was made to all warrant holders calculated by using the Black-Scholes Model.&amp;#160;&amp;#160;On March 6
 2013
 Mr. Garfinkle exercised other warrants
 with various exercise prices
 and received 26
571 shares of Common Stock. During August 2013
 Mark Hershhorn
 Edward Smith and Brian Israel
 Directors of the Company
 participated in a warrant exercised program offered to all holders of $1.50 warrants such that each warrant holder
 on a cashless basis
 can receive 4.5 shares of Common Stock for every ten warrants exercised.&amp;#160;&amp;#160;Messrs. Hershhorn
 Smith and Israel
 in the aggregate
 exercised 127
695 warrants and received 58
395 shares of Common Stock.&amp;#160;&amp;#160;As a result of the warrant modification the Company recognized $24
281 of additional expense during the quarter ended September 30
 2013 relating to the difference in value between the $1.50 warrants exercised by Messrs. Hershhorn
 Smith and Israel and the Common Stock issued.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;See also Notes 9 and 12 with respect to transactions involving our largest shareholder
 Brightline Ventures I


  

  


 delivery has occurred
 the fee is fixed or determinable
 and collectability is probable. In instances where the final acceptance of the product is specified by the customer


  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

 Goods

  

 Goods

  


  


  


 2013 and 2012 are as follows:&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&lt;table cellpadding=0 cellspacing=0 style=width: 100%; font-family: times new roman; font-size: 10pt;&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td colspan=3 valign=bottom style=border-bottom: black 2px solid; width: 21%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;12/31/13&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td colspan=3 valign=bottom style=border-bottom: black 2px solid; width: 21%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;12/31/12&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=bottom style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=border-bottom: black 2px solid; width: 10%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Number of Shares&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Weighted Average Exercise Price&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=border-bottom: black 2px solid; width: 10%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Number of Shares&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Weighted Average Exercise Price&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=bottom style=width: 23%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Outstanding at beginning of year&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;7
728
877&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.01&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;5
645
202&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.10&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=bottom style=width: 23%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Granted&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;2
176
535&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.67&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;2
354
275&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$0.80&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=bottom style=width: 23%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Exercised&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(293
650)&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$0.98&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(230
600)&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.09&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=bottom style=width: 23%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Expired and Cancelled&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(28
000)&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$2.18&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(40
000)&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$0.86&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td valign=bottom style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=border-bottom: black 4px double; width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;9
583
762&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=border-bottom: black 4px double; width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;7
728
877&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td valign=bottom style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 10%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 10%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=bottom style=width: 23%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Outstanding
 end of period&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=border-bottom: black 4px double; width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;9
583
762&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.16&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=border-bottom: black 4px double; width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;7
728
877&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.01&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td valign=bottom style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 10%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 10%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td valign=bottom style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 10%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 10%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=bottom style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=bottom style=width: 23%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Exercisable at end of period&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=border-bottom: black 4px double; width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;9
536
262&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.17&lt;/div&gt;&lt;/td&gt;&lt;td valign=bottom style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=bottom style=border-bottom: black 4px double; width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;7
582


  


 inventory consists of the following:&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&lt;table cellpadding=0 cellspacing=0 style=width: 100%; font-family: times new roman; font-size: 10pt;&gt;&lt;tr&gt;&lt;td valign=top style=width: 27%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;12/31/13&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;12/31/12&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 27%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Raw materials&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$27
575&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$42
831&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=top style=width: 27%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Packaging&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;8
178&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;1
873&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 27%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Work-in-process&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;33
527&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;64
170&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=top style=width: 27%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Finished goods&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;475
255&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;360
428&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td valign=top style=width: 27%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td valign=top style=width: 27%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$544
535&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$469



 2013 and December 31
 2012:&lt;/div&gt;&lt;/div&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&lt;table cellpadding=0 cellspacing=0 style=width: 100%; font-family: times new roman; font-size: 10pt;&gt;&lt;tr&gt;&lt;td colspan=2 valign=top style=border-bottom: black 2px solid; width: 41%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Components of derivative financial instruments&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 2%; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 11%; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=top style=width: 30%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=top style=width: 30%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;12/31/13&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;12/31/12&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 30%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Common stock warrants&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$95
049&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$6
626
255&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=top style=width: 30%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Embedded conversion features for&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 30%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;&amp;#160;convertible debt or preferred shares&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;1
399
126&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td valign=top style=width: 30%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 30%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Total&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$95
049&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$8
025
381&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td valign=top style=width: 30%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 30%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Beginning balance&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$8
025
381&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$11
031
432&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=top style=width: 30%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Change in derivative liability valuation&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(966
736)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;1
514
156&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 30%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Change in derivative liability - settlements&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(6
963
596)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(4
520
207)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td valign=top style=width: 30%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 30%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Total&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$95
049&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$8
025



 accrued expenses consist of the following:&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&lt;table cellpadding=0 cellspacing=0 style=width: 100%; font-family: times new roman; font-size: 10pt;&gt;&lt;tr&gt;&lt;td valign=top style=width: 27%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;12/31/13&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;12/31/12&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 27%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Accrued payroll and taxes&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$51
566&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$32
021&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=top style=width: 27%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Accrued settlements&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;102
000&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;110
000&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 27%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Accrued expenses and other&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;40
578&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;31
513&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td valign=top style=width: 27%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td valign=top style=width: 27%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$194
144&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$173



332&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=top style=width: 16%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;2015&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 20%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;85
444&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 16%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;2016&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 20%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=top style=width: 16%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;2017&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 20%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 16%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;2018&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 20%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td valign=top style=width: 16%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 20%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$341



 2013
 the net deferred tax asset based on a 34% tax rate consisted of the following:&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&lt;table cellpadding=0 cellspacing=0 style=width: 100%; font-family: times new roman; font-size: 10pt;&gt;&lt;tr&gt;&lt;td valign=top style=width: 25%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=top style=width: 25%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;12/31/13&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;12/31/12&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=top style=width: 25%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 25%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Net operating loss&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$32
852
315&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$30
990
050&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td valign=top style=width: 25%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 25%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Less: Valuation allowance&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(32
852
315)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 11%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(30
990



 2013 are as follows:&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&lt;table cellpadding=0 cellspacing=0 style=width: 100%; font-family: times new roman; font-size: 10pt;&gt;&lt;tr&gt;&lt;td valign=top style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 8%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Weighted&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=top style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td colspan=2 valign=top style=width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Average&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Weighted&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=top style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 8%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Remaining&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Average&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=top style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Options&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 8%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Contractual&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Exercise&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Options&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 23%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Range of Exercise Prices&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Outstanding&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 8%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Life&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Price&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Exercisable&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td valign=top style=width: 23%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;$0.01-$1.50&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;7
090
227&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 8%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;2.8&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$0.97&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;7
090
227&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td valign=top style=width: 23%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;$1.51-$3.00&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;2
368
535&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 8%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;4.5&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.67&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;2
321
035&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td valign=top style=width: 23%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;$3.01-$5.00&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;125
000&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 8%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;4.6&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$3.11&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;125
000&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td valign=top style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 4px double; text-align: center; width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;9
583
762&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=text-align: center; width: 3%; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=text-align: center; width: 8%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;3.3&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=text-align: center; width: 3%; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=text-align: center; width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.17&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=text-align: center; width: 3%; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 4px double; text-align: center; width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;9
536
262&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: center;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Stock options outstanding at December 31
 2012 are as follows:&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&lt;table cellpadding=0 cellspacing=0 style=width: 100%; font-family: times new roman; font-size: 10pt;&gt;&lt;tr&gt;&lt;td valign=top style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 8%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Weighted&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=top style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 8%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Average&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Weighted&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=top style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 8%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Remaining&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Average&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=top style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Options&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 8%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Contractual&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Exercise&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Options&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 23%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Range of Exercise Prices&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Outstanding&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 8%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Life&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Price&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Exercisable&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td valign=top style=width: 23%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;$0.01-$1.50&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;5
435
202&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 8%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;3.9&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.18&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;5
107
003&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td valign=top style=width: 23%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;$1.51-$3.00&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;210
000&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 8%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;2.0&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.49&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;210
000&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td valign=top style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 4px double; text-align: center; width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;5
645
202&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=text-align: center; width: 8%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;4.0&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 4px double; text-align: center; width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;1.13&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 3%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 4px double; text-align: center; width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;5
317



  


  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  


  


  

  

  

  

  

  

  

  

  

  

  

  

  

 Fair Value Assumptions

  

 Fair Value Assumptions

  

  

  

  

  

  

  


  


  

 Options

  

 Options

  

  

  

  

  

  

  

  

 Options
 Outstanding

  

 Options
 Outstanding

  

 Options
 Outstanding

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

 Options
 Outstanding

  

 Options
 Outstanding

  

 Options
 Outstanding

  



 including stock options
 restricted stock and employee stock purchases related to employee stock purchase plans
 on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense ratably over the requisite service periods.&amp;#160;&amp;#160;We estimate the fair value of each share-based award using the Black-Scholes option pricing model. The Black-Scholes model is highly complex and dependent on key estimates by management. The estimates with the greatest degree of subjective judgment are the estimated lives of the stock-based awards and the estimated volatility of our stock price. The Company recognized pre-tax compensation expense related to stock options of $2
318
355 and $1
547
826 for the years ended December 31
 2013 and 2012


  

  

  

  

  


 delivery has occurred
 the fee is fixed or determinable
 and collectability is probable. In instances where the final acceptance of the product is specified by the customer

 provisions are provided at differing rates
 based upon the age of the receivable. In determining these percentages
 management analyzes its historical collection experience and current economic trends. If the historical data the Company uses to calculate the allowance for doubtful accounts does not reflect the future ability to collect outstanding receivables
 additional provisions for doubtful accounts may be needed and the future results of operations could be materially affected. As of December 31
 2013 and 2012

 the Company considers all highly liquid investments with a maturity of three months or less to be cash equivalents.&amp;#160;&amp;#160;There were no cash equivalents as of December 31

 using the first-in

 office equipment and furniture
 and automobile. Estimated useful lives of up to five years are used for computer equipment and related software. Depreciation and amortization of leasehold improvements are computed using the term of the lease.&lt;/div&gt;&lt;div style=text-indent: 0pt; display: block;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-indent: 0pt; display: block;&gt;Intangible Assets&lt;/div&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Intangible assets are carried at the purchased cost less accumulated amortization. Amortization is computed over the estimated useful lives of the respective assets


 including embedded derivatives in the Company&amp;#8217;s warrants
 convertible preferred stock
 and its Convertible 8% Senior Secured Notes issued in 2008
 2009
 and 2010
 which have reset provisions to the exercise price and conversion price if the Company issues equity or other notes at a price less than the exercise price set forth in such warrants and notes
 are separately valued and accounted for on the Company&amp;#8217;s balance sheet. Fair values for exchange traded securities and derivatives are based on quoted market prices. Where market prices are not readily available


 accounts receivable
 inventory
 accounts payable and accrued liabilities. The estimated fair value of cash
 accounts receivable
 accounts payable and accrued liabilities approximate their carrying amounts due to the short-term nature of these instruments.&amp;#160;&amp;#160;None of these instruments are held for trading purposes.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;The Company utilizes various types of financing to fund its business needs
 including convertible debt with warrants attached. The Company reviews its warrants and conversion features of securities issued as to whether they are freestanding or contain an embedded derivative and
 if so
 whether they are classified as a liability at each reporting period until the amount is settled and reclassified into equity with changes in fair value recognized in current earnings. At December 31
 2013 and 2012
 the Company had warrants to purchase common stock

 which are developed by the reporting entity and reflect those assumptions that a market participant would use.&lt;/div&gt;&lt;div style=text-indent: 0pt; display: block;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Determining which category an asset or liability falls within the hierarchy requires significant judgment. The Company evaluates its hierarchy disclosures each quarter. The Company&amp;#8217;s only asset or liability measured at fair value on a recurring basis is its derivative liability associated with warrants to purchase common stock and preferred stock. The fair value of the derivative liability at December 31
 2013 and 2012 was $95
049 and $8
025
381
 respectively.&amp;#160;&amp;#160;The gain on derivative liability for the twelve months ended December 31
 2013 was $966
736 compared to a loss on derivative liability of $1
514
156 for the twelve months ended December 31
 2012.&amp;#160;&amp;#160;Below is a hierarchy table of the components of the derivative liability:&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;table cellpadding=0 cellspacing=0 style=width: 100%; font-family: times new roman; font-size: 10pt;&gt;&lt;tr&gt;&lt;td valign=top style=width: 25%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Carrying&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td colspan=4 valign=top style=border-bottom: black 2px solid; width: 22%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Fair Value Measurements Using&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 9%; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 1%; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 9%; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=top style=width: 25%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Value&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Level 1&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Level 2&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Level 3&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Total&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=top style=width: 25%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 25%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Derivative Liabilities&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=right valign=top style=width: 25%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;12/31/11&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; text-align: right; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$11
031
432&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$11
031
432&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$11
031
432&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td valign=top style=width: 25%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=top style=width: 25%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Change in derivative liabilities due to&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 25%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;settlements&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(4
520
207)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(4
520
207)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(4
520
207)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left colspan=2 valign=top style=width: 26%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Change in derivative liabilities valuation&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;1
514
156&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;1
514
156&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;1
514
156&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td valign=top style=width: 25%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(3
006
051)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(3
006
051)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(3
006
051)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td valign=top style=width: 25%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 25%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Derivative Liabilities&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=right valign=top style=width: 25%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;12/31/12&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; text-align: right; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$8
025
381&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$8
025
381&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$8
025
381&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td valign=top style=width: 25%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=top style=width: 25%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Change in derivative liabilities due to&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 25%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;settlements&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(6
963
596)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(6
963
596)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(6
963
596)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left colspan=2 valign=top style=width: 26%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Change in derivative liabilities valuation&lt;/div&gt;&lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(966
736)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(966
736)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(966
736)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td valign=top style=width: 25%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(7
930
332)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(7
930
332)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(7
930
332)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td valign=top style=width: 25%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 25%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Derivative Liabilities&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=right valign=top style=width: 25%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;12/31/13&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$95
049&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$-&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$95
049&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 1%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$95
049&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;div&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt; text-decoration: underline;&gt;Accounting for Convertible
 Redeemable Preferred Stock&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;The Company accounts for convertible and redeemable preferred stock according to its stated redemption value net of any discounts related to attached warrants or beneficial conversions features. The Company classifies these instruments on the balance sheet according to the nature of the redemption feature. Preferred shares with redemption features that are solely within the control of the Company are accounted for within permanent equity. Preferred shares that are considered mandatorily redeemable due to a fixed redemption date and amount are accounted for as liabilities. Preferred shares that are conditionally redeemable based on conditions that are outside of the Company&amp;#8217;s control are classified within temporary equity. Discounts on instruments classified as liabilities are amortized to interest expense

 2013 and 2012 was $250 and $18

 when diluted

 including stock options
 restricted stock and employee stock purchases related to employee stock purchase plans
 on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense ratably over the requisite service periods.&amp;#160;&amp;#160;We estimate the fair value of each share-based award using the Black-Scholes option pricing model. The Black-Scholes model is highly complex and dependent on key estimates by management. The estimates with the greatest degree of subjective judgment are the estimated lives of the stock-based awards and the estimated volatility of our stock price. The Company recognized pre-tax compensation expense related to stock options of $2
318
355 and $1
547
826 for the years ended December 31
 2013 and 2012

000 line of credit to the vendor at a 5.5% interest rate. The vendor may not draw down more than $75
000 during any thirty day period. The Company will be re-paid for these advances with future discounts on products manufactured by the vendor.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;The Company capitalizes distributions to the vendor related to this agreement upon disbursement based on this value to be applied towards discounts on future product purchases. Interest on the outstanding advances are recorded to interest income and capitalized to the letter of credit account
 and will be realized with future discounts as well.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;On March 28
 2014 the Company agreed to an amendment to the custom processing agreement relating to the repayment of the line of credit advances plus interest.&amp;#160;&amp;#160;Commencing on April 1
 2014
 Aveka Nutra Processing will begin paying the Company $5

 the FASB issued an accounting standards update which requires an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component and to present either on the face of the statement where net income is presented
 or in the notes
 significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income
 but only if the amount reclassified is required to be reclassified to net income in its entirety in the same reporting period provides
 subject to certain conditions
 the option to perform a qualitative
 rather than quantitative
 assessment to determine whether it is more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying amount. The update will be effective in the first quarter of 2013
 although early adoption is permitted
 the Company has not elected early adoption of this pronouncement. The update did not have a material impact on the Company&amp;#8217;s financial position
 results of operations or cash flows.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; font-style: italic; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward
 a Similar Tax Loss
 or a Tax Credit Carryforward Exists&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;In July 2013
 the FASB issued an accounting standards update which requires an entity to present an unrecognized tax benefit
 or portion thereof
 in the statement of financial position as a reduction to a deferred tax asset for a net operating loss carryforward or a tax credit carryforward
 with certain exceptions related to availability. The update will be effective in the first quarter of 2014
 although early adoption is permitted
 the Company has not elected early adoption of this pronouncement. The update is not expected to have a material impact on the Company&amp;#8217;s financial position

 the FASB issued an accounting standards update which provides
 subject to certain conditions
 the option to perform a qualitative
 rather than quantitative
 assessment to determine whether it is more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying amount. The update will be effective in the first quarter of 2013
 although early adoption is permitted
 the Company has not elected early adoption of this pronouncement. The update may
 under certain circumstances
 reduce the complexity and costs of testing indefinite-lived intangible assets for impairment
 but&amp;#160;did not have a material impact on the Company&amp;#8217;s financial position





  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

 Value

  

 Value

  

 Value

  

 Value

  

 Value

  

 Value

  

 Value

  

 Value

  

 Value

  

 Value

  

 Value

  

 Value

  

 Value

  

 Value

  

 Value

  

 Value

  

 Value

  

 Value

  

 Value

  

 Value

  

 Value

  

 Value

  

 Value

  

 Value

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  


  


  

  

  


  


  

  


  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

 Shares

  

 Shares

  

 Options

  

 Options

  

 Options

  

 Options

  

 Options

  

 Options

  

  


  

  

  

  

  

  

  

  

  

  

  


  


  


  


  


  


  


  


  


  


  


  


  


  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  



 Redeemable Preferred Stock&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;The Company accounts for convertible and redeemable preferred stock according to its stated redemption value net of any discounts related to attached warrants or beneficial conversions features. The Company classifies these instruments on the balance sheet according to the nature of the redemption feature. Preferred shares with redemption features that are solely within the control of the Company are accounted for within permanent equity. Preferred shares that are considered mandatorily redeemable due to a fixed redemption date and amount are accounted for as liabilities. Preferred shares that are conditionally redeemable based on conditions that are outside of the Company&amp;#8217;s control are classified within temporary equity. Discounts on instruments classified as liabilities are amortized to interest expense



 2012 the Company issued 238
800 shares of common stock to its four non-executive directors (59
700 each) &amp;#8211; Mark Hershhorn
 Brian Israel
 Morris Garfinkle and Edward Smith III. The Company recognized a total of expense of $160
000 related to these issuances.&amp;#160;&amp;#160;These shares were valued based on the closing price of the grant date.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;On July 2
 2012
 we entered into a Private Placement of Securities &amp;amp; Advisory Services Agreement with Maxim Group LLC
 pursuant to which Maxim agreed to act as the Company&amp;#8217;s exclusive placement agent in a proposed private placement of equity
 convertible
 debt and/or linked securities of the Company up to $10 million.&amp;#160;&amp;#160;This agreement terminated on December 31
 2012.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;In exchange for Maxim&amp;#8217;s services
 we agreed to pay Maxim with 150
000 shares of the Company&amp;#8217;s Common Stock&amp;#160;&amp;#160;valued at $150
000 for purposes of the agreement
 as well as $10
000 per month for the duration of this agreement.&amp;#160;&amp;#160;An additional 350
000 shares of Common Stock would have been issued to Maxim upon the completion of a closing that resulted in the Company receiving a minimum of $10 million.&amp;#160;&amp;#160;No such transaction occurred prior to the termination of the agreement.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;We determined that all of the securities issued pursuant to the agreement were exempt from registration under the Securities Act of 1933
 as amended (the Act) pursuant to Section 4(2) of the Act and Rule 506 of Regulation D promulgated under the Act. We based this determination on the non-public manner in which we offered the securities and on the representations of the persons purchasing such securities
 which included
 in pertinent part
 that such persons were accredited investors within the meaning of Rule 501 of Regulation D promulgated under the Act
 and that such persons were acquiring such securities for investment purposes for their own respective accounts and not as nominees or agents
 and not with a view to resale or distribution

 2013 the Company issued 114
944 shares of common stock to its four non-executive directors
 Mark Hershhorn
 Morris Garfinkle
 Brian Israel and Edward Smith (28
736 shares each). The Company recognized a total of expense of $200
002 related to these issuances.&amp;#160;&amp;#160;These shares were valued based on the closing price on the grant date.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;On October 28
 2013
 the Company entered into a Consulting Agreement with Steeltown Consulting Group
 LLC
 pursuant to which Steeltown will assist in evaluating various business and financial matters.&amp;#160;&amp;#160;The Company issued 220
000 restricted shares of common stock as consideration for the services being rendered in this agreement.&amp;#160;&amp;#160;This agreement was scheduled to terminate on January 31
 2014.&amp;#160;&amp;#160;On December 3
 2013
 the Company and Steeltown entered into a new Consulting Agreement (which replaces the agreement dated October 28
 2013) in which both the Company and Steeltown substantially agreed to the same services being rendered as the previous agreement.&amp;#160;&amp;#160;The Company issued 550
000 shares of restricted common stock as consideration for the services being rendered under this new agreement.&amp;#160;&amp;#160;This agreement will terminate on January 31
 2015.&amp;#160;&amp;#160;The Common Stock was valued at $569

 2012
 the Company issued 1
508
000 shares of its Common Stock
 $.00005 par value per share
 upon conversion to common stock of&amp;#160;&amp;#160;its 8% Convertible Secured Notes due in 2012 (the Notes)
 representing principal of $1
300
000 and interest of $208
000.&amp;#160;&amp;#160;The conversion was in accordance with the agreement
 and therefore no gain or loss was recorded.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;On April 19
 2012
 the Company issued 150
979 shares of its Common Stock
 $.00005 par value per share
 upon conversion to common stock of its Notes
 representing principal of $120
000 and interest of $30
979.&amp;#160;&amp;#160;The conversion was in accordance with the agreement
 and therefore no gain or loss was recorded.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;On November 5
 2012
 the Company issued 212
056 shares of its Common Stock
 $.00005 par value per share
 upon conversion to common stock of its Notes
 representing principal of $200
000 and interest of $12
056.&amp;#160;&amp;#160;The conversion was in accordance with the agreement

 several investors participated in a warrant exercise program that resulted in the exercise of 1
756
088 warrants into 1
756
088 shares of the Company&amp;#8217;s common stock.&amp;#160;&amp;#160;The warrant program
 which was open to all holders of $1.50 warrants
 allowed those warrant holders to exercise their warrants for a $1.25 strike price during February 2013; it also required a waiver of the anti-dilution provisions in these warrants until February 28
 2013 so that those provisions would not be triggered by the exercises. The conversion of these warrants raised $2
195
110 of cash for the Company.&amp;#160;&amp;#160;&amp;#160;As a result of this warrant modification the Company recognized $4
789
801 of additional expense for previously issued warrants during the period ended March 31
 2013.&amp;#160;&amp;#160;The value of the additional expense was based on the fair value of the warrant modification at the date the offer was made to the warrant holders calculated by using the Black-Scholes Model.&amp;#160;&amp;#160;The key inputs utilized in this model include the Company&amp;#8217;s stock price on the date of the modification of $2.30
 the computed volatility of the Company&amp;#8217;s stock price at 109.96% and the discount rate used based on a U.S. Treasury security for a comparable period to the remaining term of the warrants of .06%.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Also during 2013
 in addition to the warrant exercise program described above
 other investors exercised 531
642 warrants and the Company received proceeds of $294

 490
424 stock warrants were exercised for cash of $304
225.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;div&gt;COMMON STOCK ISSUED ON THE CASHLESS EXERCISE OF WARRANTS&lt;/div&gt;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;Beginning August 20
 2013 and in conjunction with the private placement subscription agreement entered into between the Company and Brightline Ventures I-C
 LLC (indicated below and referred to as the &amp;#8220;1.25 Raise&amp;#8221;)
 the Company (i) allowed the holders of the Company&amp;#8217;s outstanding warrants with a $1.50 per share exercise price (the &amp;#8220;$1.50 Warrants&amp;#8221;) with certain anti-dilution provisions contained in the related warrant agreements to choose to exercise their $1.50 Warrants on a cashless basis such that for every ten $1.50 Warrants exercised
 the holder received 4.5 shares of Common Stock (fractional shares were rounded up) (the &amp;#8220;Cashless Exercise Program&amp;#8221;)
 (ii) sought a temporary waiver from the holders of the $1.50 Warrants of the anti-dilution provisions in the warrant agreements with respect to the Cashless Exercise Program and potential capital-raising activities (other than the $1.25 Raise) by the Company by December 31
 2013
 and (iii) asked the holders of the $1.50 Warrants to permanently amend the warrant agreements with respect to certain ratchet provisions so as to reduce the derivative liability the Company incurs as a result of those provisions in the agreements.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;The Cashless Exercise Program resulted in 7
172
751 of the $1.50 Warrants being converted into 3
227
742 shares of the Company&amp;#8217;s common stock (including 5
718
750 $1.50 Warrants that were converted by Brightline Ventures I into 2
573
438 shares of common stock).&amp;#160;&amp;#160;As a result of the Cashless Exercise Program
 the Company recognized a loss on equity modification of $990
656&amp;#8212;the difference in value between the $1.50 Warrants exercised and the common stock issued&amp;#8212; for the three months ended September 30
 2013.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;As a result of the August 20
 2013 transaction with Brightline Ventures I
 pursuant to the anti-dilution provisions in the $1.50 Warrants that were not exercised as part of the Cashless Exercise Program
 the Company reduced the exercise price of those warrants to $1.25 per share and adjusted the number of shares issuable upon the exercise of those warrants such that for every five warrants owned
 each remaining holder of $1.50 Warrants received one additional warrant with an exercise price of $1.25.&amp;#160;&amp;#160;There were a total of 11
880
047 warrants that were not exercised as part of the Cashless Exercise Program.&amp;#160;&amp;#160;In addition
 the warrant holders agreed to permanently waive the full reset feature contained in the original warrant.&amp;#160;&amp;#160;As a result
 the Company issued an aggregate of 2
376
009 additional warrants at an exercise price of $1.25 per share (including 2
316
597 additional warrants that were issued to Brightline Ventures I) to the holders of $1.50 Warrants that were not exercised as part of the Cashless Exercise Program and recognized a settlement to additional paid in capital for the related derivative liability of $1
712
356.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Also during 2013
 in addition to the warrant exercise program described above
 other investors exercised 909
784 warrants on a cashless basis and received 378
415 shares of common stock.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;During 2012
 the Company issued 198

 two former employees exercised 91
400 stock options and the Company received proceeds of $77
734.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;During 2012
 14
600 stock options were exercised for cash of $9

 the Company issued 100
528 shares of common stock on the cashless exercise of 202
250 stock options.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;During 2012
 the Company issued 131

 2013
 the Company raised additional capital by entering into a private placement subscription agreement with Brightline Ventures I-C
 LLC
 an affiliate of its controlling stockholder
 pursuant to which it sold 376
000 shares of common stock
 for a price of $1.25 per share (the &amp;#8220;1.25 Raise&amp;#8221;)
 and received gross proceeds of $470
000.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;On September 18
 2013
 the Company entered into another private placement subscription agreement with Brightline Ventures I-C
 LLC
 pursuant to which it sold 468
571 shares of Common Stock for a price of $1.05 per share
 along with warrants to purchase 234
286 shares of common stock at an exercise price of $1.50 per share (the &amp;#8220;1.05 Raise&amp;#8221;)
 and received gross proceeds of $492
000.&amp;#160;&amp;#160;The waiver discussed above was effective for the $1.05 Raise; therefore

 2013
 the Company completed the sale of 1
866
667 shares of Common Stock at a price of $0.75 per share along with warrants to purchase 1
400
000 shares of Common Stock at an exercise price of $1.00 per share.&amp;#160;&amp;#160;The Company received after deducting various transaction expenses
 net proceeds of $1
210

 2013
 we entered into a settlement agreement with a former provider of investment services over compensation provided in a prior period for services in the raising of equity capital for the Company.&amp;#160;&amp;#160;As a result of this agreement
 the Company issued 875
000 shares of Common Stock to this party.&amp;#160;&amp;#160;As of December 31
 2012
 the Company has recorded a common stock payable in the amount of $1
881

 the Company entered into a modification with Brightline Ventures I pursuant to which Brightline Ventures I agreed to convert preferred stock into common stock on or before the respective maturity.&amp;#160;&amp;#160;As a result of this modification the Convertible
 Redeemable Preferred Stock Series II was reclassified to equity as Convertible Preferred Stock Series II as of December 31
 2012 as the shares are no longer redeemable.&amp;#160;&amp;#160;On March 18
 2013
 Brightline Ventures I converted the Series II Convertible Preferred Stock of $3
326
697 together with $533
000 of accrued dividends thereon into 3
859



 2014 the Company issued 285
716 shares of common stock to its four non-executive directors (71
429 each) &amp;#8211; Mark Hershhorn
 Brian Israel
 Morris Garfinkle and Edward Smith III.&amp;#160;&amp;#160;The Company recognized a total expense of $160
001 related to these issuances.&amp;#160;&amp;#160;These shares were valued based on the closing price on the grant date.&lt;/div&gt;&lt;div style=text-indent: 0pt; display: block;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;On February 11
 2014 the Company entered into an agreement with Edward Smith III
 a Director and Shareholder of the Company
 pursuant to which Mr. Smith agreed to lend the Company $200
000 in a convertible senior secured note.&amp;#160;&amp;#160;The note matures in two years (February 11
 2016) and bears interest at 12.5% computed based on a 365-day year.&amp;#160;&amp;#160;Accrued interest is payable either at maturity or quarterly at the option of Mr. Smith in shares of the Company&amp;#8217;s Common Stock.&amp;#160;&amp;#160;The note is substantially secured by the assets of the Company.&lt;/div&gt;&lt;div style=text-indent: 0pt; display: block;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;On March 14
 2014 the Company entered into an amendment to the original lease agreement for office space located in Mundelein
 Illinois.&amp;#160;&amp;#160;The amendment extended the term of the lease from March 15
 2014 to May 14
 2015 upon the same terms and conditions contained in the lease as amended.&lt;/div&gt;&lt;div style=text-indent: 0pt; display: block;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;On March 24
 2014
 Fordham Capital Partners
 LLC (&amp;#8220;Fordham&amp;#8221;) extended a $500
000 revolving loan (the &amp;#8220;Equipment Loan&amp;#8221;) to Z Trim Holdings
&amp;#160;Inc. (the &amp;#8220;Company&amp;#8221;) evidenced by an Equipment Revolving Note (the &amp;#8220;Note&amp;#8221;) issued by the Company to Fordham.&amp;#160;&amp;#160;The Note requires monthly payments of principal of $10
417 plus interest
 commencing on April 24
 2014 and continuing until February 24
 2015
 followed by a final balloon payment of the entire unpaid principal balance of the Note and all accrued and unpaid interest on March 24
 2015.&amp;#160;&amp;#160;The interest on the Note is calculated at a fixed rate of 20% per annum.&amp;#160;&amp;#160;The Note may be prepaid in full at any time; provided that if the Company prepays the Note prior to September 24
 2014 (such six-month period
 the &amp;#8220;Guaranteed Interest Period&amp;#8221;)
 it must pay a prepayment penalty equal to the amount by which (i) the aggregate interest that Fordham would have received on the Note during the Guaranteed Interest Period had there been no prepayment exceeds (ii) the aggregate interest paid by the Company prior to the date of prepayment.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Pursuant to the Security Agreement
 dated March 24
 2014
 between the Company and Fordham (the &amp;#8220;Security Agreement&amp;#8221;)
 the Equipment Loan is secured by all of the Company&amp;#8217;s equipment (as more specifically defined in the Security Agreement
 the &amp;#8220;Collateral&amp;#8221;).&amp;#160;&amp;#160;The Security Agreement also contains customary restrictive covenants
 including without limitation
 covenants prohibiting the Company from (i) granting additional liens in the Collateral
 (ii) selling
 leasing or transferring the Collateral
 (iii) entering into certain merger
 consolidation or other reorganization transactions
 and (iv) creating
 incurring or assuming additional indebtedness
 in each case subject to certain exceptions.&amp;#160;&amp;#160;The Security Agreement also contains customary events of default.&amp;#160;&amp;#160;If an event of default under the Security Agreement occurs and is continuing
 Fordham may declare any outstanding obligations under the Credit Agreement immediately due and payable.&amp;#160;&amp;#160;After an event of default
 interest on the Note would accrue at a rate of 25% per annum.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Additionally
 pursuant to the Factoring Agreement
 dated March 24
 2014
 between the Company and Fordham
 Fordham may purchase any Accounts of the Company (the &amp;#8220;Factoring Agreement&amp;#8221;).&amp;#160;&amp;#160;To secure payment and performance of the Company&amp;#8217;s liabilities and obligations to Fordham
 including obligations under the Factoring Agreement
 the Company granted Fordham a security interest in all of the Company&amp;#8217;s (i) Accounts
 (ii) Inventory
 (iii) Chattel Paper
 Deposit Accounts
 Documents
 Equipment
 Financial Assets
 Fixtures
 General Intangibles
 Instruments
 Investment Property
 Letter-of-Credit Rights
 Securities
 Software and Supporting Obligations
 (iv) books and records of Seller which relate to Accounts
 (v) all amounts owing to the Company under the Factoring Agreement
 and (vi) Proceeds of the foregoing.&amp;#160;&amp;#160;The Factoring Agreement terminates at any time that the Equipment Loan is paid in full.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;On March 28
 2014 the Company entered into an amendment to the custom processing agreement with Aveka Nutra Processing LLC relating to the repayment of the line of credit advances made by the Company plus interest.&amp;#160;&amp;#160;Commencing on April 1
 2014
 Aveka Nutra Processing agreed to begin paying the Company $5



 provisions are provided at differing rates
 based upon the age of the receivable. In determining these percentages
 management analyzes its historical collection experience and current economic trends. If the historical data the Company uses to calculate the allowance for doubtful accounts does not reflect the future ability to collect outstanding receivables
 additional provisions for doubtful accounts may be needed and the future results of operations could be materially affected. As of December 31
 2013 and 2012


  

  

  


  


  


  


  




  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  


  

  

  

  

  

  

  

  

  


  


  


  


  


  


  


  


  

  

  

 Value

  

 Value

  

 Value

  

 Value

  

 Value

  

 Value

  

 Value

  

 Value

  

 Value

  

 Value

  

 Value

  

 Value

  

 Value

  

 Value

  

 Value

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  




  

  

  

  

  

  







  

  

  

  

  


  

  

  

  

 Convertible

  

 Convertible

  

 Convertible

  

 Convertible

  

  

  


  


  


  


  


  


  


  


  

  


  

  


 2014
 the date that the independent registered public accountant issued its report on the audited financial statements as of and for the year ended December 31
 2013
 the Company did not have enough cash on hand to meet its current liabilities or to fund on-going operations beyond one year.&amp;#160;&amp;#160;The Company had reoccurring losses as of December 31
 2013.&amp;#160;&amp;#160;As a result
 the independent registered public accountant&amp;#8217;s audit report included an explanatory paragraph in respect of our ability to continue as a going concern. The Company intends to secure additional funding through debt or equity financing arrangements



  


  

  

 Periodic Collections-Note Receivable [Member]-Guarantee Type

  

 Periodic Collections-AVEKA Nutra Processing

  

 Periodic Collections-Subsequent Event [Member]-AVEKA Nutra Processing

  


  


  


  


  

 Measurements
 Recurring [Member]-Derivative Financial Instruments
 Liabilities [Member]-Fair Value
 Inputs

  

 Liabilities [Member]-Fair Value
 Measurements
 Recurring [Member]-Fair Value
 Inputs

  

 Liabilities [Member]-Fair Value
 Measurements

  

 Inputs
 Level 2 [Member]-Fair Value
 Measurements
 Recurring [Member]-Derivative Financial Instruments

  

 Liabilities [Member]-Fair Value
 Measurements

  

 Inputs
 Level 1 [Member]-Fair Value
 Measurements
 Recurring [Member]-Derivative Financial Instruments

  

 Measurements
 Recurring [Member]-Fair Value
 Inputs
 Level 2 [Member]-Derivative Financial Instruments

  

 Measurements
 Recurring [Member]-Derivative Financial Instruments
 Liabilities [Member]-Fair Value
 Inputs

  

  

  


000 line of credit to the vendor at a 5.5% interest rate. The vendor may not draw down more than $75
000 during any thirty day period. The Company will be re-paid for these advances with future discounts on products manufactured by the vendor.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;The Company capitalizes distributions to the vendor related to this agreement upon disbursement based on this value to be applied towards discounts on future product purchases. Interest on the outstanding advances are recorded to interest income and capitalized to the letter of credit account
 and will be realized with future discounts as well.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;On March 28
 2014 the Company agreed to an amendment to the custom processing agreement relating to the repayment of the line of credit advances plus interest.&amp;#160;&amp;#160;Commencing on April 1
 2014
 Aveka Nutra Processing will begin paying the Company $5




 2013 and 2012 are as follows:&lt;/div&gt;&lt;/div&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&lt;div&gt;&lt;table cellpadding=0 cellspacing=0 style=width: 100%; font-family: times new roman; font-size: 10pt;&gt;&lt;tr&gt;&lt;td valign=top style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 10%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;12/31/13&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 2%; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 9%; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;12/31/12&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 2%; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 9%; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=top style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td colspan=2 valign=top style=border-bottom: black 2px solid; width: 12%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Number of Warrants&lt;/div&gt;&lt;/td&gt;&lt;td colspan=2 valign=top style=border-bottom: black 2px solid; width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Weighted Average Exercise Price&lt;/div&gt;&lt;/td&gt;&lt;td colspan=2 valign=top style=border-bottom: black 2px solid; width: 11%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Number of Warrants&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=border-bottom: black 2px solid; width: 9%;&gt;&lt;div style=text-align: center; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; font-weight: bold; margin-right: 0pt;&gt;Weighted Average Exercise Price&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 23%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Outstanding at beginning of year&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;23
392
811&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.46&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;23
752
669&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.55&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=top style=width: 23%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Granted&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;4
010
295&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.18&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;650
000&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$0.83&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 23%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Exercised&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(2
287
730)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.28&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(490
424)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$0.62&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=top style=width: 23%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Cashless Exercises&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(8
082
535)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.43&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(335
541)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$0.91&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td align=left valign=top style=width: 23%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Expired and Cancelled&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(344
576)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$0.88&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;(183
893)&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$14.73&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td valign=top style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;16
688
265&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;23
392
811&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td valign=top style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 10%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=top style=width: 23%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Outstanding
 end of period&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;16
688
265&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.44&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;23
392
811&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.46&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=#cceeff&gt;&lt;td valign=top style=width: 23%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 10%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td valign=top style=width: 9%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;/tr&gt;&lt;tr bgcolor=white&gt;&lt;td align=left valign=top style=width: 23%;&gt;&lt;div style=text-align: left; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;Exercisable at end of period&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 10%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;16
688
265&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;$1.44&lt;/div&gt;&lt;/td&gt;&lt;td valign=top style=width: 2%; display: inline; font-family: times new roman; font-size: 10pt;&gt;&amp;#160; &lt;/td&gt;&lt;td align=right valign=top style=border-bottom: black 4px double; width: 9%;&gt;&lt;div style=text-align: right; text-indent: 0pt; display: block; font-family: times new roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;&amp;#160;23
392


 Award Vesting Percentage On One Hundred And Eighty Days Subsequent To Grant Date

  

  

  

 Award Vesting Percentage On Ninety Days Subsequent To Grant Date

  


  

 Award Vesting Percentage On Two Hundred And Seventy Days Subsequent To Grant Date

  

  

  


  

  

 Interest Rate

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  


  


  

  

  

  

  

  



000 the Company loaned ANP to assist it with the purchase of its Waukon
 Iowa facility) or the first month after the Company has ordered 80
000 lbs. of product for three consecutive months


  


  


  

 Maximum Borrowing Capacity-AVEKA Nutra Processing

  

 maximum-AVEKA Nutra Processing

  

  

  

  

  


  


  

  

  

  

  

  

  

  

  


  


  


  

  

  

  

  


 school districts and the general public.&amp;#160;&amp;#160;There were three significant customers who accounted for 36%
 24% and 5% of total sales for the year ended December 31
 2013.&amp;#160;&amp;#160;There were three significant customers who accounted for 36%
 24% and 9% of total sales for the year ended December 31
 2012.&amp;#160;&amp;#160;Further
 two significant customers accounted for 61% and 11% of the total accounts receivable for the year ended December 31
 2013.&amp;#160;&amp;#160;Two significant customers accounted for 77% and 9% of the total accounts receivable for the year ended December 31
 2012.&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;&gt;&amp;#160;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;The Company maintains cash deposits with major banks
 which from time to time may exceed federally insured limits.&amp;#160;&amp;#160;At December 31
 2013 and 2012
 $193
472 and $394
804
 respectively


 Goods

  

  

  

 Goods

  

  

  


 the Company was sued in Circuit Court of the 17th Judicial District
 Winnebago County
 Illinois
 by LIBCO Industries
 Inc.
 alleging the Company breached a construction contract and tortuously interfered with a business relationship
 and is seeking damages in excess of $185
000.&amp;#160;&amp;#160;The case has subsequently been transferred to the 19th Judicial Circuit Court
 Lake County
 Illinois.&amp;#160;&amp;#160;Management believes that the allegations are frivolous and wholly without merit and will vigorously defend the claim.&amp;#160;&amp;#160;Related to this matter
 Process Piping
 LLC
 a sub-contractor for LIBCO Industries
 filed a mechanics lien on the property leased by the Company
 claiming it was owed in excess of $95
000 by LIBCO Industries.&amp;#160;&amp;#160;As of December 31
 2011
 the Company accrued as a settlement loss
 the $62
500 paid to Process Piping
 LLC on March 6
 2012 in exchange for a release of its lien as well as an assignment of all of its claims against LIBCO Industries.&amp;#160;&amp;#160;On January 31
 2013
 the Circuit Court granted the Company&amp;#8217;s motion for partial summary judgment on the tortious interference claim.&amp;#160;&amp;#160;In the fourth quarter of 2013
 the parties settled all outstanding matters and the case has subsequently been dismissed. As part of the settlement
 the Company received $10
000 in cash and both parties provided releases of all respective claims.&lt;/div&gt;&lt;div style=text-indent: 0pt; display: block;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;During 2012
 the Company entered into a settlement agreement with a former employee who filed a Charge of Discrimination with the Equal Employment Opportunity Commission.&amp;#160;&amp;#160;The Company settled with a payment of $13
968 and the matter was resolved.&lt;/div&gt;&lt;div style=text-indent: 0pt; display: block;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;As of December 31
 2012
 the Company has recorded a liability in the amount of $102
000 relating to the complaint initiated by Joseph Sanfilippo and James Cluck as discussed in Note 18 below.&amp;#160;&amp;#160;The Company believes that it has good grounds to defend this suit
 and has only allocated this amount so as to be compliant with applicable accounting standards.&lt;/div&gt;&lt;div style=text-indent: 0pt; display: block;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=text-align: justify; text-indent: 0pt; display: block; font-family: Times New Roman; margin-left: 0pt; font-size: 10pt; margin-right: 0pt;&gt;On February 12
 2013
 we entered into a settlement agreement with a former provider of investment services over compensation provided in a prior period for services in the raising of equity capital for the Company.&amp;#160;&amp;#160;As a result of this agreement
 the Company issued 875
000 shares of Common Stock to this party.&amp;#160;&amp;#160;As of December 31
 2012
 the Company has recorded a common stock payable and settlement loss in the amount of $1
881



  


  


  

 Shares Issuable Upon Conversion-Brightline Ventures I

  


  

  

  


  


  

  

  


  

  


  

  


  


  

  

  

  

  

  

  

  

  

  

  

  

  

  


  


  


  


  


  


  

 Value upon reclass convertible

  

 Value upon reclass convertible

  

 Value upon reclass convertible

  

 Value upon reclass convertible

  

 Value upon reclass convertible

  

 Value upon reclass convertible

  

  

  

  

  

  

  

  

  

  

  

  

  


  


  


  


  


  


  

 Shares

  

 Shares

  

 Shares

  

  

  

  

  

  

  

  

  

  

  

  

  

  

 Shares upon reclass convertible

  

 Shares upon reclass convertible

  

  

  

  

  

  

  

 Value

  

 Value

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  


 2009. However
 the statement had not been declared effective as the Company was not Form S-3 eligible.&amp;#160;&amp;#160;A Form S-1 registration statement was filed on June 2
 2011
 and went effective on June 3
 2011.&amp;#160;&amp;#160;Under the terms of the registration rights agreement
 as partial compensation
 the Company would be required to make pro rata payments to each Investor in an amount equal to 1.5% of the aggregate amount invested by such Investor for each 30-day period or pro rata for any portion thereof following the Filing Deadline for which no registration statement was filed.&amp;#160;&amp;#160;We obtained a release and waiver of the amounts due from 74 of the 2008 investors.&amp;#160;&amp;#160;As of December 31
 2013
 there are 3 investors who have yet to sign the release and waiver.&amp;#160;&amp;#160;Under the terms of the RRA
 as of that date we potentially owe
 and recognized as liquidated damages
 the amount of $36
178.&amp;#160;&amp;#160;During 2011
 two investors did sign a release and waiver of any such claims
 and therefore we recognized a gain of $74



  

  


  


  

  





















        
        
        
        


        
        
        
        



        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        




        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        



        
        
        
        



        
        
        
        



        
        
        
        






        
        
        



        
        
        
        



        
        
        
        



        
        
        
        



        
        
        
        



        
        
        
        



        
        
        
        



        
        
        
        






        
        
        



        
        
        
        



        
        
        
        



        
        
        
        



        
        
        
        



        
        
        
        



        
        
        
        



        
        
        
        



        
        
        
        





        
        
        





        
        
        



        
        
        
        



        
        
        
        



        
        
        
        



        
        
        
        



        
        
        
        



        
        
        
        



        
        
        
        



        
        
        
        



































































































































































































































































































































































































































































    


    


    


    


    


    


    


    


    


    






    


    


    


    


    

    


    


    


    


    

    


    


 Net



    


    



 Notes



    


    

    


    


 Depletion and Amortization
 Property
 Plant



    


    


    


    


 Share-based Compensation



    


    





    





    

    


    


    

    


    





    





    

    


    


    


    


    


    

    

    


    





    





    

    


    





    





    


    


    


    

    




    


    


    





    

    


    


    


    


    


 Value






    

    



 $0.00005 par value; authorized 200
000
000 shares; issued and outstanding 39
449
138 and 25
032
444 shares
 December 31
 2013 and 2012


















    


    

    


    


    


    


    


    


    


    


    

    


    

    


    


    


    

    


    


    


    


    


    

    


    


    


    


    









    


    

    

    


    


    





    


    





    

    


    





    

    

    

    


    


    


    

    


    


    


    


    


    


    






    





    


    


 Preferred Stock



    


 Common Stock



    


    


    


    


    

    


    


    





    


    


    


    

    


    


    





    






    










 Measurements










 Measurement with Unobservable Inputs Reconciliations
 Recurring Basis







    



 Measurements



    


    


    


 Inputs



    


 Inputs



    


 Inputs



    


 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability



    



 Liabilities Measured on Recurring Basis



    


 Measurement with Unobservable Inputs Reconciliation
 Recurring Basis
 Liability
 Purchases
 Sales
 Issues




 Liabilities Measured on Recurring Basis



 Liabilities Measured on Recurring Basis



    

    


    





    


    


    


    

    


    


    

    






    

    






    









    


    


    

    


    

    


    


    


    

    


    


    


    

    


    


    

    


    

    


    


    


    


    

    


    





    


    





    

    


    

    


    


 Finished Goods



    


    

    


    

    


    


    


    


    


    

    

    


    

    










    


    

    


    





    


    

    


    


    

    






    


    


    


    

    


    

    


    


    


 Notes



    


    


    


    


    


 Carrying Value



    






    


    


    


    


    

    


    


    





    

    


    

    


    


    


    

    


    

    


    


    

    


    


    


    





    


 Loans and Financing Receivable
 Net



    


    

    


    


 Future Minimum Payments Due



    


    

    


    

    


    


 Rent Expense



    


 Future Minimum Payments Receivable



    

    


    


    


    


    


    


    





    


    


    


    


    


    

    


    





    







 $0.01 par value; authorized 1
000
000 shares
 issued and outstanding 0 and 665
339 shares
 December 31
 2013 and 2012



 Including Additional Paid in Capital



    

    

    


    

    


    

    


    

    










    






    


    

    


    


    

    


    

    





    


    

    


    


    


    


    


    


    









    


    









    
























    

    


    


    

    


    


    


    


    

    


    


    


    


    


    


    

    


    


    

    


    


    


    


    


    


    






    


 Goods



    





    



 Goods



    

    


    


    


    


    

    


    


    


    


    


    


    



 Shares Authorized under Stock Option Plans



    






    



 Notes







    


    

    

    


    


    


    


    


    


    


    

    


    


    


    


    


    


    


    


 Fair Value Assumptions



    


 Fair Value Assumptions



    


    


    


    


    





    


    


    


 Options



    


    



 Shares Authorized under Stock Option Plans




 Shares Authorized under Stock Option Plans



    

    


 Options
 Outstanding



    


    


    


    


    

    


 Options
 Outstanding



    

    


    





    


    

    


    


    


    


    


    


    

    


    


    


    


    

    


    


    


    


 Value







 Value



    

    


    


    


    

    


    






 Shares



    

    


 Options



    

    

    


    


    





    


    





    

    

    

    


    






    

    


    

    


    


    


    


    


    


    

    














    


    


    


    


    


    





    


    


    

    


    





    




    


    





    





    


    


    

    



 convertible


    

    


    

    





    

    

    


    

    

    


    

    


    

    

    


    

    

    

    

    


    

    

    


    

    


    

    


    

    


    

    


    

    


    

    


    

    


    

    

    


    




    

    


    

    

    


    


 Value


    

    


    

    

    

    


    

    


    

    


    





    

    


    

    


    

    


    

    

    


    

    

    

    

    


    

    

    


    

    

    


    

    

    


    

    

    


    

    

    


    

    

    


    

    

    


    

    


    

    

    


    

    

    


    


 Convertible


    


    

    


    

    

    


    




    


    

    

    


    

    


    


    

    

    


    




    


    

    


    




    


    

    





    

    


    

    

    


    

    

    


    




    


    


 Award Vesting Percentage On One Hundred And Eighty Days Subsequent To Grant Date


    


    

    

    


    


 Award Vesting Percentage On Ninety Days Subsequent To Grant Date


    








    


    

    



 such as employees
 directors
 Advisory Committee


    


    

    


    


 Award Vesting Percentage On Two Hundred And Seventy Days Subsequent To Grant Date


    



 for example
 but not limited to


    

    


    

    

    


    




    


    

    






 Interest Rate






    

    


    

    


    

    

    





    

    

    

    


    

    


    

    

    


    

    

    


    

    

    


    

    


    

    


    

    


    

    


    

    

    


    

    

    


    

    

    








    


    

    

    


    

    

    


    





    

    


    

    

    


    

    


    








    




    


    





    

    

    


    

    


    

    

    


    

    


    

    

    


    

    


    

    


    

    


    





    

    


    


    

    

    


    

    

    


    

    

    


    

    

    


    

    


    








    


    

    


    

    

    


    






 if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues and concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible
 near-term


    

    


    

    


    

    


    

    


    

    


    

    


    

    


    

    


    

    

    


    

    

    


    

    

    


    


    

    

    


    

    


    

    


    

    


    

    


    

    


    

    


    

    

    


    

    


859



    

    

    



 repurchased





    


    

    

    


    

    


    

    



 for example
 but not limited to


    

    



 for example
 but not limited to


    

    


    

    


    

    


    

    

    



 net of adjustments (for example


    

    


    




    



 redeemable preferred stock to convertible preferred stock



 Value upon reclass convertible



 redeemable preferred stock to convertible preferred stock



    

    

    


    




    


    


 Shares


    


    

    

    


    

    



 redeemable preferred stock to convertible preferred stock



 Shares upon reclass convertible



 redeemable preferred stock to convertible preferred stock



    

    

    


    


 Value


    


    

    

    


    

    

    


    

    


    

    

    


    

    

    


    

    

    


    

    

    


    

    

    


    

    


    

    

    


    

    

    


    

    

    


    

    





    

    

    


    

    

    


    

    


    

    


    

    

    


    

    

    


    

    

    


    

    





    


    

    

    


    




    


    

    

    


    




    


    




    


    

    


    































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































    
  
      

PROPERTY AND EQUIPMENT
 NET (Details) (USD $)

        

      










        
        
        


Property and equipment
 gross

069
718

074
040


        

269
412)

628
075)


Property and equipment
 net

800
306

445
965


        

575

134


        

084

899


        
        

000


        

334)

101






        
        


        
        
        


Property and equipment
 gross

422
110

426
432



          

        
        


        
        
        


Property and equipment
 gross

904
188

904
188



          

        
        


        
        
        


Property and equipment
 gross

182

182



          

        
        


        
        
        


Property and equipment
 gross

238

238




        
          

        
          
            

 depletion and amortization (related to property
 plant and equipment
 but not including land) that has been recognized in the income statement.
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 plant
 and equipment asset that was sold or retired during the reporting period. This element refers to the gain (loss).
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 but are not limited to
 land
 buildings
 machinery and equipment
 office equipment
 furniture and fixtures
 and computer equipment.
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 net of accumulated depreciation
 depletion and amortization
 of long-lived physical assets used in the normal conduct of business and not intended for resale. Examples include
 but are not limited to
 land
 buildings
 machinery and equipment
 office equipment
 furniture and fixtures
 and computer equipment.
              
 -Subparagraph b
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    





















    
  
      

          

        
        
        
        
        
        
        
        
        

      










 2007

          



 2007



          



 2011



          



 2011



          



 2012

          



 2012

          



 2011



          



 2011



          



        
        
        
        
        
        
        
        
        
        
        


        
        
        
        

000

000

000
        
        

000

000


        
        
        

000
        
        
        
        
        
        
        


        
        
        
        
        
        
        

500

500
        
        


        

000

968
        
        
        
        
        
        
        
        




        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 to be received by
 or to be remitted to the entity in settlement of litigation occurring during the period.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
 -Paragraph 9
 10
 11
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    





















    
  
      

STOCK OPTION PLAN AND WARRANTS
 STOCK OPTIONS (Details) (USD $)

        

      










        
        
        


        

318
355

547
826



          

        
        


        
        
        


        

728
877

645
202


        

176
535

354
275


        

650)

600)


        

000)

000)


        

583
762

728
877


        

536
262

582
022


        
        
        


        
        
        


        
        
        


        
        
        


        
        
        


        
        
        


        
        
        


        
        
        


        
        
        


        
        
        


        
        
        


        
        
        


        
        
        


        
        
        


        
        
        


        
        
        


        
        
        


        
        
        


        
        
        


        

416
238

271
123


        

103

595



          

        
        


        
        
        


        

176
535

324
275


        
        
        


        

318
355

599


        
        
        


        
        
        


        
        
        


        
        
        




        
          

        
          
            

 the aggregate unrecognized cost of equity-based awards made to employees under equity-based compensation awards that have yet to vest.
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 equity-based employee remuneration. This may include the value of stock or unit options
 amortization of restricted stock or units
 and adjustment for officers' compensation. As noncash
 this element is an add back when calculating net cash generated by operating activities using the indirect method.
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 in 'PnYnMnDTnHnMnS' format
 for example
 'P1Y5M13D' represents the reported fact of one year
 five months
 and thirteen days.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 if any
 over the period.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 if any
 over the period.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards
 net of cancellations and forfeitures
 if applicable.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
 -Subparagraph b(1)(c)
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 including vested options.
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 in 'PnYnMnDTnHnMnS' format
 for example
 'P1Y5M13D' represents the reported fact of one year
 five months
 and thirteen days.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
 -Subparagraph (SX 210.5-02.28
 -Paragraph 29
 30
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 in percentage of the total granted.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    


















begin 644 Financial_Report.xlsx
M4$L#!!0`!@`(````(00-LX-*`(``(`B```3``@6T-O;G1E;G1?5'EP97-=







$
M%``&``@````A`+55

M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````

M
%'*86C1DQFH9=R4Y3V&OQY0+3S5P6H(!WL'JC[Z//FRMS1-;W@OYGUBETZ

Y



C9!N&A001V3@\PI\\NVCMI

?P
``/__`P!02P
$%``&``@````A`+A[

''N96@O+M9D('AGCR$A#


#AKL\


5TJP4M.`6_(B[E2*5AR
=K^^O8#T-@!29-)
;H2$T!DPC@%W?1*!T?0^



9@Z67_7Z8(F


M6@WY_F*[(J/A]2@;%Z]*O'


0/OG/!2
MMX678?DAWR8KP?N?_PJX_P\``/__`P!02P
$%``&``@````A`&W@E`^'!0``



:]U0?90HIJB`?592=]T.2710GJ\O
ML?_L?05%2PW)IA!F(_(;0A4V-TI0MYCBO^M^8V)`BLFJ@:*6H8_0.P[-4[6
I82:A:QR(2!F%1@PY?3DV!;7`7CA#2#1#S4+
48O64%-@4E!!



M5QG$@+8-(C$)HV(:@\5

L*Q1<C9(W*K
MC$].).'N-'SJB:'&+VXB!
63EO-P@2A\)/`#!;O556P*=6D)H!H`DBYKX1
M1,!Y13.=2`-2L

+AY&3!!`;@
2P1ZJ1WQ!'34$
M


ODUO


MZ91[V'K/N\/K8WHV=?XII5.G\^;PO'GW#NYC^H][2O_[]/__/?SRCM]/;ZY[




M[+YL?KR?Q]ZOIKM[?3O3^2[0(8DCJSS_L=W3EKJ4PF3T@HBT]=YI!^C/U'XG

ATZGMC]/9VR\DTOQ0
HCN


M$6SBR`99`$2


MRQ]*
7&M)/)@TEZSJ6Z+VR-/RO.4?DH.1'\T!4-=:#'4@SVN!@VWCCU
M@CI(:U&FJ!H[;'15U,/8

M*

9-KQO5F%B&NR$K\.&A[&L!
9/S?M1'$I-

MO*'!&YJR03DNC=6+5@+3CC`Z&QR=!*:;P/02F'X,PB;`LN=(2:C,#%U5O['
M488-L4D
TU@9@G
/(%9)##+!&:5P*P3&


MP2[3JM+0P5R_?;!Z6H/AJ(.A0-%`XHF%THVE!TH.AT8.B#\4`BB$4(RC&
M4$R@F$(Q@V(.Q0**)10K*-906!8F..LLG'96;-XI98/NOEE(]F5M-CJ
4T7
M[-?28!KL@JPJ35SY@
*&H@Z%`T4#BB84+2C:4'2@Z$+1@Z(/Q0*(10C*,90
M3*80C&#8@[%`HJE%(7+75G#T(O%
KN+L((QUE!8%B8XZZP:CA*;=TKYH#OO


*&XHZ%(X493F2
^R4

M





:&I2B*-']
Q
MJ49SE;I)3#Q:D6%WHD$RHN^
I$$YNQXI*_/?\?*^M^BCFB&N8V)C4,7$P
M:6#2Q*2%21N3#B9=3'J8]#$98#+$9(3)&),))E-,9IC,,5E@LO2)?RM#*YBZ
MP:[?5SC*&A.J+C(A8W*-J@LV1*2ID;&Q5&KBY@)=3]C./[[CB8G3BE/8S3V
M-;_JHY@CK6%B8U+'Q
&D@4D3DQ8F;4PZF'0QZ6'2QV2`R13$29C3:83#&9

H:$ZHJ
RG5)1^J+A+%''%-@\3&I(Z)@TD#DR8F+4S:F'0PZ6+2PZ2/
MR03(28C3

J+C`/*+B@DV
M?*3B$A='+2Z4^J'BDN!NB]B,?R%BD_2KFD1^X3;S.?8DL*8`(U_B9\?V04QY
MJF/B8-+`I(E)Y
V)AU
NICT
.EC
L!DB
D(DS$F$TRFF




@(:FJQ

M1RS9@2Y2(+%QE#HF#B8-3)J8M#!I8]+!I(M)#Y
^)@-
AIB


2/`N2T_S4Q8VZ[JJP;F`
M-4QL3.J8.)@T?+/3-10:^(@+25(Y'RH-H[2P:2+20^3/B8#G\ANB3RB(8XR
MPF2


MO:U5:`7




M970T-YX;6R

+0B1964W=SS1%Z1!@N7=:2%
MF9+Q!DMXY1M/=)S@HE_4U%XPF4R]!M
6:88YOX2#E27-R1W+MPUII2;AI
82
M](N*=N+`UN27T#68/VZ[JYPU'5L:4WE2T^*G:?/VQ:QO&ZAKB?_0CG!^[^



M18'[@A_V3:*9N?-*8Y*PKR3?C6;FY]/5
3U]CC.]X/5@#*E34ZHZKU
X]6]7
MMUID28XGEF2-&2M(8LOR[!1SM-Q0F9RJ#


G#B^IBP_^YY5\```#__P
`4$L#!!0`!@`(````(0!J

MR!8'\/=;=;\#Q7L





M-K2]S_/!?








MBX8!.\GG

]`(NV&!'BM
ET-E/#N
*P

M







C7A


M?+G\.UUSL[RF:X8DEGNBV=D$DQ23#)

*DUI+U$SF
_^7F7S=7!LO


MA$F


M;8
1M2B]L`OJN39B#


$DQ23#)

*DUI+U#3F]90/
MI+$HOURFL6613[UMZ&HTIS'R`A


MQZJU1

(DQ


E!##FXOQY.D8ISA$ADF.28%)B4F%2:TE:EKS
LP'TEI4;=2T)J?
MYG]0P`;1FLO)`A



DQZ3`
MI
2DPJ36$C6I65XJ@X\KDYHO1GMJ6ALW!=(F-20.CN)BXF'B8Q)@$DHBD]IP
MO[1Z:K'+[X(8KR3!)
4DPR3'I
DQ*3I-82-:D_5TTT.ZJ)HU9/+9`VJ2%Q

2DP
M*3&I
*FU1$UEE@.?Z9_Y8K1_)C.7MBF0)LL6F#B8N)AXF/B8!)B$F$28Q)(T




W(W9$ND[:U%

`DQ3)-8$EGE
V:SX7!

(


-+S!Q
'$Q\3#Q


(DU@2
M.02Q#'-$B^D)CI)BDF&28U)@4F)285)KB9K8M*BH?Z9IU%%
I,6R)M0N-B
M(H[B8N)AXF





MPX]?4N+/^^_WS_\]%KV\^/'I)OGZ\^'Q]L_O\KS_XS5N/^6UC_]3*/_C_M/C

M#VWN[_YY.OOWQ=.WAW_BQ_O/H_N?=[*[Y85*7X(_'Q[^2FGR.5TD#[XJ/#HZ





E?ZOI+
8=(S2X

MY9.\!_S[8ZO=?G_U;XGM3]IT2XS7

MHOUL01;@Z5J2?
%+C9:]:8.BD50VUS3

SU:E
M#[N*YZA.!^++4RCL.Z4/3J.W[(-3Z:/S.
K*.O)T+

MI+RQ4YTV=OXR=/


MDFL[OI+


:81


M
Q8[3US
'

MV3F8O8

<3;[\7Z4#A[F#X6SI;H@^&\4.%M3.D#Y.QAIR/D9;.+#SL=-57H=2]
MH.9+


M
;XFY3W&Z*^TUQPRGN

4
M8Q03%%
4
Q1S%(M


8H^B@3%`
40Q0C%&
4$Q13%#

MA?/_)998H5BCV*#8HMBAV*


M8M+GU21
!DR&3$9
QDPF3*9
9DSF3!9
EDQ63-9
-DRV3'9
]DP.3.0&X;1[


:_*H2OESF.N4]V79IS*1_BO
MB=.46W%:^

8B9])@F3`9
ADQ&3L2:_

9DSF3!9
EDQ63-9
-DRV3'9
_DP$2B%+M
HI1-WHH5
MW2H3


2


1DS&39,IDQF3.9,%DR63%9,UDPV3+9,=DSV
M3`Y,)%BQUR18V3@TI`0KU\E;LG(\ZM4RJ$K)5IY@QSZ4J*5ZU1WIAFMZ52(

!DR&3
M$9

EDQ63-9
-DRV3'
M9

M3]
Y:\?[OK95(;SX6[KVOI.HZY&E;F*4R(KA(RB31IU8\#WMJ[FG6](^8:
M?28)DP&3(9


DU60/(
M-S(4+LD:P*^57)'ES5@R63%9
]DPV3+9
=DS.31,,4VDS!EX]+RJ$9)4QY
M70[M*&'*=1P:4L*4ZSBTI(1I51TS3-.I.=#5`C3;.:E#_=Q]KV[0FN/DYO
MZ#$)F(1
(B8QDSZ3A
F`R9#)B
F8R83)E
F



P&3`9
ADQ&3.9
)DRF3&9
UDP
M63)9

#DPD3K&-)$XSHY]2IU'XPB.)


TG89P/CQU^_KI
M]!?

WF+IR?_;?J5N-W?9S@T&
2
`F91$QB


!DR&3$9
QDPF3*9
9DSF3!9
EDQ6
M3-9

F4R8S)G

QDPF3*9
9DSF3!9
E
MDQ63-9
-DRV3'9
]DP
3I1Q
U\$X]*=R:%#ET*'*H4650X\JAR95#EVJ\C:M
MB]5W9AFP*:S!,Z'KV[W`]2SR07GP]A6V_H\NJM1Q9;VF`1,0B81DYA)GTG
M9
!DR&3$9
QDPF3*9
9DSF3!9
EDI8G^G-YKRXR#AC4$6'.9#9
MDQV3/9
#

\UHE71\
M2[2F#S/'L(5;-[KU#%5&*Y*`JX1
(B8QD[XF6=OZ]8;?MJZ*)%QDP&3(9
1D


8])@&3D$G$)&;29Y(P&3`9
ADQ
M&3.9
)DRF3&9


!DR&3$9
QDPF3*9
9DSF3!9
E


-DRV3'9
SDPD5#%'I)09=-S
`[-*`-67I=#


-DRV3'9

M7




!DP&3(9
1DS



$B8#)D
F
M(R9C)A
F4R8S)G
FR9+)BLF:TVRA&FVO':K:5W`VG5+9
=DSV3`Q.E'(Q#




F`R9#)B
F8R
M83)E
F


M\I^ABH%HKX$D8!(RB9C$3/I
$B8#)D
F(R9C)A
F4R8S)G
2#


!DR&3$9
QDPF3*9
9DSF
M3!9
EDQ63-9
-DRV3'9



IDQF3.9
%DR63%9
UDPV3+9
=DS^3`1
(4&TTY-*.$*==Q

2,!DP&3(9,1DSF39
IDQF3-9
M
%DR63%9
]DPV3+9



MG^LXM*4
5[E.=6.:R2JA]I9D31]FC5@;UD6*;C-#%;'98Q(P9E$3&(F?28)
MDP&3(9,1DS&39
IDQF3.9
%DR63%9
UDPV3+9
=DSV3`Q-)UJS7LE%
^H5;


!DR&3$9
Q
MDPF3*9
9DSF3!9
EDQ63-9
-DRV3'9
]DX



UG0.@9VLZ?16&+-F4P^



UC3N0)VL/+OJ6IF
M4PS



O%P9W__F7UNC]&VRPO;=9['Z\O7Y;MIM7%^)AM5X=?G=!QZ/-




%

M1-G7QT\LJ5N&^%'F#\(ZQ0G)E`H8=QXG+0E1`P$ZQ5&4)Q]IWB6;0D`:QP69

9+14P


(
;C8OF2SDKK-
M`#%ZU#*B9$3+B)$1&Q!81Y(T2\J/!1U+YLUI3S(AN\#*]J5R9@BO4%7
^5UP
MYC*B9$3+B)$1RR)8*]?[5VCE:;H.#M(*(#:M1$3%(J)EQ




MA$D+[&Y?J5DRF+0X3QR4$A$5BXB6$2

MFT=90KR*EFLR
NR<B(91$LUE4^/AGZ^#(GK:PQ(H%<8)8:9;E
[)8J!`E('&9EG.2
MPEJNR




Y(X&1



M@#H@C*!*1C2JR'_E9G3WR`D'0(6`=S]G=3[W]Y@Y-?!CB91=2]!^@H5%SD


&^N`A%VTNXY/;S\J.8B6$2
C
MED6P9-[\]@;AA7
\6&:46#
R)54I]N7)(+-$WZU$9U+2-&1BR+8


3)B602IE1$7?YE:W5%X

M:!DQ



MJ(J)HF7$R(AE$:P5






LQC(SX
MYT]\?B:@%#Q?`AXXL&EVSTW=K-?[T;)]\\^.2-ROD4Z?GIYK\3WQ/[(GG]?Q

AH
G-GM8
?NMIL&F





6.(Q*XGV*!@LBYOX-:R

\(Z02M03?6_C08
.X;W%&`:C$./'
Z$/
M):-9*'M9IV^XW[






(GB8`D



M&@EH).R093OU'ZUW$2T22Q'1'%9O_80YO$P;IE:K&2IS'(-#4G-(Q*55/!KQ


+I_T1K1%+$=$35FQ.\(37IJ(GN(@T9`5LYPF)N+2*
M1R


M51_W@N^6XCMOBJPZ9KOL?*Z5M'QC.Z'84+BUWG9I?5FP/2HW3$VL$UFW![

P-_


M`/__`P!02P



M4QW)D0\0::3JJ8&AVL1Z5)S6;E+?Q6F2E'%/Q8]PDQ=HR&;1C#^(-FVYX/Q
M(HIWU(!_W8I1OZGU[!JYGJJG[7C#9#^Q%ITPKPZ48QZ-ONT&:2BZP[R?B$Y

1BTUKH-L%)&3SFM6O#UPS*C(1&EAE9CLP`#\HE[8G0$%H2_N?R=JTU8X
MRZ





_
](7&5XX)5)/5?B?`_+C_\M]@S_B2VA$@/&J1^ELI
MZWD0B&Q+2BQ&K85_+)FO
02;ODF$#4G.-=!91%$89@$)::5;QCF_!(.ME[3

KL$KH2\Z==?9.QL@:*%2VH?-6DOE=F\V^;




M+0:UB`2MIDAV^69%5AE5E514N[-@VZ::#C-^#UI%+B7QCSHIDF2R7B23^1

M3$]!
AW6D%RC006Y&F8MO]%@
'T-MRVF5X?I-1I4D*-A&K;\1H/!)'KR)R%\
MVM][^95A=_;497U006Y^NW-
?H


P.@T&[U73?2

&8,`*HZ,M:$]Z8_LE/9[

M%(7P



`LTDB!E3@6L(`#Z=IF*E`1G)G_GS



M70PV.]O&-RWVTH)M+:--QTF`1X(4I@LSY`!6-A*N3Z.PG\EA6
0I86TB4=

M6*`(X:&BC

M*R/IEEI(IB-&@+/W!
B


ME#Z
=CW
&QG5PN'69CP#%$!+T0[[N+=**XA#LQJ-E51:\8L)W\1
0J;C*RGW
MV4S1RN9_Q(@))*Y!?+4=)X[QNQW&=M0:D.9`9D)9D/C[3&)$6/$)*!1@F-5
M=.+L^X.5F:?1;$BEE9[@FXYS16^*88/C[6+$F#'$

`/=4I/`'H

M_(40+W1HG0=

`4$L#
M!!0`!@`(````(0`8$K7(S`
``%@

M=#
V+GAM;*Q7RV[;


N$I*P]+^_?]

P([S!X1^2S$$BYVSU7?-?RLK93NR3&7
MO_CI*V6'3
)I3);
MVL%T$LW<P`.XM:-WC&DM*WD*0O_BJ0IZD4B:])X-F2N).9Y\Z#&9\LC#0



V

MN

:%0I:'^B6



7CM(=P(S4A.[WWW[6+9;
M4!3S




_PQ!VXANZ^)BX0P@04&C-1
M:D6PFNR
U#`C0BD_HI2R!`3CS$4D=L0A




M&LGQNCP'PG!M
HQA2=@K00WB*L:
(6)D!KW.N0U!.`;0-FZ7L1]%=0QC7A\:
ME/8ZWJW3=!FE=(Y@01)$(.)#!#*4S7E4;KM(@;8PDFOY(A
JY%#;+):(50

M9%7.!J'\(




G
MH1^.SM%44F8W$^L([6*\1

9WF0[/9JE/&+M
-
@S6^Y

ME)U@/*GS38=0

MMW-#CQAS

%)

MC0;))'1V
8X

MPBT6O

\4XS[6VKT$@VZPNE\*J%B4DZJ
M/X]ZKX


:V7J!V6\XRD0;@;Y9M-K2?&08C]C!0+)C*A

1I+']IQ1J(8ZQDI%FQD`E-L_^/R$=H

F,1`!\V9+:29B?
MV-GU:.HC<!@?W@GJR+3(+EPL6:L$
?984;[

M=Q9%IR&W84SQ($$8;#

;!#UW!WKU3P3IB9I6Y!)(SG3)_F9;I




MM/]^QSA-





)OQ:7




M3\Z-)AK*BI


+1]!K'@B#VX;/Y!89#(;Y%=-BFRR.IF1&8\BB,(R*=E8$
;+P+LX
M6&3Z939[9&BQ339M[-Q(3.



M^46]^0T``/__`P!02P



#.0=#QG&
G=L!I
MO=QG
`
1=JMBAY7]3!9;2FUGO6P#]&_&KO7@LU6?^/6W*MO_D94
H@UY$AG8



M%N!\FQER='/]V51ACL+D6;BL;%CN
(L:\O.^#@-OZ;Q#3%.IV8PU1%5L;PJ1
ML#K&&'F0\;[4;^A+%`$5D0;!O\`KP[-JJ-.U9XO40A@0A-)Q%BR/1@X-#O


!)$12*OM*H\=T:)2JGJ-0#


O/U64PU-%38Q
M\45BF[^+KZNKZ\?P\.'[\;#Z5M1-69TVEFL[UJHXY=6V/#UOK'_^_GP76:NF

M.

$ZV-6GBR


X1X*@]E^Z
+:JV.^?V7YU-5


M!J\GHS]W*_!GO=H6N^SET/Y5O?Y6E

MR-6A


XB'2O\P/.%8V(01F5VHTXR7W=*

MFIG?I.RXJXK3O(R:\BZR%G7QQO=X&/'Z1%'/&;!YI#H('G=L

MC:+I

%XXE
1C0OBI#`M5T_)B]:)JE+U5?SRSSH1MX+

QB-M@1NF0NB:Z3*




S.9;E$1_@AR
+@?


2FL=%5B2G5C2]


$A#TBI17.46C*XXU5*9C7JPNX&RNF/IGCT@U93HFB6$B5O4UXPFQLH

M0[+O$WA`V3W-6P\'X/G@.7LN_LCJY_+4K`[%#D(Z=@B55.
31OS05N?N*=U3

$%``&``@`
(




95L44#K'?IPE_%
EKQO
*20I^








MT*A.Y!F&Z#K)9)GFB

#F7Q^7WM\N7I




5N/2:5K65D9*RE+Q5=9'_2Y':EJ)%


3`61^_&BJ_JS\@-BDK1F30W\OAI8?]9L^G545AB=
M(+DABS;Y!HLVT#@08?
-3M=PZ\F3.F67X_:-KHU9X_4-UUN_+WI+VO9-;[L$




M-P1\0]@U+H7B0TS)+`K,D-]L\)'
Z)AX9\MS=-*MKW-?TFAKHRG4JYE*Z
M086!A
%.YY94R-*RH
5)BHL%!AH\)!A8L*#Q4^
M%?


_JG`$
T'ACNT7U

M

J10)@K+!B8$3

-)
EL0G8'#'F#^@

M``#__P


M4Z)`TDE]&]KC@`'#NF&7`;OM

MAT0B?WS_W^



M5



MD
4WEO#USG:WVW3P!F3QS25\_TJK67?Q!A0R&D^7T-JA_7Y*/8=
.-LMA6\`




F@AT8LO
MG_SV[
F+KS[]_;O')?!M@4=%^)!&1*);Y`@=\`AT




R





M
^46YS3IBI=B!F?'

M@K@RL6*/R%A0UT#FWIO]U`(H6ZJ25H&#.YD_+GO:0:-`MWD%//-J63YWFMS
MX)_N?&PR@U)N'38-36;_7,2\/5CLJG:]69[MO45%],2BS:IG60',EM!*TW[
MUQ3AG%NMK5A+&J\U





'M/B;#ZNI?JEKL<GS8`4@_O?








@HL<BCNJP2!(J\2!(J\.I*<

BK
M!
&IO9I.J^:WMR9;G2A69M+JXT07%O'-=;%9(\Q3%T&X@K
\Z:F+W@#FB/&Q





MX*RL$9SA+VFD69N-^WRW\Q9V:+*+-9@*=M0$/?FG&:LA\L_O7.?!]VRV9J?'





JG)D[HJ!JA1)(*C*D
03@R.G

F\'O:/)X]Q3-'\`6;2Y&I--Y89:5K


M;J@&@?Y.
$@/0TG=%`;)%*)P=
J.%T*3
(;25$%YP9.M#;

6KH;A





?H^


P3U

M0T'N7V94/N+[@A$?2\E]!^\(1[@(L)1+7W&A_E`\$HCZ7D_N+CVQ,[UA*
M[BF01RPRX`MQBS(?#7AV#4%V9]8JS;I\P.`X(P(#'MZTW+GP4*T`'\G%;H7
8A/I?BTTBXJ/C?[97?.3P#/<!I(BD.WL7


5IB

R:]^




A3TD1H$3PS':Y.B2JJ(MD6JJIKJCKE($DD2%@C0.$@E

?UO%?A[WQY3_^


M7


+LIBOGMZ.7&^OK.R]M\.'Z274X6X_EOGNQTMW:?9(OQ\`^+







MQG?%:+3V83SY-



6]1\?W9@ANM0_BC\LAA_S43%N/]B[-/




MLD%^FU^WYSQ$:S[F\^''(ANM7IEO/XK8/5OP!^]YP*S#S60TP/A]D1VQ/.C_



Z2


%4X+\P(AG&



M-7LVFLQFSS
X;S`E&PQG=Y

VR6F.'A^]*VVY




MOP@


M'.:

M2SW[6&(?

GSN9$6*


MLOMG2U^+ZM1\X]5D.IU\
K.!O*

MWV4V
1LLB@IF:97BQ#C90'-S]]O8.-ZCF%/F$Q^_
OQ%*-R8\C475^;92L.]


YNE%]HQT
M+`/\+]#
'7TA__ZO_YOTDVKZ67X]'5Z2UEA
L2B\03@Q!)U1&;^\&4]&D^O/
C/.1N7(M]&I[X<\\G`\`U.ARSM-I]^P/F]^.G'
MGWX\YYER)W_2^SP_``:`H86A-%G@
1HI
0-10N;KUP5ZRCG7.$[5UDIMB

M;[7TK+GRA


MJ1NKM6X
03&Z6J
86W9/,?<VKFQ0]BB`1(7UP-57LW$8B;TN;IT;G)[V:4

M^=PA()(NISEEINF


2KQ9B(

M\@5-*[PBW6EMC-6A6N*!4E)Z_+
:+34A-:AF*XTO
.YS0



M?Y

U

MG*NU#NVBM#?-[VZDWJ!U-1R)QI
%.N?F


UE?^]XY0CP`[A5+O:(M&[4Z.D.[?HDJ2!IG$AZ4ZAAR@^8K2
MY/D,KP:]U2M8`+220^RP;S]Y65Q)W[PKI3R_=A46+W$//?L_8O^B^SK7N_=

MK:=



M(E;L6$T.*[*L1&[


PB[









-VLK[A(K!\-`ZB;4BHQ!
LA0(

MD5^4
C*+Z1-B6?E=!-0Y-\S



AU.D7
)[-G5@C9



MOX9&!(I0R`VKTE2^*B



MD2Q2BFO+/:15C*V'P_@5SIVO6K`Y5GVK6KY64DT52O?A0PW)E!4SK/9VP=2$

%







6R(7A-S
@56339
M=:
$1&$\JV.!+);IP^R%\:?`$UQK*&
:]0
)O:@Z)5![F8OGO-RX@.P*2Y


43M;NG%%5I









]
M4GV7PM!2IT2ILT/TB=P@N49!`%




517?
UF?;J_QP$+
U/_?3CLZW.]L9Z9V-]MW7QQ4\__OSU

M=CO[7$VYN;FQY

V5]G2UICI(8Q2J^


MA^HNF0;L5

HY$TZ(2<!S)BK21
MX*-ZTE6*J$A9V$.)HDETY?KVS%XQ]95VG8/I:(V[A&Z^[6.Q,90IY)?I&K%
MRW.P4T:)VIK;

M%PL2&:7E4BA;6_]=4Z#;M*W2UJT=


MAQ?\\$*%4[[_%!1RV+H%+?=`$4[7)4J=JMMLAHO-Y%./Y@.*&8O`2M::HD
DZT4I/1S_XG0UB\7=D[1AP
M]O+4TP=-44W1@[II0T*J)*2H&BF



MFL^T/UZO4



BLLNT+E&8H

M#C812O&8YX4H2;%`##6@KJQ8\;@=$15](\F
H]14R6?1AVBV/?1((07AT*V0
M$G5
2J+*1H'.SY
!M#J;W%(O=KBEP@%Y]G0[W!X=#_]2@`2=R]!H&6&50NG9
M]HOM7VF#CHS5-N



M0N
+]J-3GXC.G`
0421P(&4SKI\F*[D
M'MA4%W*4.W6)$3[&U&R0=C0MB`-P<%Z&%2Q)J?#BI6;C(:55JM'[D@3MKO%
56(LGT-L*N.6JFO;GA
DO2H9Q#HX1(I6
M2/I:`=.9'6JUW5PI*%PH\8EMJTIQIPM+TC!BV?M]LDL9L%2$VW:02N/:9IK
M.1YGKXL+KAX&6-9-_U

.W@%H:P#\#2[4

4

M0\RQY!



0)WTC._H!Q]^RI)BZWRY@



MW=UK#]3M[.UN-C_^;C+]P!E7



G2BW9'6PU94@


XB/06X$_(
M*#ODX5PY='-!;W1@576%VE'7YE.G]Q[A;3XMH/N(@[C-U]*(FJ0N0K7\&N+:


:8



73XTU2



MS100Y-?#N:&^)B%


M@YU-@-+\_B&`N&L`

/



\U_`D?
+))

=ED2S:[R=G%O^9&;GZ\&/K9F'=




+Z8NK7_O%3
BYO%`42:VZLROI$R



9#PR[
M//A;=D&EAJR85)*1=8;PD98(ZQ





MUO[N[.CUT=D90-9^4;O)R

MZH%N$.XOYE=/Q&D_AM#)7DUEQRU4^Y8Q+/H_KC*62[^6]R-CUT(Q2Q].FG&#



])L.?JA'KK;'63V_B;OU6V5\12%.K65



MPBYT@PZAT&1*W\

ML`*W=JU&38]
28G&WR]RA&;N-'@ZAKK,M`(\./66J9:[CO;@76T&P_=V0;
ML6BX3-4;=?TPOWDV!QSV4VA'?CVH.!2O@H:?C+MT-2T71U;X+2*B=H-WJ0

_0@M/1GS,_I'@JP8)]IA+0`*^P:@)Z`
M[O9N9V-S+[TKTK
LY30)$A(UQ+!X16

M(T2X7X(G!AG!XDH*'T=6LS?Y:&:_OETUR/)J_BW/$Z(\3/RN(.`[G

J^^N.B7@3/25?
&I@7)#XTT[X'0



0Q\AFIH05*@H5+4U7GF[M

M6[-UQ^$K.CVH@1XE_#[\KF64



5V:('F;E+6^_&WB_=5O;0GN+POWQ3I;(]?D\;G6W@[N[VQB]DUH.[JB9X





MSEIAPNR7XZZ?D9UMXIZ5N5$LK_G9/_&B^58:Z%)G_/R98!X9]'%\NF$7C^



@L@UV/[FN
MAQTFX8#E!/3X:YVWZ:]M<NT.77N#73=C)]WT9RE:Y



NF`7JCMVX=JXJ,]G^*BI?

MD
]3@D'V!LPR2J0[
GA_1]#D+#3MEOO'AB3[98W)54D^;#^3#TFP[/CM83RX
M8;H?EMQXQY1YP0H[AM4%#6`U
9W^AW?


M#+;48\*^G[/U0&Q5F.6C*'_2MC\/F$I8

Z;2P

M?/1J=#IJ2[;NIY9*MPW5['2_6\O.O2#/@K@/[


TV0-@_(/(3XN1I4



VI2)
),'[M0.LTJ$,Y(&)O*@E]B<`6)2
M;=2GC.6I43@P`E'BH_8'M<\/@A/[##!%-7V2IK'H&$W'_$5L/$I24/&QQ0C

M_;+ZJ]M;&ZM;.*?CA^.:'=9HHI!R3Q)H3X:

MP&H[`R^(
.!$/9O5TM!;G16E![T2M8T7:+0WMH9`=2],[5V,VD_E@&G&PQ8
MK/5`L?6UC?7/[916269X\W(Y$.HK[RV1\%T8PVU)-4`N0A?!M-M=6=Y1GSW



'1M
?Y6_:T6S1/-EFVE/CAOIY*_Q+/JAW[^=ZZ
M19U1U.N?5(=;+![P;S203(H;W6SS_YH\7@5%/CFREO[?=`NAV:[/1;]
=-YDYY$I
(]
M*]/@$



M)56Z1[5Y#G-NV$U2WU51:O=L]8^TE`GUW.9#\PQ;=4(.5@)WXEZ/:(?O13+8

81Y
\-$EGS'8O39@K(+@ELG


V&3+HI6;9S`5N@4)&NHRDH
M6PR=)!&V8\$
W;`?\+&3QKZ


MRPC/K:U2`-/4MYYZ9;05JC-;E]
^BW`4LT(P<@/-#32CD]H.I#$O]VB?1
%)A2
7W1&CZD1&-C[\T&FK_CY6_](
MFM
0G\/&3H1]WF-0FX1)BY34S=4ABO\.)7&9








PA[


G:U!/J55Y7

:H2L832@1C&T1ZB.UF%9?S$
DZ_AF9J/_



M+E5@K+=2WC4\$Y5CT64FW[50

UPW]PUR
M:9=2
7&1N[%V



X[\]WS_!:F91Z%D1^D2PC*RVCS`
MF\,?C`5!`R/Y`&'1H;%S\
3E',O.#82RQ?'PM%)TZ=G/'I5S.@.39\P-?P*
M_S`Q+-AD4[3&<W7;S!Z



M&MM9OYY.+KS)TBF?*!I7

M99_9E)^Q_I/-C'O?K)V`GLH+GN&N#:8V&1(R[*6JP*;

M9QYSB(-M&XU96RU\HC+Y`'$UA`O*WO-^KRSY+T)`(*:.HKG6D33[&1;8@=



Q8=S$\3\)JW_Z_UT1M]P


.'GG=.%=`)JF*ZU0\F)!$LY';V#;TC5VD&5;FUO_]W_]
M;T&1SN`*I,CD!\BNLY7LOCI[8BI)U2C/$51&EC;6I/4?WM'TS.$M/XR]I'[




M;\(L6






MFKHOP'1BR+C
.PJNNGMPP8OTLR-C8[7/Y.F-K24NASES-H%Z\K+*X^'R_@=\
MSI9A;*$D+`6\1;&@KW`6&(=E1+5K!F8`8$(8(S7?MV6=I-`I?AR;I'@;6ZJX

8@/IS6!/1(

1AV4W@F]'0A`XWZ=L';AI%2!D;\B?0
MT+/MS2HV.!,*/26M21O_H?X?926WE5PKBZ64E15WQ

;YU?VP_-




3-Q0DPTM[1C]P%EP8:](O9[E
YR8NIM
M7H

+1H4
5`B
I:J_@KR





A%LRL4/JQH-&FI-T+07R^N+!'*N9]^JO

ZU8+6+%@KTYO'D5U;BEB


:'LUHY:+FD+




VX7;;&';8=K^!G=2?]T8';+?Y!M3=[[Z_]9;5N=O1
MCM-U^*RQXXZ'.]S3

%V;K,6SFA+;RYR+=!5OQ%^2A@'?8P8!/\(7C;+:.<++ASFI:@[R`RD

=#OJ

V&=(A6]\
MWOYM,+3?AOW6;^E6XJSGGIVT7B(]=H6,;/G$TJ_I:C_4^SLK-'#ZBF5!
]:

4




M(;.SM\&49/OK]CHU



#ELK0GD@D)@ET_
M97.WX\OKXRU2GMW&






MVI]GU

`(46'8^K&:_C8AUZ/;PCT





M9I.WOBDW?45QUCHHT9MJLC(JP5D$MC=B%^_DQ;R#+&5W2Q?W/=DG0&V'-Q9#





P
`[)+_3$DJ2:U7
M


MO4=RNL#1D]





MRD?4RN7BXO_`?(5(:

M?(]LH=D&88

+RC'E3\.H^W?73S
[OB2
MU+B

4)5)'QR?^@1:.OM[]
WWQ][XA



[G[*!OFW@
MI51\F[M.N7WWZ9LGW]KP0V_P_P-K\I.'QZSP#.T\N:4C%B^&PR._OKWM7P\G

7_I-+J

?LHL%0=4)_.(:
])NH4ML&&HIX8H6H/1.7QUNXQ24J!O0

MUF7(7C[0K$R
41MK:M:Z=@5B];A*3UU[PBVAYO?CJQ974@'OZ+2SE-]_\M\6
M

^!%ZG+W5_ZOGL\FHB



M
_1L;B%PB1S)U:S4\@JJ&;*?9JH60YG'!7A92YIY8RAS+((4$0\=*R.6[(



MIB4)8FWCFQWLPJ;!(YVKPPOU:G0Z^LJTT]])63VELG7_X!1'ZN[S$;_]I4:7






M)7W

MSK&'@B?HN[FH)(@`EF(!$@K)Z7G.FGSQ_GZ*P?\`(&

N8O\
??/?SIC[_+30!0Q%(`


M=D=U]!G4!#$08M.S99Y&5\+FK!40!N$433BXV2?//+%?
[9$N\OK0_#8JV
M1
&\!?%-+M:S

GOBV`@6#!X91
7K\JC@02]MJ*H!
M*2HU`N/MW'BP

5.BDXKQ[G=1H9`3J6





4%_C];=
`\.F'KU%(XDO\](@:0

WL]^/$T4\PC
MN\DQ`JK#N

1VY1B]O
M9GI@9M'E1.'A
9#`HX3AL#:9F&BR#!F89MA0I`=XH'J@S6XL=S_O
'I;@BIN
MA]/GI0!&JU'_#B\F5L`7&EB19\Z6CX@N;4F(MU#-80YTGK[\D9U;DAX?[Z]_

XC)B[\D/^((M/-R\FR]^K5#%[\X
G
E%FH)

M45%


M$^E5J!J!%$F\O:)?E3:8^8





F@;][3B
MCKT+CD']+%F4LS`7

M\CM_!/91Q-X,59HT$,O%MNNG2U)I^C81*9O(LFFMR8!;8D6I-!#!;WZ.`X

/('=$66:CJ`
$MBW3'2X0JYC!&
8P(
MF\`-1A@V$/0=5^61Q3WD

M%HG57WXT.V@U!N\DC]4A%H3D77+EJ)(-VD7]P\FAH]J!55E0K'B[NGTS=/

KC
V73ZO=.@W*P4(XE\


I'5&*
MF\^(:T$BB+G1/

/6;94$C9BV<G!Z!!7YFT^]\U7UT?C=?7V

O/_O1_L'



M5L]
$3
H?6;M_/65NL.F,-\_Q\M&$QLQR8G]RSMY*^[9-:K_^'9RU%I5[



Z7+/38/8
]\W?[






M34]JDR!O3='BVFD8%W-+TIH6:MX(.5;



6`_=*+V5!GIU=K_6-NLPC0D+RZ08M1Y(6+A.$?=I.E<(QJL

A)Z57
MP2P*M
6N$:9I1<`AKG0DF%;L];#$L#A$;9P%B`B

ML5U8TZ\-_LH1Q

DDT7D
M$9IGJ-Q1Z54*72LL2)H%\&CYAHU)LNG*$U[?9D+6Z&P&7P6@@-SUXVW?Y#)^
M[XI#7#T([)9
I5#Y6_RD(XD0B903BF3^\CB!

@`/S.4^;S$5

O-(4I6^
+[90\AU6:G([4VN=1##&9)C2*\YS`I!OMNC[Y:1T
MBJK7OWW1'P;.7O^2LYZYO3Z








_+GW3JGW







3S:0

8*17Z4\161=T9/9.(03OS*E'ODLC)U%&&U7$$5*/M1V5((&XRQT
M^H'H0-

MJZWYQP;[



M_Q8Y$$D)930H&@HY

I.:5U9!T%;0ZX=+=4&!809XC-4N)F$.RG#@AD/S(ZGIE$









M8:K%=]IX
7P%FY


MJ8UHTVGX[)




P9`U%4&1+HDZE+17I$S9O&`G/._.=!6

0)#251/^$KXE*V.+KU4E08FOR

=!






)^9V


OL
MIV5^(0913JDUNLYWP^!\/DK4R6&QHY?H'@\VRU!BIQJ0S1Q<OIT/BOODT\<

M=BL@'J
!0`W$VUE0DK-K2R+141-XCV(ZLW^;GNSP]!1C*QAQ`U.F*[?N](:7




MXGEJ;$

M'&`CJ?4-
X[`P
1D`RNB^S%1/V`-=I



M26G5%I$R-B0F3=

MBA#I@$
K%JB2LIMYGL@KTF#ALHZT


DYJ!-6
/2GI7
U/^.4B
MZ0&/UUOX4(./XZN@'GYDXV1&DFI\V*/

W@DS
V[(X9DR\/ZK9SN(4N_P$``/__`P!02P
$%``&``@````A
M`)S1%


&5



M*
_&@(Q2$=J4$F'1$F$:=H3%-$;1%`8$U&2.$#F`MP1%B\1)B&'6%.I3:(




M\M$PJ<)%7<$T[U;7#P%07&3D\H;LN80*@:BX4N)C=F528'MBS

#&

M-
GCC]L#'-U

HTI/-$^J


?+T69
MO)ZAWU]DD:2==O/E3C[/TK*HBD
]`SF#-_2^SX[A&*#T_+3/H`?
=JVDAZW^

RVS_6W:AX#:
$QN!UZ)X8VB\9T50V;BK

M;K(!X2YF^`CW4?2S((+H82(O3&6K0P
A/BJ(_(]G9[U\
CX@6M.6V7$&_O:

F$N(?_\@9[T298(Q
M1FI
.

P+!(?E!KMR)4\N\.]5G+4M




M/)3P42)`B1`E(I2(583@








M


GC[SX5KZE:34`A5.Y


FNONAX&&N3R6)\3++3




M.9LO'BC+K%&!SZO*3)OKQB



M3&TB

P:B+6Y`#DENW!XG6%$YS4]HJK$4`[G=Q23=
N32;]J(.P^8R
M8]UB%C)C]QE-)IP^

M^HRI(R;N
UT=R7+HDY+EO(-.X2FCMIY?)5DO`G(KH8ZSP1=9.&#C@(
#+@YX


M+Y#A]XUC_*K5$(;+BZF

M6$5(IL.R5C)=/?/AM&PVK*+EF?-:
/.Z9\

M%T



M)&+3B$
C+HUX-.+32-`@;8YI*




ML[:U?^^P=G*%$X=348`[_.\:K_P&UQ.:S[_#P``__\#`%!+`P04``8````


M5%MOFS`8?9^T_V#YO1AR(4L44K6KLE5:I6G:Y=DQ'V`58V0[MW^_S[BAI.VV




`$3(
T/?

MC*Y/WSR=O'`0
$



$%``&``@`


EYSXB8N.*V6!8,*=.Q(T#+%]_XB2[[6@[Y_&9T)T]^(UGSW2?!BJ^L
MHQ`VM$DW8

!W@0I:DFVC?O#=9\JJ6D&W(RA(U[4H

\[UF?:[Q;45V

W7
$Y
_RL




5


MQ07?US

Z!%5@0:;M.
Y@!IMVHV'YC/CJKR%V8UG;=).B_C%U$[W]#
M'/GESRI+?V8E@VR#3^C`CO
7E/Y(\18
M@:CGQL'_JJ

MUF#W'&:$$UNE[T]

M:7L.R(T=$_5SAB%-(SF+FA?_D\AI0U$0MPWB`7W[W)VY#W-GOAB/8A%1
\&G
MN(ZWZXI?#%@U\)WB%.
:=%80^3HSXNCF^M%488X8Y!&C;$Q8[C`+`?Z\;@/?
M7ENOD-.DU81#C2



)/E2K.V3@
M


#?9YOH
8Y2&.?*$@M=$MU/
M$.T3K43F5'K*B
?4`T8\UC6*ED\GD?D^U4O@M&.0/__F4//E82OJ/'8&'E.4

M(-YS7E\O\.2@.US;_@8``/__`P!02P
$%``&``@````A`





M*-B

S=\

MW&1&'&VNGZ4*.:+)$[K
;5CND(6&_KPMXM?.6]0T^2H69YK6%^Q:A38L!K
+=LWN]YPK_).F10(6Z)%BMX--UT!#A0]#Q
M#D`<!GV$)6FCB;J*U;7%#U&






U





M$:J2`6HHCC/_?J_206UQ*
Z%(ZL/+ZOK;6O+_-='GBGOJ0I+A:J/ABJBIB
MG*3%8:'^^X_[



ME(X
*$CT4?^_I$EU7*BF-1A/AJ8.N+)#I')3*JDJ\9E4./^?0?J7%!
QOD1
MR/ZKW1@8T[$^MIY0&36IP


M!6+=N9;LNXI!J:C**Y59J#!IH!@$7'Y?VM9PKKV#-?$7LVHS.D^L&X+Z0&4=

\F;#.M;+9MYI:-

%X/QF^89JH'8B!L`AW9;+L9KIPPDI\H

M
HO2Q66NJL1MC'E)_*
5UF20E'2FP8



E


2YX;6R4F%N/JS84A=\K]3\@WD_`D
LD





MQ._279[Q\\X-E[/%R@\1X
Z!

B


:-H1D23@[T`@E8A[0DR?
M$$U&;WC@=K`
$SV?'\1],X$+)SUJI%\8VPDT(R81*@2B4G,!T*QM
\MBJJ
M&\*6L5L67P)N5*K%H-Y6)I($3-=0S*5*Q)\2B8U0


MXA[!3F]^VM^==.E*ACE`#:WH[O

MN=/VVW)U89-8KH=:
H]MV
9&=4(FCG9-0QXPB!=F#%=QAMQA(KHD:`H1Z(
M(&AU3P1:^2(D&26=FK%=Q@C@BES0]0(HO%-GP79)I59N`G+GT'B@`QE0BW

M
_S+@









[?9J;9H<7R_[?:;U__8H)%KRC8R






M[LSPG9A;
KF-[


I64B6RK0::3
K&X-B!KD[*P

N]:H(T:R\ZQS$X?%82E1Y0!

LM24NL]0BGJ5C

(5A6B&I%.-C\2=ZU!8<L07WQ
57W(L--6=[
A

L2]
+7X(2].RSI;T3
K7)'/
MJL)

./DL*



M&(:ARU)W74&HTT(Q+AH?%82M1_R
85QP2TUI'5OZ:^N]+=9TQ9%:5F8;3E



=PMFH9;



\H:PP?%82M1^R
UQ_4&!.S-3BT()XXTNP.@U;$8

M^@07U:B]B6+.*4*





^3:C;Q+

OU$E







M9KG


MS])WV^3^RB':9/HK*Q5BI$E&-2-J$+4


M$E&%2#DD;(!5&





?B26G1J%.G3$?B46N0:'Y43+3(7:I^2BL%-96


&1C(XDKR#/Z4BWOP3-E(YT[YC%D8?1

UW=21\@#6C/PR



`4$L#!!0`!@`(````(0`FN5=1``0`

R+GAM;*Q776^C.A!]O]+^

MV'[Z:WTE[1
](\0L8*CIQCXSUD2.0_
SJC(Z(PVJX9
C::N





2=&GB^E\
1



M9/E&R(/%X)*80*H`6LC0!\0,F?9V/!7)CYPYWJ,^]X&JBN-C-K$TD3J&&I



M6.X
IO61$#:\\^0OY*V_P,``/__`P!02P,$%``&``@````A`YZ'BW5`@``

$&23B+QP&8[/\9D9#]NK


M`TP[T2)/Z#Z(KX.`LMVV2]!?*4YF]$Q


MP)74$EL#
L(?N_M)9K9


.L!

MN)




R&?_SN/P```/__`P!02P
$%``&
M``@````A`
K3
F.2D?SJDR56;S];6NK!?4DA(W6]N;N;:%F@SG97/9VC^^/WU9
MV1:A:9.G%6[0UGY#Q/ZZ^_VWS1VWSZ1`B%K`T)M75!ZC1R'9`6J4S+#5]3`



MB^]_HO)24CW'!PQ8U'^%B.204:!9N;/&5.&*Q``?ZVZ9%L#,I*^\NN]S&FQ
MM?W5S%_-O?DXJT3(O2I9)RVE=T(Q?5_(LKKN`2+W['`5;($
R]T/\(1=!QP
M[3@\]Z








WXJ&WFHV]T6O=0?Z0JV
'S?4-



M
F)WZ\^?5@<AGU7.F':`H5(QR;6NEYZG

IZP!Y'L

ED^[2HAZ;8`



M*4Y/L`3B\[E`$HC=(#@F
(\@HZ`+^LHN%UY+V`Z:3#W%@.?+29H$1Z(MLJ@
M-EX9P:@,]36IW-M`5R8\+Q/U9;#H$;3NNE$\!+B.B2A8M/PV`XN9=#S%M$S

7N

34N





`G-O






H+V91AU:$0YLL50A6]/`(1Q=9!`ZN\5F#$);

NDD_(`7[`BNG76TOOS?
MZK5HQR?+6W




AVE':F5JJJ/M6

6



25;
MH%B+6MCGCA0CR=*GLE&:KFN(^Q`EE)VXN\T%O11
*Z

P)


5G
N_S\$GQO!N_(5&K_28O\BV@X)!O*Y`JP5FKC
MH$^Y

7966AVF
(R
65YL^/W#!(*-`$H[%C
M8JH&!^)I'=`0FAAV[=B]Q6&8ZC($K:#1FAN[$HX1([8U5LG?'A
=F3S'
MZ


J




MM%F[:.:[#FE*NJ^:X]K]^V?^L'=KB^:?7&F#5F['Z1SOVU^_67U1MOG[D1(
M[X'IEN[I[Z_))[7E2=2%]V

#]36O/26
M'GC:K/85*&!I=UIR6+N/*,G1PO4VJR%!_U3DK5/^=[H3??NMK?8_JH9`MJ%.
MK`)/E#XST^][!@'9L]CY4($_6V=/#L7+N?^+OOU.JN.IAW+/01$3ENP_4M*5
MD%%P,POFS%-)SQ``_'7JBDT-R$CQ/CS?JGU_6KMA-)O'?HC`W'DB79]7S*7K
ME]=3^M_N1$2KKB30#B!YQ4G-XBA(




MD:2E%I)92*XB6L@PV/TA
V
]9(Y`CF4T.PM)+22SD%Q%M/CBK\3'C/7X.()A

M4H^/;_2S&*9(?ZK*YRV%5

A[Z`410:

%71T*6OPHNL24``[FC*%@C&*(1\[
M:85'^:F`



E%KG-UFZ
M88[U?&VZBFC$-*7G?PFNTTI0*2PL

.\7PIOKYH4#AE%




/E/


Q&%BZN[I1)3M)+
A
M=L'`1@3W8



MT8LST!/MX;YD.`Z=X'Z

=Y4!I+W]`0-YXX[;Y#P``__\#`%!+`P04


M
YX;6RL6-N.HT80?8^4?T\KS$7&QO97MF&259*IC:W3PSN&VC`=H/)[Y
M^U31=-
7UO%&\S(
AZKBG.JBJMNKSV]E8;V2NLEIM;;=R=2V2)710UZ=UO:W



)


M:Q_%]R=N
)W#.^_Y^;T?7/G;@[L.\+2CU?NX$YFX=1W_^--P*-SAMW''V3
MP_+3I3M.VW2SJNG-@AJ&!#27%+\(-X(@/
\L*2+S/TH\9!R#;#'*VH:/#U+:


)!$

AQ4`2&5&D0&!9RGBWX46/QAUC_J8=


(&
MA

Y]K17'








M'I^N?WR^_G[_8_O^^)_;Q^._?OC/_WCWY_W#[X_?MMNG(^WAQ^/[XV]/3S_?



/;C?OCY6\!O^CSNN_?UA<G;\[^;M.Q1O?YE.FC6VQ2W<


6Y3*(*



&0S895W3&I?F!9




M=C;:G`RG@E22*E)-:D@MJ2/UI

MH6
T5LVY+P56Z2B:&NU'$:DD5:2:U)!:4D?J28,AF]6\PGS)PMQ35$5N
M2`6I)%6DFM206E)'ZDF#(9N,JT)??GXMQZ(U/K\\K;5E/XJ6IV?)9#2UFH;1
MN]U#%2R546J20VI)76DGC08LF&EA?GSD]&2U;<G
XQ\73T]!19L59(J4DUJ

M%




MI(;4DCI23QH


MI

7
J=4TC
9]1256R585J28UI);4D7K28
B&Y2KH

HN[
MY2)]6=-W5*MI&.T[!BK9JB+5I(;4DCI23QH


M4DFJ2#6I(;6DCM23!D
V2%=*SQAB8^5MAAB*\8U[OTHZQ$`E6U6DFM206E)'
MZDF#(9.
+O+/26;7W

M0=$P2E];\1TUGD-^!:DD5:2:U)!:4D?J28
A&]:\\GO-\MN3&49CJX@*MBI)
M%:DF-:26U)%ZTF#()C.O_%ZS_/:4S$;I:RM3JVD8C?M2QT`E6U6DFM206E)'
MZDF#(1O6O/)[S?+;DR:\\#=O2`6I)%6DFM206E)'ZDF#(9M
6GZ_OFY:LS3W
MY)Y3HYDJO6(^M0K9%J225)%J4D-J21VI)PV&;)#S2O
U2W-/9HB-K2(JV*HD
M5:2:U)!:4D?J28
AFTQ:FA]XPF/YO?;EMZV;TBOF4ZMI&.T[!BK9JB+5I(;4
MDCI23QH


M9JI7??[GC%6[)SM1+=.+YE.K
)P*4DFJ2#6I(;6DCM23!D
VQWE5^QFK=D_1

M[-T[$F#(1MKKM)?Z#OF?*I_N_^Y2W5&Q*SXSSW%$8,*W\I]W=**KFV47)?

MYY[B`P(JV*HD5:2:U)!:4D?J28
%ID&X2@OET&KZ3'E!
M*DD5J28UI);4D7K28,B&E:XJTN'ULAF5BXWSD?11&??%?.O3J]-DNMN$%N?[
M6:L(I&$8!9\4W65H-76L`MF.20%:AU93QR;0LQW;T&KJV`6R'9.'VH=64\<A
MT*\ZFL-SD:YCTL/SLK-_MQN[OO&D#WF%YXP-J25I(I4DQI22^I(/6DP9!-S

7

BF)-J'5--B*0)HFHI23.:(
K::.52#;

M';M`MF/R4/O0:NHX!/I51WLLW*)DQL`=US!FX([DWB`^1;I.2J#-Q;Y5./&+

M&[MLQW7R4'MV'`YUM

M:3!D$TN7=

MNKN])$762*$(UK?

M5)%J4D-J21VI)PV&;&*J.
R`/G#VN^;)R!WI4!'L6TU'MK@`E:2*5)
:4DOJ
M2#UI

MT&KJV`1ZMF





W4:AI&^XZ!2K:J2#6I(;6DCM23!D
VK'D+@RLN##Q%8V9#*D@E
MJ2+5I(;4DCI23QH

YCN



;
M3*GEI

M3#'!%!-


M3
G!E!Q






;+5IO:H#!%!-


M

M3
G!E!Q

D3#'!%!-


M3#'!%!-



M8U7&ZHPU&6LSUF6LS]A@+8G)E;=S8AK+81O3:


8*V2875\U^:@OW/YX&G088VBDF

\9N#O
MJFPGMWW7

G!E!Q


=63QV_;[5-Q







M6:N/[N*3VZ(^NHM-9LN9LM9M67);E+4NB.2V*&O=@R.W15GK'A29+6OUT2WU

M5MSTL:V4]7BS.6Q1UN




YY5UOFI2E^R9H`[9<T<Q9X^








5]






.V8I

MO(V\7S(PGU0R[J75R:'VYVQL-K8DRK3L
(C+?;5(ZIPA6LHW4M#RXNX\Y#(X




Y
M7BJPI50J[J75T-?RDY&61)G*'0FZZQ6\=8:56=07!:T-X)4N\DQTL!OI-*
MP8Z^C0((%YVZ*DOF'5LDA);HXHB.(R:.6!&A4GE[.5XJ
*-4*B9$HX9NEK54
M2X)LWW88!)'K8K`HX((SK
R2C539\LH7CT+42'_)0O=9[*C%%Y4&(6R@W%T]


NNYP&['+&



\J2^
MK%M4H(`!+J
/]60!`YRQ$38(W1`(*H!`95D




J2S/


!A-NG\OIZX@$A]%F'101$QQ$31ZR($
GR
MN\QU3[-52O%34X2@B?B2WY(H:X
.@Z!RF255S98W+:4;*6AY[7IPKD0E8?YZ



M7






MC]D@!*WC_HZPN'I*'`FI=^*(CB

MKYJM42V&88BS\
4VPJ1EG20#I]*O9IH@






M'=$E8*;Y%&I*@.#E'


M!V\NXSJ.F#CB7[


M`/__`P!02P

\```@R

M^TS`2=``1MB9S/S[K785[JX$\

MF8ZB9+9=K'=3K/!P&%.C?GE9+ZNO]?)]6^U:+'*H-HL6^#=OZWUSK+9=CBFW

M#W53O[3W4&Z&1$_'G


M;]K_U!__K-:O;RVT.X81N8$]K'Y]K9HE*`IE[G7L*BWK#1`_R?;M9L:H,CB
M9_?S8[UJW^93D]S':604P?/5=-^6[N2T\GRO6GK[5\(ZD;4%]%4!'Y2$:6O




M[`?`Z

*\A&,?DE./G;78G2EM
MSF4J$)-T4FJC

MUD;E;'ET'SNTY7Z5!(.FE-G






@



J@PBC3)1Z0^7BB309

R

@O3E3P[(#6
P-D5@W=
MO]NK4J-#2W)^(1*Y




`4$L#!!0`
&PO=V]R:W-H965T<R]S:&5E=#<N




M9EL#/.^25





NE
WG([9
:T_:.-9'&%E



!.V676N;+VAJ'
V9$+F=%;9!PXQ?`\

&0]CJW'C3$_$4:FNIV:0=NI?OD=A98

8FKG[G0
K=Y;^W&S:GU^:1\GJW8
D?X#C(&&%OPKU86H#:IX
M#I1A
(/L:C](_
:J!CR'::`L3(#VM81YSZ';PP#`N5+VM'&CJO^#+/\```#_
M_P
Q
MC0*
!21._GW/
!?F







NVG/&UH8;`9O


MQQ(8PO)&DJ6%=$G&0*H!2#)TR2=(9BS0Y5KB_2#$&F-A`]55U5E@DYTR47$8


ML:4Z@G2SHX2Q'PZZO]
S*/IH.V0D6+A`5DK!SD`2`TEU!*F$-KJF\J;L
@XL

MQM&*%1#*NSLWVH



`PW(/UU
MP1CWX&9D@B?V(_APFN`/@+^_#!D3!1%\GI@.<1C!T7\7T1P`?<441P(W+.
MCN3/K#D6=6N5Y`QS_LS;







P`/QWHQW#7-:1X$=;;+#VD]*D_Y$5HV975(&_A9;8/Z




M7VKG_X-Z5[[\5A7K/XIC#FK#..$(/);E$YI^72
$G0/6^XL:@;^JP3K?I
_[

#%$E_J.=+

]U4Q[^TS:A\:1]1

M3LYT%*8C/$W'4(RBFSB



F)\#'EN#0V


)18WBT?63'_?*




E_)X
B7OT
M%$'6M#1%['UVK*S5M


C!=.:%Y6

M\=HB@[7.$?Z-V:LK(\DB4RSI(N






ZVN9S5=P?
);X)+Z
9_IM6V.-:#?;Z!9!ZKLZQ*7Y/K'XTY%7HL&[C?5@=$._ASAAQN4\=XGK@I
MR\;^`.6]@\D[O\'``#__P
`4$L#!!0`!@`(````(0!]@;('K1
``*%P```9


+=


MGW=7U-QU/%#L\^WU[36U].'=TYIZ$-)^\;;Z_/[RX^C.WXXOKS^\&Q+TK_7J




PD(34['#;]S<+3]CA/0OJ;


D:BT3DBSI)5`2:`F,!%8)X&O
M`$L$#7M(Q(2*I3T'Y9H(*IIM6$W




_!+M66\4B?H[NB*UP^





I$6+Q9*64.E&1YN'Z;6@/J$9;2GSZ^B&#S95

Z++177\$YEJ$.JV4%2@R5%ECS8C

B
M7HZ:[X5]



MA/C

MNEJ.7`&COV95$5%5`MT84(]((=*(#*+R'R#/$^!T=;]SE4Q7PRK/K/+8MH




!X!4:2M':40&



FE'MT.:H(?49
M6.V1I[CE5.M:/.W.3YB$:
35XS*A&4W#)6


Y\WDC.^#DJ

I11:@SXD*QVC`YJ@AM1EPH+*G+447H



3XE4*'[WFJ'+J^XS8J9^+8:AR5!'JC+BP#
/!

MT[D8B@J%&I%!9)O-R^G:H=`SQ!

M%I%#Y!GBN9#K!)F+T\PB+A^F$?&9#SYZS5%E.ND3.E9/J?DBU+DM/@^5J3T-

M082/FW-4F9KZC

RBPBA\@SQ#,4+/KIMXC`^=R


!/WKIZ`Z?_+G
MLIX2$N=&*DN1=&Y&


)92FW59RDB(2S^@_=&.J$CO4&[$Y:DPOTAZA$I1!J10601


R2MT)&J0
\3KIRR*@#U&*40:40&D47D$'F&


M.U6\YU)X3X-B\@A\@SQ-)QGZ!9HZ#*JTYBNHQ2B'284_51J*DX[WLTM4

M@WD^XPH4O3:[`D7$JG0F[\UUBQA5U4R?D!64384FT*A;@O%N#`HM&UA*;9A
MCPZ%OBTLA\I3*@V_G!!.FWIQ';(J#K7':(^H6#']B4^A0='4A0-A%SBNJ`B
MG-W`X(\'40EM2SB=Z$K47F//B%QJ.5\\+3*!81,ZXGS+XL%A%5GS5VB'I$



;#$Q4!&Q8]VB'I$I%.2P9RL4@





Q&8FP8


]_)X1K60_O-OC^&-+]\OQ75A64!-RRVWX':;A



;FAGU)][0``WU


FR5([T6
M_2Z\]!R31.\]OPMO-<<MEK:$UY;C%OHN_YV.MU]$8NFK^-3!UJFECZWO#'V0
MC*W=CZDS]`JTUA;J#CT$V=IM47OQVILF=`1T&NA:
OU_N#H!^*^/7Q9_??#


'^QP4__%L`````__\#`%!+`P04``8`````$`)Z`.KEL#


2
Y+&MGO5-KWF\^?


&&+:5GR0BA?_


MQMCB51Z
H4WC#]-


M/MUZZ.11=6=YSK


]J!3)V_)\RJ8S:!@HH]_4+S7%HQ

M0?$*2@I6%ZY@Y]$_

?``#__P
`4$L#!!0`



M^??[99%)9N1)5ZEJYJ75/AE!
C\&@Q%DD?SP'W]__'[RM\WSR\/3CX^GLW?G







M

MX7/W\&



=3*:_@?]%Q_;=/%]=7'\[^ID/Q






6*/)J1(#E*`E`52`W2@+0@74B
D@H1H^3NC.6L;:3UQ&0L

644:4$Q5$)5%%
M5!

$E]&E!




*
MG`

ECV\N#5:[


G%E?_2-

M4[DV/X]O_







U1U19Y`5*VXG
M]H@U=@U^SBMWI,9I#BBC54Y4$)5$%5%-U!U1)U!1IEEW!'L5F9K;@O_`;E5

M

2/*B0JBDJ@BJHD:HI:H
Z0P]VA-




M:VX[B@&Y@C&HYB)!UY.55R8CRHD*HI*H(JJ)&J*6J#/(BA5W%+O3W
78./@Y

M.H.L
JE^X;@(8[MP
7$*:QU?#)ROOF!'E1`512501U40-44O4&63%.JP)
MN&`3


4M';N4XRQXK,SN&U?[AY5,
M'/)^YR17C_G'V.^;R'N=R0.$.`<IHE1
O\P[3B@G*HA*HHJH
M)FJ(6J+.(/6U6'-S-;<-C




M[;Z(.[`X[;[IK'C%QFQ`8=8ER@;DGB

MFZ3C



M4?;

T^Z;

MW#&^^-MI\%K-HX#H)Z3901Y40%44E4$=5$#5%+U!ED%8O;N-V9_9K]VH#V
M%



M940Y44%4$E5$-5%#U!)U!ED57;L27K/J4]SA*O9MCWW@Y*Z#KZZ[JUVY[C1
M9I(5*)^6Y*T*HI*H(JJ)&J*6J#/(RNHZCU#6/8=MWZB$OQ2X[I%]X06=#U9












D')N5%BGG
MZONW%XS\[X?"M`SX)Z3S+U=@%3@(%))C#)!:9P03F&0DTQ@D@E

H4L

HH))
M5#)&K)(U,.:C]DYNP_/@CA3[+'_2##)!#O)!:9P03F&0DTQ@D@E

H4L
MDBGN1/Z)V&.7
CL?NXT@[UU&]WLDZF@6Q!Z81`63J&`2%4RB@DE4
(D*)E'!




M'W12#DS*@4DY

8)()3#*!2::0




M8$6E0E6)5B=8$VM0G661;)Y&KC4*;CV];A$^%6P;'T#I
;*E[_=?'I7II$
M'5VGV.3J+3J&`2%4RB@DE4
(D*)E%#%HGJBN%0U#W);?A@N%6N+ZB#UG
]

M)@48F`(

8)(I9)%









M1_/IB\\X


M\?Y6'_5-^&C$?7X[-:+YZ




M];7H\)1I^GDL;`M'9/[9ULX)H^2F=;SBZI14?6+FE%1E=X#22W3#LG%6NW



M=@;JQKX\/;WZ?TBBLS^?GG_?=F2?_E\`````__\#`%!+`P04``8`````$`


MWZRBYT-YRAYW=-_?#3O;-_-%W_+S:GLBJ?ZBMR-^


M;


)@(1`(B`QD`1(VB=*
M?.C!^('X

M2OU2;+ZN2][S#$PBBYY__*G(G*@Q:LE2Q@B(RXE)M;%;JJ:I%3T/9#XG%A62


:KW:0'XICQ2BCT25.52C

4VM1?%`Y@_)+*UN!B`+!V5:K8A`%@_*M$=_`K)T0&;


M+G3+5@/O2LI]`52A7(5-1D+A)44A@*=%4;2@IC@52A-M1$6$EA*M![0C4]
MK,_EYYQ*YYM#K4EWR)3ILQ!Y+R$/F(`D0AH@A1CA!EI(C1AKQOL1N[#Z


N0VEJ_X[#7AY0+


P^`9%21%'O87@M%8]Y+;(4OI=6VLE/13Z@T+





MT84FN!7VFV!U98JYY>:]7K%_Q!(>:CZLG#$
5X4&AK
M0TU0F%X2JOE@VZAS^1CY&.2[L?ZNA/J3IG[)

M2A6D1DS?QEVH[+A?H^4Z4-FU7LP15K+JN8@\1#ZB`%&(*$(4(TH0I0I2@T6]

!V&@N7.$:6)'2VQC6M]+3JMB






YJ7H;AN.JX3E5U



M:SZFN&J`XER4!7WK2'6M2OVOUQJWR;D$W:^6FZ2NWN9T5=%VF*+W0%=`8/
M=*YY9^P


`RTX&/'^7

(63&<M#AKTR\O3'5M`:]#517&JU5DU:2!TS
M)!XCBA(X!.^@A+%`$\)#1NGM'#7.@!LYOY(B3:24&1*/$44*$(^E+,\7T?3,
MN(M8?%/`$6<WTF!OIBTCC81;-$/B,:($N/Z=`)FQ&B!'W&[:=D<LG'1#(G'
MB!+-1HV&#X\5&ZDT+]+G`$



M(X6-O4FNZ
^DO18UT4IT`8UF-XM;OO/S%]K/Y#.FL*IWXSF'WV8(-D9S!7?/
M!6
J7M@7R%][QQ\```#__P


#]*87]8__[2\

MVU`G5H$]I:_


5A_0
MM@=&G8ZBH;?H76(5V*E`
@$D#:ZNP846NK_X^THP)UCFDTHX?B#'N!4VT`)#
MN3S9)!I
!AT:LM.09(I(4F#5_X!R


C?Y\R
Q8


M)#:0Q=ZIU$04





NO_P4``/__`P!02P
$

M




;_SGK_\_W//]V]M=US?V!L\#J=_XAV$XKX.@

VN[9IR@(_=/NC/'2NW.*@Y!G$8YD%3UB=_C+#N;&*TNUU=
ML2]M]=*PTS`&Z=BQ'&#^_:$^]U.TIK()UY3=\\OY4]4V9PCQ5!_KX3L&];VF
GB)+DBZP(DPA$;P0)QAEA@E_*H;R_Z]HW#ZH&)/MSR6LP
M6D-@?4:0O=]X
36G%\`DI.*4SN^A;A
)+1R`B2D8&#_
S/96^HC0R`
M09?3B@%@`IJ
^$$FNQ0O(XM3Q)]NI/`FD[Q-!NI&3EA`;[*$1C!$/TH&'$A4

M+9B'(XF

MJ!D1D6@0D446*


O1$J1


M@@-ZRPE-)G6/

U(QPR?J`)'#B
KV\2

(S]$*Y




M4OE0:/A@5WHXDLAH&6%H'PHG1J`W43
RHB,N%YQZ$U:\0AH:VH7``WH3
M-2


M/9_[_P$``/__`P!02P

MK515O3P[8(*U@)'M;';_OC.84$/(I2]1&([/F3
SMEG=OU:E]4*%9+Q.;-_Q







+*=IOWWMXM3BINT

MDR=AR.7J\Z?E7NE[4PEA`V!H34XJ:[N
4L
KT3`3JDZT\*94NF$6'O66FDX+
M5O2'FIHF4932ALF6.(9





`R/E&$0R]&-

M/DEQNC[PC^?Z+(9Z'R+C@L_2R6G#J:_Z?JD1[$NYR+3_EL8#

M#)[S%0X1O[_3TV9P^Y[]@2#8EW*18S

M

!-(&A53IJFZ5-FF:]O'L@`&K@)'M-.V_
MW[V8

MT88U&:MDPQ/RS#6YWGS\L#Y(]:!+SHT##(U.2&E
&U.JTY+73+NRY0U\R:6J

MO[#5Z1RZFJF'?7N1RKH%BIVHA'GN2(E3I_%]T4C%=A7X?O)#EKYP=R\G]+5(

E`D)KMSHTEOX`'=V

+C)@J\-7V$RJ4]YL9BX#I@_`%!0710!K7Y
MR@A&92PMIG)C`V.9X+S







2Q[?*2PC'

M'K_




*W7:U=
[
EV\5
M-8*K_0TC/_CI/2.PY9%.1
\@3CI(=:)!D:-!


M4C/8$^XW(SH(
2
@I71;1X
B'8H)1#5A9U`T_;]E0[07(E5`@[H/]H=;1T0%
ML


MY7EMI/R

MB;:A'N$K%(.SKSV!R;;GO.EO\`'RN];Z/P```/__`P!02P
$%``&``@````A
M`
S8PQ8Q1C93M/^^UUCRJ#I-OK

I%4V;XQ_?;BTN
C*5-3FO5\`P_


M1;(FT6*1$$E%@SU#JN=PJ*(0C-\H=I2\L9Y$\YI:R-]4HC7/;)+-H9-4WQ_;
MZ9DQ0'40O[U)%B)%EZ5S9*TT

MD`T!IMTV%^#`E1UI7F1X'Z;7&TQVVZX^/P4_F=$S
I4Z?=0B_RP:#L6&-KD&





!3J3X2G;G93'F=FV3U?S-NV52ACTS-;%Z8\6/



.3/#L+QY%JWWQ)3FLLM)Y(?$8UTA2][5




M

2]/D9#;W


MIQ4`Y/U&$0Q-&M

MIUDOEQK!TU0NDMAY'@_

M5/M(?.1E





RYX;6RL6-MN








U


A33A/J=

W^E8=IM5:Y:7%O/QRV3R$&+0%:Q'EFT!*B1=3BH&6&%K&B




+7K-G+'@B[#MKOBSQ+)53IKO*LKIIJ*T?X.1.%
M8_<7'6!'1?:[SN6+.W;L_JM#L[00'@[V[1HA&.?/CA+D2K1HC2O&]<YR+N#
MR&15CYK\'Y#MQAK]3!NAZ$RL0UKG:2F!E@KK7MKG8M_(VKVOZE_-3@C9.#8$
M=!_;QWYL_SF_=3]]:2/@Z3Q2(71



QL

MD:`


M5X$[(VO



R#0O_K/:D*8%OIA4W`3_IC.FX


T#5H]]

M;W)E+GAM;B!`$HH``!````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M`)R104_#(!B&[R;^AX9[2]D6

M75X4PE+1.GAPK047%/@DDHRGPI:H#L%2C+VH07.?Q8:)X:YUFH=X=!6V7+SS



MDL667-

O````__\#`%!+`0(M`!0`

M````````````800``%]R96QS+RYR96QS4$L!`BT`%``&``@````A`#IH-4AI


``!I6@``&0````````````````#3

MI6&;0`




O

V+GAM;%!+`0(M`!0`





&UL4$L!`BT`%``&``@`

N

U$!0``GQ4``!@`````````````````


M&I0X^`4``



M`BT`%``&``@````A`-KV%7R!!```H1
``!D`````````````````DTH!`'AL


BYX;6Q02P$+0`4``8`````$`QG1S9@#
&UL4$L!`BT`%``&``@````A

O

JF*4/`\``)M1```9````````

M:&5E='






M-YX;6Q02P$+0`4``8`````$`=^51\
P#```5#@``&0``````````````


M+W-H965T


M```8`````````````````

``$2P``&`````````````````QI@$`

\
M```@R
``!@`````````````````R+





``!D`````````
M````````?




(!`'AL
M+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$+0`4``8`````$`-15HF.$;

O

YX;6Q02P$+0`4``8`````$`HT2J9)\$```0$```&0``````

Q+GAM;%!+`0(M`!0`



M

``!D`````````````




EK

`
end











    
  
      

          

        

      






        
        


        

 the Company offers a one-year warranty for most of the products it sold.


        
        




        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 including the approximate term of the product warranty
 how the product warranty arose
 and the events or circumstances that would require the warrantor to perform under the product warranty.
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    





















    
  
      

          

        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        

      






























 2013

          



 2013

          



 2013

          



 2012

          



 2013



          



 2012



          



 2012

          



 2012

          



 2012

          



 2013

          



 2013

          



 2013

          



 2013

          



 2013

          



 2012

          



 2013

          



 2013

          



 2012

          



 2013

          



 2013



          



 2012

          



 2013



          



 2012

          



 2012

          



 2012



          



 2013

          



 2013



          



 2013



          



 2013



          



Subsidiary
 Sale of Stock [Line Items]
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        

944

800
        
        
        

000

000
        
        
        
        
        
        
        
        
        
        
        
        
        

000
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        

				 2015

				 2014
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        

800
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        

933

000
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        

000
        
        
        
        


        
        

736
        
        
        
        
        
        
        
        
        

736

700
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        

000 per month for the duration of this agreement.
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        

000
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        

002

000
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        

000
000
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        

000
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        

000
000
        
        
        
        
        
        


        
        
        

403

800
        
        
        
        
        
        
        
        
        

056

979

508
000
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        

859
697


Common stock
 par value (in dollars per share)
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        

000

000

300
000
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        

056

979

000
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        

756
088

424
        
        
        
        

642
        
        
        
        
        
        
        
        
        


        
        
        
        
        

489
846

225
        
        
        
        
        
        
        
        
        
        
        
        
        
        

195
110

225
        
        
        
        

736
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        

606
157

663
        
        
        
        
        
        
        
        

172
751

756
088

663
        
        
        
        

784
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        

780
457
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        

789
801
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        

880
047
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        

286
        
        
        
        
        
        
        
        
        
        
        

376
009
        
        
        

400
000
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        

 the holder received 4.5 shares of Common Stock (fractional shares were rounded up)
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        

 each remaining holder of $1.50 warrants received one additional warrant with an exercise price of $1.25 per share.
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        

528

161
        
        
        

528

161
        
        
        
        
        
        
        
        

227
742
        
        
        
        
        
        

415
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        

718
750
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        

573
438
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        

656)
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        

316
597
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        

712
356
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        

528

161
        
        
        

528

161
        
        
        
        
        
        
        
        

227
742
        
        
        
        
        
        

415
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        

600

400
        
        
        
        
        
        
        


        
        
        
        
        

734

526
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        

250
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        

866
667
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        

571

000
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        

000

000
        


        

210
165
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        

000
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        

881
250
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        

881
250
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        

326
697
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        

000


        
        
        

403

800
        
        
        
        
        
        
        
        
        

056

979

508
000
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        

859
697




        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 on or before a certain date.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 lawyers and accountants. The term is often expanded to include other professions
 for example
 pharmacists charging to maintain a medicinal profile of a client or customer.
              
 -Subparagraph (SX 210.6-07.2(a)
(b)
(c)
(d))
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 if any
 over the period.
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 -Paragraph 4
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 -Paragraph 29
 30
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 but is not limited to
 shares issued for services contributed by vendors and founders.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
 -Subparagraph (SX 210.5-02.28
 -Paragraph 29
 30
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 but is not limited to
 services contributed by vendors and founders.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 -Paragraph 29
 30
 31
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 convertible
 debt and/or linked securities under Advisory Services Agreement.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 to each director.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    





















    
  
      

          

        

      






        
        


        
The following tabular presentation reflects the components of derivative financial instruments on the Company&#8217;s balance sheet at December 31
 2013 and December 31
&#160;$95
&#160;$6
626
&#160;1
399
&#160;$95
&#160;$8
025
&#160;$8
025
&#160;$11
031
&#160;(966
&#160;1
514
&#160;(6
963
&#160;(4
520
&#160;$95
&#160;$8
025
381




        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    


















/* Updated 2009-11-04 */
/* v2.2.0.24 */
/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}
..report table.authRefData a {
	display: block;
	font-weight: bold;
}
..report table.authRefData p {
	margin-top: 0px;
}
..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}
..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}
..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}
..report table.authRefData table{
	font-size: 1em;
}
/* Report Styles */
..pl a
 .pl a:visited {
	color: black;
	text-decoration: none;
}
/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica
 Arial
 san-serif;
	margin-bottom: 2em;
}
..report hr {
	border: 1px solid #acf;
}
/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}
..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica
 Arial
 san-serif;
	text-align: left;
}
..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	word-wrap: break-word;
}
..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}
..report td.pl div.a {
	width: 200px;
}
..report td.pl a:hover {
	background-color: #ffc;
}
/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}
/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}
/* Even rows... */
..report .re
 .report .reu {
	background-color: #def;
}
..report .reu td {
	border-bottom: 1px solid black;
}
/* Odd rows... */
..report .ro
 .report .rou {
	background-color: white;
}
..report .rou td {
	border-bottom: 1px solid black;
}
..report .rou table td
 .report .reu table td {
	border-bottom: 0px solid black;
}
/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}
/* styles for numeric types */
..report .num
 .report .nump {
	text-align: right;
	white-space: nowrap;
}
..report .nump {
	padding-left: 2em;
}
..report .nump {
	padding: 0px 0.4em 0px 2em;
}
/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}
..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}
..report .text .more {
	display: none;
}
..report .text .note {
	font-style: italic;
	font-weight: bold;
}
..report .text .small {
	width: 10em;
}
..report sup {
	font-style: italic;
}
..report .outerFootnotes {
	font-size: 1em;
}











    
  
      

          

        
        
        
        

      


 2013

          











 2014








 2014



          



 2014








 2014





          



 2014



          



        
        
        
        
        
        
        
        
        


        

944
        
        
        
        
        

716
        


        
        
        
        
        
        
        
        
        


        

736
        
        
        
        
        
        

429


        

002

002

000
        
        
        

001
        


        
        
        
        

000

000
        
        
        


        
        
        
        
        
        
        
        
        


        
        
        
        

				 2016
        
        
        
        


        
        
        
        
        
        
        
        
        


        
        
        
        
        

417
        
        
        


        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        


        
        
        
        
        
        

000
        
        




        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 in CCYY-MM-DD format.
              
 -Paragraph 2
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 due to related parties.
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 net of any shares forfeited. Shares issued could result from the issuance of restricted stock
 the exercise of stock options
 stock issued under employee stock purchase plans
 and/or other employee benefit plans.
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 -Paragraph 29
 30
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 net of stock value of such awards forfeited. Stock issued could result from the issuance of restricted stock
 the exercise of stock options
 stock issued under employee stock purchase plans
 and/or other employee benefit plans.
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 -Paragraph 29
 30
 31
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 they do not form part of the executive management team.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 to each director.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    





















    
  
      

          

        

      






        
        


        
The Company from time to time enters into certain types of contracts that contingently require the Company to indemnify parties against third party claims. These contracts primarily relate to: (i) divestiture agreements
 under which the Company may provide customary indemnifications to purchasers of the Company&#8217;s businesses or assets; (ii) certain real estate leases
 under which the Company may be required to indemnify property owners for environmental and other liabilities
 and other claims arising from the Company&#8217;s use of the applicable premises; and (iii) certain agreements with the Company's officers
 directors and employees
 under which the Company may be required to indemnify such persons for liabilities arising out of their employment relationship.&#160;&#160;The terms of such obligations vary. Generally
 a maximum obligation is not explicitly stated. Because the obligated amounts of these types of agreements often are not explicitly stated
 the overall maximum amount of the obligations cannot be reasonably estimated. Historically
 the Company has not been obligated to make significant payments for these obligations
 and no liabilities have been recorded for these obligations on its balance sheet as of December 31
In general
 the Company offers a one-year warranty for most of the products it sold.&#160;&#160;To date
 the Company has not incurred any material costs associated with these warranties.




        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 or each group of similar guarantee obligations
 including (a) the nature of the guarantee
 including its term
 how it arose
 and the events or circumstances that would require the guarantor to perform under the guarantee; (b) the maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee; (c) the current carrying amount of the liability
 if any
 for the guarantor's obligations under the guarantee; and (d) the nature of any recourse provisions under the guarantee
 and any assets held either as collateral or by third parties
 and any relevant related party disclosure. Excludes disclosures about product warranties.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    





















    
  
      

          

        
        
        
        
        
        
        
        
        
        
        
        

      














 2012

          



 2013

          



 2012

          



 2007



          



 2011



          



 2011



          



 2012

          



 2012

          



 2011

          



 2011



          



 2011



          



Loss Contingency
 Settlement [Abstract]
        
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        

000

000

000
        
        
        

000

000


        
        
        
        
        
        
        
        
        
        

500
        
        
        
        


        
        
        
        
        
        
        
        
        
        

500

500
        
        
        


        
        
        
        
        
        
        
        
        
        
        
        

500
        
        


        

000
        
        
        
        
        
        
        
        
        
        
        
        
        


        
        

000

968
        
        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        

000
        
        
        
        
        
        
        
        


        
        
        
        
        

000
        
        
        
        
        
        
        
        
        


        
        
        

881
250

881
250
        
        
        
        
        
        
        
        
        
        




        
          

        
          
            

 which may include attorneys' fees and other litigation costs.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 to be received by
 or to be remitted to the entity in settlement of litigation occurring during the period.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
 -Paragraph 9
 10
 11
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
 -Paragraph 9
 10
 11
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 the components of which are not separately disclosed on the income statement
 resulting from ancillary business-related activities (that is
 excluding major activities considered part of the normal operations of the business) also known as other nonoperating expense recognized during the period. Such amounts may include: (a) unusual costs
 (b) loss on foreign exchange transactions
 (c) losses on securities (net of profits)
 and (d) miscellaneous other expense items.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    





















    
  
      

          

        
        
        
        
        
        

      














 2012



          



 2012

          



 2012

          



 2012

          



 2012



          



 2012



          



        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        


        
        

000
        
        
        

000
        
        
        


        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        

000
        
        


        
        
        
        
        
        
        
        
        
        


Interest rate 
default (in hundredths)
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        
        
        
        


        
        
        
        
        
        
        

508
        
        


        
        
        
        
        
        
        

000
        
        


        
        
        
        
        
        
        
        
        
        


Fair Value Assumptions
 Expected Volatility Rate (in hundredths)
        
        
        
        
        
        
        
        
        


Fair Value Inputs
 Discount Rate (in hundredths)
        
        
        
        
        
        
        
        
        


Debt discount
 net of amortization
        
        
        
        
        
        

608
        
        


        
        
        
        
        
        
        

000
        
        


        
        

819
        
        

819
        
        
        
        




        
          

        
          
            
                
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 -Paragraph 16
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 in percentage terms (for instance
 the standard deviation or variance)
 for a given stock price.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 but not limited to
 weighted average cost of capital (WACC)
 cost of capital
 cost of equity and cost of debt.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 typically the entity's common stock
 at the option of the issuer or the holder.
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 interest or any breach of covenant that existed at the end of the period.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    





















    
  
      

          

        

      










        
        
        


        
        
        


        
        
        


        
        
        


        
        
        


        
        
        


Fair Value
 Liabilities Measured on Recurring Basis
 Unobservable Input Reconciliation [Line Items]
        
        


        

736)

514
156


        
        
        


        
        

425


        
        
        


        

318
355

547
826



          

        
        


        
        
        


        

000
        


        
        
        


Credit drawn down
 maximum per period

000
        


        
        
        


        

000
        




 Measurements
 Recurring [Member] | Derivative Financial Instruments


        
        


Fair Value
 Liabilities Measured on Recurring Basis
 Unobservable Input Reconciliation [Line Items]
        
        


Derivative Liabilities
 beginning of period

025
381

031
432


        

963
596)

520
207)


        

736)

514
156


        

930
332)

060
501)


Derivative Liabilities
 end of period

049

025
381




 Measurements
 Recurring [Member] | Level 1 [Member] | Derivative Financial Instruments


        
        


Fair Value
 Liabilities Measured on Recurring Basis
 Unobservable Input Reconciliation [Line Items]
        
        


Derivative Liabilities
 beginning of period
        
        


        
        
        


        
        
        


        
        
        


Derivative Liabilities
 end of period
        
        




 Measurements
 Recurring [Member] | Level 2 [Member] | Derivative Financial Instruments


        
        


Fair Value
 Liabilities Measured on Recurring Basis
 Unobservable Input Reconciliation [Line Items]
        
        


Derivative Liabilities
 beginning of period
        
        


        
        
        


        
        
        


        
        
        


Derivative Liabilities
 end of period
        
        




 Measurements
 Recurring [Member] | Level 3 [Member] | Derivative Financial Instruments


        
        


Fair Value
 Liabilities Measured on Recurring Basis
 Unobservable Input Reconciliation [Line Items]
        
        


Derivative Liabilities
 beginning of period

025
381

031
432


        

963
596)

520
207)


        

736)

514
156


        

930
332)

060
501)


Derivative Liabilities
 end of period

049

025
381



          

        
        


        
        
        


        
        
        



          

        
        


        
        
        


        
        
        



          

        
        


        
        
        


        
        
        



          

        
        


        
        
        


        
        
        



          

        
        


        
        
        


        
        
        



          

        
        


        
        
        


        
        
        



          

        
        


        
        
        


        
        
        



          

        
        


        
        
        


        
        
        



          

        
        


        
        
        


        
        
        




        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 which are expenses incurred with the objective of increasing revenue for a specified brand
 product or product line.
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 whichever is longer) that are expected to be uncollectible.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
              
 -Paragraph 8
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 changed net asset value
 or other comprehensive income (a separate component of shareholders' equity); purchases
 sales
 issues
 or settlements of assets; and net transfers in to or out of this category within the fair value hierarchy.
              
 -Subparagraph c(1)
 c(2)
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 sales
 issues
 and settlements in relation to liabilities measured at fair value on a recurring basis using unobservable inputs (level 3).
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 in 'PnYnMnDTnHnMnS' format
 for example
 'P1Y5M13D' represents the reported fact of one year
 five months
 and thirteen days.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 physical assets used in the normal conduct of business and not intended for resale
 in 'PnYnMnDTnHnMnS' format
 for example
 'P1Y5M13D' represents the reported fact of one year
 five months
 and thirteen days. Examples include
 but not limited to
 land
 buildings
 machinery and equipment
 office equipment
 furniture and fixtures
 and computer equipment.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 on which interest has been imputed
 as calculated from its issuance value or purchase price. The calculated effective interest rate considers factors such as the issued face value or price paid for the receivable
 the time period between payments
 and the time until maturity [full receipt] of the receivable.
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 equity-based employee remuneration. This may include the value of stock or unit options
 amortization of restricted stock or units
 and adjustment for officers' compensation. As noncash
 this element is an add back when calculating net cash generated by operating activities using the indirect method.
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    





















    
  
      

          

        

      


 2013

          



 2012

          



        
        
        


        

472

804




 Goods


        
        


        
        
        


        
        
        




 Goods


        
        


        
        
        


        
        
        




 Goods


        
        


        
        
        


        
        
        




 Goods


        
        


        
        
        


        
        
        



          

        
        


        
        
        


        
        
        



          

        
        


        
        
        


        
        
        



          

        
        


        
        
        


        
        
        




        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 which serves as the benchmark (or denominator) in the equation
 this concept represents the concentration percentage derived from the division.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    





















    
  
      

          

        
        
        
        
        

      


























        
        
        
        
        
        
        


        
        

400

600
        
        
        


        
        

528

161
        
        
        


        
        
        
        
        
        
        


        
        
        

000
        
        
        


        
        
        
        
        
        
        


        
        
        
        
        
        
        


Outstanding
 end of period (in dollar per share)
        
        
        
        
        
        


        
        
        

641
        
        
        


        
        
        
        
        
        

286



          

        
        
        
        
        
        


        
        
        
        
        
        
        


        
        

606
157

663
        
        
        


        
        

528

161
        
        
        



          

        
        
        
        
        
        


        
        
        
        
        
        
        


        
        

392
811

752
669
        
        
        


        
        

010
295

000
        
        
        


        
        

287
730)

424)
        
        
        


        
        

082
535)

541)
        
        
        


        
        

576)

893)
        
        
        


Outstanding
 end of period (in shares)
        

688
265

392
811
        
        
        


        
        

688
265

392
811
        
        
        


        
        
        
        
        
        
        


        
        
        
        
        
        
        


        
        
        
        
        
        
        


        
        
        
        
        
        
        


        
        
        
        
        
        
        


        
        
        
        
        
        
        


Outstanding
 end of period (in dollar per share)
        
        
        
        
        
        


        
        
        
        
        
        
        


        

376
009
        
        

400
000

000

286


        

316
597
        
        
        
        
        


        
        
        
        
        
        
        


        
        

000
        
        
        
        


        
        
        
        
        
        
        


        
        
        
        
        
        
        



          

        
        
        
        
        
        


        
        
        
        
        
        
        


Inception to date
 weighted average issue price (in dollars per share)
        
        
        
        
        
        



          

        
        
        
        
        
        


        
        
        
        
        
        
        


Inception to date
 weighted average issue price (in dollars per share)
        
        
        
        
        
        



          

        
        
        
        
        
        


        
        
        
        
        
        
        


        
        
        

000
        
        
        


        
        
        
        
        
        
        


        
        
        

133
        
        
        



          

        
        
        
        
        
        


        
        
        
        
        
        
        


        
        
        

000
        
        
        


        
        
        
        
        
        
        


        
        
        

508
        
        
        




        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 on or before a certain date.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    





















    
  
      

          

        

      






        
        


        
The Company generally recognizes product revenue when persuasive evidence of an arrangement exists
 delivery has occurred
 the fee is fixed or determinable
 and collectability is probable. In instances where the final acceptance of the product is specified by the customer
Management of the Company makes judgments as to its ability to collect outstanding receivables and provide allowances for the portion of receivables when collection becomes doubtful. Provisions are made based upon a specific review of all significant outstanding invoices. For those invoices not specifically reviewed
 provisions are provided at differing rates
 based upon the age of the receivable. In determining these percentages
 management analyzes its historical collection experience and current economic trends. If the historical data the Company uses to calculate the allowance for doubtful accounts does not reflect the future ability to collect outstanding receivables
 additional provisions for doubtful accounts may be needed and the future results of operations could be materially affected. As of December 31
 2013 and 2012
For purposes of the statement of cash flows
 the Company considers all highly liquid investments with a maturity of three months or less to be cash equivalents.&#160;&#160;There were no cash equivalents as of December 31
Inventory is stated at the lower of cost or market
 using the first-in
Property and equipment are stated at cost less accumulated depreciation and amortization.&#160;&#160;Maintenance and repair costs are expensed as incurred.&#160;&#160;Depreciation is calculated using the straight-line method over the estimated useful lives of the assets.&#160;&#160;Estimated useful lives of five to ten years are used for machinery and equipment
 office equipment and furniture
Intangible assets are carried at the purchased cost less accumulated amortization. Amortization is computed over the estimated useful lives of the respective assets
The amount of current and deferred taxes payable or refundable is recognized as of the date of the financial statements
All derivatives have been recorded on the balance sheet at fair value based on the lattice model calculation. These derivatives
 including embedded derivatives in the Company&#8217;s warrants
 convertible preferred stock
 and its Convertible 8% Senior Secured Notes issued in 2008
 2009
 and 2010
 which have reset provisions to the exercise price and conversion price if the Company issues equity or other notes at a price less than the exercise price set forth in such warrants and notes
 are separately valued and accounted for on the Company&#8217;s balance sheet. Fair values for exchange traded securities and derivatives are based on quoted market prices. Where market prices are not readily available
The Company valued the warrants and conversion features in their convertible notes and preferred stock using a lattice valuation model
The Company&#8217;s financial instruments consist of cash and cash equivalents
 accounts receivable
 inventory
 accounts payable and accrued liabilities. The estimated fair value of cash
 accounts receivable
The Company utilizes various types of financing to fund its business needs
 including convertible debt with warrants attached. The Company reviews its warrants and conversion features of securities issued as to whether they are freestanding or contain an embedded derivative and
 if so
 whether they are classified as a liability at each reporting period until the amount is settled and reclassified into equity with changes in fair value recognized in current earnings. At December 31
 2013 and 2012
 the Company had warrants to purchase common stock
- Level three &#8212; Unobservable inputs developed using estimates and assumptions
Determining which category an asset or liability falls within the hierarchy requires significant judgment. The Company evaluates its hierarchy disclosures each quarter. The Company&#8217;s only asset or liability measured at fair value on a recurring basis is its derivative liability associated with warrants to purchase common stock and preferred stock. The fair value of the derivative liability at December 31
 2013 and 2012 was $95
049 and $8
025
381
 respectively.&#160;&#160;The gain on derivative liability for the twelve months ended December 31
 2013 was $966
736 compared to a loss on derivative liability of $1
514
156 for the twelve months ended December 31
&#160;$11
031
&#160;$11
031
&#160;$11
031
&#160;(4
520
&#160;(4
520
&#160;(4
520
&#160;1
514
&#160;1
514
&#160;1
514
&#160;(3
006
&#160;(3
006
&#160;(3
006
&#160;$8
025
&#160;$8
025
&#160;$8
025
&#160;(6
963
&#160;(6
963
&#160;(6
963
&#160;(966
&#160;(966
&#160;(966
&#160;(7
930
&#160;(7
930
&#160;(7
930
&#160;$95
&#160;$95
&#160;$95
Accounting for Convertible
The Company accounts for convertible and redeemable preferred stock according to its stated redemption value net of any discounts related to attached warrants or beneficial conversions features. The Company classifies these instruments on the balance sheet according to the nature of the redemption feature. Preferred shares with redemption features that are solely within the control of the Company are accounted for within permanent equity. Preferred shares that are considered mandatorily redeemable due to a fixed redemption date and amount are accounted for as liabilities. Preferred shares that are conditionally redeemable based on conditions that are outside of the Company&#8217;s control are classified within temporary equity. Discounts on instruments classified as liabilities are amortized to interest expense
The Company expenses all advertising costs as incurred.&#160;&#160;The amount for the year ended December 31
 2013 and 2012 was $250 and $18
Basic net income (loss) per share includes no dilution and is computed by dividing net income (loss) available to common stockholders by the weighted average number of common stock outstanding for the period. Diluted earnings per share is computed by dividing net income by the weighted average number of shares outstanding and
 when diluted
The Company estimates the fair value of share-based payment awards made to employees and directors
 including stock options
 restricted stock and employee stock purchases related to employee stock purchase plans
 on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense ratably over the requisite service periods.&#160;&#160;We estimate the fair value of each share-based award using the Black-Scholes option pricing model. The Black-Scholes model is highly complex and dependent on key estimates by management. The estimates with the greatest degree of subjective judgment are the estimated lives of the stock-based awards and the estimated volatility of our stock price. The Company recognized pre-tax compensation expense related to stock options of $2
318
355 and $1
547
826 for the years ended December 31
 2013 and 2012
The Company has entered into a custom processing agreement with a vendor in order to provide the Company with a partner for future manufacturing initiatives. The Company has agreed to make available a $500
000 line of credit to the vendor at a 5.5% interest rate. The vendor may not draw down more than $75
The Company capitalizes distributions to the vendor related to this agreement upon disbursement based on this value to be applied towards discounts on future product purchases. Interest on the outstanding advances are recorded to interest income and capitalized to the letter of credit account
On March 28
 2014 the Company agreed to an amendment to the custom processing agreement relating to the repayment of the line of credit advances plus interest.&#160;&#160;Commencing on April 1
 2014
 Aveka Nutra Processing will begin paying the Company $5
In February 2013
 the FASB issued an accounting standards update which requires an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component and to present either on the face of the statement where net income is presented
 or in the notes
 significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income
 but only if the amount reclassified is required to be reclassified to net income in its entirety in the same reporting period provides
 subject to certain conditions
 the option to perform a qualitative
 rather than quantitative
 assessment to determine whether it is more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying amount. The update will be effective in the first quarter of 2013
 although early adoption is permitted
 the Company has not elected early adoption of this pronouncement. The update did not have a material impact on the Company&#8217;s financial position
Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward
 a Similar Tax Loss
In July 2013
 the FASB issued an accounting standards update which requires an entity to present an unrecognized tax benefit
 or portion thereof
 in the statement of financial position as a reduction to a deferred tax asset for a net operating loss carryforward or a tax credit carryforward
 with certain exceptions related to availability. The update will be effective in the first quarter of 2014
 although early adoption is permitted
 the Company has not elected early adoption of this pronouncement. The update is not expected to have a material impact on the Company&#8217;s financial position
In July 2012
 the FASB issued an accounting standards update which provides
 subject to certain conditions
 the option to perform a qualitative
 rather than quantitative
 assessment to determine whether it is more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying amount. The update will be effective in the first quarter of 2013
 although early adoption is permitted
 the Company has not elected early adoption of this pronouncement. The update may
 under certain circumstances
 reduce the complexity and costs of testing indefinite-lived intangible assets for impairment
 but&#160;did not have a material impact on the Company&#8217;s financial position
 results of operations or cash flows.




        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15
 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    


















begin 644 Financial_Report.xls
M[[N_34E-12U697)S:6]N.B`Q+C`-E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O
M;VL-D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y
M/2(M+2TM/5].97AT4&%R=%\W9CAA-S)B.5]B-S9A7S1E8V%?860V95\U.65A
M
#(R



M@T*+2TM+2TM/5].97AT4&%R=%\W9CAA-S)B.5]B-S9A7S1E8V%?860V95\U
M.65A,#(R,&8P-V8-D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-V8X

C!F





M.F]F9FEC93IO9F9I8V4B('AM;&YS.G@]
T0B=7)N.G-C:&5M87


N
M;W)G+U12+U)%0RUH=&UL-#`B/@T*/&AE860^#0H\;65T82!N86UE/3-$(D5X

T1&:6QE+4QI


04Y#15]32$5%



O4VAE970P
RYH=&UL(B\^
&-E;%=O<FMS:&5E



O







M3F%M93Y354U-05)97T]&7U-)1TY)1DE#04Y47T%#0T]53E0\+W@Z3F%M93X-





O4VAE970Q
BYH=&UL(B\^
&-E;%=O<FMS:&5E


15].3U1%4U]0

M


M(#QX.DYA;64^3$E154E$051%1%]$04U!1T53/]X.DYA;64^#0H@(`@/'@Z



M:W-H965T/@T*(`@(#QX.DYA;64^1$52259!5$E615],24%24Q)5$E%4SPO


M:&5E='



O4VAE970Q.2YH=&UL(B\^
&-E;%=O<FMS:&5E




M8V5L5V]R:W-H965T/@T*(`@(#QX.DYA;64^24Y#3TU%7U1!6$53/]X.DYA

M15)37T%.1%]#3TY#14Y44D%4/]X.DYA;64^#0H@(`@/'@Z5V]R:W-H965T

&-E;%=O<FMS:&5E=#X-B`@(#QX.D5X8V5L5V]R:W-H965T/@T*

C





M4D5
051%1%]005)465]44D%.4T%#5$E/3E



C@N:'1M;(O/@T*(`@

M(`@/'@Z3F%M93Y354U-05)97T]&7U-)1TY)1DE#04Y47T%#0T]53E0R/]X

MB`@(#QX.D5X8V5L5V]R:W-H965T/@T*(`@(#QX.DYA;64^24Y614Y43U)9


M:&5E=#X-B`@(#QX.D5X8V5L5V]R:W-H965T/@T*(`@(#QX.DYA;64^1$52
M259!5$E615]

S
N:'1M
M;(O/@T*(`@/]X.D5X8V5L5V]R:W-H965T/@T*(`@/'@Z17AC96Q7;W)K




O4VAE970S


M3E1?04-#3U5.5#




&-E;%=O<FMS:&5E


#I.86UE/DY/5$5?
M4D5#14E604),15]$971A:6QS/]X.DYA;64^#0H@(`@/'@Z5V]R:W-H965T
M4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#0P+FAT;6PB+SX-B`@
&-E;%=O<FMS:&5E=#X-B`@(#QX.D5X8V5L5V]R:W-H965T/@T*
M(`@(#QX.DYA;64^04-#4E5%1%]%6%!%3E-%4U]$971A:6QS/]X.DYA;64^
M#0H@(`@/'@Z5V]R:W-H965T4V]U<F-E($A2968]


M.D5X8V5L5V]R:W-H965T/@T*(`@(#QX.DYA;64^0T].5D525$E3$5?3D]4
M15-?4$%904)
15]$971A/]X.DYA;64^#0H@(`@/'@Z5V]R:W-H965T4V]U

&-E;%=O<FMS:&5E=#X-B`@(#QX.D5X8V5L5V]R:W-H965T/@T*(`@
M(#QX.DYA;64^4%)%1D524D5$7U-43T-+7T1E=&%I;',\+W@Z3F%M93X-B`@

M-#
N:'1M;(O/@T*(`@/]X.D5X8V5L5V]R:W-H965T/@T*(`@/'@Z17AC


O4VAE970T-YH=&UL(B\^#0H@(`\+W@Z17AC96Q7


O4VAE970T


T0B5V]R:W-H965T
&-E;%=O<FMS:&5E=#X-B`@


O4VAE970T-RYH=&UL(B\^#0H@
&-E;%=O<FMS:&5E=#X-

\


M4%1)3TY?4$Q!3E]!3D1?5T%24D%.5%
T/]X.DYA;64^#0H@(`@/'@Z5V]R




M:&5E='
O4VAE970U



M.DYA;64^34%*3U)?0U535$]-15)37T%.1%]#3TY#14Y44D%4



T0B5V]R:W-H

M='

M



F(Y7V(W-F%?-&5C85]A9#9E7S4Y96$P
M


]
M





]
T1T:#Y*=6XN(#








T1T;W`^16YT:71Y($-E;G1R86P@
M26YD97@@2V5Y/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG
#`P
M
3`U


]




]





]









]



]


]


]
T1T97AT





T1T;W`^1&]C=6UE;G0@5'EP93PO=&0^



T1T;W`^06UE;F1M96YT

]





]
T1T97AT/D1E8R`S

]

M860V95\U.65A
#(R

T0G=&5X



S$L(#(P
3
\
M8G(^/]T:#X-B`@(`@(`@/'1H(&-L87-S/3-$=&@^1&5C+B`S
2P@
C`Q
M

]



]

]
T1N=6UP/B0@-#0S+#0W



T1T
M;W`^06-C;W5N='


]



]
T1N=6UP/C0V.2PS


M97AP96YS97

]
T1N=6UP/C$S-BPX

2PU
#4L
3
R

M
2PU-3`L







]
T1N=6UP/C4U


]
M
T1N=6UP/C$Q+#@Y


#8\






]
T1R


]
T1N
M=6UP/C0L-3

]
T1P




]

M






]


]
T1N=6UP/C



]

#0Y/'-P


M9VX]








]

#`L


M96UB97(@
S$L(#(P
3
@86YD(#(P




T1T;W`^0V]M;6]N('-T




]


M/3-$;G5M/B@Q


3
L-#0Q+#(S

]
T1R974^#0H@




]
T1N=6UP/C
L
38X+#`T


M24Q)5$E%4R`F86UP.R!35$]#2TA/3$1%4E

]
T1N=6UP/C
L.#8W+#DX



M
T1T;W`^4V5R:65S($E)(%M-96UB97)=/]T9#X-B`@(`@(`@/'1D(&-L


]
T1P




S@\

M
F(Y7V(W-F%?-&5C85]A9#9E7S4Y96$P






]

T1)1#!%34E!





G


]





#`P


#`P




#`L


C`P+#`P

]


]
T1N=6UP/C(U+#`S





T1T;W`^
M4V5R:65S($E)(%M-96UB97)=/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$


]



]


]
T1N
M=6UP/C$L
#`P+#`P

]
T1P

@:7-S=65D


M9VX]

]
T1N=6UP/C`\

M-C4L
S


M=%\W9CAA-S)B.5]B-S9A7S1E8V%?860V95\U.65A
#(R



M87-C:6DB#0H-CQH
M=&UL/@T*(`\:&5A9#X-B`@(`\345402!H='1P+65Q=6EV/3-$0V]N=&5N



M*B!$;R!.;W0@4F5M;W9E(%1H:7

M(&-O;'-P86X]
T0Q(')O=W-P86X]










]
M







]

BPQ


]





T1T;W`^1U)/4U
@34%2
M1TE./]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$;G5M/B@R+#$W

M86QI9VX]




T1T;W`^4V5L;&EN


]
T1N=6UP/C8L-#@P+#`S



M;7`^-BPT.#`L
#


T1T;W`^3U!%4D%424Y'($Q/4U
\+W1D/@T*



]





]



C




]
T1N=6T^*#$P-RD\






]
T1N
M=6UP/CDV-BPW


M
2PS

M1&YU;7`^-#DL







]


M


]

S4I/'-P

]

]
T1N=6T^*#$S+#0S
M

M1&YU;3XH.2PU.#

]
M







T1T;W`^3D54($Q/
M4U

]


551%




]

M+W1A8FQE/@T*(`\+V)O9'D^#0H\+VAT;6P^#0H-BTM+2TM+3U?3F5X=%!A

C!F
#=F#0I#;VYT
M96YT+4QO8V%T:6]N.B!F:6QE.B\O+T
Z+S=F.&$W
F(Y7V(W-F%?-&5C85]A
M9#9E7S4Y96$P

#4N:'1M;`T*0V]N



^


M1$E$
$5/



]
T1T:#Y#;VUM;VX@






M8V4@870@1&5C+B`S
2P@
C`Q




BPT



M
3(L-3DT+#


2P@
M
C`Q

]
T1T97AT








]



]

M1&YU;7`^








]







]



@


]






]
T1N=6UP/C
L-S@Y+#@Q





]
M




]

]



#QS


#`P

]
T1T



M=&EB;&4@;F]T97

]
T1N=6UP


]



]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^




]
T1N=6UP/C



]
T1N=6UP/C


]
T1R93X-B`@(`@






]


@


]
T1N=6T^*#$P


M

]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P



]




]


]


]
T1N=6UP/C$T+#8P




]





]





M=&EO;G


]


3
Q+#$V


]

]
T1N


RPY



]
T1T



]

]





M;7`^


]


]
T1N=6UP/C0P+#4P.#QS



]



]


]
T1R

M


]





]


]
T1N=6UP






]
T1N=6UP/C`\


M
3$L



]


2PX.#$L
C4P

M

M86QI9VX]



]
T1N






@8V]N


M:&%R97


S

]
T1T


]
T1N


M1&YU;3XH.2PU.#


]

2PR-3(\

M+#$U-RPR




]
T1N=6T^*#$Q
RPT-#$L
C



2P@
C`Q
CPO

]
T1N=6UP/C8V-2PS
M







]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]


]

#`L




]


]




]

S`L.3




]






]
T1N=6UP/C(L






]




]


]
T1N=6UP/C(L-#@Y



]
T1N=6UP/C(L
M



]




\+W1D

]






]
T1N=6UP/C



]




]







M(&]P=&EO;G


]







]
M





]

]
T1N=6UP/C$P
M

]
M




]
M







]



]

]
T1N=6UP


M;7`^
BPS
3@L









]




]
M





]

30T/'-P86X^



]
M



]





]





]








]
T1N=6T^*#$S+#0S

3
L-#
R+#(V


M8V4@870@1&5C+B`S
2P@
C`Q



]
T1N=6UP/B0@
3

M/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$;G5M/B0@*#$R-BPX-S
L-#DQ



]
T1N=6UP/C
Y+#0T.2PQ
M





C!F
M
#=F#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T
Z+S=F.&$W
F(Y7V(W
M-F%?-&5C85]A9#9E7S4Y96$P

#8N



^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C




M051%345.5%



]
T1T:#Y$96
N(#

S$L(#(P





]


]


]








]
T1N=6UP/C$V

]








]


]




T1T;W`^





]
T1R93X-



]


]



]

M;7`^


M9VX]





3`L
#`P/'-P86X^

M;VYG/D-H86YG97

M97


T1T
M;W`^06-C;W5N='


]
T1N=6UP/C$V+#`R


]
T1P;!V86QI9VX],T1T;W`^26YV96YT;W)Y/]T9#X-B`@(`@

]
T1N=6T^*#(Q



]




]
T1N=6T^*#0S-RPY
S4I/'-P



M140@24X@3U!%4D%424Y'($%#5$E6251)15




]



]
T1N=6UP/C$Q


]





]


]

T

M.2PU


\+W1D

]
T1N=6UP/C


]


]
T1N=6UP/C0L-S
Y




M




T1T;W`^0T%32!!5!4
M2$4@4$5224]$($5.1$5$($1%0T5-0D52(#
Q/]T9#X-B`@(`@(`@/'1D




]


]








]


]
T1R



]
T1N



2PX-S$L
#









#$L.3`X/'-P86X^

BPX-C0L
M






3






3



T1T;W`^1&ES

]




]






34W+#(S.#QS






\8G(^

]
T1R93X-

]


M


M:6=H=#H@




M='
N)B
Q-C`[)B
Q-C`[5&AE($-O;7!A;GDF(S@R


@=&\@=&AE



M:65S+B8C










F(Y7V(W-F%?-&5C85]A9#9E7S4Y96$P
C(P9C`W9@T*



]

M:60]

]
T1T



T1T;W`^



]
T1R;SX-B`@(`@

]

M)V9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97




@3F5W(%)O;6%N.R!M87)G:6XM;&5F=#H@
'!T


B`F(S@R






Q-C`[/]D:78^/&1I=B!S='EL93TS1=T
M97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@9F]N=UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@;6%R9VEN
M+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q



2P@
M


M92!Y96%R(&5N9&5D($1E8V5M8F5R(#












24-)15



]



]
T1R;SX-B`@(`@

T0G9F]N=UF86UI;'DZ(=4



'0M:6YD96YT.B`P<'0[(&1I<W!L87DZ

@3F5W(%)O;6%N.R!M87)G:6XM
M;&5F=#H@

'!T

M97


'!T


M



3!P=#L@;6%R9VEN+7)I9VAT



M8FEL:71I97







Q-C`[/]D:78^/&1I=B!S='EL
M93TS1=T97AT+6%L:6=N.B!L969T.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@;6%R
M9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q





@9&5F97)R960@=6YT:6P@

M;&4]
T0G=&5X=UA;&EG;CH@;&5F=#L@=&5X=UI;F1E;G0Z(#!P=#L@9&ES

M

Q-C`[/]D:78^/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!L
M969T.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF
M86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N
M=US:7IE.B`Q


@87


@87)E('!R;W9I9&5D(&%T




@=')E;F1S+B!)9B!T

M='5R92!R97-U;'1S(&]F(&]P97)A=&EO;G
@8V]U;&0@8F4@;6%T97)I86QL



'!T


'!T.R!T97AT+61E8V]R871I;VXZ('5N9&5R;&EN93LG

\+V9O;G0^/]D:78^/&1I=B!S
M='EL93TS1=T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SLG/CQB



M

@;V8@=&AE








@3F5W(%)O;6%N.R!M87)G:6XM;&5F=#H@
'!T.R!F;VYT+7-I

'!T.R!T97AT+61E8V]R871I;VXZ

T0G=&5X



Q
M-C`[/]D:78^/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!L969T.R!T97AT
M+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ(%1I
M;65S($YE=R!2;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
M


Q-C`[)B
Q-C`[5&AE($-O;7!A


M87)G:6XM;&5F=#H@

38P.SPO

T0G=&5X=UA;&EG;CH@;&5F=#L@=&5X=UI;F1E


3!P=#L@


T0G



M)B
Q-C`[/]D:78^/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!L969T.R!T
M97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ
M(%1I;65S($YE=R!2;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE
M.B`Q

Q-C`[)B
Q-C`[36%I;G1E

@:6YC=7)R
M960N)B
Q-C`[)B



M;65N=!A;F0@9G5R;FET=7)E+!A;F0@875T;VUO8FEL92X@17-T:6UA=&5D




M;6]R=&EZ871I;VX@:7




M97
@3F5W(%)O;6%N.R!M87)G:6XM;&5F=#H@


'!T.R!T97AT+61E8V]R871I;VXZ('5N9&5R








@8F%S960@;VX@=&AE(&9A:7(@



@=&\@8F4@9&ES


M=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R


'0M:6YD96YT.B`P<'0[(&1I<W!L87DZ(&)L

@3F5W(%)O;6%N.R!M87)G:6XM;&5F
M=#H@

'!T.R!T


T0G=&5X=UA;&EG;CH@;&5F=#L@=&5X=UI;F1E;G0Z

M;BUR:6=H=#H@

Q-C`[/]D:78^/&1I=B!S='EL93TS1=T97AT
M+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@9F]N=UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@;6%R9VEN+6QE
M9G0Z(#!P=#L@9F]N=US:7IE.B`Q



@8F5T


M1=T97AT+6%L:6=N.B!L969T.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@9F]N=UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@;6%R9VEN


M97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y

M)SXF(S$V



@3F5W(%)O;6%N.R!M87)G:6XM;&5F=#H@
'!T.R!F;VYT





M
C`P.2P@86YD(#(P






@:6YC;W)P




871T:6-E(%9A;'5A=&EO;B!-;V1E;#PO





Q-C`[/]D:78^/&1I=B!S='EL93TS
M1=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@;6%R
M9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q





@87)E
M(&1E=&5R;6EN960@8F%S960@;VX@;6%N86=E;65N==S('!R;VIE8W1I;VYS
M(&%N9!T:&4@97AP97)T)B
X
C$W.W
@8V%L8W5L871I;VYS+B!4:&5S92!P







L(&%C8V]U;G1S(')E8V5I




M(&%C8W)U960@;&EA8FEL:71I97



38P.R8C

M=')U;65N='

N/]D:78^
M/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N
M=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R




@3F5W(%)O;6%N.R!M87)G:6XM
M;&5F=#H@

'!T




@:7-S=65D(&%S('1O('=H971H97(@=&AE


M=&EL('1H92!A;6]U;G0@:7

S$L(#(P
3
@
M86YD(#(P



M92!I;G!U='

M

M

@;W(@;&EA8FEL:71I97
[/]D:78^/&1I=B!S
M='EL93TS1=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@
'!T

CL@




M97
@3F5W(%)O;6%N.R!M87)G:6XM;&5F=#H@

M97





@3F5W(%)O;6%N.R!M87)G:6XM;&5F=#H@
'!T.R!F







X
C$W.W
@


M92!O9B!T:&4@9&5R:79A=&EV92!L:6%B:6QI='D@870@1&5C96UB97(@
S$L
M(#(P
3
@86YD(#(P
3(@=V%S(0Y-2PP-#D@86YD(0X+#`R-2PS.#$L(')E

#LF(S$V
#M4:&4@9V%I;B!O;B!D97)I=F%T:79E

@96YD960@1&5C96UB
M97(@
S$L(#(P
3

2P@
C`Q
BXF(S$V
#LF
M(S$V

M='EL93TS1=W:61T:#H@,3`P)3L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R

T1T;W`@




M


T0G=&5X=UA
M;&EG;CH@8V5N=&5R.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z



M

M86QI9VX]

T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@
G!X


3!P=#LG/B8C

T1T;W`@

T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@
G!X('-O;&ED.R!W:61T

M93H@
3!P=#LG/B8C


@;F5W(')O

!S;VQI
F4Z(#$P<'0[)SXF(S$V,#L@/]T




@;F5W(')O;6%N.R!M87)G:6XM;&5F
M=#H@



T0G8F]R
M9&5R+6)O='1O;3H@8FQA8VL@
G!X('-O;&ED.R!W:61T:#H@.24[)SX\9&EV



CPO9&EV

24[(&1I


Q-C`[(#PO=&0^/'1D('9A;&EG;CTS1'1O


T0G=&5X=UA;&EG;CH@8V5N=&5R.R!T
M97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ


M97














T1T






M=F%T:79E($QI86)I;&ET:65S/]D:78^/]T9#X\=&0@=F%L:6=N/3-$=&]P



M




M(S$V




M)SXF(S$V














'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN
M+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q

M=#LG/C$R+S


M=&EM97



@;F5W
M(')O;6%N.R!M87)G:6XM;&5F=#H@



Q-C`[)#$Q+#`S
2PT
S(\+V1I=CX\+W1D







T0G=&5X


M;&4]

M9VX]

T0G=VED=&@Z(#$E.R!D:7-P;&%Y.B!I;FQI;F4[

3!P
M=#LG/B8C

3H@
M=&EM97
@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@



Q-C`[)#$Q+#`S
2PT
S(\
M+V1I=CX\+W1D/CPO='(^/'1R(&)G8V]L;W(]


@



M97



M=&EM97





#L@




M



M86QI9VX]

T0G=VED=&@Z(#$E.R!D:7-P;&%Y.B!I;FQI

M
3!P=#LG/B8C


T0G=VED=&@Z(#$E.R!D:7-P;&%Y.B!I

M93H@
3!P=#LG/B8C


T0G=VED=&@Z(#$E.R!D:7-P;&%Y


3!P=#LG/B8C


T0G=VED=&@Z(#$E.R!D:7-P


3!P=#LG/B8C


T0G=VED=&@Z(#$E.R!D


3!P=#LG/B8C




@;F5W(')O
M;6%N.R!M87)G:6XM;&5F=#H@

M;BUR:6=H=#H@

Q-C`[)B
Q-C`[)B
Q-C`[)B
Q-C`[)B
Q-C`[
M)B
Q-C`[)B


M(')I9VAT.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N
M=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@
M9F]N=US:7IE.B`Q

38P.R@T
M+#4R

M=&0@86QI9VX]



M86QI9VX]

C`L
C`W*3PO9&EV/CPO


M87DZ(&EN;&EN93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N
M=US:7IE.B`Q



M

'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN
M+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q

M=#LG/D-H86YG92!I;B!D97)I=F%T:79E(&QI86)I;&ET:65S('9A;'5A=&EO



M86QI9VX]



M9VX]




'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE
M9G0Z(#!P=#L@9F]N=US:7IE.B`Q

M/B8C

C4E


3!P=#LG/B8C




T0G=VED=&@Z(#$E.R!D


3!P=#LG/B8C



@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@
M


Q

M:#H@


Q-C`[(#PO=&0^/'1D(&%L


M9#X\=&0@86QI9VX]





T0G
M=VED=&@Z(#$E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE

3!P=#LG/B8C
38P.R`\+W1D/CQT


M
T0G=VED=&@Z(#$E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T

3!P=#LG/B8C
38P.R`\+W1D


M;&4]
T0G=VED=&@Z(#$E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY

3!P=#LG/B8C
38P.R`\

T1T;W`@

T0G=VED=&@Z(#$E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M

3!P=#LG/B8C
38P

T1T

T0G=VED=&@Z(#$E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M

3!P=#LG/B8C
M




@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@
'!T


M=&EV92!



Q-C`[



Q-C`[(#PO=&0^/'1D('9A;&EG;CTS1'1O



Q



Q-C`[(#PO=&0^/'1D('9A;&EG;CTS


M=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE.B`Q

M)B



Q-C`[(#PO=&0^/'1D('9A;&EG


M9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE.B`Q
'!T




Q-C`[(#PO=&0^/'1D('9A


M93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE.B`Q
M










M)SXQ
B\S
2\Q



Q-C`[(#PO=&0^



M
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!M87)G

38P.R0X+#`R-2PS.#$\+V1I=CX\+W1D/CQT










M




3!P

#LD.PP,C4L,S@Q/]D:78^











@;F5W



@



M97



M=&EM97





#L@

'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q

M:'0Z(#!P=#LG/B8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P
M.R8C
38P.W-E='1L96UE;G1S/]D:78^/]T9#X\=&0@=F%L:6=N/3-$=&]P



M
#L@/]T9#X\=&0@86QI9VX],T1R:6=H=!V86QI9VX]

M




#LH-BPY-C
L

M:#H@


Q-C`[(#PO=&0^/'1D(&%L





@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@
'!T


Q-C`[

M


Q-C`[(#PO=&0^/'1D(&%L:6=N




T0G=VED=&@Z(#$E.R!D:7-P;&%Y.B!I

M93H@
3!P=#LG/B8C


B!V86QI9VX]
M


T0G=&5X










@;F5W(')O
M;6%N.R!M87)G:6XM;&5F=#H@

M;BUR:6=H=#H@

Q-C`[+3PO9&EV/CPO=&0^/'1D('9A;&EG;CTS


M=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE.B`Q

M)B





@;F5W(')O;6%N
M.R!M87)G:6XM;&5F=#H@

M:6=H=#H@

Q-C`[*#DV-BPW
S8I/]D:78^/]T9#X\=&0@=F%L




#L@/]T9#X\=&0@86QI9VX],T1R:6=H=!V86QI9VX]
T1T





M

T0C8V-E
F4Z(#$P<'0[)SXF(S$V,#L@/]T9#X\=&0@=F%L:6=N/3-$=&]P



M
#L@/]T9#X\=&0@86QI9VX],T1R:6=H=!V86QI9VX]

M
T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@
G!X('-O;&ED.R!W:61T:#H@.24[

M=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!M

38P.R@W+#DS




T0G=VED=&@Z(#$E


3!P=#LG/B8C


@;F5W(')O;6%N.R!M87)G:6XM;&5F
M=#H@


M)B

M:61T:#H@


Q-C`[(#PO=&0^/'1D




M

#LH-RPY
S`L
S
R*3PO

M




M)SXF(S$V













@;F5W(')O;6%N.R!F;VYT+7-I




@;F5W(')O;6%N.R!F;VYT



@;F5W(')O;6%N.R!F



M969T.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N
M=US:7IE.B`Q

M3&EA8FEL:71I97


T0G=VED=&@Z(#DE.R!D:7-P;&%Y


3!P=#LG/B8C


T0G=VED=&@Z(#DE.R!D:7-P


3!P=#LG/B8C


T0G=VED=&@Z(#DE.R!D


3!P=#LG/B8C


T0G=VED=&@Z(#DE


3!P=#LG/B8C


T0G=VED=&@Z


3!P=#LG/B8C
38P.R`\+W1D/CPO='(^/'1R
M(&)G8V]L;W(]
T1W:&ET93X\=&0@86QI9VX]



@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@
M


3(O
M
S$O
3




'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R
M9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q

M(#!P=#LG/B8C


M9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T

38P.R0M/]D:78^/]T9#X\=&0@




#L@/]T9#X\=&0@86QI9VX],T1R:6=H=!V86QI9VX]
M

T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@-'!X(&1O=6)L




#LD+3PO9&EV

24[(&1I







@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@
M


Q



Q-C`[(#PO=&0^



@;F5W(')O;6%N
M.R!M87)G:6XM;&5F=#H@

M:6=H=#H@




@3F5W(%)O
M;6%N.R!M87)G:6XM;&5F=#H@

M;BUR:6=H=#H@
'!T.R!T97AT+61E8V]R871I;VXZ('5N9&5R;&EN93LG/D%C

3H@8FQO8VL[(&UA<F=I;BUL


Q-C`[/]D:78^/&1I
M=B!S='EL93TS1=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@
M
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ(%1I;65S($YE=R!2
M;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!M87)G





@9F5A='5R97
N(%1H92!#;VUP86YY(&-L
M87-S:69I97




M='5R97




M=&EO;B!D871E(&%N9!A;6]U;G0@87)E(&%C8V]U;G1E9!F;W(@87
@;&EA
M8FEL:71I97








T0G


'!T

Q-C`[/]D:78^/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!J=7-T
M:69Y.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF
M86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N
M=US:7IE.B`Q


M(S$V
#LF(S$V

M97-P96-T:79E;'DN/]D:78^/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!J
M=7-T:69Y.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R

#L\+V1I


@
M3F5W(%)O;6%N.R!M87)G:6XM;&5F=#H@


'!T.R!T97AT+61E8V]R871I;VXZ('5N9&5R;&EN




M:6=H=#H@

Q-C`[/]D:78^/&1I=B!S='EL93TS1=T97AT+6%L
M:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@9F]N=UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@;6%R9VEN+6QE9G0Z
M(#!P=#L@9F]N=US:7IE.B`Q





M:&5R92!T:&4@:&]L9&5R(&ES(&5N=&ET;&5D('1O(&5X97)C:7-E('9I82!A


@

@86YD(&]P=&EO;G
@;VX@82!N970@8F%S
M:7
N/]D:78^/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!J=7-T:69Y.R!T
M97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z

#L\+V1I=CX\9&EV('-T


@3F5W(%)O;6%N.R!M
M87)G:6XM;&5F=#H@

M=#H@
'!T.R!T97AT+61E8V]R871I;VXZ('5N9&5R;&EN93LG/E-T;V-K+4)A




M97









2P@
C`Q
R!A;F0@
C`Q


3H@8FQO8VL[(&UA<F=I;BUL969T


Q-C`[/]D:78^/&1I=B!S
M='EL93TS1=T97AT+6%L:6=N.B!L969T.R!T97AT+6EN9&5N=#H@
'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@
M;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q





N(%1H92!#

M
!L:6YE(&]F(&-R961I=!T;R!T:&4@=F5N9&]R(&%T(&$@-2XU)2!I;G1E

@




Q-C`[
M/]D:78^/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT
M+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ(%1I
M;65S($YE=R!2;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
M



M:7

@

N($EN=&5R97-T(&]N('1H92!O=71S=&%N

M(&%N9!C87!I=&%L:7IE9!T;R!T:&4@;&5T=&5R(&]F(&-R961I=!A8V-O
M=6YT+!A;F0@=VEL;!B92!R96%L:7IE9!W:71H(&9U='5R92!D:7-C;W5N
M='
@87



M(S$V
#LF(S$V

30L($%V96MA





'0M86QI9VXZ(&IU
M<W1I9GD[(&9O;G0M<W1Y;&4Z(&ET86QI8SL@=&5X=UI;F1E;G0Z(#!P=#L@


3!P=#L@;6%R9VEN+7)I

M3W5T(&]F($%C8W5M=6QA=&5D($]T:&5R($-O;7!R96AE;G-I=F4@26YC;VUE
M/]D:78^/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT
M+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P


'0M:6YD96YT.B`P<'0[(&1I

@3F5W(%)O;6%N.R!M
M87)G:6XM;&5F=#H@

M=#H@

C`Q
RP@=&AE($9!4T(@:7-S=65D(&%N




M:69I960@=&\@;F5T(&EN8V]M92!I;B!I='
@96YT:7)E='D@:6X@=&AE('-A

M86EN(&-O;F1I=&EO;G


M(&EN=&%N9VEB;&4@87-S970@:7


@;F]T(&5L96-T960@96%R





3!P=#L@;6%R9VEN+7)I9VAT.B`P
!96YE



M:69Y.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN

#L\+V1I=CX\


@3F5W
M(%)O;6%N.R!M87)G:6XM;&5F=#H@










N/]D:78^/&1I=B!S='EL93TS1=T
M97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y

M)SXF(S$V





@=&AA;B!I='







M95\U.65A
#(R



M87-C:6DB#0H-CQH=&UL/@T*(`\:&5A9#X-B`@(`\3454


T1T97AT+VIA=F%S

@0V]M


]


]

M86QI9VX]



T1T;W`^24Y614Y4
M3U)9/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL

F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R!M
M87)G:6XM<FEG:'0Z(#!P=#LG/DY/5$4@-`F(S@R
3$[($E.5D5.5$]263PO





T1T




M(S$V

M;&4]
T0G=&5X=UA;&EG;CH@8V5N=&5R.R!T97AT+6EN9&5N=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@




M



M97
@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@




M9'1H.B`Q

M97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE
M.B`Q

38P.R0R-RPU-S4\+V1I



M='EL93TS1=T97AT+6%L:6=N.B!R:6=H=#L@=&5X=UI;F1E;G0Z(#!P=#L@


3!P=#L@;6%R9VEN+7)I

#LD-#(L.#







#LX

M:#H@


Q-C`[(#PO=&0^/'1D(&%L

24[

M=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!M



T1L969T('9A;&EG





M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N


3$E



3!P=#L@

#LT-S4L
C4U/]D:78^/]T9#X\


@;F5W(')O;6%N.R!F;VYT+7-I

#L@/]T9#X\=&0@86QI9VX],T1R:6=H=!V86QI
M9VX]


T0G


M




M)SXF(S$V



M93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE.B`Q
M





@;F5W(')O;6%N.R!F;VYT+7-I

#L@/]T9#X\=&0@86QI9VX],T1R:6=H=!V86QI
M9VX]

T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@-'!X(&1O






M93TS1=T97AT+6%L:6=N.B!R:6=H=#L@=&5X=UI;F1E;G0Z(#!P=#L@9&ES


3!P=#L@;6%R9VEN+7)I9VAT

#LD-#8Y+#
P





@3F5W(%)O;6%N.R!M87)G:6XM
M;&5F=#H@

'!T



F(Y7V(W
M-F%?-&5C85]A9#9E7S4Y96$P







]



]
T1T:#Y$96
N(#



M;&4]




T1T

T0G=VED=&@Z(#



M(S$V


M=&5R.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N
M=US:7IE.B`Q
'!T.R!F;VYT+7=E:6=H=#H@8F]L9#L@;6%R9VEN+7)I9VAT

B\S
2\Q



Q-C`[






3(O
S$O
3(\+V1I=CX\+W1D/CPO
M='(^/'1R(&)G8V]L;W(]

'0M:6YD96YT.B`P<'0[(&1I<W!L87DZ

@;F5W(')O;6%N.R!M87)G:6XM
M;&5F=#H@

'!T





M9VX]

T0G=VED=&@Z(#(E.R!D:7-P;&%Y.B!I;FQI;F4[

3!P
M=#LG/B8C



T0G=VED=&@Z(#
T

T0G=&5X=UA;&EG;CH@;&5F=#L@=&5X=UI;F1E


3!P=#L@



@;F5W(')O;6%N

#L@/]T9#X\=&0@86QI9VX],T1R
M:6=H=!V86QI9VX]

T0G=VED=&@Z(#$Q)3LG/CQD:78@





@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@
'!T.R!F


BPY
#0L
3@X

M9VX]


M/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!L969T.R!T97AT+6EN9&5N=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R


Q-C`[(#PO=&0^/'1D(&%L:6=N

24[)SX\

M
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!M87)G






#
L
3@R



T0G
M=VED=&@Z(#0E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE

3!P=#LG/B8C
38P.R`\+W1D/CQT



@;F5W(')O;6%N.R!M87)G:6XM;&5F
M=#H@


M


S0E.R!D:7-P;&%Y


3!P=#LG/B8C

M:61T:#H@


M93H@

3`L


B4[(&1I




24[)SX\9&EV('-T

'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q

M:'0Z(#!P=#LG/B0Q


M;&4]
T0G=VED=&@Z(#





M9!D97!R96-I871I;VX\+V1I=CX\+W1D/CQT9!V86QI9VX]

M;&4]
T0G=VED=&@Z(#0E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY

3!P=#LG/B8C
38P.R`\



T0G=VED=&@Z(#(E.R!D


3!P=#LG/B8C

F4Z(#$P<'0[(&UA<F=I;BUR:6=H=#H@,'!T.R<^4')O<&5R
M='D@86YD(&5Q=6EP;65N=P@;F5T/]D:78^/]T9#X\=&0@=F%L:6=N/3-$



M(S$V
#L@/]T9#X\=&0@86QI9VX],T1R:6=H=!V86QI9VX]

M;&4]
T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@-'!X(&1O=6)L93L@=VED=&@Z


M;W5B;&4[('=I9'1H.B`Q

M(')I9VAT.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N
M=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@
M9F]N=US:7IE.B`Q


M8VL[)SXF(S$V



@3F5W(%)O;6%N.R!M87)G:6XM;&5F=#H@
'!T.R!F



#$S(&%N9`R,#$R+!R97-P

M970@8F]O:R!V86QU92!O9B`D



M+#

3`L

M;V8@)#0Y+#$P


F(Y7V(W-F%?-&5C85]A
M9#9E7S4Y96$P






]

T1)1#!%344^#0H@(`@(`\='(^#0H@



#$S/&)R/CPO=&@^#0H@(`@(`\




]

@
M3F5W(%)O;6%N)RP@5&EM97



@3F5W(%)O
M;6%N.R!M87)G:6XM;&5F=#H@


M
3$[($Y/5$4@4D5#14E604)



M97-S:6YG+!,3$,@*8C.#(R
#M!3E`F(S@R





38P.R8C
38P.R8C
38P.R8C
38P.U!R


@;V8@-#`L


#`L


M8W1I;VX@=F]L=6UE('1O('!O=&5N=&EA;&QY(&%S(&UU8V@@87
@
2PP
#`L
M


#`@;&EN


Q-C`[)B
Q-C`[5&AE(&QI;F4@;V8@8W)E


@=VAI8V@@97AC;'5D97
2!N;W0@9')A=R!D;W=N(&]N('1H92!L:6YE(&]F(&-R
M961I=!M;W)E('1H86X@)#<U+#`P





#`@=&AE($-O;7!A;GD@




M(S@R

M(&%S('=E;&P@87

#$S('=E(&%D=F%N8V5D
M(&$@=&]T86P@;V8@)#4P


#$T('1H





M86YC97



M-S9A7S1E8V%?860V95\U.65A
#(R

M;G0]

2!R





]
T1R93X-B`@(`@



M:7IE.B`Q





M=#H@

38P.SPO9&EV/CQD:78@



M:6=H=#H@





M9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE.B`Q
'!T



24[)SX\9&EV



3(O
S$O
3
\+V1I

T1T

T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@
G!X('-O;&ED.R!W
M:61T:#H@

M97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE
M.B`Q






M(S$V


M=&EM97

#L@/]T
M9#X\=&0@86QI9VX],T1R:6=H=!V86QI9VX]

T0G=VED



24[

M=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!M

38P.S$P
BPP
#`\+V1I=CX\+W1D/CQT






M)SXF(S$V
#LQ
3`L

M(V-C965F9CX\=&0@86QI9VX]



M9VX]


T0G




@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@
'!T.R!F;VYT+7-I


Q-C`[




3!P=#LG
M/B8C
F4Z(#$P<'0[)SXF(S$V,#L@/]T9#X\=&0@=F%L










M/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!R:6=H=#L@=&5X=UI;F1E;G0Z


3!P=#L@;6%R

#LD
3DT+#$T-#PO9&EV/CPO=&0^/'1D


M;&EN93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE
M.B`Q



M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N


C!F
M


M;G0]

2!R




S$L(#(P
M
3



M24)
12!.3U1%4R!005E!0DQ%/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$

'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@
M;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!F;VYT+7=E:6=H

3$[0T].



#$R($-/3E9%4E1)0DQ%($Y/5$53/]D:78^/&1I=B!S
M='EL93TS1=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@
'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I




@3F5W(%)O;6%N.R!M87)G:6XM;&5F=#H@
M




X




#M.;W1E)B
X
C(Q.R!A;F0@8V]L
M;&5C=&EV96QY('1H92`F(S@R
C`[3F]T97
F(S@R

M='

#`L
#`P

#M#;VUM;VX@4W1O8VLF(S@R
C$[*2XF(S$V
#LF(S$V
M




F
M(S@R

@;V8@;W5R($-O;6UO;B!3=&]C:RXF
M(S$V
#LF(S$V

3@E*2!P97(@86YN=6TN)B
Q-C`[)B
Q-C`[071T86-H


M:&%R97


38P
M.R8C



M86QC=6QA=&5D('5S:6YG('1H92!;&%C:R!38VAO;&5S(&UO9&5L(&%N9!W
M87


@;VX@=&AE(&=R86YT(&1A=&5S(&]F(0P+C4Y(&%N9`D
M





#`L
#`P


M8VLN)B
Q-C`[)B
Q-C`[07
@;V8@1&5C96UB97(@
S$L(#(P
3(L('1H92!#





C!F
#=F#0I#
M;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T
Z+S=F.&$W
F(Y7V(W-F%?-&5C
M85]A9#9E7S4Y96$P

34N:'1M;`T*


M:G


M9#TS1$E$



M
S$L(#(P
3



]








M=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R




@3F5W(%)O;6%N.R!M87)G:6XM
M;&5F=#H@

'!T

3(L('1H92!#;VUP86YY(&5N=&5R960@:6YT;R!A;B!A



M9B!397)I97

RPS
C8L-CDW/&9O


M9#LG/B8C
38P.SPO9F]N=#YS:&%R97
@;V8@=&AE($-O;7!A;GDF(S@R




M3$
N)B
Q-C`[)B








38P
M.R8C
38P.S$Q+#4X
BPY.#
\9F]N=!S='EL93TS1=D:7-P;&%Y.B!I;FQI


2XU
M







M1&5C96UB97(@
S$L(#(P
3(N(%1H92!V86QU92!R96-L87-S:69I960@=&\@


M;'5E(&]F('1H92!S:&%R97

S@@8F%S960@

RPS
C8L-CDW(&%N9!A(')E;6%I;FEN
M9R!D:7-C;W5N=!O9B`D
2PQ-CDL-#4Y+B!&=7)T:&5R;6]R92P@=&AE(&%C
M8W)U960@9&EV:61E;F1S(')E;&%T:6YG('1O('1H92!397)I97
@24D@0V]N

M960@=&\@4W1O8VMH;VQD97)S)B
X

@;V8@1&5C96UB
M97(@
S$L(#(P
3(N)B
Q-C`[)B

M;G



M;G1O(#
L.#4Y+#8Y-R!S:&%R97
@;V8@=&AE($-O;7!A;GDF(S@R

M;VUM;VX@4W1O8VLN)B
Q-C`[)B
Q-C`[07
@;V8@36%R8V@@
S$L(#(P
3
@


Q-C`[)B
Q-C`[5&AE('9A;'5E(&]F('1H
M92!397)I97






M=&]C:R!C;VYV97)T960@:6YT;R!#;VUM;VX@4W1O8VL@:6X@
C`Q
CPO9&EV




3!P=#L@

34L(#(P
3(L($)R:6=H
M=&QI;F4@5F5N='5R97
@22!C;VYV97)T960@)#DP-RPQ
C`@*&EN8VQU9&EN



Q
M-C`[)B


T+#@P

T+#@P
M

@;V8@=&AE
M($-O;7!A;GDF(S@R

'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT




@3F5W(%)O;6%N.R!M87)G:6XM;&5F=#H@
'!T


M96UB97(@-RP@
C`Q


@;V8@=&AE($-O;7!A;GDF(S@R

M;VUM;VX@4W1O8VLN/]D:78^/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!J
M=7-T:69Y.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R

#L\+V1I


@
M3F5W(%)O;6%N.R!M87)G:6XM;&5F=#H@



3$L(#(P
3(L('1H
M92!#;VUP86YY)B
X
C$W.W





M
R!S:&%R97
@;V8@=&AE($-O;7!A;GDF(S@R


38P.R8C
38P.U1H92!A9V=R96=A

M
38P.R8C



M('1W96QV92!M;VYT:'
@96YD960@1&5C96UB97(@
S$L(#(P
3(N/]D:78^
M/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N
M=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R




@3F5W(%)O;6%N.R!M87)G:6XM
M;&5F=#H@

'!T

34L(#(P

M9`D,CDP+#`P,`H:6YC;'5D:6YG(&%C8W)U960@9&EV:61E;F1S*2!O9B!3
M97)I97

M8VL@:6YT;R`R.3`L



M87)G:6XM;&5F=#H@

38P.SPO




3!P

3
L(#(P
3(L('1H







@8F%S:7

@;V8@=&AE($-O;7!A;GDF(S@R

@

M;R!P=7)C:&%S92!A;B!A9V=R96=A=&4@;V8F(S$V
#LF(S$V
#LR+#@U.2PS





2P@
C`Q






@)#(L
34W+#(S.!B87-E9!O;B!A(&=R;W-S

M9&5N9'



38P.R8C
38P.U1H97-E





2P@
C`Q



F(Y7V(W-F%?-&5C85]A9#9E7S4Y96$P
C(P



]
T1R



]
M
T1T:#Y$96
N(#
Q+`R,#$S/&)R/CPO=&@^#0H@(`@(`\+W1R/@T*(`@




]
M

@3F5W
M(%)O;6%N)RP@5&EM97



@3F5W(%)O;6%N
M.R!M87)G:6XM;&5F=#H@


3`@+2!
25%5
M241!5$5$($1!34%'15


M87)G:6XM;&5F=#H@

38P.SPO




3!P


@;V8@=&AE($-O;7!A;GDF(S@R


#`X('1H92!#;VUP86YY(&5N=&5R

@*'1H92`F
M(S@R
C`[4E)!)B
X






M;B!S=&%T96UE;G0@;VX@1&5C96UB97(@
30L(#(P
#DN($AO=V5V97(L('1H

@
M9FEL960@;VX@2G5N92`R+`R,#$Q+!A;F0@=V5N=!E9F9E8W1I=F4@;VX@
M2G5N92`S+`R
#$Q+B8C
38P.R8C





#LF(S$V
#M792!O



L('1H92!A;6]U;G0@;V8@)#
V+#$W

L

M


;V-A=&EO;CH@9FEL93HO+R]#.B\W9CAA-S)B
M.5]B-S9A7S1E8V%?860V95\U.65A
#(R




M97%U:78]


]


T0Q(')O=W-P86X]

M1$52259!5$E612!


]





]


]

M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97



M+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@9F]N=UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@;6%R9VEN+6QE
M9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!F;VYT+7=E:6=H=#H@8F]L9#L@



#$P*2!H

@=&\@=&AE(&5X97)C:7-E('!R:6-E(&EF

M97




M9FEN86YC:6%L('-T871E;65N='
N/]D:78^/&1I=B!S='EL93TS1=T97AT
M+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B

M(S$V



@3F5W(%)O;6%N.R!M87)G:6XM;&5F=#H@
'!T.R!F;VYT+7-I


M;&EA8FEL:71I97

C4L
S@Q(&%T($1E8V5M8F5R(#
Q+`R,#$R
M+B8C,38P.R8C,38P.U1H92!G86EN(')E8V]G;FEZ960@9'5R:6YG('1H92!T
M=V5L=F4@;6]N=&AS(&5N9&5D($1E8V5M8F5R(#,Q+`R



#$S+!A9&1I=&EO;F%L('!A:60@:6X@8V%P:71A;!I;F-R96%S








'!T.R!M87)G


T0G=&5X




M)SY4:&4@87-S=6UP=&EO;G

M87(@96YD960@1&5C96UB97(@
S$L(#(P
3
@:6YC;'5D960@=&AE(&-L;W-I






M(#$X




'0M86QI9VXZ(&-E;G1E<CL@=&5X=UI;F1E;G0Z

M;BUR:6=H=#H@

Q-C`[/]D:78^/&1I=B!S='EL93TS1=T97AT
M+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B



!S='EL93TS
M1=W:61T:#H@
3`P)3L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9F]N=US:7IE.B`Q



@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@
'!T.R!F;VYT





T0G=VED=&@Z(#


@;F5W(')O;6%N.R!F;VYT+7-I






T0G=VED
M=&@Z(#

@


T0G=&5X=UA;&EG
M;CH@8V5N=&5R.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P







T0G=VED=&@Z(#$Q




M969T.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N
M=US:7IE.B`Q


@9F]R/]D:78^/]T9#X\=&0@=F%L:6=N/3-$


M=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE.B`Q

M)B

M


Q-C`[(#PO=&0^/'1D('9A;&EG

3$E.R!D:7-P;&%Y.B!I;FQI;F4[

3!P
M=#LG/B8C
38P.R`\+W1D/CPO='(^/'1R(&)G8V]L;W(]
T0C8V-E969F/CQT


@
M;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@



Q-C`[)B
Q-C`[8V]N=F5R=&EB;&4@


T0G=VED=&@Z(#$Q)3LG/CQD




M/3-$)W=I9'1H.B`Q


Q-C`[(#PO


M87DZ(&EN;&EN93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N
M=US:7IE.B`Q


3$E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M

3!P=#LG/B8C
38P
M.R`\+W1D/CPO='(^/'1R(&)G8V]L;W(]



@;F5W(')O;6%N
M.R!M87)G:6XM;&5F=#H@

M:6=H=#H@


M=&0@86QI9VX]


@;F5W(')O;6%N
M.R!M87)G:6XM;&5F=#H@

M:6=H=#H@

Q-C`[)#@L
#(U+#
X


T0G
M=VED=&@Z(#

M97




M/3-$)W=I9'1H.B`S
F4Z(#$P<'0[(&UA<F=I;BUR:6=H=#H@,'!T.R<^0F5G:6YN:6YG(&)A
M;&%N8V4\+V1I=CX\+W1D/CQT9!A;&EG;CTS1')I9VAT('9A;&EG;CTS1'1O





M

M9#X\=&0@86QI9VX]

3H@
M=&EM97
@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@



Q-C`[)#$Q+#`S
2PT
S(\
M+V1I=CX\+W1D/CPO='(^/'1R(&)G8V]L;W(]
T1W:&ET93X\=&0@86QI9VX]
M


M=B!S='EL93TS1=T97AT+6%L:6=N.B!L969T.R!T97AT+6EN9&5N=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA






M(S$V

M:61T:#H@


M93H@

#LQ+#4Q-PQ-38\
M+V1I=CX\+W1D/CPO='(^/'1R(&)G8V]L;W(],T0C8V-E969F/CQT9!A;&EG






S`E.R!D:7-P;&%Y


3!P=#LG/B8C


@;F5W(')O;6%N.R!F




T0G=VED=&@Z(#
P)3LG/CQD

T0G=&5X=UA;&EG;CH@;&5F=#L@=&5X=UI;F1E;G0Z(#!P


3!P=#L@;6%R9VEN





M
T0G=VED=&@Z(#(E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T

3!P=#LG/B8C
38P.R`\+W1D

C4L
S@Q/]D:78^/]T9#X\+W1R
M/CPO=&%B;&4^/]D:78^/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!C96YT

M;&5F=#H@

38P.SPO9&EV/CQD






#LF(S$V




2PV.#@@

N/]D:78^/&1I=B!S='EL93TS1=T
M97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y

M)SXF(S$V



@3F5W(%)O;6%N.R!M87)G:6XM;&5F=#H@
'!T.R!F;VYT


@82!R97-U;'0@
M;V8@=&AE($%U9W5S=`R,P@
C`Q

M=&QI;F4@5F5N='5R97





@=&\@)#$N






2XU





BPS-S8L
#`Y


M)#$N









Q-C`[)B


M-BPW


S$L(#(P
3
N/]D
M:78^/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN
M9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@




@3F5W(%)O;6%N.R!M87)G
M:6XM;&5F=#H@

M



#LF(S$V




2PY
3
@;VX@=&AE(&5X97)C:7-E(&1A=&5S+B8C
38P
M.R8C










M85\T96-A7V%D-F5?-3EE83`R
C!F









3XQ
B!-;VYT:'

2P@
M
C`Q

]



]


'!T



M:78^/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!L969T.R!T97AT+6EN9&5N
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ(%1I;65S($YE

M)SY#3TU-3TX@4U1/0TL@25-3545$($9/4B!315)624-%4R!)3B`R
#$R/]D
M:78^/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!L969T.R!T97AT+6EN9&5N
M=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R



@3F5W(%)O;6%N.R!M87)G:6XM
M;&5F=#H@

'!T

C`Q

C
X
M+#@P


@1V%R9FEN:VQE(&%N
F5D(&$@
M=&]T86P@;V8@97AP96YS92!O9B`D,38P+#`P,!R96QA=&5D('1O('1H97-E

#LF(S$V
#M4:&5S92!S:&%R97
@=V5R92!V86QU

M=&4N/]D:78^/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!J=7-T:69Y.R!T
M97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z



@3F5W(%)O;6%N
M.R!M87)G:6XM;&5F=#H@

M:6=H=#H@










34P+#`P


M;G0L(&%S('=E;&P@87
@)#$P+#`P

#LF(S$V
#M!;B!A9&1I=&EO
M;F%L(#
U



M:6YG(&$@;6EN:6UU;2!O9B`D
3`@;6EL;&EO;BXF(S$V
#LF(S$V
#M.;R!S


T0G=&5X



M)B
Q-C`[/]D:78^/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!J=7-T:69Y
M.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI
M;'DZ(%1I;65S($YE=R!2;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US
M:7IE.B`Q


M=&AE(&YO;BUP=6)L:6
@;6%N;F5R(&EN('=H:6-H('=E(&]F9F5R960@=&AE
M('-E8W5R:71I97
@86YD(&]N('1H92!R97!R97-E;G1A=&EO;G
@;V8@=&AE


L('=H:6-H(&EN

B('=I=&AI;B!T:&4@;65A;FEN
M9R!O9B!2=6QE(#4P







M=B!S='EL93TS1=T97AT+6%L:6=N.B!L969T.R!T97AT+6EN9&5N=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ(%1I;65S($YE=R!2;VUA

M3TX@4U1/0TL@25-3545$($9/4B!315)624-%4R!)3B`R
#$S/]D:78^/&1I
M=B!S='EL93TS1=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@
M
'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN



@3F5W(%)O;6%N.R!M87)G:6XM;&5F
M=#H@



BP@
C`Q

3$T+#DT


#`L

M8V5S+B8C
38P.R8C



'!T.R!M


T0G



3!P=#L@;6%R9VEN+7)I9VAT.B`P


3$


38P.R8C
38P.U1H92!#;VUP


2P@

#$S

@=&AE(&%G


#LF(S$V



M8VL@87



Q+`R
M,#$U+B8C,38P.R8C,38P.U1H92!#;VUM;VX@4W1O8VL@=V%S('9A;'5E9!A


M='EL93TS1=T97AT+6%L:6=N.B!L969T.R!T97AT+6EN9&5N=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@

M4U1/0TL@25-3545$($9/4B!$14)4($-/3E9%4E-)3TX\+V1I=CX\9&EV('-T



M:'0Z(#!P=#LG/B8C






2PU
#@L
#`P


P
PP,#`@86YD(&EN=&5R97-T(&]F(0R
#@L
#`P
M+B8C
38P.R8C




#$R


3(P+#`P






C`P+#`P

@1D]2($-!4T@\+V1I


'!T.R!M

T0G



3!P=#L@;6%R9VEN+7)I9VAT.B`P

C`Q




@;V8@=&AE
M($-O;7!A;GDF(S@R

Q-C`[)B
Q-C`[5&AE





C`Q
SL@:70@86QS;R!R

#$S

BPQ.34L

M;VUP86YY+B8C
38P.R8C
38P.R8C

@




M;VQA=&EL:71Y(&]F('1H92!#;VUP86YY)B
X
C$W.W

M870@



M9B`N

3H@8FQO8VL[(&UA<F=I;BUL


Q-C`[/]D:78^/&1I
M=B!S='EL93TS1=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@
M
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ(%1I;65S($YE=R!2
M;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!M87)G

3
L(&EN(&%D9&ET:6]N
M('1O('1H92!W87)R86YT(&5X97)C:7-E('!R;V=R86T@9&5S8W)I8F5D(&%B

M-S



M93H@

#L\+V1I=CX\9&EV


@3F5W(%)O
M;6%N.R!M87)G:6XM;&5F=#H@

M;BUR:6=H=#H@

3(L(#0Y

C4N/]D
M:78^/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN
M9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@

38P.SPO9&EV/CQD:78^0T]-



X

X
C(Q.RD@=VET


2XU

@=V5R92!R;W5N9&5D

M92!H;VQD97)S(&]F('1H92`D
2XU

M(&%N9!P;W1E;G1I86P@8V%P:71A;UR86ES:6YG(&%C=&EV:71I97
@*&]T

M(&]F('1H92`D
2XU






2XU

@;V8@8V]M;6]N('-T;V-K
M*2XF(S$V
#LF(S$V

@
M;VX@97%U:71Y(&UO9&EF:6-A=&EO;B!O9B`D.3DP+#8U-B8C.#(Q
CMT:&4@
M9&EF9F5R96YC92!I;B!V86QU92!B971W965N('1H92`D
2XU

S`L(#(P
M
3
N/]D:78^/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!J=7-T:69Y.R!T
M97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z



@3F5W(%)O;6%N
M.R!M87)G:6XM;&5F=#H@

M:6=H=#H@

@82!R97-U;'0@;V8@=&AE($%U9W5S=`R,P@
C`Q
M







M='
@=&\@)#$N



@

2XU

@=&AA=!W97)E(&YO=!E


M;B!A9V=R96=A=&4@;V8@
BPS-S8L

@










M


M;&4]


M=#H@

Q-C`[/]D:78^/&1I=B!S='EL93TS1=T97AT+6%L:6=N
M.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M9F]N=UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@;6%R9VEN+6QE9G0Z(#!P
M=#L@9F]N=US:7IE.B`Q

M9R`R





Q-C`[/]D
M:78^/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!L969T.R!T97AT+6EN9&5N
M=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ(%1I;65S($YE
M=R!2;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!M

&5R8VES960@.3$L-#`P('-T;V-K(&]P=&EO;G,@86YD('1H
M92!#;VUP86YY(')E8V5I=F5D('!R;V-E961S(&]F(0W-RPW
S0N/]D:78^
M/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N
M=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R




@3F5W(%)O;6%N.R!M87)G:6XM
M;&5F=#H@

'!T

3(L(#$T+#8P


M87DZ(&)L;V-K.R!M87)G:6XM;&5F=#H@

M=#LG/B8C








S$L


N/]D:78^/&1I
M=B!S='EL93TS1=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@
M
'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN




@3F5W(%)O;6%N.R!M87)G:6XM;&5F
M=#H@

'!T.R!T
M97AT+61E8V]R871I;VXZ('5N9&5R;&EN93LG/D-/34U/3B!35$]#2R!)4U-5
M140@24X@4%))5D%412!03$%#14U%3E13/]D:78^/&1I=B!S='EL93TS1=T
M97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y

M)SXF(S$V



@3F5W(%)O;6%N.R!M87)G:6XM;&5F=#H@
'!T.R!F;VYT




L
M($Q


M:&%R92`H=&AE(8C.#(R,#LQ+C(U(%)A:7-E)B,X,C(Q.RDL(&%N9!R96-E




M:'0Z(#!P=#LG/B8C





M97!T96UB97(@
3@L(#(P
3
L('1H92!#;VUP86YY(&5N=&5R960@:6YT;R!A


M:&%R92`H=&AE(8C.#(R,#LQ+C`U(%)A:7-E)B,X,C(Q.RDL(&%N9!R96-E

#LF(S$V
#M4


#4@

M.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE

#L\+V1I=CX\9&EV


@3F5W(%)O
M;6%N.R!M87)G:6XM;&5F=#H@

M;BUR:6=H=#H@
'!T.R!T97AT+61E8V]R871I;VXZ('5N9&5R;&EN93LG/D-/
M34U/3B!35$]#2R!)4U-5140@24X@4%53$E#($]&1D5224Y'/]D:78^/&1I





M(S$V
#LF(S$V






38P.R8C

M=6QT(&]F('1H:7

@;V8@0V]M;6]N(%-T;V-K('1O('1H:7

Q
M-C`[)B
Q-C`[07
@;V8@1&5C96UB97(@
S$L(#(P
3(L('1H92!#;VUP86YY



12!0


M87)G:6XM;&5F=#H@

38P.SPO




3!P



M97-P96-T:79E(&UA='5R:71Y+B8C
38P.R8C

M('1H:7
@;6]D:69I8V%T:6]N('1H92!#;VYV97)T:6)L92P@4F5D965M86)L


S
L
#`P(&]F(&%C8W)U960@9&EV

M;VUP86YY)B
X
C$W.W









M4D%.5%



]

]
T1T97AT

M=&]P/E-43T-+($]05$E/3B!03$%.($%.1!705)204Y44SPO=&0^#0H@(`@


M97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z



@3F5W(%)O;6%N.R!M87)G:6XM;&5F=#H@
M


3
@)B
X
C$Q.R!35$]#2R!/4%1)3TX@
M4$Q!3B!!3D0@5T%24D%.5%


M.R!M87)G:6XM;&5F=#H@

38P

T0G=&5X=UA;&EG;CH@;&5F=#L@=&5X=UI


3!P



2P@
C`Q
M


@=V5R92!E





#LF(S$V
#LF(S$V
#LF(S$V
#M);B`R
#$R

3DX+#8V
R!S:&%R97
@;V8@



N)B
Q-C`[)B

C`Q
BP@
30L-C`P('-T
M;V-K(&]P=&EO;G

M($-O;7!A;GD@:7-S=65D(#$S





'!T.R!M87)G


T0G=&5X





@:7-S
M=65D(&)Y('1H92!#;VUP86YY(&%S(&]F($1E8V5M8F5R(#
Q+`R,#$S(&%N
M9`R

M

T0G=VED
M=&@Z(#$P





3(O
S$O
M
3


T0G8F]R9&5R+6)O='1O
M;3H@8FQA8VL@
G!X('-O;&ED.R!W:61T:#H@.24[(&9O;G0M9F%M:6QY.B!T

3!P=#LG/B8C
38P.R`\+W1D


M;&4]
T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@
G!X('-O;&ED.R!W:61T:#H@


3(O
M
S$O


T0G8F]R9&5R+6)O
M='1O;3H@8FQA8VL@
G!X('-O;&ED.R!W:61T:#H@.24[(&9O;G0M9F%M:6QY

3!P=#LG/B8C
38P.R`\
F4Z(#$P<'0[)SXF(S$V,#L@/]T9#X\=&0@=F%L






T0G=&5X=UA;&EG;CH@8V5N=&5R.R!T
M97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ

M
B!V86QI9VX]

T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@
M
G!X('-O;&ED.R!W:61T:#H@

B!V86QI9VX]

M;&4]
T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@
G!X('-O;&ED.R!W:61T:#H@
M


M+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
M


M97AT+6%L:6=N.B!L969T.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE
M9G0Z(#!P=#L@9F]N=US:7IE.B`Q

M/D]U='-T86YD:6YG(&%T(&)E9VEN;FEN9R!O9B!Y96%R/]D:78^/]T9#X\


@;F5W(')O;6%N.R!F;VYT+7-I

#L@/]T9#X\=&0@86QI9VX],T1R:6=H=!V86QI
M9VX]


T0G




@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@
'!T.R!F;VYT


Q-C`[)#$N-#8\



'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!M87)G:6XM




M86QI9VXZ(')I9VAT.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z
M(#!P=#L@9F]N=US:7IE.B`Q

M




@;F5W(')O;6%N.R!M87)G:6XM;&5F
M=#H@


M)B





@;F5W(')O;6%N.R!M
M87)G:6XM;&5F=#H@

M=#H@

Q-C`[-C4P+#`P
#PO9&EV/CPO=&0^/'1D('9A;&EG;CTS


M=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE.B`Q

M)B




R4[


@;F5W
M(')O;6%N.R!M87)G:6XM;&5F=#H@







#L@/]T9#X\=&0@86QI9VX],T1R:6=H=!V86QI9VX]
T1T




M97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE
M.B`Q



@;F5W(')O;6%N.R!F

#L@/]T9#X\=&0@86QI9VX],T1R:6=H
M=!V86QI9VX]


M93TS1=T97AT+6%L:6=N.B!R:6=H=#L@=&5X=UI;F1E;G0Z(#!P=#L@9&ES


3!P=#L@;6%R9VEN+7)I9VAT

#LH-#DP+#0R-D\+V1I=CX\+W1D/CQT9!V86QI9VX]
M

T0G=VED=&@Z(#(E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O

3!P=#LG
M/B8C




T0G=VED=&@Z(#(S)3LG

T0G=&5X=UA;&EG;CH@;&5F=#L@=&5X=UI;F1E;G0Z


3!P=#L@;6%R

\+V1I=CX\+W1D






3!P=#L@;6%R9VEN+7)I9VAT.B`P




@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@
'!T.R!F


Q-C`[)#$N
M-#



M
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!M87)G

38P.R@S
S4L-30Q*3PO9&EV/CPO=&0^/'1D


M;&EN93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE
M.B`Q



T0G=&5X

M9'1H.B`R

3H@
M=&EM97
@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@



M9VX]


@;F5W
M(')O;6%N.R!M87)G:6XM;&5F=#H@



Q-C`[*#





Q-C`[(#PO




T1R


M('=I9'1H.B`Q



M9VX]

T0G=VED=&@Z(#DE.R!D:7-P;&%Y.B!I;FQI;F4[

3!P
M=#LG/B8C




'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R
M9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q

M(#!P=#LG/B8C
38P.S(S+#
Y
BPX


T0G=VED=&@Z


3!P=#LG/B8C
38P.R`\+W1D/CPO='(^/'1R
M(&)G8V]L;W(]
F4Z(#$P<'0[)SXF(S$V,#L@/]T9#X\


@;F5W(')O;6%N.R!F;VYT+7-I



Q-C`[(#PO


M87DZ(&EN;&EN93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N
M=US:7IE.B`Q



Q-C`[

B4[(&1I


Q-C`[(#PO=&0^/'1D('9A;&EG;CTS1'1O


Q

B4[


Q-C`[(#PO=&0^/'1D('9A;&EG;CTS

M=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE.B`Q

M)B


R4[)SX\


@;F5W(')O
M;6%N.R!M87)G:6XM;&5F=#H@

M;BUR:6=H=#H@


T0G=VED=&@Z(#(E.R!D


3!P=#LG/B8C








3H@
M=&EM97
@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@



Q-C`[)#$N-#8\+V1I=CX\
M+W1D/CPO='(^/'1R(&)G8V]L;W(]


@;F5W(')O


M9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE.B`Q
'!T


M:#H@


Q-C`[(#PO=&0^/'1D('9A

M93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE.B`Q
M


M:61T:#H@


Q-C`[(#PO=&0^/'1D

M;&EN93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE
M.B`Q




Q-C`[(#PO=&0^

M(&EN;&EN93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US
M:7IE.B`Q


M9'1H.B`R

3H@
M=&EM97
@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@






Q-C`[(#PO=&0^



'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!M87)G:6XM

38P.S$V+#8X.PR-C4\+V1I=CX\+W1D/CQT9!V
M86QI9VX]

T0G=VED=&@Z(#(E.R!D:7-P;&%Y.B!I;FQI

M
3!P=#LG/B8C


M=&0@86QI9VX]







3!P=#L@;6%R

2P@
C`Q
R!A;F0@
M
C`Q




M('-H87)E+B8C
38P.R8C



'!T.R!M87)G:6XM






M:&5R92!W97)E(#0L

C`Q
RXF
M(S$V
#LF(S$V

C`L(#(P
3
@=')A



BPS-S8L

M='




M92XF(S$V
#LF(S$V

C`Q
RP@






'!T.R!M87)G


T0G=&5X







S`L




38P.R8C




L-C0Q('5S

M)#0P+#4P.!A;F0@=V5R92!A='1A8VAE9!T;R!D96)T+B!4:&5S92!W87)R


M;VX@;V8@=&AE(')E;&%T960@;F]T97
@:6X@
C`Q
BX@5&AE(&]T:&5R('!O

@97%U86P@=&\@-34P+#`P


M9&5D($1E8V5M8F5R(#


38P.SPO9&EV/CQD:78^4U1/0TL@3U!424].(%!


M;&5F=#H@

38P.SPO9&EV/CQD




3!P=#L@;6%R


@


C
E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY

3!P=#LG/B8C
38P.R`\

M
R!V86QI9VX]

T0G8F]R9&5R+6)O='1O;3H@8FQA
M8VL@
G!X('-O;&ED.R!W:61T:#H@

@=F%L:6=N/3-$

M=&5R.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N
M=US:7IE.B`Q
'!T.R!F;VYT+7=E:6=H=#H@8F]L9#L@;6%R9VEN+7)I9VAT

B\S
2\Q

C
E.R!D:7-P;&%Y.B!I;FQI

M
3!P=#LG/B8C


T0G8F]R9&5R+6)O='1O;3H@
M8FQA8VL@
G!X('-O;&ED.R!W:61T:#H@


T0G=VED=&@Z(#(E.R!D


3!P=#LG/B8C
3H@8FQO8VL[(&9O;G0M9F%M



R4[(&1I


Q-C`[(#PO=&0^/'1D('9A;&EG;CTS1&)O
'0M86QI9VXZ(&-E;G1E

M




T0G=&5X=UA;&EG;CH@8V5N=&5R.R!T97AT+6EN9&5N=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R


M;&]R/3-$(V-C965F9CX\=&0@86QI9VX]
T1L969T('9A;&EG;CTS1&)O='1O

M:6=N.B!L969T.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P
M=#L@9F]N=US:7IE.B`Q

M86YD:6YG(&%T(&)E9VEN;FEN9R!O9B!Y96%R/]D:78^/]T9#X\=&0@=F%L




#L@/]T9#X\=&0@86QI9VX],T1R:6=H=!V86QI9VX]
M


T0G



M:61T:#H@


Q-C`[(#PO=&0^/'1D

M.B`Q


B4[


Q-C`[(#PO=&0^/'1D(&%L:6=N/3-$



C



T0G
M=VED=&@Z(#(E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE

3!P=#LG/B8C
38P.R`\+W1D/CQT
M9!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T
M:#H@


M

#LR+#$W-BPU
S4\+V1I





@;F5W(')O;6%N.R!M87)G:6XM
M;&5F=#H@

'!T

Q-C`[
BPS-30L




M(S$V
#L@/]T9#X\=&0@86QI9VX],T1R:6=H=!V86QI9VX]
T1B;W1T;VT@





#LD
M


T0G=VED=&@Z

T0G=&5X=UA;&EG;CH@;&5F=#L@=&5X=UI


3!P





M9#X\=&0@86QI9VX]



@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@
'!T.R!F;VYT+7-I


Q-C`[*#(S

M9VX]






#L@/]T9#X\=&0@86QI9VX],T1R:6=H=!V86QI9VX]
T1B


T0G=&5X


M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N

M9VX]


@
M;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@



Q-C`[*#0P+#`P
D\+V1I=CX\+W1D
M/CQT9!V86QI9VX]

T0G=VED=&@Z(#(E.R!D:7-P


3!P=#LG/B8C
38P.R`\+W1D/CQT9!A;&EG;CTS1')I9VAT
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@.24[)SX\9&EV('-T

'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q

M:'0Z(#!P=#LG/B8C


M9'1H.B`R


Q-C`[(#PO=&0^/'1D





Q-C`[(#PO



M=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE.B`Q

M)B


M97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE
M.B`Q




M93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE.B`Q
M





@;F5W(')O;6%N.R!F;VYT


M



M93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE.B`Q
M

Q-C`[(#PO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS



M87DZ(&EN;&EN93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N
M=US:7IE.B`Q

Q-C`[(#PO=&0^/'1D('9A;&EG;CTS1&)O='1O


T0G=VED=&@Z


3!P=#LG/B8C

M9'1H.B`R

3H@
M=&EM97
@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@




M
T0G=VED=&@Z(#(E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T

3!P=#LG/B8C
38P.R`\+W1D
M/CQT9!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=B


M/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!R:6=H=#L@=&5X=UI;F1E;G0Z


3!P=#L@;6%R

#LY+#4X
RPW-C(\+V1I=CX\+W1D/CQT




3H@
M=&EM97
@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@



Q-C`[-RPW


@;F5W(')O

#L@/]T9#X\=&0@86QI9VX]
M,T1R:6=H=!V86QI9VX]


M/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!R:6=H=#L@=&5X=UI;F1E;G0Z


3!P=#L@;6%R

#LD
2XP


M

M=&EM97




M:#H@


Q-C`[(#PO=&0^/'1D('9A



Q-C`[(#PO

T1B

T0G=VED=&@Z(#(E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O

3!P=#LG
M/B8C


M;&4]



#L@



M:61T:#H@


Q-C`[(#PO=&0^/'1D



Q-C`[

M

T0G=VED=&@Z(#(E.R!D:7-P;&%Y.B!I;FQI;F4[

3!P
M=#LG/B8C

C

M1=T97AT+6%L:6=N.B!L969T.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN





M;&4]
T0G=VED=&@Z(#(E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY

3!P=#LG/B8C
38P.R`\

M.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US
M:7IE.B`Q



@;F5W(')O

#L@/]T9#X\=&0@86QI9VX]
M,T1R:6=H=!V86QI9VX]

T0G8F]R9&5R+6)O='1O

M



M:78^)B

!O9B!W:&EC:`Y


M92!O9B`D

N

'0M:6YD96YT.B`P<'0[(&1I


M(#!P=#LG/B8C








38P.R8C
38P.U1H:7
@

@;&ES=&5D(&EN('1H92!T86)L
M92!B96QO=RXF(S$V
#LF(S$V



M;&0@8W5R=F4@:6X@969F96-T(&%T('1H92!T:6UE(&]F(&=R86YT+CPO9&EV





Q-C`[/]D:78^/&1I=B!S='EL93TS1=T
M97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y



!S='EL
M93TS1=W:61T:#H@
3`P)3L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9F]N=US:7IE.B`Q


'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN
M+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!F;VYT+7=E:6=H=#H@8F]L

#$S/]D:78^/]T9#X\=&0@=F%L




!S;VQI9#L@=VED=&@Z(#$R)3LG/CQD

T0G=&5X=UA;&EG;CH@8V5N=&5R.R!T97AT+6EN9&5N=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R


'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q



M=&5R.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N
M=US:7IE.B`Q


@;F5W(')O;6%N.R!F







T0G=VED=&@Z(#$R)3LG/CQD

T0G=&5X=UA;&EG;CH@8V5N=&5R.R!T97AT+6EN9&5N=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R



@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@
'!T.R!F;VYT+7-I



M

S

M=B!S='EL93TS1=T97AT+6%L:6=N.B!L969T.R!T97AT+6EN9&5N=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA
'0M86QI9VXZ(&-E;G1E<CL@=&5X=UI;F1E;G0Z(#!P


3!P=#L@;6%R9VEN




Q

3(E


M:6=N.B!L969T.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P
M=#L@9F]N=US:7IE.B`Q


M)W=I9'1H.B`Q






@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@
'!T


BXV.34\
M+V1I=CX\+W1D/CPO='(^/'1R(&)G8V]L;W(]
'0M:6YD96YT.B`P<'0[

@;F5W(')O;6%N
M.R!M87)G:6XM;&5F=#H@

M:6=H=#H@

#@E/]D:78^/]T9#X\=&0@=F%L:6=N



M)SXF(S$V


M

B`M(#$P
R4\+V1I=CX\
M+W1D/CPO='(^/]T86)L93X\+V1I=CX\+V1I=CX\9&EV/B8C,38P.SPO9&EV
M/CQD:78^/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT
M+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ(%1I
M;65S($YE=R!2;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
M



Q-C`[)B
Q-C`[1'5R:6YG(#(P
3(L
M('1H92!#;VUP86YY(&=R86YT960@
BPS
C0L

@=&\@96UP


#LF
M(S$V

M960@:6X@8F]T:`R,#$S(&%N9`R

@9G)O;2!T


M87)G:6XM;&5F=#H@

38P.SPO




3!P

2P@
C`Q
M


M)B
Q-C`[)B
Q-C`[07
@;V8@1&5C96UB97(@
S$L(#(P
3(@=&AE($-O;7!A
M;GD@:&%D(#$P+#(W
2PQ
C

M=6YD97(@=&AE(%!L86XN/]D:78^/&1I=B!S='EL93TS1=T97AT+6%L:6=N
M.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@

#L\


M97
@3F5W(%)O;6%N.R!M87)G:6XM;&5F=#H@





T0G=VED=&@Z(#$P








T1T;W`@




M




M(S$V






@;F5W(')O;6%N.R!M87)G
M:6XM;&5F=#H@



'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!F;VYT+7=E:6=H



M87DZ(&EN;&EN93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N
M=US:7IE.B`Q



Q-C`[

M86QI9VX]

T0G=VED=&@Z(#(E.R!D:7-P;&%Y.B!I;FQI

M
3!P=#LG/B8C


T0G=VED=&@Z(#
E.R!D:7-P;&%Y.B!I

M93H@
3!P=#LG/B8C



@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@
'!T.R!F;VYT




Q-C`[




T0G=VED=&@Z(#
E


3!P=#LG/B8C


M

M=&EM97



T0G=&5X=UA;&EG;CH@
M8V5N=&5R.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N
M=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@


T0G=&5X=UA;&EG;CH@8V5N=&5R.R!T97AT+6EN9&5N
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE



@;F5W(')O;6%N.R!M87)G
M:6XM;&5F=#H@




@;F5W(')O;6%N.R!F;VYT+7-I


M=&5R.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N
M=US:7IE.B`Q
'!T.R!F;VYT+7=E:6=H=#H@8F]L9#L@;6%R9VEN+7)I9VAT


M=&5R.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N
M=US:7IE.B`Q
'!T.R!F;VYT+7=E:6=H=#H@8F]L9#L@;6%R9VEN+7)I9VAT

\+V1I=CX\+W1D/CQT


M
T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@
G!X('-O;&ED.R!W:61T:#H@.24[



M86QI9VX]

T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@
G!X









M86QI9VX]

T0G=VED=&@Z(#
E.R!D:7-P;&%Y.B!I;FQI

M
3!P=#LG/B8C
'0M86QI9VXZ(&-E;G1E<CL@=&5X=UI;F1E;G0Z


3!P=#L@9F]N

M86QI9VX]


M
T0G=&5X=UA;&EG;CH@8V5N=&5R.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R


T0G=&5X=UA;&EG;CH@8V5N=&5R.R!T97AT+6EN9&5N
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE




T0G=VED=&@Z(#
E


3!P=#LG/B8C

'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE
M9G0Z(#!P=#L@9F]N=US:7IE.B`Q

M/B8C


M=&EM97


'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!M87)G:6XM




T0G

T0G=&5X=UA;&EG;CH@8V5N=&5R
M.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI



T0G=&5X=UA
M;&EG;CH@8V5N=&5R.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z




M

T0G=VED=&@Z(#
E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O

3!P=#LG
M/B8C

M+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
M

38P.R0Q+C8W/]D:78^/]T


@;F5W(')O;6%N.R!F;VYT


M8V5N=&5R.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N
M=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@
M9F]N=US:7IE.B`Q

38P.S(L
M


C


M

T0G=VED=&@Z(#(E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O

3!P=#LG
M/B8C


M97
@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@



Q-C`[
3(U+#`P
#PO9&EV/CPO


M87DZ(&EN;&EN93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N
M=US:7IE.B`Q

3H@8FQO8VL[(&9O



#LT

M9VX]


T0G
M=&5X=UA;&EG;CH@8V5N=&5R.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN


T0G=&5X=UA;&EG;CH@8V5N=&5R.R!T97AT+6EN9&5N=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R



M;&EG;CH@8V5N=&5R.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z
M(#!P=#L@9F]N=US:7IE.B`Q

M



Q-C`[


T0G=&5X=UA;&EG;CH@
M8V5N=&5R.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N
M=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@



M

#LD
2XQ-SPO9&EV/CPO

M97([('=I9'1H.B`S)3L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9F]N=US:7IE.B`Q

Q-C`[(#PO=&0^/'1D('9A;&EG;CTS1'1O


T0G
M=&5X=UA;&EG;CH@8V5N=&5R.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN

M9&EV/CPO9&EV/CQD:78^)B
Q-C`[/]D:78^/&1I=B!S='EL93TS1=T97AT



2P@
C`Q

@9F]L
'0M86QI9VXZ(&IU<W1I9GD[

M=#H@

38P.SPO9&EV/CQD:78@



M:6=H=#H@






M9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE.B`Q
'!T


M:#H@


Q-C`[(#PO=&0^/'1D('9A

M93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE.B`Q
M


M:61T:#H@


Q-C`[(#PO=&0^/'1D
'0M86QI9VXZ(&-E;G1E<CL@=&5X=UI;F1E;G0Z(#!P=#L@9&ES




T0G=VED=&@Z(#
E.R!D:7-P;&%Y


3!P=#LG/B8C


@;F5W(')O;6%N.R!F


M9'1H.B`R


Q-C`[(#PO=&0^/'1D


M;&EN93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE
M.B`Q



Q-C`[(#PO=&0^


M(&EN;&EN93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US
M:7IE.B`Q

3H@8FQO8VL[(&9O;G0M






@;F5W
M(')O;6%N.R!M87)G:6XM;&5F=#H@




@;F5W(')O


M/3-$)W=I9'1H.B`R


Q-C`[(#PO


M87DZ(&EN;&EN93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N
M=US:7IE.B`Q



Q-C`[

R4[(&1I


Q-C`[(#PO=&0^/'1D('9A;&EG;CTS1'1O
3H@8FQO8VL[



M.B`Q




M:61T:#H@


Q-C`[(#PO=&0^/'1D

M;&EN93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE
M.B`Q



T0G=VED=&@Z(#(E


3!P=#LG/B8C



@;F5W(')O;6%N.R!M87)G:6XM;&5F
M=#H@




T0G=VED
F4Z(#$P<'0[)SXF(S$V,#L@/]T

24[)SX\9&EV




T1T



T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@
M
G!X('-O;&ED.R!W:61T:#H@
C


M97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE
M.B`Q




Q-C`[(#PO


T0G=&5X
M=UA;&EG;CH@8V5N=&5R.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE


'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!F;VYT+7=E



M87DZ(&EN;&EN93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N
M=US:7IE.B`Q



T0G=&5X=UA;&EG;CH@8V5N=&5R.R!T97AT
M+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I


@;F5W(')O
M;6%N.R!M87)G:6XM;&5F=#H@

M;BUR:6=H=#H@



T0G=VED



T0G=&5X=UA
M;&EG;CH@8V5N=&5R.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z



@;F5W(')O;6%N.R!M
M87)G:6XM;&5F=#H@

M=#H@

Q-C`[)#$N


T0G=VED=&@Z(#DE




@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@
'!T


M)#
N

M86QI9VX]





M86QI9VX]

T0G=VED=&@Z(#
E.R!D:7-P;&%Y.B!I;FQI

M
3!P=#LG/B8C

M.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US
M:7IE.B`Q



@;F5W(')O;6%N


M;&EG;CH@8V5N=&5R.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z
M(#!P=#L@9F]N=US:7IE.B`Q

M
38P.S(Q
PP,#`\+V1I=CX\+W1D/CPO='(^/'1R(&)G8V]L;W(],T0C8V-E
M969F/CQT9!V86QI9VX]

T0G=VED=&@Z(#(S)3L@9&ES

@;F5W(')O;6%N.R!F


'0M86QI9VXZ(&-E;G1E<CL@=VED
M=&@Z(#DE.R<^/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!C96YT97([('1E
3H@
M=&EM97
@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@



Q-C`[-2PV-#4L


@;F5W(')O;6%N



@;F5W
M(')O;6%N.R!M87)G:6XM;&5F=#H@





M8V5N=&5R.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N
M=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@
M9F]N=US:7IE.B`Q

38P.S$N
M
3

M9VX]

T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@-'!X(&1O



3!P=#L@;6%R9VEN+7)I

#LU+#
Q-RPP
#
\+V1I=CX\+W1D/CPO='(^/]T
M86)L93X\+V1I=CX\+V1I=CX\+V1I=CX\9&EV/B8C,38P.SPO9&EV/CQD:78^
M/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!L969T.R!T97AT+6EN9&5N=#H@
M
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ(%1I;65S($YE=R!2
M;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!M87)G

Q+`R,#$S(&%N9`R
M

BPQ
#


;V-A=&EO;CH@9FEL93HO+R]#.B\W9CAA-S)B.5]B
M-S9A7S1E8V%?860V95\U.65A
#(R




M:78]

]
M


T0Q(')O=W-P86X]




M1'1H/D1E8RX@
S$L(#(P
3
\8G(^/]T:#X-B`@(`@(#PO='(^#0H@(`@



]
T1P;!V86QI9VX],T1T;W`^
M4T545$Q%345.5!
3U-315




@3F5W(%)O;6%N
M.R!M87)G:6XM;&5F=#H@

M:6=H=#H@

C`Q
2P@=&AE($-O;7!A;GD@=V%S
M('-U960@:6X@0VER8W5I=!#;W5R=!O9B!T:&4@
3=T:!*=61I8VEA;!$



@;V8@)#$X-2PP
#`N)B
Q-C`[
M)B



M('1H92!C;&%I;2XF(S$V
#LF(S$V
#M296QA=&5D('1O('1H:7
@;6%T=&5R




#`P(&)Y($Q)0D-/($EN9'5S
M=')I97
N)B
Q-C`[)B
Q-C`[07
@;V8@1&5C96UB97(@
S$L(#(P
3$L('1H
M92!#;VUP86YY(&%C8W)U960@87

L('1H92`D

0R!O;B!-87)C:`V
M+`R

M87

@8VQA:6US





M97
@3F5W(%)O;6%N.R!M87)G:6XM;&5F=#H@



3(L('1H92!#;VUP
M86YY(&5N=&5R960@:6YT;R!A('-E='1L96UE;G0@86=R965M96YT('=I=&@@



#LF(S$V





@3F5W(%)O;6%N.R!M87)G
M:6XM;&5F=#H@

M

@;V8@1&5C96UB97(@
S$L(#(P
3(L('1H92!#;VUP86YY(&AA

#(L
M
#`P(')E;&%T:6YG('1O('1H92!C;VUP;&%I;G0@:6YI=&EA=&5D(&)Y($IO






@3F5W(%)O;6%N.R!M87)G
M:6XM;&5F=#H@

M

3(L(#(P
3
L('=E(&5N=&5R960@:6YT;R!A





M
2PX.#$L


'0O:'1M;#L@



M9SY)3D-/344@5$%815


]

]




3!P=#LG/CQD:78^/&1I=B!S='EL93TS
M1=T97AT+6%L:6=N.B!L969T.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@9F]N=UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@;6%R9VEN

3L@24Y#3TU%
M(%1!6$53/]D:78^/&1I=B!S='EL93TS1=T97AT+6EN9&5N=#H@
'!T.R!D
M:7-P;&%Y.B!B;&]C:SLG/B8C

T0G=&5X





C`Q
R!A;F0@
C`Q
BP@=&AE($-O;7!A;GD@:6YC=7)R960@


#LF(S$V



#LF(S$V
#M4:&4@8W5M=6QA=&EV92!N970@;&]S
&EM871E;'D@)#DV+#8R-PT-34@
M86YD(0Y


@96YD960@1&5C96UB97(@
M
S$L(#(P
3
@86YD(#(P





M=!B87-E9!O;B!A(#



M;&5F=#H@

38P.SPO9&EV/CQD



M;BUR:6=H=#H@





M93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE.B`Q
M


M:61T:#H@
3$E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE

3!P=#LG/B8C
38P.R`\+W1D/CQT


M

M=&EM97






T1T;W`@

T0G=VED=&@Z(#(E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M

3!P=#LG/B8C
38P


@;F5W(')O;6%N.R!M87)G
M:6XM;&5F=#H@


Q+S$R/]D:78^/]T9#X\



Q-C`[(#PO=&0^/'1D('9A;&EG;CTS

3$E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O

3!P=#LG
M/B8C

M9VX]






M9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T


M9VX]


@;F5W
M(')O;6%N.R!M87)G:6XM;&5F=#H@



Q-C`[)#
P+#DY


T1T

T0G=VED=&@Z(#(E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M

3!P=#LG/B8C
M

M9V-O;&]R/3-$(V-C965F9CX\=&0@86QI9VX]
T1L969T('9A;&EG;CTS1'1O





M='EL93TS1=T97AT+6%L:6=N.B!R:6=H=#L@=&5X=UI;F1E;G0Z(#!P=#L@


3!P=#L@;6%R9VEN+7)I

#LH
S(L.#4R+#






M(S$V
#LH
S`L.3DP+#`U



T0G=VED=&@Z


3!P=#LG/B8C

M=&0@86QI9VX]

M


M



3!P

#LD+3PO9&EV/CPO=&0^/'1D


M;&EN93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE
M.B`Q



M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N




#LF(S$V
#M/=7(@
M=&%X(')E='5R;G



M4&%R=%\W9CAA-S)B.5]B-S9A7S1E8V%?860V95\U.65A
#(R






M34524R!!3D0@0T].0T5.5%)!5$E/3E



]





M93TS1=T97AT+6%L:6=N.B!L969T.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@;6%R

3L@34%*

M

3H@
M5&EM97
@3F5W(%)O;6%N.R!M87)G:6XM;&5F=#H@







38P.R8C
38P.U1H

M=6YT960@9F]R(#
V)2P@

M=&AE('EE87(@96YD960@1&5C96UB97(@
S$L(#(P
3
N)B
Q-C`[)B
Q-C`[

S8E+`R-4@86YD(#DE(&]F('1O=&%L('-A;&5S(&9O

M9!F;W(@-C$E(&%N9`Q
24@;V8@=&AE('1O=&%L(&%C8V]U;G1S(')E8V5I
M=F%B;&4@9F]R('1H92!Y96%R(&5N9&5D($1E8V5M8F5R(#

@86-C;W5N=&5D

2P@
C`Q
BX\+V1I


'!T.R!M


T0G



3!P=#L@;6%R9VEN+7)I9VAT.B`P



2P@
C`Q
R!A;F0@
C`Q
BP@)#$Y


#LF(S$V

M;V1I8V%L;'D@87-S97-S97











3XQ
B!-;VYT:'
@

M/'1H(&-L87-S/3-$=&@^1&5C+B`S
2P@
C`Q



]


]



M='EL93TS1=T97AT+6%L:6=N.B!L969T.R!T97AT+6EN9&5N=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@

3L@
M0T]-34E45$U%3E13/]D:78^/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!J
M=7-T:69Y.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R

#L\+V1I


@
M3F5W(%)O;6%N.R!M87)G:6XM;&5F=#H@


'!T.R!T97AT+61E8V]R871I;VXZ('5N9&5R;&EN
M93LG/D)U:6QD:6YG($QE87-E/]D:78^/&1I=B!S='EL93TS1=T97AT+6%L
M:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C

M

3H@
M5&EM97
@3F5W(%)O;6%N.R!M87)G:6XM;&5F=#H@






M)B
Q-C`[)B
Q-C`[5&AE($-O;7!A;GD@97AT96YD960@=&AE(&QE87-E(&EN


#LF(S$V
M

M=64N)B
Q-C`[)B
Q-C`[268@=V4@=V5R92!T;R!L;W-E('1H:7





@






3!P=#LG/B8C

M86QI9VX]

T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@
G!X
M('-O;&ED.R!W:61T:#H@

M;&EG;CH@8V5N=&5R.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z
M(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!F;VYT+7=E:6=H=#H@8F]L9#L@;6%R

M9V-O;&]R/3-$(V-C965F9CX\=&0@86QI9VX]
T1L969T('9A;&EG;CTS1'1O







#LR-38L
M
S



T0G=VED=&@Z(#(P)3LG/CQD:78@


M:6=N.B!L969T.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P
M=#L@9F]N=US:7IE.B`Q

38\





T0G=VED=&@Z(#$V)3LG/CQD:78@

T0G=&5X=UA;&EG;CH@;&5F=#L@=&5X=UI;F1E;G0Z(#!P=#L@


3!P=#L@;6%R9VEN+7)I

#$W/]D:78^/]T9#X\=&0@86QI9VX]


@;F5W(')O;6%N.R!M87)G
M:6XM;&5F=#H@

M





T0G=VED=&@Z



M9#X\=&0@86QI9VX]


@;F5W(')O
M;6%N.R!M87)G:6XM;&5F=#H@

M;BUR:6=H=#H@

Q-C`[)#
T
2PW-S8\+V1I=CX\+W1D/CPO='(^
M/]T86)L93X\+V1I=CX\9&EV/B8C,38P.SPO9&EV/CQD:78^)B,Q-C`[/]D

3H@
M5&EM97
@3F5W(%)O;6%N.R!M87)G:6XM;&5F=#H@



M96YS92!F;W(@=&AE('EE87)S(&5N9&5D($1E8V5M8F5R(#
Q+`R,#$S(&%N
M9`R


'!T.R!D:7-P





M;B!-87)C:`Q-P@


N
M)B
Q-C`[)B


M-3EE83`R
C!F
#=F#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T
Z+S=F
M.&$W
F(Y7V(W-F%?-&5C85]A9#9E7S4Y96$P

M+U-H965T

M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-B`@/&AE860^#0H@(`@/$U%5$$@


^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE



]



251)




T0G9F]N=UF86UI;'DZ(=4:6UE



M86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N



#`N)B
Q-C`[)B
Q-C`[


M(')U;&EN9W

@86YD('1H870@:70@:&%S(&=R;W5N
M9'

@

3`R+#`P
M



@3F5W
M(%)O;6%N.R!M87)G:6XM;&5F=#H@



C`Q
2P@=&AE($-O;7!A
M;GD@=V%S('-U960@:6X@0VER8W5I=!#;W5R=!O9B!T:&4@



@;V8@)#$X-2PP
#`N
M)B
Q-C`[)B



M9&5F96YD('1H92!C;&%I;2XF(S$V
#LF(S$V
#M296QA=&5D('1O('1H:7
@





#`P(&)Y($Q)0D-/
M($EN9'5S=')I97
N)B
Q-C`[)B
Q-C`[07
@;V8@1&5C96UB97(@
S$L(#(P
M
3$L('1H92!#;VUP86YY(&%C8W)U960@87

L

0R!O;B!-
M87)C:`V+`R

M(&QI96X@87

@






@3F5W(%)O;6%N.R!M87)G:6XM;&5F=#H@
'!T.R!F;VYT+7-I


3(L('1H
M92!#;VUP86YY(&5N=&5R960@:6YT;R!A('-E='1L96UE;G0@86=R965M96YT



#LF(S$V


M-F5?-3EE83`R
C!F
#=F#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T
Z
M+S=F.&$W
F(Y7V(W-F%?-&5C85]A9#9E7S4Y96$P

M971S+U-H965T

M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-B`@/&AE860^#0H@(`@/$U%


^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O




#$S/&)R/CPO=&@^#0H@(`@(`\+W1R/@T*


]





3$[($=505)!3E1%15
\
'0M:6YD96YT.B`P<'0[(&1I<W!L87DZ

Q-C`[/]D:78^/&1I=B!S='EL93TS1=T97AT+6%L:6=N
M.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M9F]N=UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@;6%R9VEN+6QE9G0Z(#!P
M=#L@9F]N=US:7IE.B`Q


M='EP97





M8V@@=&AE($-O;7!A;GD@;6%Y('!R;W9I9&4@8W5S=&]M87)Y(&EN9&5M;FEF
M:6-A=&EO;G







#LF(S$V
#M4:&4@=&5R;7

@8V%N;F]T(&)E(')E87-O;F%B






M
38P.R8C



M83`R
C!F
#=F#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T
Z+S=F.&$W
M
F(Y7V(W-F%?-&5C85]A9#9E7S4Y96$P

M965T

M(G5S+6%S8VEI(@T*#0H\:'1M;#X-B`@/&AE860^#0H@(`@/$U%5$$@:'1T


^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@


]






M;&4]


M;BUR:6=H=#H@


@;V8@8V]M;6]N('-T;V-K('1O

X


38P+#`P


C`Q


#`@*&EN8VQU9&EN9R!A






'!T.R!M87)G:6XM







2P@
C`Q
BP@=&AE($-O;7!A;GDF(S@R


@1V%R9FEN

M9!T;R!C;VYV97)T(0Q-RPT
#
@*&EN8VQU9&EN9R!A8V-R=65D(&1I=FED




@;6%T=7)I='DN
M)B
Q-C`[)B
Q-C`[5&AE(&%G9W)E9V%T92!C;VYV97)S:6]N(&)Y('1H92!D



2P@
C`Q


M.R!M87)G:6XM;&5F=#H@

38P



M



L($UA


N)B
Q-C`[)B
Q-C`[5&AE





2XU


M='
@86YD(')E8V5I=F5D(#(P

M:69I8V%T:6]N('1H92!#;VUP86YY(')E8V]G;FEZ960@)#0U+#4Y-B!O9B!A




@36]D96PN)B
Q-C`[)B
Q-C`[3VX@36%R
M8V@@-BP@
C`Q











@86YD(')E8V5I=F5D(#4X+#
Y
M-2!S:&%R97
@;V8@0V]M;6]N(%-T;V-K+B8C
38P.R8C



S`L(#(P
3






'!T


M



3!P=#L@;6%R9VEN+7)I9VAT



M83`R
C!F

O4VAE970R-RYH=&UL#0I#;VYT96YT+51R





M;W0@4F5M;W9E(%1H:7


]

M86X]

#$S


]


M/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL93TS


M.B!L969T.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N
M=UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@
M9F]N=US:7IE.B`Q
'!T.R!F;VYT+7=E:6=H=#H@8F]L9#L@;6%R9VEN+7)I

M.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M9F]N=UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@;6%R9VEN+6QE9G0Z(#!P
M=#L@9F]N=US:7IE.B`Q


BP@

2PT


M:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@9F]N=UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@;6%R9VEN+6QE9G0Z
M(#!P=#L@9F]N=US:7IE.B`Q



M
#`L

M(S$V
#LF(S$V


3$L(#(P





M+!,3$,@*8C.#(R
#M&;W)D:&%M)B
X
C(Q.RD@97AT96YD960@82`D-3`P
M+#`P


M;B8C.#(R

#M);F
N(AT:&4@
M)B,X,C(P.T-O;7!A;GDF(S@R,C$[*2!E=FED96YC960@8GD@86X@17%U:7!M
M96YT(%)E=F]L=FEN9R!.;W1E(AT:&4@)B
X
C(P.TYO=&4F(S@R
C$[*2!I

#LF(S$V
#M4










M;G0N/]D:78^/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!J=7-T:69Y.R!T
M97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z

#L\+V1I=CX\9&EV('-T


@3F5W(%)O;6%N
M.R!M87)G:6XM;&5F=#H@

M:6=H=#H@





N)B
Q-C`[)B
Q-C`[5&AE

#LF(S$V
6%B;&4N)B
Q-C`[)B
Q-C`[069T



3LI+B8C
38P.R8C
38P.U1O('-E8W5R92!P87EM

M:70@06-C;W5N='

@;W=I



M;&PN/]D:78^/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!J=7-T:69Y.R!T
M97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z

#L\+V1I=CX\9&EV('-T


@3F5W(%)O;6%N
M.R!M87)G:6XM;&5F=#H@

M:6=H=#H@

C@L(#(P
30@=&AE($-O;7!A;GD@96YT


3$
@




;V-A=&EO;CH@9FEL93HO+R]#.B\W9CAA-S)B.5]B-S9A7S1E8V%?860V
M95\U.65A
#(R

T1#;VYT96YT

]
T13:&]W+FIS/B\J




24-)15


M/3-$
3XQ
B!-;VYT:'

2P@
C`Q
SQB

]


]





M/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ(%1I;65S($YE

M=VET:!A8V-O=6YT:6YG('!R:6YC:7!L97,@9V5N97)A;&QY(&%C8V5P=&5D
M(&EN('1H92!5;FET960@4W1A=&5S(A5+E


M=&EO;G


@870@=&AE(&1A=&4@;V8@=&AE









M=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R




@3F5W(%)O;6%N.R!M87)G:6XM
M;&5F=#H@

'!T





X
C$W.W
@:&ES

T1T;W`^06QL;W=A;F-E(&9O




T0G



M/&)R(\^)B,Q-C`[/]D:78^/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!J
M=7-T:69Y.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N
M=UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@





L(&UA;F%G96UE;G0@86YA;'EZ97
@:71S


@9F]R(&1O=6)T9G5L(&%C8V]U;G1S(&UA

M;VYS(&-O=6QD(&)E(&UA=&5R:6%L;'D@869F96-T960N($%S(&]F($1E8V5M
M8F5R(#
Q+`R,#$S(&%N9`R







M
2P@
C`Q
R!A;F0@
C`Q









M97AT+6%L:6=N.B!L969T.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B

M(S$V

3H@
M5&EM97
@3F5W(%)O;6%N.R!M87)G:6XM;&5F=#H@








T0G









Q-C`[/]D:78^/&1I=B!S
M='EL93TS1=T97AT+6%L:6=N.B!L969T.R!T97AT+6EN9&5N=#H@
'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@
M;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q



M=&EZ871I;VXN)B
Q-C`[)B


@:6YC=7)R960N)B
Q-C`[)B
Q-C`[1&5P





]




@86-C=6UU;&%T960@86UO



M86QI9VX]

T0G


;VYG+4QI=F5D($%S




Q-C`[/]D:78^/&1I=B!S='EL
M93TS1=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@
'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@
M;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q



@




@8V]S='
@


]





M:7


N)B
Q-C`[)B



@:6X@9&5F97)R960@=&%X


]

T0G



M/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ(%1I;65S($YE



M9&5R:79A=&EV97


M(%-E8W5R960@3F]T97
@:7-S=65D(&EN(#(P
#@L(#(P





M=6YT960@9F]R(&]N('1H92!#;VUP86YY)B
X
C$W.W
@8F%L86YC92!S:&5E









M:6]N($UO9&5L/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/&1I

M97AT+6%L:6=N.B!L969T.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@9F]N=UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@;6%R9VEN+6QE
M9G0Z(#!P=#L@9F]N=US:7IE.B`Q



M=B!S='EL93TS1=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ(%1I;65S($YE=R!2

M='

@:6X@=&AE:7(@8V]N=F5R=&EB
M;&4@;F]T97




M8V5N87)I;W
N(%!R;V)A8FEL:71I97




M;W5T('1H92!C;VUP;W5N9!E;6)E9&1E9!D97)I=F%T:79E(&EN(&]R9&5R





'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ(%1I;65S($YE=R!2;VUA
M;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!M87)G:6XM

M;&4]


M=#H@

Q-C`[/]D:78^/&1I=B!S='EL93TS1=T97AT+6%L:6=N
M.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M9F]N=UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@;6%R9VEN+6QE9G0Z(#!P
M=#L@9F]N=US:7IE.B`Q

M;VUP86YY)B
X
C$W.W




M(&QI86)I;&ET:65S+B!4:&4@97-T:6UA=&5D(&9A:7(@=F%L=64@;V8@8V%S



N)B
Q-C`[)B
Q-C`[3F]N92!O9B!T:&5S92!I;G-T



2P@
C`Q
R!A
M;F0@
C`Q

M(&-O;6UO;B!S=&]C:RP@=&AE(&9A:7(@=F%L=65S(&]F('=H:6-H(&%R92!C

T0G

M:'0[('=I9'1H.B`Q

@3F5W(%)O;6%N

M;&4]



3!P=#L@;6%R9VEN+7)I





@3F5W(%)O
M;6%N.R!M87)G:6XM;&5F=#H@

X
C$R




@3F5W(%)O;6%N
M.R!M87)G:6XM;&5F=#H@

X
C$R.R!)
M;G!U='

3([
M(%5N;V)S97)V86)L92!I;G!U='


L('=H:6-H(&%R92!D979E;&]P960@8GD@=&AE

M;G

'!T.R!D:7-P;&%Y.B!B;&]C






@











2P@
M
C`Q
R!A;F0@
C`Q
B!W87
@)#DU+#`T.2!A;F0@)#@L
#(U+#
X


38P.R8C


#$R+B8C
38P.R8C
M



T0P('-T


@;F5W(')O

C4E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M

3!P=#LG/B8C
38P

T1T



M+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
M





Q-C`[(#PO=&0^/'1D('9A;&EG;CTS

M('=I9'1H.B`Q)3L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N
M=US:7IE.B`Q


M.B`Y)3L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE
M.B`Q



T0G=VED=&@Z(#$E


3!P=#LG/B8C
3H@8FQO8VL[(&9O;G0M9F%M




M
T0G=VED=&@Z(#$E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T

3!P=#LG/B8C
38P.R`\+W1D
3H@8FQO



'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!F;VYT+7=E

979E;`R/]D:78^


3H@
M=&EM97
@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@


M/DQE=F5L(#


T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@
M


M;BUR:6=H=#H@
6QE/3-$

M97



M=&EM97





#L@




M




M(S$V

M9V-O;&]R/3-$(V-C965F9CX\=&0@86QI9VX]
T1L969T('9A;&EG;CTS1'1O



T1T;W`@

T0G=VED=&@Z(#$E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M

3!P=#LG/B8C
38P

T1T

T0G=VED=&@Z(#$E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M

3!P=#LG/B8C
M

M

T0G=VED=&@Z(#$E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O

3!P=#LG
M/B8C

M9VX]

T0G=VED=&@Z(#$E.R!D:7-P;&%Y.B!I;FQI;F4[

3!P
M=#LG/B8C

M86QI9VX]

T0G=VED=&@Z(#$E.R!D:7-P;&%Y.B!I;FQI

M
3!P=#LG/B8C

M9VX]


T0G


M
T0G=VED=&@Z(#$E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T

3!P=#LG/B8C
38P.R`\+W1D





#LD+3PO

24[


Q-C`[(#PO=&0^/'1D(&%L:6=N/3-$




M93TS1=T97AT+6%L:6=N.B!R:6=H=#L@=&5X=UI;F1E;G0Z(#!P=#L@9&ES


3!P=#L@;6%R9VEN+7)I9VAT

#LD
3$L
#
Q+#0S
CPO9&EV/CPO=&0^/'1D('9A;&EG


M9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE.B`Q
'!T





T0G=VED


3!P=#LG/B8C


T0G
M=VED=&@Z(#$E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE

3!P=#LG/B8C
38P.R`\+W1D/CQT


M
T0G=VED=&@Z(#$E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T

3!P=#LG/B8C
38P.R`\+W1D


M;&4]
T0G=VED=&@Z(#$E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY

3!P=#LG/B8C
38P.R`\

T1T;W`@

T0G=VED=&@Z(#$E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M

3!P=#LG/B8C
38P


M969T.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N
M=US:7IE.B`Q

M97)I=F%T:79E(&QI86)I;&ET:65S(&1U92!T;SPO9&EV/CPO=&0^/'1D('9A


M93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE.B`Q
M




Q-C`[(#PO=&0^/'1D


M;&EN93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE
M.B`Q



Q-C`[(#PO=&0^


M(&EN;&EN93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US
M:7IE.B`Q



Q-C`[(#PO


M87DZ(&EN;&EN93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N
M=US:7IE.B`Q



Q-C`[

24[(&1I


Q-C`[(#PO=&0^/'1D('9A;&EG;CTS1'1O


Q




@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@
'!T.R!F


Q-C`[*#0L


M9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T



M86QI9VXZ(')I9VAT.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z
M(#!P=#L@9F]N=US:7IE.B`Q

M



M=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!M

38P.R@T+#4R


C`L


'0M:6YD96YT.B`P<'0[(&1I<W!L87DZ

@;F5W(')O;6%N.R!M87)G:6XM
M;&5F=#H@

'!T

@=F%L=6%T:6]N
M/]D:78^/]T9#X\=&0@86QI9VX]




M=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!M



M9VXZ(')I9VAT.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P
M=#L@9F]N=US:7IE.B`Q

38P



M
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!M87)G

38P.S$L-3$T+#$U-CPO9&EV/CPO=&0^/'1D


M;&EN93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE
M.B`Q



T0G=&5X





3!P

#LH
RPP
#8L
#4Q*3PO9&EV

24[(&1I






M9VX]



M
T0G=VED=&@Z(#$E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T

3!P=#LG/B8C
38P.R`\+W1D


@;F5W(')O;6%N
M.R!M87)G:6XM;&5F=#H@

M:6=H=#H@

Q-C`[*#
L
#`V+#`U
















T1T;W`@






M:79E($QI86)I;&ET:65S/]D:78^/]T9#X\=&0@=F%L:6=N/3-$=&]P('-T



#L@




M




M(S$V




M)SXF(S$V









'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE
M9G0Z(#!P=#L@9F]N=US:7IE.B`Q

M/C$R+S


M97



@;F5W(')O
M;6%N.R!M87)G:6XM;&5F=#H@

M;BUR:6=H=#H@

Q-C`[)#@L
#(U+#
X
3PO9&EV/CPO=&0^/'1D


M;&EN93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE
M.B`Q








M

M:#H@


Q-C`[(#PO=&0^/'1D(&%L


C4L
S@Q/]D:78^/]T9#X\=&0@=F%L:6=N/3-$



M(S$V
#L@/]T9#X\=&0@86QI9VX],T1R:6=H=!V86QI9VX]

M;&4]
T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@
G!X('-O;&ED.R!W:61T:#H@

M9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T

38P.R0X+#`R-2PS.#$\+V1I=CX\
M+W1D/CPO='(^/'1R(&)G8V]L;W(]


@;F5W(')O



@;F5W



@



M97



M=&EM97




M

T0G=VED=&@Z(#$E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O

3!P=#LG
M/B8C

M9VX]

T0G=VED=&@Z(#$E.R!D:7-P;&%Y.B!I;FQI;F4[

3!P
M=#LG/B8C

M86QI9VX]

T0G=VED=&@Z(#$E.R!D:7-P;&%Y.B!I;FQI

M
3!P=#LG/B8C


T0G=VED=&@Z(#$E.R!D:7-P;&%Y.B!I

M93H@
3!P=#LG/B8C


T0G=VED=&@Z(#$E.R!D:7-P;&%Y


3!P=#LG/B8C




@;F5W(')O;6%N.R!M
M87)G:6XM;&5F=#H@

M=#H@

Q-C`[)B
Q-C`[)B
Q-C`[)B
Q-C`[)B
Q-C`[)B
Q-C`[
M)B


M.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US
M:7IE.B`Q

38P.R@V+#DV
RPU


@;F5W

#L@/]T9#X\=&0@86QI
M9VX],T1R:6=H=!V86QI9VX]


M/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!R:6=H=#L@=&5X=UI;F1E;G0Z


3!P=#L@;6%R

#LM/]D:78^/]T9#X\=&0@=F%L:6=N



M)SXF(S$V
#L@/]T9#X\=&0@86QI9VX],T1R:6=H=!V86QI9VX]
T1T;W`@





#LM


@;F5W(')O

#L@/]T9#X\=&0@86QI9VX]
M,T1R:6=H=!V86QI9VX]


M=B!S='EL93TS1=T97AT+6%L:6=N.B!R:6=H=#L@=&5X=UI;F1E;G0Z(#!P


3!P=#L@;6%R9VEN

#LH-BPY-C
L-3DV*3PO9&EV/CPO=&0^/'1D


M;&EN93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE
M.B`Q



T0G=&5X

M+6%L:6=N.B!L969T.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z
M(#!P=#L@9F]N=US:7IE.B`Q

M86YG92!I;B!D97)I=F%T:79E(&QI86)I;&ET:65S('9A;'5A=&EO;CPO9&EV



M




T1R

M9VX]

T0G=VED=&@Z(#$E.R!D:7-P;&%Y.B!I;FQI;F4[

3!P
M=#LG/B8C


T1T;W`@

T0G=VED=&@Z(#$E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M

3!P=#LG/B8C
38P



@;F5W
M(')O;6%N.R!M87)G:6XM;&5F=#H@




P+#
S
BD\+V1I=CX\+W1D








M(S$V


@

#L@/]T9#X\=&0@
M86QI9VX],T1R:6=H=!V86QI9VX]

T0G8F]R9&5R+6)O
M='1O;3H@8FQA8VL@


'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R
M9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q

M(#!P=#LG/B8C
38P.R@W+#DS





C4E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O

3!P=#LG
M/B8C

M9VX]

T0G=VED=&@Z(#DE.R!D:7-P;&%Y.B!I;FQI;F4[

3!P
M=#LG/B8C

M86QI9VX]

T0G=VED=&@Z(#DE.R!D:7-P;&%Y.B!I;FQI

M
3!P=#LG/B8C


T0G=VED=&@Z(#DE.R!D:7-P;&%Y.B!I

M93H@
3!P=#LG/B8C


T0G=VED=&@Z(#DE.R!D:7-P;&%Y


3!P=#LG/B8C


T0G=VED=&@Z(#DE.R!D:7-P


3!P=#LG/B8C
38P.R`\+W1D/CPO='(^/'1R(&)G8V]L;W(]
M















M






M.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US
M:7IE.B`Q



@;F5W(')O;6%N.R!F

#L@/]T9#X\=&0@86QI9VX],T1R:6=H
M=!V86QI9VX]

T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@




M
#LD.34L


M97

#L@/]T9#X\
M=&0@86QI9VX],T1R:6=H=!V86QI9VX]

T0G8F]R9&5R

M='EL93TS1=T97AT+6%L:6=N.B!R:6=H=#L@=&5X=UI;F1E;G0Z(#!P=#L@


3!P=#L@;6%R9VEN+7)I

#LD.34L
#0Y/]D:78^/]T9#X\+W1R/CPO=&%B





M/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ(%1I;65S($YE















]

]


@3F5W(%)O;6%N)RP@5&EM97
L



@3F5W(%)O;6%N.R!M87)G:6XM;&5F
M=#H@

'!T.R!T

M/]D:78^/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT
M+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P


'0M:6YD96YT.B`P<'0[(&1I

@3F5W(%)O;6%N.R!M
M87)G:6XM;&5F=#H@

M=#H@

@86QL(&%D=F5R=&ES:6YG

38P.R8C
38P.U1H92!A;6]U;G0@9F]R
M('1H92!Y96%R(&5N9&5D($1E8V5M8F5R(#
Q+`R,#$S(&%N9`R
#$R('=A



]



;W-S*2!097(@0V]M;6]N(%-H87)E/]D:78^
M/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N
M=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R




@3F5W(%)O;6%N.R!M87)G:6XM
M;&5F=#H@

'!T






@;F]T(&1I9F9E


]

]

M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97




@3F5W(%)O;6%N.R!M87)G:6XM;&5F=#H@
'!T.R!F;VYT

'!T.R!T97AT+61E8V]R871I

M+T]P=&EO;G


M;&5F=#H@

38P.SPO9&EV/CQD




3!P=#L@;6%R




]

M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97




@3F5W(%)O;6%N.R!M87)G:6XM;&5F=#H@
'!T.R!F;VYT+7-I

'!T.R!T97AT+61E8V]R871I;VXZ



L(&EN

M;7!L;WEE92!S=&]C:R!P=7)C:&%S97




@8GD@


2P@
C`Q
M
R!A;F0@
C`Q


]




#`@;&EN92!O



'0M86QI9VXZ(&IU<W1I

M;&5F=#H@

38P.SPO9&EV/CQD




3!P=#L@;6%R



@;VX@9G5T=7)E('!R;V1U



M;F4@;V8@8W)E9&ET(&%D=F%N8V5S('!L=7

Q-C`[)B
Q


M



M;VYO=6YC96UE;G1S/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG

'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@9F]N=UF86UI;'DZ(%1I;65S($YE=R!2;VUA;CL@;6%R9VEN
M+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q



#L\+V1I=CX\9&EV('-T
'0M86QI9VXZ(&IU<W1I9GD[(&9O;G0M<W1Y;&4Z(&ET86QI







M:7


C`Q
RP@86QT




N/]D
M:78^/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN
M9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@




L(&]R(&$@


M9'







30L(&%L=&AO=6=H(&5A




M93H@





'!T.R!M


T0G



3!P=#L@;6%R9VEN+7)I9VAT.B`P



L('-U8FIE8W0@


M('1H86X@;F]T('1H870@=&AE(&9A:7(@=F%L=64@;V8@86X@:6YD969I;FET

3








N/]D:78^/]D:78^/'-P


M.5]B-S9A7S1E8V%?860V95\U.65A
#(R

M;G1E;G0]


M




3XQ
B!-;VYT
M:'

2P@
C`Q


]


]

]

M)V9O;G0M9F%M:6QY.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97




@3F5W(%)O;6%N.R!M87)G:6XM;&5F=#H@
'!T


M:7
@82!H:65R87)C:'D@=&%B;&4@;V8@=&AE(&-O;7!O;F5N='
@;V8@=&AE

M(&-E;&QP861D:6YG/3-$





Q-C`[(#PO=&0^/'1D


M;&EN93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE
M.B`Q



M


@;F5W(')O
M;6%N.R!M87)G:6XM;&5F=#H@





6QE/3-$


Q-C`[(#PO=&0^


M(&EN;&EN93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US
M:7IE.B`Q



T0G=&5X=UA;&EG;CH@8V5N=&5R.R!T97AT+6EN
M9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S


M=&5R.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N
M=US:7IE.B`Q
'!T.R!F;VYT+7=E:6=H=#H@8F]L9#L@;6%R9VEN+7)I9VAT





@;F5W(')O;6%N.R!M87)G:6XM
M;&5F=#H@



T0G
M8F]R9&5R+6)O='1O;3H@8FQA8VL@
G!X('-O;&ED.R!W:61T:#H@.24[)SX\


SPO

24[


Q-C`[(#PO=&0^/'1D('9A;&EG;CTS


T0G=&5X=UA;&EG;CH@8V5N=&5R
M.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI


C4E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M

3!P=#LG/B8C
M

M

T0G=VED=&@Z(#DE.R!D:7-P;&%Y.B!I;FQI;F4[(&9O

3!P=#LG
M/B8C

M9VX]

T0G=VED=&@Z(#DE.R!D:7-P;&%Y.B!I;FQI;F4[

3!P
M=#LG/B8C

M86QI9VX]

T0G=VED=&@Z(#DE.R!D:7-P;&%Y.B!I;FQI

M
3!P=#LG/B8C


T0G=VED=&@Z(#DE.R!D:7-P;&%Y.B!I

M93H@
3!P=#LG/B8C


T0G=VED=&@Z(#DE.R!D:7-P;&%Y


3!P=#LG/B8C
38P.R`\+W1D/CPO='(^/'1R(&)G8V]L;W(]
T0C




















M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N


T1R













@;F5W(')O;6%N



@;F5W(')O



@;F5W



@



M97


'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN
M+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q

M=#LG/B8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P.R8C
38P


M=&EM97

#L@/]T
M9#X\=&0@86QI9VX],T1R:6=H=!V86QI9VX]

T0G=VED


M




@;F5W(')O;6%N
M.R!M87)G:6XM;&5F=#H@

M:6=H=#H@

Q-C`[+3PO9&EV/CPO=&0^/'1D('9A;&EG;CTS1'1O



Q





@;F5W(')O;6%N.R!M
M87)G:6XM;&5F=#H@

M=#H@



M9VXZ(')I9VAT.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P
M=#L@9F]N=US:7IE.B`Q

38P
M.R@T+#4R

B!V86QI9VX]
T1T;W`@











@;F5W(')O;6%N.R!M
M87)G:6XM;&5F=#H@

M=#H@




Q-C`[





@;F5W(')O;6%N.R!M87)G
M:6XM;&5F=#H@

M

Q-C`[
2PU
30L
34V/]D:78^/]T9#X\=&0@=F%L:6=N/3-$



M(S$V
#L@/]T9#X\=&0@86QI9VX],T1R:6=H=!V86QI9VX]

M;&4]




#LQ+#4Q
M-PQ-38\+V1I=CX\+W1D/CPO='(^/'1R(&)G8V]L;W(],T0C8V-E969F/CQT
M9!V86QI9VX]



@;F5W(')O;6%N.R!F;VYT+7-I


M9#X\=&0@86QI9VX]





T0G=VED=&@Z(#$E.R!D:7-P


3!P=#LG/B8C



@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@
'!T


Q-C`[

M


Q-C`[(#PO=&0^/'1D(&%L:6=N







3!P=#L@

#LH
RPP
#8L
#4Q*3PO9&EV/CPO

T1T;W`@




M




M(S$V




M)SXF(S$V













@;F5W(')O;6%N.R!F;VYT+7-I


M97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE
M.B`Q

M:71I97

M86QI9VX]

T0G=VED=&@Z(#DE.R!D:7-P;&%Y.B!I;FQI

M
3!P=#LG/B8C


T0G=VED=&@Z(#DE.R!D:7-P;&%Y.B!I

M93H@
3!P=#LG/B8C


T0G=VED=&@Z(#DE.R!D:7-P;&%Y


3!P=#LG/B8C


T0G=VED=&@Z(#DE.R!D:7-P


3!P=#LG/B8C


T0G=VED=&@Z(#DE.R!D


3!P=#LG/B8C
38P.R`\+W1D/CPO='(^/'1R(&)G8V]L
M;W(]
T1W:&ET93X\=&0@86QI9VX]



@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@
'!T.R!F


3(O
S$O
3(\

M

T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@
G!X('-O;&ED




3!P=#L@;6%R9VEN+7)I9VAT.B`P







T1R:6=H



M
T0G=VED=&@Z(#$E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T

3!P=#LG/B8C
38P.R`\+W1D


@;F5W(')O;6%N
M.R!M87)G:6XM;&5F=#H@

M:6=H=#H@

Q-C`[)#@L
#(U+#
X

C4E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T

3!P=#LG/B8C
38P.R`\+W1D


M;&4]
T0G=VED=&@Z(#DE.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY

3!P=#LG/B8C
38P.R`\

T1T;W`@

T0G=VED=&@Z(#DE.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M

3!P=#LG/B8C
38P

T1T

T0G=VED=&@Z(#DE.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M

3!P=#LG/B8C
M

M

T0G=VED=&@Z(#DE.R!D:7-P;&%Y.B!I;FQI;F4[(&9O

3!P=#LG
M/B8C

M9VX]

T0G=VED=&@Z(#DE.R!D:7-P;&%Y.B!I;FQI;F4[

3!P
M=#LG/B8C
38P.R`\+W1D/CPO='(^/'1R(&)G8V]L;W(]
T1W:&ET93X\=&0@
M86QI9VX]

C4E













M


T0G=&5X




M(S$V
#LF(S$V
#LF(S$V
#LF(S$V
#LF(S$V
#LF(S$V
#LF(S$V
#MS971T

M:61T:#H@


Q-C`[(#PO=&0^/'1D




T0G=VED=&@Z(#$E.R!D:7-P


3!P=#LG/B8C



M;&4]
T0G=VED=&@Z(#$E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY

3!P=#LG/B8C
38P.R`\



T0G=VED=&@Z(#$E.R!D:7-P;&%Y


3!P=#LG/B8C






T0G=VED=&@Z(#DE



3!P=#L@





'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN
M+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q

M=#LG/B8C


M+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
M

38P.RT\+V1I=CX\+W1D/CQT



'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE
M9G0Z(#!P=#L@9F]N=US:7IE.B`Q

M/B8C
38P.R@Y-C8L-S



Q-C`[




M93TS1=T97AT+6%L:6=N.B!R:6=H=#L@=&5X=UI;F1E;G0Z(#!P=#L@9&ES


3!P=#L@;6%R9VEN+7)I9VAT

#LH-RPY
S`L
S
R*3PO9&EV/CPO=&0^/'1D('9A;&EG


M9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE.B`Q
'!T





M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N


T0G=VED=&@Z(#$E.R!D


3!P=#LG/B8C



@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@
M


Q

P+#
S














T0G=VED=&@Z

T0G=&5X=UA;&EG;CH@;&5F=#L@=&5X=UI


3!P



@;F5W(')O



@;F5W



@



M97



M=&EM97




M.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US
M:7IE.B`Q



@;F5W(')O;6%N.R!F

#L@/]T9#X\=&0@86QI9VX],T1R:6=H
M=!V86QI9VX]

T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@




M
#LD.34L


M97

#L@/]T9#X\
M=&0@86QI9VX],T1R:6=H=!V86QI9VX]

T0G8F]R9&5R

M='EL93TS1=T97AT+6%L:6=N.B!R:6=H=#L@=&5X=UI;F1E;G0Z(#!P=#L@


3!P=#L@;6%R9VEN+7)I

#LD+3PO9&EV/CPO=&0^/'1D('9A;&EG;CTS1'1O



Q



@
M;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@



Q-C`[)T\+V1I=CX\+W1D/CQT9!V
M86QI9VX]

T0G=VED=&@Z(#$E.R!D:7-P;&%Y.B!I;FQI

M
3!P=#LG/B8C
'0M86QI9VXZ(')I9VAT
M.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI


T0G=VED=&@Z(#$E


3!P=#LG/B8C
'0M86QI9VXZ(')I9VAT.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE


M7S=F.&$W
F(Y7V(W-F%?-&5C85]A9#9E7S4Y96$P
C(P9C`W9@T*0V]N=&5N





]

T1)

M97

]
T1T:#Y$96
N(#
Q




M





M97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z

#L\+V1I=CX\9&EV('-T




M


@




3!P=#LG
M/B8C


@;F5W(')O;6%N
M.R!M87)G:6XM;&5F=#H@




@;F5W(')O;6%N.R!F

!S;VQI9#L@=VED

T0G=&5X=UA;&EG;CH@8V5N=&5R.R!T
M97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ


T0G=VED



M




@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@
'!T.R!F;VYT+7-I


Q-C`[)#(W+#4W-3PO

B4[


Q-C`[(#PO=&0^/'1D(&%L:6=N/3-$

24[)SX\9&EV

'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!M87)G:6XM

38P.R0T
BPX
S$\+V1I=CX\+W1D/CPO='(^/'1R
M(&)G8V]L;W(]
T1W:&ET93X\=&0@86QI9VX]
T1L969T('9A;&EG;CTS1'1O



F4Z(#$P<'0[)SXF(S$V,#L@/]T9#X\=&0@
M86QI9VX]


@
M;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@



Q-C`[
2PX-S
\+V1I=CX\+W1D/CPO
M='(^/'1R(&)G8V]L;W(]
F4Z(#$P<'0[(&UA<F=I;BUR:6=H=#H@,'!T
M.R<^5V]R:RUI;BUP<F]C97-S/]D:78^/]T9#X\=&0@86QI9VX],T1R:6=H
M=!V86QI9VX]


M;&4]




@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@
'!T.R!F


Q-C`[-C0L
M



M

M9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T

38P.S0W-2PR-34\+V1I=CX\+W1D






3!P=#L@;6%R9VEN+7)I9VAT.B`P





Q-C`[(#PO=&0^/'1D('9A;&EG

3$E.R!D:7-P;&%Y.B!I;FQI;F4[

3!P
M=#LG/B8C

M86QI9VX]







M9&]U8FQE.R!W:61T:#H@




#LD

M:61T:#H@


Q-C`[(#PO=&0^/'1D





F(Y7V(W-F%?-&5C85]A9#9E7S4Y96$P
C(P9C`W



]
T1R97!O


T0Q/C$R($UO

#$S/&)R/CPO=&@^#0H@




]


@3F5W(%)O;6%N)RP@5&EM
M97
6QE/3-$)W1E
'0M:6YD96YT.B`P<'0[(&1I<W!L87DZ(&)L

@3F5W(%)O;6%N.R!M87)G:6XM;&5F
M=#H@


M070@1&5C96UB97(@


T0G



M)B
Q-C`[/]D:78^/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!J=7-T:69Y
M.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE



!S='EL93TS1=W:61T:#H@
3`P)3L@
M9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE.B`Q
'!T




M(S$V

M;&4]
T0G=&5X=UA;&EG;CH@8V5N=&5R.R!T97AT+6EN9&5N=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@




M


M=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE.B`Q

M)B



M(')I9VAT.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N
M=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@
M9F]N=US:7IE.B`Q

BPQ
M



M/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!R:6=H=#L@=&5X=UI;F1E;G0Z


3!P=#L@;6%R

C8L-#
R/]D:78^/]T9#X\+W1R/CQT





@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@
'!T.R!F;VYT


BPY
#0L


@;F5W(')O;6%N

#L@/]T9#X\=&0@86QI9VX],T1R
M:6=H=!V86QI9VX]

T0G=VED=&@Z(#$Q)3LG/CQD:78@



M.B!L969T.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N
M=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@
M9F]N=US:7IE.B`Q





T0G=VED=&@Z(#(E


3!P=#LG/B8C


M;&4]
T0G=VED=&@Z(#











M-#`L
C


@

#L@/]T9#X\=&0@
M86QI9VX],T1R:6=H=!V86QI9VX]

T0G=VED=&@Z(#$Q





T0G=VED=&@Z(#0E.R!D:7-P;&%Y


3!P=#LG/B8C












3!P=#L@;6%R9VEN+7)I9VAT.B`P

C8Y+#0Q





M+V1I=CX\+W1D/CPO='(^/'1R(&)G8V]L;W(]



@;F5W(')O
M;6%N.R!M87)G:6XM;&5F=#H@

M;BUR:6=H=#H@


T1R


@;F5W(')O;6%N.R!M87)G:6XM;&5F
M=#H@


M)#$L.#`P+#



Q-C`[(#PO=&0^





F(Y7V(W-F%?-&5C85]A9#9E7S4Y96$P
C(P9C`W



]
T1R97!O



3XQ
B!-;VYT:'
@16YD960\

M87-S/3-$=&@^1&5C+B`S
2P@
C`Q

]
T1P

]
T1T97AT

M=&]P/D%C8W)U960@97AP96YS97
@86YD(&]T:&5R/]T9#X-B`@(`@(`@

M9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ(%1I;65S
M($YE=R!2;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T



T0G
M=VED=&@Z(#$P





M9VX]

T0G=VED=&@Z(#(E.R!D:7-P;&%Y.B!I;FQI;F4[

3!P
M=#LG/B8C


@;F5W(')O
M;6%N.R!M87)G:6XM;&5F=#H@



M


M=B!S='EL93TS1=T97AT+6%L:6=N.B!L969T.R!T97AT+6EN9&5N=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA

\+V1I=CX\



T1R


@;F5W(')O;6%N
M.R!M87)G:6XM;&5F=#H@

M:6=H=#H@

Q-C`[)#
R+#`R




@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@
'!T




T1T;W`@

T0G=VED=&@Z(#(E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M

3!P=#LG/B8C
38P



M
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!M87)G

@86YD(&]T:&5R/]D
M:78^/]T9#X\=&0@86QI9VX]



@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@
'!T.R!F;VYT





@;F5W(')O

#L@/]T9#X\=&0@86QI9VX]
M,T1R:6=H=!V86QI9VX]

T0G=VED=&@Z(#$Q)3LG/CQD





@;F5W(')O;6%N.R!F;VYT+7-I




M87DZ(&EN;&EN93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N
M=US:7IE.B`Q





3!P=#LG/B8C




24[

M=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!M

38P.R0Q-S
L-3
T/]D:78^/]T9#X\

M.65A
#(R






M;VYG/D1%4DE6051)5D4@3$E!0DE
251)15



]
T1R93X-B`@(`@




'!T



'!T.R!M87)G


T0G=&5X



M/'1A8FQE(&-E;&QP861D:6YG/3-$




M=&5R.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N
M=US:7IE.B`Q

@
M;V8@9&5R:79A=&EV92!F:6YA;F-I86P@:6YS=')U;65N='
\+V1I=CX\+W1D

M86QI9VX]

T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@
G!X
M('-O;&ED.R!W:61T:#H@

@;F5W(')O


M(&EN;&EN93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US
M:7IE.B`Q


3$E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY

3!P=#LG/B8C
38P.R`\

T1T;W`@




M


Q-C`[(#PO=&0^/'1D




M;BUR:6=H=#H@

3(O
S$O
3


T0G8F]R9&5R
M+6)O='1O;3H@8FQA8VL@
G!X('-O;&ED.R!W:61T:#H@



'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q



M

M9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T

38P.R0Y-2PP-#D\+V1I=CX\+W1D






3!P=#L@;6%R9VEN+7)I9VAT.B`P

#LD-BPV
C8L





3$E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O

3!P=#LG
M/B8C

M9VX]






M9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T

38P.R8C



24[)SX\

M
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!M87)G






#LQ
M+#
Y.2PQ
C8\+V1I=CX\+W1D/CPO='(^/'1R(&)G8V]L;W(]
T1W:&ET93X\




T0G=VED=&@Z(#(E.R!D:7-P


3!P=#LG/B8C

M


M=B!S='EL93TS1=T97AT+6%L:6=N.B!L969T.R!T97AT+6EN9&5N=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA


T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@




24[)SX\9&EV

'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!M87)G:6XM

38P.R0X+#`R-2PS.#$\+V1I=CX\+W1D/CPO='(^
M/'1R(&)G8V]L;W(]

M)W=I9'1H.B`S



M;&4]
T0G=VED=&@Z(#(E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY

3!P=#LG/B8C
38P.R`\

M/3-$(V-C965F9CX\=&0@86QI9VX]


M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N

T1T







T0G=VED=&@Z(#
P)3LG/CQD

T0G=&5X=UA;&EG;CH@;&5F=#L@=&5X=UI;F1E;G0Z(#!P


3!P=#L@;6%R9VEN

M=F%L=6%T:6]N/]D:78^/]T9#X\=&0@86QI9VX]


@;F5W(')O;6%N.R!M87)G:6XM;&5F
M=#H@


M)B
Q-C`[*#DV-BPW
S8I/]D:78^/]T9#X\=&0@=F%L:6=N/3-$=&]P('-T



#L@
M/]T9#X\=&0@86QI9VX],T1R:6=H=!V86QI9VX]

T0G


M
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!M87)G




@;F5W(')O;6%N.R!M87)G
M:6XM;&5F=#H@

M






#LH

F4Z(#$P<'0[)SXF(S$V,#L@/]T9#X\=&0@=F%L:6=N/3-$=&]P('-T



Q-C`[

B4[(&1I


Q-C`[(#PO=&0^/'1D('9A;&EG;CTS1'1O

3$E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M

3!P=#LG/B8C
M
38P.R`\+W1D/CPO='(^/'1R(&)G8V]L;W(]



@;F5W(')O
M;6%N.R!M87)G:6XM;&5F=#H@

M;BUR:6=H=#H@


M9#X\=&0@86QI9VX]


@;F5W(')O
M;6%N.R!M87)G:6XM;&5F=#H@

M;BUR:6=H=#H@

Q-C`[)#@L
#(U+#
X


M83`R
C!F
#=F#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T
Z+S=F.&$W
M
F(Y7V(W-F%?-&5C85]A9#9E7S4Y96$P

M965T

M(G5S+6%S8VEI(@T*#0H\:'1M;#X-B`@/&AE860^#0H@(`@/$U%5$$@:'1T


^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@

$4Q04%#/@T*(`@(`@/'1R/@T*(`@(`@




]



M9SY35$]#2R!/4%1)3TX@4$Q!3B!!3D0@5T%24D%.5%



T1T;W`^4W5M

'0M:6YD96YT

'!T.R!M87)G






@:7-S=65D(&)Y('1H92!#
M;VUP86YY(&%S(&]F($1E8V5M8F5R(#
Q+`R,#$S(&%N9`R
#$R(&%R92!A


T0G=VED=&@Z(#$P






3(O
S$O
3
\+V1I=CX\+W1D

M86QI9VX]

T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@
G!X


3!P=#LG/B8C


T0G8F]R9&5R
M+6)O='1O;3H@8FQA8VL@
G!X('-O;&ED.R!W:61T:#H@.24[)SX\9&EV('-T



3(O
S$O
3(\+V1I=CX\


T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@
M


3!P=#LG/B8C
38P.R`\+W1D/CPO='(^/'1R
F4Z(#$P<'0[)SXF(S$V,#L@/]T9#X\=&0@=F%L:6=N/3-$=&]P('-T



#L@


T0G=&5X=UA;&EG;CH@8V5N=&5R.R!T97AT+6EN9&5N=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R

B!V86QI9VX]
T1T

T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@
G!X('-O;&ED.R!W
M:61T:#H@

B!V86QI9VX]

T0G8F]R9&5R
M+6)O='1O;3H@8FQA8VL@
G!X('-O;&ED.R!W:61T:#H@


'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!F;VYT+7=E


M969T.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N
M=US:7IE.B`Q

M(&%T(&)E9VEN;FEN9R!O9B!Y96%R/]D:78^/]T9#X\=&0@=F%L:6=N/3-$



M(S$V
#L@/]T9#X\=&0@86QI9VX],T1R:6=H=!V86QI9VX]

M;&4]




@
M;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@



Q-C`[)#$N-#8\+V1I=CX\+W1D/CQT



'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE
M9G0Z(#!P=#L@9F]N=US:7IE.B`Q

M/B8C


M.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US
M:7IE.B`Q






@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@
'!T.R!F;VYT



M9VX]



@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@
M


Q
M-C`[-C4P+#`P



Q-C`[(#PO=&0^





'0M:6YD96YT.B`P<'0[(&1I<W!L

@;F5W(')O;6%N.R!M87)G
M:6XM;&5F=#H@

M




#L@
M/]T9#X\=&0@86QI9VX],T1R:6=H=!V86QI9VX]

T0G




M
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!M87)G

38P.R0Q+C(X/]D:78^/]T9#X\=&0@=F%L




#L@/]T9#X\=&0@86QI9VX],T1R:6=H=!V86QI9VX]
T1T





M
#LH-#DP+#0R-D\+V1I=CX\+W1D/CQT9!V86QI9VX]

M
T0G=VED=&@Z(#(E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T

3!P=#LG/B8C
38P.R`\+W1D


M86QI9VX]


M



3!P=#L@;6%R9VEN+7)I9VAT.B`P






#LH




M97
@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@



Q-C`[)#$N-#
\+V1I=CX\+W1D



'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN
M+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q

M=#LG/B8C
38P.R@S
S4L-30Q*3PO9&EV/CPO=&0^/'1D('9A;&EG;CTS1'1O



Q




R4[)SX\


@;F5W(')O
M;6%N.R!M87)G:6XM;&5F=#H@

M;BUR:6=H=#H@



@;F5W(')O;6%N.R!M87)G
M:6XM;&5F=#H@

M

Q-C`[*#




M


Q-C`[(#PO=&0^/'1D(&%L:6=N












M;&4]
T0G=VED=&@Z(#DE.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY

3!P=#LG/B8C
38P.R`\



M9VXZ(')I9VAT.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P
M=#L@9F]N=US:7IE.B`Q

38P
M.S(S+#
Y
BPX


T0G=VED=&@Z(#DE.R!D:7-P;&%Y


3!P=#LG/B8C
38P.R`\+W1D/CPO='(^/'1R(&)G8V]L;W(]
T0C
F4Z(#$P<'0[)SXF(S$V,#L@/]T9#X\=&0@=F%L:6=N/3-$



M(S$V


Q-C`[(#PO=&0^/'1D('9A;&EG


M9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE.B`Q
'!T




Q-C`[(#PO=&0^/'1D('9A


M93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE.B`Q
M




Q-C`[(#PO=&0^/'1D


M;&EN93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE
M.B`Q



Q-C`[(#PO=&0^



'0M:6YD96YT.B`P<'0[(&1I<W!L87DZ

@;F5W(')O;6%N.R!M87)G:6XM
M;&5F=#H@

'!T

M86QI9VX]

T0G=VED=&@Z(#(E.R!D:7-P;&%Y.B!I;FQI

M
3!P=#LG/B8C


M9VX]





@;F5W(')O
M;6%N.R!M87)G:6XM;&5F=#H@

M;BUR:6=H=#H@

Q-C`[)#$N-#8\+V1I=CX\+W1D/CPO='(^/'1R
M(&)G8V]L;W(]
F4Z(#$P<'0[)SXF(S$V,#L@/]T9#X\


@;F5W(')O;6%N.R!F;VYT+7-I



Q-C`[(#PO


M87DZ(&EN;&EN93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N
M=US:7IE.B`Q



Q-C`[

B4[(&1I


Q-C`[(#PO=&0^/'1D('9A;&EG;CTS1'1O


Q

B4[


Q-C`[(#PO=&0^/'1D('9A;&EG;CTS

M=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE.B`Q

M)B


R4[)SX\


@;F5W(')O
M;6%N.R!M87)G:6XM;&5F=#H@

M;BUR:6=H=#H@


B4[


Q-C`[(#PO=&0^/'1D(&%L:6=N/3-$



'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE
M9G0Z(#!P=#L@9F]N=US:7IE.B`Q

M/B8C
38P.S$V+#8X.PR-C4\+V1I=CX\+W1D/CQT9!V86QI9VX]
T1T;W`@

T0G=VED=&@Z(#(E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M

3!P=#LG/B8C
38P




T1R





]

]

M.B`G5&EM97
@3F5W(%)O;6%N)RP@5&EM97



M97
@3F5W(%)O;6%N.R!M87)G:6XM;&5F=#H@



M=7

@
M;V8@1&5C96UB97(@
S$L(#(P
3
@86YD(#(P
3(@87)E(&%S(&9O;&QO=W
Z
M/]D:78^/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT
M+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P


'0M:6YD96YT.B`P<'0[(&1I



T0P


@;F5W



T0G=VED


3!P=#LG/B8C


@;F5W(')O;6%N.R!M
M87)G:6XM;&5F=#H@


Q+S$S/]D:78^/]T


@;F5W(')O;6%N.R!F


T0G=&5X=UA
M;&EG;CH@8V5N=&5R.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z


T1B;W1T

T0G=VED=&@Z(#(E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M

3!P=#LG/B8C
M


@;F5W(')O;6%N
M.R!M87)G:6XM;&5F=#H@


M97

M86QI9VX]

T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@
M


M;BUR:6=H=#H@









M(&EN;&EN93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US
M:7IE.B`Q

Q-C`[(#PO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S

M+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
M


C

M1=T97AT+6%L:6=N.B!L969T.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN

T1R:6=H


@;F5W(')O;6%N
M.R!M87)G:6XM;&5F=#H@

M:6=H=#H@

Q-C`[-RPW





#L@/]T9#X\=&0@86QI9VX],T1R:6=H=!V86QI9VX]
M





M)SXF(S$V
#LD
2XP
3PO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S


M9VAT.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N
M=US:7IE.B`Q

38P.S4L-C0U
M+#(P



M97
@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@



Q-C`[)#$N
3`\+V1I=CX\+W1D
M/CPO='(^/'1R(&)G8V]L;W(]
T1W:&ET93X\=&0@86QI9VX]
T1L969T('9A

'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R
M9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q





T0G
M=VED=&@Z(#(E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE

3!P=#LG/B8C
38P.R`\+W1D/CQT
M9!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T

M+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
M

38P.R0Q+C8W/]D:78^/]T


@;F5W(')O;6%N.R!F

#L@/]T9#X\=&0@86QI9VX],T1R:6=H
M=!V86QI9VX]

T0G=VED=&@Z(#$P)3LG/CQD:78@








T0G=VED=&@Z(#(E


3!P=#LG/B8C
38P.R`\+W1D/CQT9!A;&EG;CTS
M1')I9VAT('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@

M/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!R:6=H=#L@=&5X=UI;F1E;G0Z


3!P=#L@;6%R

#LH
CDS+#8U
D\+V1I=CX\+W1D/CQT
M9!V86QI9VX]

T0G=VED=&@Z(#(E.R!D:7-P;&%Y


3!P=#LG/B8C


'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R
M9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q

M(#!P=#LG/B8C
38P.R0P+CDX/]D:78^/]T9#X\=&0@=F%L:6=N/3-$8F]T



M(S$V
#L@/]T9#X\=&0@86QI9VX],T1R:6=H=!V86QI9VX]
T1B;W1T;VT@





M=&EM97

#L@/]T
M9#X\=&0@86QI9VX],T1R:6=H=!V86QI9VX]

T0G


M93H@

#LD
2XP.3PO9&EV


R4[)SX\9&EV


@;F5W(')O;6%N
M.R!M87)G:6XM;&5F=#H@

M:6=H=#H@



@;F5W(')O;6%N.R!M
M87)G:6XM;&5F=#H@

M=#H@

Q-C`[*#(X+#`P
D\+V1I=CX\+W1D/CQT9!V86QI9VX]
M

T0G=VED=&@Z(#(E.R!D:7-P;&%Y.B!I;FQI;F4[

3!P
M=#LG/B8C

M86QI9VXZ(')I9VAT.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z
M(#!P=#L@9F]N=US:7IE.B`Q

M


M=&EM97

#L@/]T
M9#X\=&0@86QI9VX],T1R:6=H=!V86QI9VX]

T0G






B4[


Q-C`[(#PO=&0^/'1D(&%L:6=N/3-$



'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN
M+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q

M=#LG/B8C

CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O



Q-C`[(#PO=&0^/'1D('9A

M;W5B;&4[('=I9'1H.B`Q




Q-C`[(#PO=&0^


F4Z(#$P<'0[)SXF(S$V,#L@/]T9#X\=&0@=F%L:6=N






Q-C`[(#PO=&0^



Q


3`E.R!D:7-P;&%Y.B!I;FQI

M
3!P=#LG/B8C


T0G=VED=&@Z(#DE.R!D:7-P


3!P=#LG/B8C
38P.R`\+W1D/CPO='(^/'1R(&)G8V]L;W(]
M




T0G=VED=&@Z(#(E


3!P=#LG/B8C
38P.R`\+W1D/CQT9!A;&EG;CTS
M1')I9VAT('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=W:61T:#H@.24[)SX\

M
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!M87)G

38P.R0Q+C$V/]D:78^/]T9#X\=&0@=F%L




#L@/]T9#X\=&0@86QI9VX],T1R:6=H=!V86QI9VX]
M

T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@-'!X(&1O


M=&0@86QI9VX]



@;F5W


M;&EN93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE
M.B`Q

Q-C`[(#PO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL




Q-C`[(#PO=&0^/'1D('9A;&EG;CTS1&)O

M:#H@


3!P=#LG/B8C


M;&4]
T0G=VED=&@Z(#DE.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY

3!P=#LG/B8C
38P.R`\
M+W1D/CPO='(^/'1R(&)G8V]L;W(]


@


M(&EN;&EN93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US
M:7IE.B`Q

Q-C`[(#PO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S




Q-C`[(#PO=&0^/'1D('9A;&EG;CTS

M:61T:#H@
3`E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE

3!P=#LG/B8C
38P.R`\+W1D/CQT

T1B;W1T;VT@

T0G=VED=&@Z(#DE.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M

3!P=#LG/B8C
38P
M.R`\+W1D/CPO='(^/'1R(&)G8V]L;W(]
T1W:&ET93X\=&0@86QI9VX]
T1L

'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!M87)G:6XM


T0G=VED=&@Z(#(E


3!P=#LG/B8C
38P.R`\+W1D/CQT9!A;&EG;CTS
M1')I9VAT('9A;&EG;CTS1&)O='1O;2!S='EL93TS1=B;W)D97(M8F]T=&]M





3!P=#L@;6%R9VEN+7)I9VAT.B`P




M=&0@86QI9VX]


@;F5W(')O
M;6%N.R!M87)G:6XM;&5F=#H@

M;BUR:6=H=#H@

Q-C`[-RPU.#(L
#(R/]D:78^/]T9#X\=&0@


@;F5W(')O;6%N.R!F;VYT+7-I

#L@/]T9#X\=&0@86QI9VX],T1R:6=H=!V86QI
M9VX]





3!P=#L@;6%R9VEN+7)I9VAT.B`P

#LD
2XP


M9VX]



3!P=#LG/CQT86)L93X\='(^/'1D('9A;&EG;CTS1'1O

S
E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M

3!P=#LG/CPO






C`Q
SPO9&EV/CPO=&0^/'1D('9A;&EG


M9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE.B`Q
'!T



B4[)SX\9&EV



C`Q
CPO9&EV/CPO



M)W=I9'1H.B`Q






@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@
'!T


S@\
M+V1I=CX\+W1D/CPO='(^/'1R(&)G8V]L;W(]
T1W:&ET93X\=&0@86QI9VX]
M

S

M=B!S='EL93TS1=T97AT+6%L:6=N.B!L969T.R!T97AT+6EN9&5N=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA


B4[)SX\9&EV

XX,24\+V1I=CX\+W1D/CQT9!V86QI
M9VX]

T0G=VED=&@Z(#
E.R!D:7-P;&%Y.B!I;FQI;F4[

3!P
M=#LG/B8C

M97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE
M.B`Q

S0@+2`P+C0R)3PO9&EV



@;F5W(')O;6%N
M.R!M87)G:6XM;&5F=#H@

M:6=H=#H@



T0G=VED=&@Z(#$R)3LG

T0G=&5X=UA;&EG;CH@8V5N=&5R.R!T97AT+6EN9&5N
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE

T1T;W`@

T0G=VED=&@Z(#








@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@
'!T.R!F;VYT+7-I


BXV.34\+V1I=CX\+W1D


M;&4]

T0G=&5X=UA;&EG;CH@
M8V5N=&5R.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N
M=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@


'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!M87)G:6XM


'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q



M97
@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@



#
E/]D:78^/]T





@3F5W
M(%)O;6%N.R!M87)G:6XM;&5F=#H@





T0G=VED=&@Z(#$P








M

M=&EM97





#L@





@;F5W(')O;6%N.R!M87)G:6XM;&5F
M=#H@


'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN
M+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!F;VYT+7=E:6=H=#H@8F]L



M;&EN93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE
M.B`Q



Q-C`[(#PO=&0^

M

T0G=VED=&@Z(#(E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O

3!P=#LG
M/B8C

M9VX]

T0G=VED=&@Z(#
E.R!D:7-P;&%Y.B!I;FQI;F4[

3!P
M=#LG/B8C

3H@
M=&EM97
@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@





Q-C`[(#PO=&0^




T0G=VED=&@Z(#
E.R!D:7-P


3!P=#LG/B8C


T0G=VED

@



T0G=&5X=UA;&EG;CH@8V5N=&5R
M.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI
F4Z(#$P<'0[)SXF(S$V,#L@/]T


T0G=&5X=UA;&EG;CH@8V5N=&5R.R!T97AT+6EN9&5N=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA




@;F5W(')O;6%N.R!M87)G:6XM;&5F
M=#H@







M97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE
M.B`Q



M97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE
M.B`Q




T0G8F]R
M9&5R+6)O='1O;3H@8FQA8VL@
G!X('-O;&ED.R!W:61T:#H@.24[)SX\9&EV




M

T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@
G!X('-O;&ED









M

T0G=VED=&@Z(#
E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O

3!P=#LG
M/B8C
'0M86QI9VXZ(&-E;G1E<CL@=&5X=UI;F1E;G0Z(#!P=#L@



M


T0G=&5X
M=UA;&EG;CH@8V5N=&5R.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE



T0G=&5X=UA;&EG;CH@8V5N=&5R.R!T97AT+6EN9&5N=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA



T0G=VED=&@Z(#
E.R!D:7-P


3!P=#LG/B8C

M;CH@8V5N=&5R.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P
M=#L@9F]N=US:7IE.B`Q

38P


@


'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R
M9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q

M(#!P=#LG/B8C



T0G=VED=&@Z

T0G=&5X=UA;&EG;CH@8V5N=&5R.R!T97AT
M+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I


T0G=&5X=UA;&EG;CH@
M8V5N=&5R.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N
M=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@



T1T;W`@

T0G=VED=&@Z(#
E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M

3!P=#LG/B8C
38P

M=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!M

38P.R0Q+C8W/]D:78^/]T9#X\=&0@





M.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US
M:7IE.B`Q

38P.S(L
S(Q+#`S


C


T1T;W`@

T0G=VED=&@Z(#(E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M

3!P=#LG/B8C
38P


@;F5W
M(')O;6%N.R!M87)G:6XM;&5F=#H@



Q-C`[
3(U+#`P
#PO9&EV/CPO=&0^/'1D


M;&EN93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE
M.B`Q

3H@8FQO8VL[(&9O;G0M9F%M



#LT+C8\+V1I

T1T


T0G=&5X=UA
M;&EG;CH@8V5N=&5R.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z


M;&4]
T0G=&5X=UA;&EG;CH@8V5N=&5R.R!T97AT+6EN9&5N=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@


M8V5N=&5R.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N
M=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@
M9F]N=US:7IE.B`Q

38P.SDL


M97AT+6%L:6=N.B!C96YT97([('=I9'1H.B`S)3L@9F]N=UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9F]N=US:7IE.B`Q

Q-C`[(#PO=&0^


T0G=&5X=UA;&EG;CH@8V5N=&5R
M.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI




3!P=#L@

#LD
2XQ-SPO9&EV/CPO=&0^/'1D

M9'1H.B`S)3L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US
M:7IE.B`Q



T0G=&5X=UA
M;&EG;CH@8V5N=&5R.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z

M9&EV/CQD:78^)B
Q-C`[/]D:78^/&1I=B!S='EL93TS1=T97AT+6%L:6=N



2P@
C`Q




'!T


M


M







Q

B4[


Q-C`[(#PO=&0^/'1D('9A;&EG;CTS

M=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE.B`Q

M)B

M


Q-C`[(#PO=&0^/'1D('9A;&EG
3H@



M86QI9VX]

T0G=VED=&@Z(#
E.R!D:7-P;&%Y.B!I;FQI

M
3!P=#LG/B8C
F4Z(#$P<'0[)SXF(S$V,#L@/]T9#X\


@;F5W(')O;6%N.R!F;VYT+7-I



M


Q-C`[(#PO=&0^/'1D('9A;&EG


M9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE.B`Q
'!T




Q-C`[(#PO=&0^/'1D('9A


M93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE.B`Q
M




M93H@




@;F5W(')O;6%N
M.R!M87)G:6XM;&5F=#H@



@;F5W(')O;6%N.R!F


M9'1H.B`R


Q-C`[(#PO=&0^/'1D


M;&EN93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE
M.B`Q



Q-C`[(#PO=&0^


M(&EN;&EN93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US
M:7IE.B`Q

3H@8FQO8VL[(&9O;G0M



24[



M


Q-C`[(#PO=&0^/'1D('9A;&EG

M9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE.B`Q
'!T




T0G=VED=&@Z(#(E.R!D:7-P


3!P=#LG/B8C



@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@
'!T




T0G=VED=&@Z(#@E
F4Z(#$P<'0[)SXF(S$V,#L@/]T9#X\=&0@







M;&4]

M9VX]

T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@
G!X('-O
M;&ED.R!W:61T:#H@
C


M9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T


M:61T:#H@


Q-C`[(#PO=&0^/'1D


T0G=&5X=UA;&EG
M;CH@8V5N=&5R.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P
6QE/3-$)V)O<F1E<BUB;W1T

'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R
M9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!F;VYT+7=E:6=H=#H@



M;&EN93L@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE
M.B`Q



T0G=&5X=UA;&EG;CH@8V5N=&5R.R!T97AT+6EN9&5N
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE


@;F5W(')O;6%N.R!M
M87)G:6XM;&5F=#H@

M=#H@



T0G=VED=&@Z(#DE


T0G=&5X=UA;&EG;CH@
M8V5N=&5R.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N
M=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@




@;F5W(')O;6%N.R!M87)G:6XM
M;&5F=#H@

'!T

Q-C`[)#$N







@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@
'!T.R!F;VYT


N
#`\

M





M

T0G=VED=&@Z(#
E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O

3!P=#LG
M/B8C

M+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
M

38P.R0Q+C0Y/]D:78^/]T


@;F5W(')O;6%N.R!F;VYT


M8V5N=&5R.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N
M=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@
M9F]N=US:7IE.B`Q

38P.S(Q
M
PP,#`\+V1I=CX\+W1D/CPO='(^/'1R(&)G8V]L;W(],T0C8V-E969F/CQT
M9!V86QI9VX]



@;F5W(')O;6%N.R!F;VYT+7-I





@
M;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@



Q-C`[-2PV-#4L
C`R/]D:78^/]T


@;F5W(')O;6%N.R!F;VYT

'0M:6YD96YT.B`P<'0[

@;F5W(')O;6%N
M.R!M87)G:6XM;&5F=#H@

M:6=H=#H@


'0M86QI9VXZ(&-E;G1E<CL@
M=VED=&@Z(#$Q)3LG/CQD:78@<W1Y;&4],T0G=&5X=UA;&EG;CH@8V5N=&5R
M.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US
M:7IE.B`Q

38P.S$N
3
\+V1I

T1T

T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@-'!X(&1O=6)L93L@
'0M86QI9VXZ(&-E;G1E<CL@=&5X=UI;F1E;G0Z(#!P=#L@9&ES<&QA


3!P=#L@;6%R9VEN+7)I9VAT.B`P

#LU+#
Q-RPP
#

;V-A=&EO;CH@9FEL93HO+R]#.B\W9CAA
M-S)B.5]B-S9A7S1E8V%?860V95\U.65A
#(R

M:&5E=#


M='`M97%U:78]

]

T0Q(')O=W-P86X]
T0R/CQS=')O



#$S/&)R/CPO=&@^#0H@(`@(`\




M9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ(%1I;65S
M($YE=R!2;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T

Q+`R,#$S+!T


T0G=VED
M=&@Z(#$P



M
T0G=VED=&@Z(#(E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T

3!P=#LG/B8C
38P.R`\+W1D


M9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE.B`Q
'!T



24[)SX\9&EV



3(O
S$O
3
\+V1I

T1T

T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@
G!X('-O;&ED.R!W
M:61T:#H@

M9VX]

T0G=VED=&@Z(#(E.R!D:7-P;&%Y.B!I;FQI;F4[

3!P
M=#LG/B8C
F4Z(#$P<'0[)SXF(S$V,#L@/]T9#X\+W1R

T1L969T('9A;&EG




24[)SX\9&EV('-T

'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q

M:'0Z(#!P=#LG/B8C
38P.R0S
BPX-3(L
S$U/]D:78^/]T9#X\=&0@=F%L




#L@/]T9#X\=&0@86QI9VX],T1R:6=H=!V86QI9VX]
T1T



T1W



Q-C`[(#PO=&0^/'1D('9A;&EG;CTS1'1O

3$E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M

3!P=#LG/B8C
M

M




M)SXF(S$V

M=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!M

Z(%9A;'5A=&EO;B!A;&QO=V%N8V4\




T0G
M=VED=&@Z(#(E.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE

3!P=#LG/B8C
38P.R`\+W1D/CQT

M=CX\+W1D/CPO='(^/'1R(&)G8V]L;W(]
T1W:&ET93X\=&0@=F%L:6=N/3-$

M=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N=US:7IE.B`Q

M)B

M


3!P=#LG/B8C


T0G=VED

@


M97AT+6%L:6=N.B!L969T.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE
M9G0Z(#!P=#L@9F]N=US:7IE.B`Q





24[)SX\9&EV

'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@;6%R9VEN+6QE9G0Z(#!P=#L@9F]N=US:7IE.B`Q
'!T.R!M87)G:6XM



;V-A=&EO;CH@9FEL93HO+R]#.B\W9CAA-S)B.5]B-S9A7S1E
M8V%?860V95\U.65A
#(R

V+FAT;6P-


M@T*/&AT;6P^#0H@(#QH96%D/@T*(`@(#Q-151!(&AT='`M97%U:78]
T1#

]
T13:&]W

M1'1L(&-O;'-P86X]
T0Q(')O=W-P86X]

M5%


]

]



]


@3F5W(%)O;6%N)RP@5&EM97
L



@3F5W(%)O;6%N.R!M87)G:6XM;&5F
M=#H@





@87)E(&%S(&9O;&QO=W
Z/]D
M:78^/&1I=B!S='EL93TS1=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN
M9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@



M87DZ(&)L;V-K.R!M87)G:6XM;&5F=#H@


T0P('-T



@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@
M




@;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@
'!T.R!F

M:'0Z(#!P=#LG/B8C

T0G=&5X=UA;&EG
M;CH@8V5N=&5R.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M9F]N=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P


M.B!L969T.R!T97AT+6EN9&5N=#H@
'!T.R!D:7-P;&%Y.B!B;&]C:SL@9F]N
M=UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@;6%R9VEN+6QE9G0Z(#!P=#L@
M9F]N=US:7IE.B`Q

30\+V1I




T0G=VED=&@Z(#$V)3LG/CQD

T0G=&5X=UA;&EG;CH@;&5F=#L@=&5X=UI;F1E;G0Z(#!P


3!P=#L@;6%R9VEN

#$U/]D:78^/]T9#X\=&0@86QI9VX]
T1R:6=H


@;F5W(')O;6%N.R!M
M87)G:6XM;&5F=#H@

M=#H@


M;&]R/3-$(V-C965F9CX\=&0@86QI9VX]









M9VX]


T0G


T0G=VED



M

#$X/]D:78^/]T9#X\=&0@
M86QI9VX]


@
M;F5W(')O;6%N.R!M87)G:6XM;&5F=#H@





T0G

M97

#L@/]T9#X\
M=&0@86QI9VX],T1R:6=H=!V86QI9VX]

T0G8F]R9&5R
M+6)O='1O;3H@8FQA8VL@-'!X(&1O=6)L93L@=VED=&@Z(#(P)3LG/CQD:78@




F(Y7V(W-F%?-&5C85]A9#9E7S4Y96$P
C(P



]
T1R




M1'1H/D1E8RX@
S$L(#(P
3
\8G(^/]T:#X-B`@(`@(`@/'1H(&-L87-S
M/3-$=&@^1&5C+B`S
2P@
C`Q


]


]








T1T;W`^0V%S

M


]



]
T1P





L

]






]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^




]


Q


]



]



M;&EG871I;VYS(%M


]


]
T1N=6UP/C4P









]



]



M1&5R:79A=&EV92!&:6YA;F-I86P@26YS=')U;65N='
L($QI86)I;&ET:65S
M(%M-96UB97)=/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]







2PP
S$L-#





MB`@(`@(`@/'1D(&-L87-S/3-$;G5M/B@T+#4R,PR




]
T1N=6T^*#
P+#`V





M96P@




]




T1T;W`^1&5R:79A=&EV92!


]





]



]
T1N

M/3-$=&]P/E1O=&%L(&-H86YG92!I;B!D97)I=F%T:79E(&QI86)I;&ET:65S



]



]



]








]

#QS


]



]
M




]
T1R93X-B`@(`@


T1T;W`^1&5R:79A=&EV92!


]



M3&5V96P@



]




T1T;W`^1&5R:79A=&EV
M92!

C4L

3$L
#
Q+#0S


]

C`L


]

]
T1N

]
T1P

]

P
M+#
S

M;G5M/B@S


T1T;W`^1&5R:79A=&EV92!




#(U+#
X

]
M
T1P;!V86QI9VX],T1T;W`^36EN:6UU;2!;365M8F5R73PO=&0^#0H@(`@

]



]
T1R;SX-B`@(`@

M=6P@;&EV97

]
T1T












T1T;W`^17-T:6UA=&5D






]
T1T





]






]
T1R93X-B`@(`@





]
T1T97AT






M



]




]


]

\+W1D/@T*(`@(`@



T1T;W`^075T;VUO8FEL97
@6TUE



M(%M


]



]


]








T1T;W`^

65A<G


M+2TM/5].97AT4&%R=%\W9CAA-S)B.5]B-S9A7S1E8V%?860V95\U.65A
#(R
M


M
M87-C:6DB#0H-CQH=&UL/@T*(`\:&5A9#X-B`@(`\345402!H='1P+65Q





T0Q(')O=W-P86X]







]




BPX







]

M=F%L:6=N/3-$=&]P/D9I;FES:&5D(&=O;V1S/]T9#X-B`@(`@(`@/'1D






]
T1N=6UP/C0V.2PS
M









]

CXQ
B!-;VYT:'

M1&5C+B`S
2P@
C`Q

#$R/&)R/CPO=&@^#0H@(`@(`\+W1R/@T*(`@(`@



M


]
T1N=6UP/B0@
3`L



T1T

M(&-L87-S/3-$;G5M/B@X+#(V.2PT

C@L



M1&YU;7`^
2PX
#`L



]
T1N=6UP/C8X
BPQ
M



]



]




3`L







]





]



]
T1N=6UP/C8L-#(V+#0S



]



]












]
T1N=6UP/C8P
RPQ.#(\

M
#
L






T1T;W`^


]
T1N=6UP/B0@


M96-A7V%D-F5?-3EE83`R
C!F
#=F#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE
M.B\O+T
Z+S=F.&$W
F(Y7V(W-F%?-&5C85]A9#9E7S4Y96$P
C(P9C`W9B]7


^+RH@1&\@3F]T(%)E;6]V92!4

$5:2T%%/@T*(`@(`@

2!R;W=S




]
T1T



M


]









M=6-T:6]N('9O;'5M97


#`L


M('9O;'5M92!R97%U:7)E;65N='


]
T1R93X-


#`P/'-P86X^




]







]

]
T1N
M=6UP/C$P+#`P


]


M9VX]



T1T;W`^0W)E9&ET(&1R87=N(&1O=VX@;6%X:6UU;2!P97(@

#`\



]


]





M92!L:6YE(&]F(&-R961I=`H;W1H97(@=&AA;B!T:&4@)#$P+#`P,!T:&4@

M:&%S92!O9B!I='




M




MCPO:'1M;#X-@T*+2TM+2TM/5].97AT4&%R=%\W9CAA-S)B.5]B-S9A7S1E
M8V%?860V95\U.65A
#(R


T0G


^#0H@(`@(`\


]
T1T
M:#Y$96
N(#

M1'1H/D1E8RX@
S$L(#(P
3(\8G(^/]T:#X-B`@(`@(#PO='(^#0H@(`@




]





3`R+#`P
#QS


M/3-$=&]P/D%C8W)U960@97AP96YS97



]
T1R974^#0H@




;V-A=&EO;CH@9FEL93HO+R]#.B\W9CAA-S)B.5]B
M-S9A7S1E8V%?860V95\U.65A
#(R




M:78]

]
M


M3TY615)424)
12!.3U1%4R!005E!0DQ%(A$971A:6QS*2`H55-$(0I/&)R




]


]
T1T:#Y$96
N(#

]
T1T:#Y-87(N(#



S$L(#(P
3(\8G(^
C`Q
B!#;VYV



]



]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]



]




M






]




]

M(`@(`@/'1D(&-L87-S/3-$=&5X=#XG




I/]T9#X-B`@(`@(`@


]



]

]





M



]






]


]








]





]



]
M
T1N=6UP/B0@





]




]



M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]



]


]
T1R93X-

]
M



]






]





]
T1N=6UP/B0@

]
T1N=6UP/B0@


]
T1T






L($1I

I/]T9#X-B`@(`@(`@/'1D


]






]





]




]
T1T97AT


M;7`^
C`P+#`P




M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]
M







]
M

]

T0R

M;'-P86X]



M(&-O;'-P86X]

M86X]

T0Q

T0Q/C$R($UO


@16YD960\

3X\+W1H

3XQ
B!-;VYT
M:'

M/3-$


#$R/&)R

]
T1T:#Y$96
N(#

]
T1T:#Y$96
N
M(#


3@L(#(P
3

]
T1T:#Y397`N(#

C`Q



M/]T:#X-B`@(`@(`@/'1H(&-L87-S/3-$=&@^1&5C+B`S
2P@
C`Q
SQB


M87-S/3-$=&@^1&5C+B`S
2P@
C`Q


M8G(^/]T:#X-B`@(`@(`@/'1H(&-L87-S/3-$=&@^1&5C+B`S
2P@
C`Q
M


2P@
C`Q


CDL(#(P
3(\8G(^0G)I9VAT;&EN

0R!;365M8F5R73QB


#$R/&)R/D)R:6=H=&QI;F4@5F5N='5R97
@


3$



0R!;365M


M/'1H(&-L87-S/3-$=&@^1&5C+B`S
2P@
C`Q


M97)I97

M(&-L87-S/3-$=&@^1&5C+B`S
2P@
C`Q


2P@
C`Q




M+B`Q-2P@
C`Q





]



]



]




]





T1T;W`^5F%L=64@


]
T1T




]





]





]
T1N=6UP/B0@
RPS



]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^



]
T1T97AT



]
M




]
T1N=6UP/C$Q+#4X
BPY.#





]


]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P



]



]
T1N=6UP/B0@
2XU/'-P




]
T1N=6UP/B0@


]



]



]






]




]




]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]




]
M




]


]
T1T97AT



]
M




]



]


]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^



T1T;W`^



]





]



]



]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P

BPQ

C



]




]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]




]
T1T




]






]


M=F5R=&5D(&EN=&\@8V]M;6]N('-T;V-K/]T9#X-B`@(`@(`@/'1D(&-L




]





]





]


]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P



T1T


]
T1N=6UP/C$W+#0P


]



]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]
T1T97AT



]
M






]





]





]





]

S


]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]
T1T97AT




]




]


M

]
M




]



]



]

@4&%Y86)L

]



]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]
T1T97AT




]



]


]




]


2PX-S$L
#




]




]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^



]



]
T1N=6UP/C$W
M+#0P


]
T1N=6UP/C(Y


]

I/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG


]
T1N



RPS



]





]
T1N=6UP/CDP-RPQ


RPS










]
T1T97AT



]
M




]



]



M@T*+2TM+2TM/5].97AT4&%R=%\W9CAA-S)B.5]B-S9A7S1E8V%?860V95\U
M.65A,#(R,&8P-V8-D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-V8X

C!F

O



04



T0Q/CPO=&@^#0H@(`@(`\+W1R/@T*(`@(`@

#$S/&)R


]





:7%U:61A=&EO;B!D86UA9V5S




]







]


]
T1T

M/3-$=&]P/D%C8W)U960@;&EQ=6ED871E9!D86UA9V5S/]T9#X-B`@(`@

]
T1N=6UP/B0@
S8L


]
T1N




]
T1N=6UP/B0@-S0L




]

3(@36]N=&AS




3(@36]N=&AS($5N

M

]


]
T1T:#Y$96
N(#
Q





M871I=F4@;&EA8FEL:71I97

M/'1H(&-L87-S/3-$=&@^1&5C+B`S
2P@
C`Q



#$S/&)R



]
T1T
M:#Y$96
N(#


#$S


2P@
C`Q



M97

2P@
C`Q



M1F5A='5R97



M259!5$E612!




]




]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]


M/DEN=&5R97-T(')A=&4@;VX@8V]N=F5R=&EB;&4@;F]T97
@*&EN(&AU;F1R
M961T:'


]
T1T97AT



]
M




]





]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]




]
T1T



]





]





]






]




]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]









]
T1N=6UP
M/C$L


]



]





]



]




]



]
T1R;SX-



2PP
S$L-#


]


]




]
T1T



]

]
T1N=6T^*#DV-BPW
M

M;7`^
2PU
30L




]





]








]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$;G5M/B@T+#4R
M

]
M




]




3DI/'-P



]
T1N=6UP/C@L
#(U+#
X




]





]




]



]
M




]




]
T1N=6UP/C4L-#DS
M+#DQ


]





]




]









]




]




]


M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]





]


C4L
C

S


]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P



T1T
M;W`^4')O:F5C=&5D('9O;&%T:6QI='D@8F%S960@;VX@82!H:7-T;W)I8V%L



]



]
T1N=6UP/C$X
BXP



]




]


M8FEL:71Y(&]F(&%N(&5V96YT('1O(&1E9F%U;'0@*&EN(&AU;F1R961T:'
I



]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]
T1T




]



]
T1P

]




]



]
T1T




]



]
T1T97AT




]



]
T1N=6UP/B0@


]



]
T1R;SX-B`@(`@



]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]
T1N=6UP/B0@
M

]
M





]



]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]




]
T1T



]



]




]





T1T;W`^3G5M8F5R



]



]
T1T




]





]


]



M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]
T1T97AT






]





]
T1N=6UP/C(L


]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P








]





]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^



T1T;W`^


]



]



]



]
T1T




]





]




;V-A=&EO;CH@9FEL93HO+R]#.B\W9CAA-S)B
M.5]B-S9A7S1E8V%?860V95\U.65A
#(R




M97%U:78]


]



M9SY%455)5%D@*$1E=&%I;'


@

M
CXQ
B!-;VYT:'







]

]

]

]

]
M

]
T1T


]


]

]

T0S

3@L(#(P
3
\8G(^/]T
M:#X-B`@(`@(`@/'1H(&-L87-S/3-$=&@^2F%N+B`R
BP@
C`Q


#$R/&)R

]
T1T:#Y$96
N(#

C`Q

M(`@(`@/'1H(&-L87-S/3-$=&@^36%R+B`S
2P@
C`Q


M=&@^1&5C+B`S
2P@
C`Q

M/]T:#X-B`@(`@(`@/'1H(&-L87-S/3-$=&@^1&5C+B`S
2P@
C`Q
CQB

M(&-L87-S/3-$=&@^2F%N+B`R
BP@
C`Q





#$R/&)R/D-O;6UO


@6TUE

M
2P@
C`Q

]
T1T
M:#Y$96

]
M


]

C`Q
SQB


#$R/&)R


C@L(#(P
3
\8G(^

]
M
T1T:#Y$96
N(#

M
3(L(#(P
3

M/]T:#X-B`@(`@(`@/'1H(&-L87-S/3-$=&@^1&5C+B`S
2P@
C`Q
SQB


]
T1T:#Y$96
N(#


#$S/&)R/D9O




#(L(#(P

2P@
C`Q


2P@
C`Q


C`Q


]




]



]



]




]




]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]





]




]



]


]









]




]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^

34P+#`P
M

]
T1T





]



]




]
T1T97AT



]
M




]



]



]
T1T




]





]

M/'1D(&-L87-S/3-$=&5X=#Y*86X@

M



]
M




]



]





]




]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]


M(#4V.2PX




]



]



]




]
M
T1N=6UP/C$U



]





]





]



]



]
T1T97AT




]

I

C@L-S
V/'-P86X^


]






]





]





]



]



]
T1R



]





]



]



]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]
T1T97AT







M=FEC97
@8V]S='

]
T1T97AT



]
M




]



]



]

3`L



]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]
T1T97AT



]
M




]




]




]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]







]



]



]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]
T1T97AT



]
M



#`L



]






]





]





]





]



]



#`\





]



]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]
T1T97AT



]
M




]






]




]
T1N=6UP/C$W+#0P
M

]
M




]



]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]
T1T97AT



]
M




]
T1N=6UP/C


]
T1P;!V86QI9VX],T1T;W`^0V]M;6]N('-T;V-K+!P87(@=F%L



]







]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^



]




]




]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^



T1T;W`^



]




]





C`L
M

M;7`^
2PS
#`L




]





]





]


]



]



]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P



]
M




]



]




M(&1E8G0@8V]N=F5R=&5D/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X


]
M




]


3(L



C`X+#`P



]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]




]
T1T



]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]




]
T1T




]



2PW-38L





]


S$L-C0R/'-P86X^


]





]


]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]
T1T97AT



]
M




#0L




]


]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]





]




]






]



]





]





]




]
M







]





]
T1N=6UP/B0@

]








]



]



]






]
T1T




]




]




]




]





]
T1T




]




]



]




]




]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^



T1T;W`^




]




]




]
T1T




]





]





]




]

]
T1T




]



]



]




]




]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^



T1T;W`^


]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]
T1T97AT



]
M







]





]



]




]



]
T1T97AT



]
M





]




]



]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P




]



]




]





]




]




]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]

I/]T9#X-B`@(`@(`@/'1D(&-L87-S



]



]



]





]




]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]




I/]T9#X-B`@(`@(`@/'1D


]



]




]


]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]




]
T1T






]



]




]



M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]




]
T1T



M86QI9VX]




]



]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]
T1T97AT






]





]





]


]

]
T1T97AT



]
M




]



]



]




]








]
T1N=6UP/C$P

]



M



]





]
T1N=6UP/C
L




]



34\



]
T1T



]


]
T1T97AT



]
M




]



]





]




]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]



M='

]
T1T




]





]






]




]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]






]



]




]



]




]
T1T




]




]


]




]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]




]
T1N
M=6UP/C(L



]





]





]


]
T1T97AT



]
M




]



]
T1N=6UP/C$L-S$R+#




]




]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]




I/]T9#X-B`@(`@(`@/'1D(&-L




]
T1N=6UP/C$S


]
T1T97AT



]
M



RPR




]





]




T1T;W`^3G5M


M;G


]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]




]
T1T




]





]





]




]


]



]



]




]




]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]
T1N=6UP
M/CDQ+#0P


]




]



]
M




]



]



]




]



]
T1R93X-

I/]T9#X-B`@




]



]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]
T1T97AT



]
M




]



]



]



]
T1T




]





]





]





]


T1T;W`^



]





]
T1N=6UP/B0@

]



]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]
T1T97AT



]
M




]







]



]




]




]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]





]



]
M
T1N=6UP/C$L


]



]




]




]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]




]
T1T




]



]



]




]




]
T1N=6UP/C@W-2PP
#`\



]
T1T




]


M




]





]





]






]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^



T1T;W`^




]





]





]





]



]



]
T1T



]



]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]
T1T97AT



]
M




]



]



S
L









]


]
T1N=6UP
M/C$L-3`X+#`P


]



]



]




;V-A=&EO;CH@
M9FEL93HO+R]#.B\W9CAA-S)B.5]B-S9A7S1E8V%?860V95\U.65A
#(R
&8P



]



M4D%.5%
@*$1E=&%I;'

@16YD

CXQ
M
B!-;VYT:'





M/3-$

M/'1H(&-L87-S/3-$=&@^075G+B`R

]
T1T:#Y$96
N(#
Q+`R,#$S/&)R/CPO=&@^#0H@(`@

S$L(#(P
3(\8G(^/]T:#X-B`@

]


]
T1R93X-B`@(`@

]




T1T;W`^4W1O8VL@;W!T





]
T1R93X-B`@(`@



]
T1N=6UP/C$S



]
T1R;SX-

]





]






]



]


]

]




]


]



]



]





T1T;W`^0V]M;6]N(%-T;V-K(%M-96UB97)=



]





]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]


RPV
#8L

3DX+#8V
SQS


T1T

@*&EN('-H87)E

]
T1T



]


]





]
M


M:6=N/3-$=&]P/D]U='-T86YD:6YG(&%T(&)E9VEN;FEN9R!O9B!P97)I;V0@

]



]


]
T1N=6UP/C0L


M




]



]
T1N=6T^*#(L



]



]

I/]T9#X-B`@(`@(`@/'1D(&-L



]
T1N=6T^*#




]
T1N=6T^*#$X
RPX.3





]


]







]






]




]
T1N=6UP/B0@


]



]


]


]
T1T97AT






]

]
T1T97AT






]



]





]




]
T1R93X-B`@(`@





M97

W-BPP
#D\




]
T1N=6UP/C
P+#`P



BPS
38L


]
M



@




]
M


]
T1P


]
T1N=6UP/C$W
M
BPP








T1T;W`^0F%S92!N=6UB97(@;V8@=V%R


]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P



]





]

M='


]
T1T










]





]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]






]



]




]

]
T1T



M86QI9VX]




]




]
T1T



]




]




]




]

]





M



]




]




]



]




'0O:'1M



]


]

]
T1T:#Y$96
N(#
Q+`R,#$R/&)R/CPO=&@^#0H@(`@











]




]
T1R93X-

]



T1T;W`^

M1&YU;7`^
BPQ-S8L-3

BPS-30L



C@L




]




T1T;W`^

M97


M+#4X
BPP





]

]
T1N=6UP/B0@

]
M
T1N=6UP/B0@












]
T1N=6UP
M/B0@









]

]



M(`@(`@/'1D(&-L87-S/3-$=&5X=#XG


M






]
T1R








]

]
T1N=6UP/C`N

@


]







]
T1N=6UP/C$P.XP,4\

M
#
N



]




M-S$L




]

]
M



]


]




]
T1N=6UP/C(L



]



]


]
T1N=6UP/B0@
BPS
3@L



]
T1R93X-B`@(`@



T1T;W`^




]




]
T1R93X-B`@(`@




M(#(W


M-3EE83`R
C!F

O4VAE970T.2YH=&UL#0I#;VYT96YT





M;R!.;W0@4F5M;W9E(%1H:7

M;'-P86X]
T0Q(')O=W-P86X]




CXQ
B!-;VYT:'

2P@
M
C`Q

#$R/&)R/CPO=&@^#0H@(`@(`\+W1R/@T*(`@(`@/'1R(&-L87-S



M:&%R97

RPW







]


]
M


]
T1N=6UP/CDL-3
V+#(V



T1T;W`^)#`N
#$@+2`D
M
2XU



]

@


]



]


]
T1N=6UP/B0@
2XU/'-P86X^









@



]


]
T1R93X-


]




T1T;W`^)#$N-3$@+2`D
RXP


]
M

@075T:&]R


]



]



]
T1R;SX-B`@(`@

]
T1N
M=6UP/C(L





]





3`L

RXP
`M(0U
M+C`P(%M-96UB97)=/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG


]







]
T1N=6UP/B0@
RXP



]




I/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$;G5M

C4L



]


@-R!M;VYT:'



]





I/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$;G5M

C4L






]
M

T0Q/C
@36]N=&AS

M1#
^
3(@36]N=&AS($5N9&5D/]T:#X-B`@(`@(`@/'1H(&-L87-S/3-$



!-;VYT:',@16YD960\+W1H/@T*(`@(`@(`\=&@@8VQA

]





]

]
M





]
T1T:#Y$96
N(#

M1'1H/D9E8BX@
3(L(#(P
3


M
2P@
C`Q


]
T1T:#Y*




M
S$L(#(P


]



]
T1T:#Y$96
N(#

#$Q/&)R/DUE8VAA;FEC

M8RX@
S$L(#(P









]



]



]


]
M






]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^

M86QI9VX]


]




]


BPU

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^



]
T1T




]



]
T1N=6UP/C8R+#4P





T1T;W`^06UO=6YT(&%C8W)U960\


]



]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P




]


]
T1N=6UP/C$P+#`P


]




]



]
T1R93X-



]





]




]


]



]




]




]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]
M




]







]




M:'1M;#X-@T*+2TM+2TM/5].97AT4&%R=%\W9CAA-S)B.5]B-S9A7S1E8V%?
M860V95\U.65A,#(R,&8P-V8-D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O

C!F

M:&5E='
O4VAE970U
2YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG


M87-C:6DB#0H-CQH=&UL/@T*(`\:&5A9#X-B`@(`\

T1T97AT+VIA

@

T0Q(')O=W-P86X]
M



]
T1T:#Y$96
N(#

S$L(#(P
M












]


]


\

M.3`L


97-S.B!V86QU871I;VX@86QL;W=A;F-E/]T9#X-B`@(`@
M(`@/'1D(&-L87-S/3-$;G5M/B@S
BPX-3(L



]



M85\T96-A7V%D-F5?-3EE83`R
C!F

O4VAE970U
BYH


M87-C
M:6DB#0H-CQH=&UL/@T*(`\:&5A9#X-B`@(`\345402!H='1P+65Q=6EV






T0Q(')O=W-P86X]


CXQ
B!-;VYT:'

M
2P@
C`Q





]





]
T1N=6UP/B`Q.3




]
T1R:#X-B`@(`@

]
T1T97AT








T1T;W`^4V%L97
@4F5V96YU92P@
M1V]O9'



]



]

]
T1N=6UP/C
V

M86QI9VX]
T1T;W`^4V%L97
@4F5V96YU92P@1V]O9'


]



]

]



T1T;W`^4V%L97
@
M4F5V96YU92P@1V]O9'







T1T;W`^0V]N8V5N=')A=&EO



T1T;W`^06-C;W5N='
@4F5C96EV86)L92!;365M


]



M8V5N=')A=&EO;B!2:7-K(%M


]






M



T1T;W`^




M96-E:79A8FQE(%M-96UB97)=('P@0W5S=&]M97(@0V]N8V5N=')A=&EO;B!2
M:7-K(%M-96UB97)=('P@0W5S=&]M97(@5'=O(%M-96UB97)=/]T9#X-B`@



]




]
T1P;!V86QI9VX],T1T;W`^0V]N8V5N=')A=&EO;B!R:7-K(AI;B!H


M87)T7S=F.&$W
F(Y7V(W-F%?-&5C85]A9#9E7S4Y96$P
C(P9C`W9@T*0V]N





]

M


CXQ
B!-;VYT:'
@16YD960\

M87-S/3-$=&@^1&5C+B`S
2P@
C`Q

#$R/&)R/CPO=&@^#0H@(`@(`\+W1R



]
T1T97AT

M=&]P/C(P

]
T1T

M/3-$=&]P/C(P

]
T1T

M/3-$=&]P/C(P



T1T;W`^
C`Q

]



]



]
M
T1N=6UP/C


]


]

@6TQI


M9VX]



T1T;W`^4F5Q



M-3EE83`R
C!F
#=F#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T
Z+S=F
M.&$W
F(Y7V(W-F%?-&5C85]A9#9E7S4Y96$P


M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-B`@/&AE860^#0H@(`@/$U%5$$@


^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE

$4Q


CX\



]


]


T0Q/C
@36]N=&AS($5N9&5D

2!-
M;VYT:'


3XQ
B!-;VYT:'


2P@
C`Q
M

M


M(#(P





@26YT

@4F5L871I;VYS:&EP(%M-96UB97)=

M87-S/3-$=&@^36%R+B`P-BP@
C`Q

@;&EE;B!O;B!0


M(&-L87-S/3-$=&@^36%R+B`S
2P@
C`Q

@;&EE;B!O


M/'1H(&-L87-S/3-$=&@^1&5C+B`S
2P@
C`Q

@;&EE





@0V]N=&EN9V5N8VEE


]



]





]
T1N=6UP/B0@
C`P+#`P
#QS

]
M
T1N=6UP/B0@
3@U+#`P





]



]





T1T;W`^4V5T=&QE

]
T1T97AT





]
T1N=6UP/B0@
3
L.38X/'-P86X^


]





M;V-A=&EO;CH@9FEL93HO+R]#.B\W9CAA-S)B.5]B-S9A7S1E8V%?860V95\U
M.65A
#(R

T1#;VYT96YT+51Y

]
T13:&]W+FIS/B\J($1O


M86X]
T0Q(')O=W-P86X]



]
M











]




3(@36]N=&AS($5N9&5D

^

]

M1'1H(&-O;'-P86X]
T0Q/C$@36]N=&AS($5N9&5D/]T:#X-B`@(`@(`@

R!-;VYT:'
@16YD960\+W1H

M/3-$=&@^2F%N+B`R
BP@
C`Q

#$R/&)R/CPO=&@^#0H@


]
T1T:#Y$96
N(#

]


S$L(#(P
3












]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]



]

]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P





M86QI9VX]




]




]




]
T1T97AT




]


]
M

]
T1T97AT






]



]
T1R;SX-









]



]





]



]
T1R;SX-B`@(`@




]



]






]




]


M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]
T1T97AT



]
M
T1N=6UP/B0@






]
T1T97AT



]
M
T1N=6UP/C(P



]





]




]
T1N=6UP/C(V+#4W


#`\


M-3@L


]



]



]



]


]



]




T1T;W`^


]



]




;V-A=&EO;CH@9FEL93HO+R]#
M.B\W9CAA-S)B.5]B-S9A7S1E8V%?860V95\U.65A
#(R
&8P-V8O5V]R:W-H


M151!(&AT='`M97%U:78]

]


]





]
T1T:#Y$96
N(#
Q

M
S$L(#(P
3(\8G(^/]T:#X-B`@(`@(`@/'1H(&-L87-S/3-$=&@^1F5B
M+B`Q
2P@

M=V%R9!3;6ET:P@1&ER96-T;W(@86YD(%-H87)E:&]L9&5R(%M-96UB97)=



0R!;365M




2P@


M96-T;W)S(%M-96UB97)=/&)R/CPO=&@^#0H@(`@(`\+W1R/@T*(`@(`@



]
T1T97AT



]

3$T+#DT-#QS

]
T1T97AT


M;7`^


]



]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]
M

I/]T9#X-B`@



]



]
M


]
T1N=6UP/B0@
C`P+#`P


]





]


\


]
T1N=6UP/C(P

]
T1T





]





T1T;W`^36%T=7)I='D@9&%T93PO

]


]
T1T



]


]


BXU




]






]



]



]
T1T97AT





]


M8FQE(&EN(&5V96YT(&]F(&1E9F%U;'0@*&EN(&AU;F1R961T:'





]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^



]


M



;V-A=&EO;CH@9FEL93HO+R]#.B\W9CAA-S)B.5]B-S9A7S1E8V%?860V
M95\U.65A
#(R




M.F]F9FEC92(^#0H@/&\Z36%I;D9I;&4@2%)E9CTS1(N+B]7;W)K8F]O:RYH
M=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,#$N:'1M;(O/@T*(#QO
M.D9I;&4@2%)E9CTS1)3:&5E=#`R+FAT;6PB+SX-B`\;SI&:6QE($A2968]
M
T0B4VAE970P
RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T
#0N

T0B4VAE970P.2YH=&UL(B\^#0H@
M/&\Z1FEL92!(4F5F/3-$(E-H965T
3`N:'1M;(O/@T*(#QO.D9I;&4@2%)E
M9CTS1)3:&5E=#$Q+FAT;6PB+SX-B`\;SI&:6QE($A2968],T0B4VAE970Q
M,BYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,3,N:'1M;(O/@T*
M(#QO.D9I;&4@2%)E9CTS1)3:&5E=#$T+FAT;6PB+SX-B`\;SI&:6QE($A2
M968]
T0B4VAE970Q-2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T
M
38N:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#$W+FAT;6PB+SX-
MB`\;SI&:6QE($A2968],T0B4VAE970Q.YH=&UL(B\^#0H@/&\Z1FEL92!(
M4F5F/3-$(E-H965T
3DN:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E
M=#(P+FAT;6PB+SX-B`\;SI&:6QE($A2968],T0B4VAE970R,2YH=&UL(B\^
M#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,C(N:'1M;(O/@T*(#QO.D9I;&4@
M2%)E9CTS1)3:&5E=#(S+FAT;6PB+SX-B`\;SI&:6QE($A2968]
T0B4VAE
M970R-YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,C4N:'1M;(O
M/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#(V+FAT;6PB+SX-B`\;SI&:6QE
M($A2968]
T0B4VAE970R-RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H
M965T
C@N:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#(Y+FAT;6PB
M+SX-B`\;SI&:6QE($A2968],T0B4VAE970S,YH=&UL(B\^#0H@/&\Z1FEL
M92!(4F5F/3-$(E-H965T
S$N:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3
M:&5E=#
R+FAT;6PB+SX-B`\;SI&:6QE($A2968],T0B4VAE970S,RYH=&UL
M(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,S0N:'1M;(O/@T*(#QO.D9I
M;&4@2%)E9CTS1)3:&5E=#,U+FAT;6PB+SX-B`\;SI&:6QE($A2968]
T0B
M4VAE970S-BYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T

M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#
X+FAT;6PB+SX-B`\;SI&
M:6QE($A2968],T0B4VAE970S.2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$
M(E-H965T-#`N:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#0Q+FAT
M;6PB+SX-B`\;SI&:6QE($A2968]
T0B4VAE970T
BYH=&UL(B\^#0H@/&\Z
M1FEL92!(4F5F/3-$(E-H965T-#
N:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS
M1)3:&5E=#0T+FAT;6PB+SX-B`\;SI&:6QE($A2968],T0B4VAE970T-2YH
M=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T-#8N:'1M;(O/@T*(#QO
M.D9I;&4@2%)E9CTS1)3:&5E=#0W+FAT;6PB+SX-B`\;SI&:6QE($A2968]
M
T0B4VAE970T.YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T-#DN
M:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#4P+FAT;6PB+SX-B`\
M;SI&:6QE($A2968]
T0B4VAE970U
2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F
M/3-$(E-H965T-3(N:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#4S
M+FAT;6PB+SX-B`\;SI&:6QE($A2968],T0B4VAE970U-YH=&UL(B\^#0H@


C!F

 'defref_us-gaap_SubsidiarySaleOfStockLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_ValueOfConvertiblePreferredStockConvertedIntoCommonStock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_ConvertiblePreferredStockSharesIssuableUponConversion'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_PercentageThatTwoMillionPlusWarrantsAreOfTotal'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_AmountReclassifiedToPermanentEquity'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_CarryingValueReclassifiedToPermanentEquityOnDateOfTransaction'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentUnamortizedDiscount'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_ValueOfAccruedDividendsOnConvertiblePreferredStockConvertedIntoCommonStock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PreferredStockSharesOutstanding'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_PreferredStockConversion'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DividendsPayableCurrentAndNoncurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_NumberOfSharesOutstandingPreferredSharesConvertIntoCommonStock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_GainLossOnPreferredStockConversion'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccountingPoliciesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccountingPoliciesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_UseOfEstimates'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RevenueRecognitionPolicyTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventoryPolicyTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxPolicyTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DerivativesPolicyTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DerivativesReportingOfDerivativeActivity'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AdvertisingCostsPolicyTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EarningsPerSharePolicyTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquityPolicyTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_NoteReceivablePolicyTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_NumberOfNonExecutiveDirectors'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_SharesIssuedForServices'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_RecordedLossFromAggregateConversion'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_WarrantsExercisePriceAfterReduction'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_WarrantsExercised'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_CommonStockIssuedForConversionOfWarrantsInShares'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_CompensationExpenseRelatedToFairValueOfWarrantModifications'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_NumberOfSharesIssuedPer10Warrants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_ConversionFactorPerWarrant'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_LiquidatedDamagesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_LiquidationDamages'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_LiquidationDamagesBasePeriod'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_AccruedLiquidatedDamagesNumberOfInvestorsWhoHaveSignedReleaseAndWaiver'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_AccruedLiquidatedDamagesNumberOfInvestorsWhoHaveNotSignedReleaseAndWaiver'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_AccruedLiquidatedDamagesCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_AccruedLiquidatedDamagesNumberOfInvestorsWhoHaveSignedReleaseAndWaiverDuringPeriod'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NonoperatingGainsLosses'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventoryDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_GoingConcernAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_GoingConcernTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PayablesAndAccrualsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_InitialTermOfCustomProcessingAgreement'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_RenewalTermOfCustomProcessingAgreement'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_MonthlyMinimumProductionRequirements'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_AverageMinimumMonthlyProductionVolumes'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_FutureMonthlyProductionVolumeRequirementsMaximum'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_SpecifiedQuantityOfProductOrderedForThreeConsecutiveMonthsForLoanPaybackTerms'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_LineOfCreditFacilityReceivableMaximumBorrowingCapacity'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_LoanAdvances'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_OperatingCostDrawdownForCapitalExpendituresMaximum'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_CreditDrawnDownMaximumPerPeriod'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_DrawdownPeriodThreshold'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_LoanPaybackTerms'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NotesReceivableNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InterestReceivableNoncurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_NoteReceivablePeriodicCollections'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLeasesRentExpenseNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLeasedAssetsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AreaOfRealEstateProperty'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_RequiredMonthlyRentalPayments'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AssetsCurrentAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccountsReceivableNetCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventoryNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AssetsCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AssetsNoncurrentAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NotesAndLoansReceivableNetNoncurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherAssetsNoncurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AssetsNoncurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Assets'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LiabilitiesCurrentAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccountsPayableCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccruedLiabilitiesCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_AccruedLiquidatedDamagesCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DerivativeLiabilitiesCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LiabilitiesCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Liabilities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquityAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockSharesSubscriptions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AdditionalPaidInCapitalCommonStock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RetainedEarningsAccumulatedDeficit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquity'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LiabilitiesAndStockholdersEquity'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquityAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PreferredStockIncludingAdditionalPaidInCapitalNetOfDiscount'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_ChangeInDerivativeLiabilityDueToConversionOfPreferredStock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_ChangeInDerivativeLiabilityDueToExerciseOfWarrants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DerivativesFairValueLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DerivativeLiabilitiesCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_DerivativeLiabilityRollForward'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DerivativeLiabilitiesCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_ChangeInFairValueOfDerivativeLiability'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_ChangeInDerivativeLiabilityConversion'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DerivativeLiabilitiesCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DerivativeLiabilityNotionalAmount'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueAssumptionsExpectedVolatilityRate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueInputsProbabilityOfDefault'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_PercentageInProbabilityOfEventToDefaultPerMonth'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_WarrantsExercisePriceAfterReduction'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_UnexercisedWarrantsDescription'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_BaseNumberOfWarrantsConsideredForAdditionalWarrant'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_NumberOfWarrantsThatNotExercised'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_DebtInstrumentConvertibleNumberOfWarrantsIssued'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_SettlementToAdditionalPaidInCapitalForRelatedDerivativeLiability'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForCash'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProceedsFromIssuanceOfWarrants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetIncomeLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensation'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_SharesIssuedForDirectorFees'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_ExpenseForModificationOfWarrantsPreviouslyIssuedForServices'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AmortizationOfDebtDiscountPremium'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Depreciation'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GainLossOnDispositionOfAssets'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventoryWriteDown'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_UnrealizedGainLossOnDerivatives'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_GainLossOnPreferredStockConversion'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_SettlementLossPayableInCommonStock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherNoncashExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInInventories'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_IncreaseDecreaseInLetterOfCreditOperatingActivities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProceedsFromSaleOfOtherAssets'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProceedsFromStockOptionsExercised'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProceedsFromWarrantExercises'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProceedsFromConvertibleDebt'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SupplementalCashFlowInformationAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_CashLessExerciseOfWarrants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_CashlessExerciseOfOptions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_SharesIssuedForSettlementLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtConversionOriginalDebtAmount1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_PreferredStockConversion'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PreferredStockAccretionOfRedemptionDiscount'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_ChangeInDerivativeLiabilityDueToConversionOfNp'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_ChangeInDerivativeLiabilityDueToExerciseOfWarrants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_ChangeInDerivativeLiabilityDueToConversionOfPreferredStock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DividendsCommonStockCash'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_UnvestedSharesReturnedByVendor'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_DiscountOnConvertibleDebtDueToAttachedWarrants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_DividendsPayableReclassedToEquityWithPreferredStockModification'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_PreferredStockSeriesReclassedToEquityWithModification'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RisksAndUncertaintiesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_MajorCustomersAndCreditConcentrationTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_LitigationContingentLiabilityAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LegalMattersAndContingenciesTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NatureOfOperations'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquityAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockParOrStatedValuePerShare'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockSharesAuthorized'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockSharesIssued'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockSharesOutstanding'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquityAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PreferredStockParOrStatedValuePerShare'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PreferredStockSharesAuthorized'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PreferredStockSharesIssued'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PreferredStockSharesOutstanding'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_DocumentAndEntityInformationAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityRegistrantName'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityCentralIndexKey'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_CurrentFiscalYearEndDate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityWellKnownSeasonedIssuer'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityVoluntaryFilers'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityCurrentReportingStatus'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityFilerCategory'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityPublicFloat'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityCommonStockSharesOutstanding'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_DocumentFiscalYearFocus'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_DocumentFiscalPeriodFocus'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_DocumentType'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_AmendmentFlag'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_DocumentPeriodEndDate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquityNoteAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SalesRevenueNetAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SalesRevenueGoodsNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SalesRevenueNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CostOfRevenueAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CostOfGoodsSold'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventoryWriteDown'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CostOfRevenue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GrossProfit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingExpensesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SellingGeneralAndAdministrativeExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingExpenses'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingIncomeLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NonoperatingIncomeExpenseAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherNonoperatingIncome'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InvestmentIncomeInterest'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InterestExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InterestExpenseDebt'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GainsLossesOnSalesOfOtherAssets'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_ExpenseForModificationOfWarrantsPreviouslyIssuedForServices'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_GainLossOnPreferredStockConversion'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GainLossRelatedToLitigationSettlement'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NonoperatingIncomeExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetIncomeLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PreferredStockDividendsIncomeStatementImpact'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PreferredStockAccretionOfRedemptionDiscount'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EarningsPerShareBasicAndDiluted'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ReceivablesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommitmentsDisclosureTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EquityAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PreferredStockTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PayablesAndAccrualsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtDisclosureTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_LiquidatedDamagesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_LiquidatedDamagesTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_ShareBasedCompensationWarrantsTableTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock'
<div style=font-family: 'Times New Roman'
 Times




MM8-_?KE^
)_1R&AE^\



6J:/-5/&SF5Z`O\HK[8[*D/'V34P&]FL_Y
KXZ-57L/5QSV3E


_*H6MS)[EZF$'&M6A3*M

2'K7::M)X]*8

M+;73T@YYT$





8`)@'U4@29
M=8@[XM*&_




M)I96V#Q=8:4$3.Q+##,Z4%'@(X08`UNEZD#85(.X@Z3\DHGY;M,#0FRK-J


F.7<?=-H-!$-2:]6]


L
I[V%AZDECR7

M7&U3H;G&#KH=G!%D8?_2










P`7=



BQX0.Y;=ZZ@X

QJ[#




)
?:



M)78&EE?



I%HJM'*\^_



H8B0;MP'2EO\/(HG)TEC2T
I[YCG06$




`K%X51;V(BS



M'*H24
H2D0-*RT5IFJ:`TC(L?AU0^E:D@
7G:_$AGB%D/&-7]U9`^%R.\/EN
M\#`]^0*!B.H#$1R/DJ@ZQ)I$8#&[Z)3%+,C),#BZEG,]4P&L%@$%G,\#:?

MUG!/8B9BO8Z]WSX3-QB'+^-
2Y(R/IQ))Z.)9M:9
949`A0.8`)'J(NB4C;L

`%(J/\VN8=G@Z!3PT/6F3L:4R(9

M(O

SD3VS
&=8IB@$P%P\]PS:LHG:4NP9)#]M^=
%4*[2E3%]
M0%/N3E


M35?;ZN$T&$A_'6VIQ66%


M!U=8(L!SJH=


VY)3DG0:8DLH9RBD^
2(V&.D
/O-#WA5:




'A4L/FEJ

M+B'8^VR0`7:^VY(N(6RMZ7)'7TDXE.HKG9-GT6MKA1!AD.^_(N(]N\2YL-B5
MC0\C.L.ED]]3@@WGRB





VV$\8H%\K







91RERE#^&SN*]V-?&2#D_T^+
MLO$)
[M!9\Y6$

M0;GOHS@CQV+WMTV+DT:FED5FIT-%ZL/!NM[


`H2#_9R@NM#E;J3V8G
;K?2TMS/!=T]&:3

DW)?1=!^0UP8+^_4JU@C46;V
M=






M1])3TX(E)G/(4Z03H*2AE]X&KL)Z7I&!XAGY%R$V!.`X

7I:M[U/


:^!ZPUO,91@LR`.9(XV<`[+GA1V!H,<F
MG9'O(KI2MJM;L_HG#1!JBEA

MPAO'NUZ.]\;AJ

M=';XG8*V'A7:VMJ`72)@JG+GN\Y@JOQ#_'O9G;SL97J7OU'5NW=K7&W:PQTR
M/BO0R`^(MW\$\MDLH$03GCLY2XD3O3:VK_MYCR.67



8/_GQ4S2

M2

M;&3&3CS^



LR.

.9G1E_
MO\I^OH@NK28@FU?$.U:2R\O'WQ?,*YG.]:!$;VF00E@+SQ[]SW6F:K:^0!

E\
MRR]&S.WAYG9LJ[:^YF/=D@X7-%E@/5+SL!+3X'R0YG!*E)T!O81RB0.)CYN
M9D5AF3)G^(7A+$A[#J`@R)I!TS%:&PL]X=;X!$
ZTX5UP'48F02*XKRP.6K
M$P'J8?HH#K#Z%
T1
*:





MI^LU6KVYN]7KG4ZO9W3:&ZS^ZAL+!@Y(X23`(R0L/&C[KFN!^I]@PP
\72F(
M4E#

`A\NPI(I8^GZYC/@Z5P^V]@$S#7Q]I&L
M

Y3Q9AT=DHH3H&B





3C==;I-<O!2ZJJI[Y:P9_*WU@0COS`4Y4K^]4*







TI
M)VX`(Q4L!5M/XSAGE








M%34?&BR6PV)G::69ZF%16`O)XJ]C
2ZRUS:P&H8F_K/$;&0S''H!94SUI@OP
M


M$\0`KZA
6/!N%H`4YE[)GE7_(Y?_1+X\23W%JM2)1:
Y4SM'-3OJZU!`_;





M^-HP\





M#1U9+X`W)7H%LD_/AEC4A@K^\$Q[G`V1&F/M#KP2`

M6*S_

&O+/G6F\EZ@9T$
MBP/]Q6KGV%+O_J3XE

YVX\&)A

+Z2H1]F3D'F;`Z`8Z&D



6O
('NV7*\
))7



MHPFCS$5PY+#L8G;B$3^%X
BA&W_UPI84$
\#F4R#L\SAKJ49ND:XPT]K]2!*



5



*;@HL%.9EL^UPQ=NHP+40LKTNKC^

M`9$^)6[6H_5-N0A#%HG\)7#:?DOCPA=87!T#7O-HY:_#V_QE?+50(Z^1/#`_


H*R
[[0S7Y?-SK'UW%ZB;1@
M73/UEFEL#JQ

MYZ4*G*FNVWI3EUMO?KJZO_[MXO'ZMROER_7%Q^LOUX_7S?'UFL?7ERS`.L(S
MN612_EZ8)3*]M^`/YKJ4V\5#]V-*_Y

M


MNQ%OY?-F2IDS2C3
AA:JK)&[9M/-;-Q\J#HIPC`8#3%2`Q;$I._-=OZV
MWX%TGZ_L1VG8[WHJN.HJ^.I%#QD+TR8Q

I

^?KW
J
M=;90+

S)K9'@?
41TE+6AQO'M!9*\![






@N5$0ZRH(WNN8Z&
]Q2XPX@2=


<QZ8GN&*?V1RTID4YPJ[[Q/$Y$;
MX3T.`5IJV]!40^LN(TS?6JV3\WVJ8F=-;&S$Z/.FK&S'R@9-_VK'HG)IWMW





M6VI90\)C(X'$('








MH!3]#F5[%





M`9

A*UL'L4'9N`'_HL`)S









MY%3J3M9

*CU/PD^?U-'Q_)&/8.61Q\SJ8PKFB
AN$X2O)FG6SB3U5


M;215KF:0TN7]ZV6X]`[6R%:-3L7/^Y;+;
.@Y1FT7BJN+GE91^7/\MN?-Z_H






M\J).(=3*1&K=5-8;P?Y8J.M?J7T&[9N1(!:9EH2S)FZ+WFFLADH%)8(O$J




16^;PN
WBC@WY[AO[:=E0

*%L!PT.K

&_T3;73+MLY

MJ(HCJ@JC=.N]QE[NI^V0ULC`T7W&WFXK#+WQ[*!2K'*BY3/Z:KMGJMVES:RJ

@)W+M



MB!XLK
G=WY`JTPO860*;ZPS3.L


9
73&F68`
=.PW[T9W[*:Z
U?O^\VP<G1]=ZC5W;,ZJ[YUV#4&V6-&]O
MZ1PL:PTXTTPS.<E(TS*O:KR+:VP#]ZSY_R;.JU&?F2Y=$2%_7%[JMEN8^=
MGY(,Y)Y;HD%;X='`;,?`K!
@TK^%8/E!XIEOSAATL!P`8A][-_;S^#C!PDY
M*)



6+0Z0
R3'XV4?*LK)^2-

#%Z`
#VUI7=4P^PMZD$






<FV?!5$=<7L7YD&</WZ
O8):I)U*Z;7

M4DWREG9E)NW*VHTM.Q@'ZD8;FT?75N!K9\E*-L.J(*IK9\G

M]
B.=F1O

MU
ZE6\=43$BOU]M;+'REZJMBQ!S.[P5[^+K[LL'G6L^@?&7/V#(^*T*H1M
M;C17SBUM+JM4T+
KGQ92^[MKS8WFYLY(HP\KQY5UU8=UOT%6L?WM&S)$C1YN

&[K*T58[K9KNKD[GWEFKCI9J&R&IFWF#7=H&
M-P/K3*':J3%37V-K5^Y&VHY[BA_[.M:7L99]^C9'L&Q)S7G7MB&F_<SEIYT

MLV?+FOSXR0D'KA_&`;L=7DH@W?/&X)=^&(4/V-SX(T)]9TW'@/3P$0CP$3']



M1)QEK'+I6F&H7-!.\6






$WC$BM)]/-
DD7,/K+3,3H+RJ/(:E*R`)GNBVN#AL
MM49MFSU$KOBL0,_H-C.CT`^FP4417(EZ.^($IWD6$]A4B)/Y6/!8ICDK
M2VA-I1&_=V


MO'4/^L4;.*Y#.N8B^LR`$2TW'3[W\'H6IC5C8;1S4_*2=@!.Q9QU)\X'#(N
M!H,@!FF86-,`7`H2,D`+^=P






S587+M7&L7

$X[


.36M)5\*9



M/4/O_A0JPQ2W3H9;9%80D8AN5N%E;+SZ01]`LD%#N%P[6@/*O@DQE9\Y)'@J

NF*OL!(HU




(A;3#=+\0Z^])TIPOS)=414CNPYXK%]&2DH#J7$W`E1=5^2L9
M`$2`UY$#ZUV*E97BF&/Z\I)6JC0CO955)]6T[U?)D20U/7FNDK4D*RKC8JL0


3\;


H??6X8BS(HO+=W-H=E.
&S\I_R?VT9
0






&6



M23=


MYM##J.R%N8I9
58V4U8V9UDY_?@WAP56
!A-:0EY_N
0T0_F//_61QJZ?5
S
0XU-C0`&XK*J4F!T4A!?:3@S;CO
M2QB\-MS9.Q+G(DWHZJ7;$0;A^6-2
$6FU&CD8+&87DC4K#SS6O5(CD[E():
:3CDAOVJMSC<<E?5(6^4168VQDN.B-:?&CS
MSSB,G.%T[6.;&3BV.;;YR%S_57%Q5)&B5@H=:3T*H<]7Z</;YYI0?I.6G

MZV^N3Q=?GS[!V






VH5^

M2BB[^.:$V6

*0W


M8=3?AJ#HC:#47E!VP/LKY6NQH)AO0U#
&@O*6:??
=O]3B
O!Y.7RHFD8J
M


M7T



JL)%RAHNR['9\-6H&
MB%)9;_3%*^-);T^^:R]



0?
ME??.!T#6P-,HI##@`%+XD8QBJ[R.G(&HQPD8PL`/P7!]38`&@`2`RF*7#.



M(5'XJP!/M@B@T=CZDRDAZ#N2+)AW8DTY\$@FOC0)!LZHGI\CX
AZ87QHX!G




MNIG*P`D&\1B


TK,%;B#J^W@<NSS+(P%^9D306;`O#?QOI+%A
MS'?]CMHQ6FJKW:9%ONOKJM[JJH;63O8,CJIH(\]W$?
;0M2+)XJAA=MK4

@$.(QV(6A6)PF[!<J96N
M[E9&A52IOHMIJ+VVH9IZN]I:_70)H*G]OJ9J;:VL\JYK1?%&F3?*?_2](6%


2A0TW.A(81Y8EP3Y#R-P-

M!I9+BB3V1.8!SW.=S1JS1?('JAV11X)IPI0RF660I8/0D$EZALB=H/1#2WD.



2XSK]1
8E)


M!1]#KL2RU2J[7;/3*K/(92!48MEK

7U$LK4%1L]H+9672#BVL-L93]P




/LI9-E`'Z?99ZR$P2OTT7


MW^JVC7:[`/;%TQQI



M&5T5G











MX
5Y]F&J$)[`T@&\201O&$C]&+&%'E6I(+HZV'('M182
O;^]#`)V9(NAV%/




MQ0U;8@*.SA*R81

VE/22]H&\]REU4$T;S:0:








N_




<8V!%2:&U!;O1;-56#&P.;#P


LW4.0ZH7M2RC&)X?YNQ7\BK-?^

MC^Y`0RAV8+TJ6`$IB1+/`#_&#O;4D^%=MYU$61'!SV#8/!)V$![;HN4Y2^IH


O0LX(S-B3U`L,
M+9`AZM*C1:*#W4%,T6P:$+PSXB$\!U;$07G!WA:2Y




0*
M*-?R2-IQH])IL]EEP6'1SHF$1B`#DR4`R_#^#N`FT,K`;D,0O;=KBAR5
MM3&\=R*LO7-./@JZ3XFUUXJQ[QS;6A?^VT%LTZ?N1N'XS3)0?K-
'G!&S0)









Y0!





!`EJ]


M\R)+TKFS'/L
+W2*D_K-5CE#E16KS*;'V:\]
?=NUWC/
#
+J'=E!1[=J#[$

N^N%[5J1K+N^@RB2'=)O




V+JX)7/?@\8/Q
;VYEK]FS
M^4=Y\\VFF^V\X25W6R7TN&(5VCXVO!'Q54F

219';!Z_LR@=:.P(?)[KFE;=
MH,V!ZC?-X


MT!HGQ;20WCR+/3U%4[%2R3\!6!PLN:$$%H$[8J(`C3])BI@E=YDLO/_B@J[!

M]
K#T'(?MI'I,#;C;#\Z2(G;E4(
7Q@(N?:0.%$]*8=(.(!J
CI20CAJ.9

`O#
O)@7%)K)!R8%H.S8-
+(P/R5M\Z8X

MUS$CCO2S-`P0#JHN
\0VXNO]512[5;+$-YQQ9.F0$K_NI)=;@?K6_*1^8!






MJI+4U+WC94'/'M(BI










P+@B6WS=.;
MO+*M`5_Y
VY(_X[%AU:LD8\GADM&RP;#Q.

MN+-\XX[6
OI&D5HJ2/'9(93K;:MZX
-TC2(Q*8`2QNQLPAF?8B#-(Q9Y.A1/
MS

M_L]^'!R4?]()-]L,,&]VH'Y+[W87VXE%4\D%.&`[]F]^E
E$O$:*G+R*



!.K:QF7
%TTBE?WP





FZ,JG2V!7=EJE[
M
LL^\#CG^.OMKF'V%N%Q+7A/`\D[D-\E;L(NT)OSYJD23T[


M#X?!+:Y-'IH1U[@!?$@.W/)^\%Z15OZ^ZN$PMLEMUD/AJ]1M[*


WVXB9FI=3

MX%Z

\GRF[8!K9*ZGD\Y@5N`Z

/:-!0
G


SO;BLY&('


M4;JQ(O
-7$(%X5

L;F`3#:9BMJTT]=`F_830U1ZD6?9(E=T[[V88S=2

ME*HHALJKW$BCRG'@;)_
]\T8X.@:O?0L*'IEU
`..&2$!3;QT7KO(ZLF1ZE7




F2\&3N


M*LS)[FZ.7O




-'/PAX^`KV&C9[*K@:[P\8
ML\//@3^6_

M













M!]B:^A73Y0B$M#P(4TIDEBH9)3#VWK9A2-]DN?&4B&6.Q!@Q73QB[*6H\#








M::Q_OU)(!PS+
ZTMIG
+VVDK+MWXP=1_T
VY:$99RA@-9?9*F;DBSQ)F?I#D


MDVR=[+W


6;SC!IDE]JBIEFM2G)O6I'MYSD_K4I#Y5

WU^P2YI40^]J(DH-!OU^86\&S!<F<7T.JKNJ8O+*`K?RZ115B0U9?F

+(R7`9K(`A^M;'L+'G!=*.
)^\:/8LP








M)X'#NZCBE\]HU!0;9IOS&BK-&A?Q

MG
\SDRSY\W*.FD.QG@/&95:P%\AS5VUIYKZ82XR^'G.A^.-FANO%
3JX3C1=

M]][HJ5VSD\!`EGNEI05(96-K:&ALC8
86V__QO;463-U!HVNX
VU3#[NZ)R!
M


PY6`))



M!UI`


@@#7

-4@B.'







MKN`\@KVV!@
``L(X%RWI!,PYX&;/H'`P&SO3BA&02:%<$5@`@=L*1ZV;M=/-T`NF

MT:DQ.3*W$P+3!;-W)4X0PAHIMLX0D;`F)_+DS@ON!@YU[YR$`64)%_M%Q$
MM+Z@YQ@!\W$C$#].YX&DPU/Z]/CJ%YV6FK(I
K[[63]O]3.:50EAV[)'[7AA
M%:%T\S0)57
JGRVG.`W#(1?A&$\YK,D$#RR8%Q`R-G$
M5QPFS625\)1T?O[YSOA[[ZNN?5J%^%V`6QLT&BD:C2JC<4Y9!6QL.<BXM*+`
M&D2QY2H8-MHWCL7`DIS--A]`MIE!AFNQM@%#YM_-[_JO5T@?_-UK$L5UQFR
MXQJ)C4E2'N


+.(@8@T9HLL\6E$-3PG@\




M[31$OV1OO
9

I[G$BXRNVQC
X^J*

MY[[:[IEJMU/]DY25(GQL$*IC6DZ45^MS]'UL7BV[8VH
0`D04$J.#4
%T/!6
M-&S##)5@AC=[-B(EWZG8?P&3[K#\L7\BL9\3=4[JXTB?\

MLI34QX4_:2E9FKW:;!X:?[%^_F(U='O##)5@AB8$WO!M'?FV46(-
S1I+Y0;



2H:74
I'$Y351$BT.ZX6^
*J6K
M?:U_-KI`JJJ^

MA&[/J#9;A.J6L0S5;]

MQ(7


MWFUB\U.!@R;GO$'*'/9D``6MZA[DO?4*/P'!'

MKMHN6^SQ6$)[LLAO&6K/W








MW1Z/U_;H59;S4LR#%BEH=AO'WVU4G2_>R.%TDS905


BN*83\*@P0;LVOCG1TM%GSB-D6*`Z2?./=&#F[
;?84

M[K8Z^U3/L$YC+W&JU.FIFM%6S=XN2\`WRK]1_F]'^7]D\*V'!Z3BT/)M.N^E




M;5UM=THV6Z^NHUI3Y)O80:RI-U4LH6\^2JAKP![:LDO$C6SN#_FZM@+Y;]M^


XS&X*%YL
MN0I6R8%_37B3!^ZYA/$3K-L*
5UAX(_9XE@Z'_

M.=[S%QRLVF'VJM2GV9A(


CZIEAAR*)E
M-:7YLX_6MPM\



M%R#DG7:NZ6?O]/.E]U8J:G0KR8PK\R&ZJM;75
-84=&GBMJADI9R=;FY\\U+










MNF+VKU2Z8WVOK-=.D^A:5]6T94F^S27JQI+MB_\
76LNGAVR&$A]45U#.]:J

M=FK


MNH224I


M*:/8LP

Q^GV2-WUA2_(H1\MIS@-\N-V448QF
^2P+C

MP#U*4.N[G[7S?K^[4B'M8V$G3*(=RA`G4;=K')5$]T[XIS(
&(.-.6QFP217
M3LLAB)\!PFL!X(&
$-%'TWKZGNBS9%FG2IU=2P]\MR_I*4.=7V!DU&Y(A9

3

MZ`]GG^U%PIQ*I\=S_(&CN4JUUX8!3%%U5%BMHMIP-%MXLCAG]DTV1CH_TA


[6M5'.H74[R-5JKU#`TT`_A3N+Q+UPK#VR%-4;S,
M/Q[BI]Q'2N8/EATVI0^FT&R$B/7-Y^1_8T]X61=2J^Q_E6+V@6ABTBZ]4*U




MM&(AG_U@R)PHQAPVSR8`:80JT

M)Y=3(P&B/$T5^3D!C$+0J`J:3(5LIB(9354AAP7MII(83@4MYQJ[S'T:\&7B

M








MOR,[ZK@]$IBT(1^BM!1FH!5HM:J,&C/[.X]#+H%*JLKQ79`+;
MJ%5GH`'








74C\9NS;S#U7
M$!'I:NE6IQ^0
(L_:;'PR8H4)U1BEZ/*!:PEUZ`!+FR+A#_#TOUG#_TEQ4)T
P;IS*#

`%


2A4.2-(L3[&DTRH&#B'V&;
9!OJ3*R0+8&@S@(

HKE@)C8)`-/#F8]&E*OPV`%/Z8!6JZ4'C*
M9B[6L=E2B
Z.9&'02@+0/'@F4!'IX8X&7

MX0C&PHA@%JC
T!O%@2=4I^OZKWQ1/

$)IORG#['@O/D80


MUF5;@Y/`_-@V^1


+BH35`BY/N*YH@PTY$!9P_L-N@QJA@
M+BB=6JY!K4EY2:'/I:@C_S73(I(<


MQM9@!)`$



M#B/RV#_
O+!27;&Z(`G8=N`)9/(A
`=



R+%HSG?$A7/W2X1OD*




MD@`VOP



M

G(\)<L2
MK_&P/RB4HHD0&I*:(30DU.8X(=@H

Y








578Q9J`WOJ6%IE`\YB/U.&=!Y8HEW`$KOD9*4J/
MS*K0+'D#5AB6N,%;D$5/DZJFP#/I$GWZ4Z%R$UJ=
?FWA$/)L'(+VA`8K`?



*4QBQQIA_@0&#




IZ(FG

M.YQ8@^1O(?+7=(Q-@#

M2DZ:XE8AG$1V.0#T(\_?_SZW25A2XF9=G3L']TXKRER*0


HZ94D@*J4@Y?J/P:;D2Z
MDNCJ;Z@WUA6ADN#HU0)GY]CY05*VC=K=&9%J*?`DZ]76R6^0*GR_J3=TJ21=



MU)L[J%5EDV;]S?J;];_=];_I.Z@5OQ#TIN^@IC6+JTVC-QHI:.XZ-F1IR-(H
ML[=#GN:DMAX.;;/^9OW-^M_N^IL+J
T%U$9JFO4WZV_6WYR6-1=0-XEAUVO[




MO1?82*?(5QQX/XRLB/%7QA.D+:7D

MOUI!8.&/`
@3\]C0&3B6*V`*84`D5E1'+#P7)&7,'M
'2&F`48C5B(68)A
M%






C@?$)V!%2=P=

M_$OEUMWFDZO*Q(^`EN@2B^?)WOH3[DDA]E(/&E`RB8/!#RN_ICTEP(3A0P
M*XS!D/


M@EMG'VGCC%0$1[3PCN/LTI8M)`VE/@7*#PLBC#60*=B4.V/8.E+
1QE:3B#B


MK


Y@0A]A`7C3GP?P;+S[P#X:EIOB:'P<)]P`9M2Z1#_PCLXB


;.!KABCH[&42D:/@`(80LS?P!^#JD=U&Z291)


H4
%

MT`1EJ[63];DLBD2XAPN+V`7QDYR

MD9_0RI]ZIHH.SZV`LVSB+D&W95J9F%4ZO0U8XN4+%VM&/Z8\-''C

MP[[

M8*^!NR%^HE(GYJV`PKSVE


X!;X`?E%_`*P@HE+K++-
MP*-$25`*'K%H?@1[1Q<YT^
+]$@N+&@V--\U
??!G,2X$=$#O#L`A9.LM[
MYCEG,&-25%G&@RQ



9R`

MW;T84&[+X
M89@6
N/*$U8CHF03C*2_/'ZJI
D\M'?#3O&A3]!T3)F%W+#2V

[+
MY8$GBD%OKG%;1]&XCGA?.NUHE&^-E.\C'H0`6U]GOL(7\A6N
U_A`H6!GV5?

%-@U'`0./\H_X\^G

MW.)C@AXZ%;`E/Z.LXQ0BI
O8#].(:7H
`W(4^JY]+F%A)80I!JZ]`:85$M\O




LWH92B[Q&


M]5:_U3H]-0O:(+%

2`B2

+V=GJUV\X[;'=;1'WI-S%^.OSNP@)K!'I7^Q.+`=X-2K.Z:;-<
MOC_

UW;8?@U5)1V:/C\!A
NHG/4%

M






$

M]_HE`_05-_


O?+WM









!'(IA05BVRY[=_5M$B13:YJY?X+H;:U7OA?Q
M&Z5(*Z5(Q]0.0)'-6KWND2!+K(IDE$[(TM36NNS;6BPIJC/'R*62.$\).\N*
M3


_0K$`K/Z##[1^!C(`YW(!RR'%?Y+(P


ML\

H]N;K1:Y/;1;^E)S:]&/
MXSQMO_;#K;E4T9GE?L:!&%

2;;*C.=
UL]?N
MMKJ[E\R=^


;0C
:*JW#.;L;%5(`^KEXNYI=G[

X
7H99!B?I!CG$5!\+[1
M3J`\''@_1!GGKXPIZ*F\84`GKZ0P7G@O6)R0)^GQ#?M:+(&HSDR\`\L0\
M-G0&#FCA+

4U1]2KD-YI190GHYORR^[K$/




M=(1R$
MN






M&Y'JR(D)6`WFO.!C%@B*YXSC






+)VHC3$#KA5..*MO%4NHB`B+
/T##T]8*)FK[G)`*G
M#

'X*(^`%AXZXLJTG(=@:+\:R'F`I_A
M;+$*VW





O^:J_KG;;'57K];+D5=J9







;Z9'
0M%%ANZ'
17%J'6&]NG63IS\&/3$_9
?J@

M=
0!UU1(
P)B!3ROGW.%P'C`QN`=$%Y9


]D'5?&*TC%WQ*&0#V)JV^IK:
5E+&**%7$J04]*0[.6AT
M^&ZTI1I&^]C9D
G

Q#RQY/R;C*4?
`!

=+QQ(80!CYZ
?.^^!Y0+A=3TN.42$QD4F'


0Q4O@33C^0[(521@=_IS-
M%#9YR`:0@T(0_EDL`C-(P+S7Y*89'DEB?EW992?L#&[D8

M@+O$=MIA(KTZEU\3^


M76[G@YG2U2M?CH/1/1BT7YGW1/?$;220&

75U^OHY<&YROS&_/!P)G

M





M7:3+4-E(*D8[[^9.T59H
@JY+*OMM427:9(N6WFS/-5?UA!O3O!JOG+M`OF0


M!3&EP[D97\=*8J-D]






M%3^7I8V(-+RY-A\T\6P0CQITT'5BGJ20%O(;8VJ)LUA7S*FG@BMPI1J^8UB
MS+6]ODYN,&=-S/6K17'




M66$5B1XF-B^



8Z7R@I3S1KVG5%+P;;9RWO\_N
M5TOWH
U.^\RVIC1BL5LB;&0Z'&UX^*Z$.61788+$LT'?1Q29P'LV_!H[/[M$


M
!*71INPOWA$/56.+'@G[





\]0F/@*JS-\-_
M`5*!?4-OXSI!P!T]FC]U=<`<8_8%=GJQ!2\TP`#:D;3?)Q0A!2!W-RSP;OE
34PX8&`!@-R`[V:5JX&O?%`_\%1)?JE&4WO9(&&ZX##K7%


KN4T_9L$SIEEA$6[?=6QQ65AT$X'5^\&SY25-6:4S



MW)!-4*]^8A


M#77HK*?XKCW3D9



FY





M.?N4O83OX!NWGO3X2LL$^MGAO_ZJ:?`GJ&YG;+GA7[_3OONYW^ETS4ZVGA63

H[0G
(O9HIK^&
MYAXWAG0

;J*]YTCW72U+C'+3=SWS'
MCMIS@!'

MHM`&[Y1.JCK9Z_B4K9ENO(=)\@6^.AMXL=.
1YXF1BLBX[K@':DQ0K(9+\)8







M8F


[2K
MT4
;


M[7R:C.0IZ@1M1%K7&Q)A@JY
@]QN-3N-0@@E#[@71L&VFQ(%VV[E0H%(T!1D
M4@DSVK2:7^E9]4;
[

M1WD`=O5SE$`4'6ZX=\/\KKO5!C-4;R4



M&J=G&K-'



[U;-?O6`YE/+


M%JZM




R8[NH-Y8JD2V]P&\

#94-RYTX4J+Q(:KW5
M[K2K5HF87LHZQR)O4=]^JRH]FC!G\`ME:R*(CFWU:

MTA0F-8)8WH=YRV=L\.HI=TC70`;POT)Y3`.,R2J8\/),RZ7NE%0\DO=IJ8


M\
]Y6/-$H

M2I!'P6M_]B@+.KE*-T/+RV/IIC7N#4
FMF:U/SG5_J18E:S9##F[H/NV\:IR


M
.N<NY<]-_6&[@2VX
S%(?=41ATB`Q

G2&P





M+O!54CUBU1N-
&'X@S
0XRS5=U.MR[NX[ZEM=3/ZQHT[Z!'&QFQQ-T8.O2$&

MV$=



M&X.'`32SEA[OY^_=]=

IPFD7







6F%2B(
;
M#U^4CGVVVXKBTM.O7RSTQW^XL!8-!L\+(D#(2?TF:*
?+DJHPG=;S0(J(T


AHCQAX\A5E8HSF&[H$R;SYR!C-Q
M/80+X].E(1;&\WZ0.NI<Y%LY7SASOCKNF`:;P[YO5*N5:K7**$D54UW%1A(\
MBV1(*IT9/-HX;_Q`:414$!_S?$1/\IF)LZ!T+]RDCM0?D9:A[[OM6@3H:
M6*1K]NP&8'B&\);8`XB334ESCYP%_&R*9TYD^EF(:4M?


M
03F4ZQ6[8:/\R`4WSQ2%AEE)


M'#F86
;TQ0TRR]$'YVCFBPWK4$.EDE&$SD49&KE=KV!/^&4Q1Q.U3\C?EL
M)BH#R


M@C+*E%Z5T4N;?TO;G4J)``'
5A.IF1&;WPMKBCO[E-JV-%0



PQQ?QM[PE78/1W.'4&ZF])VXL[

M1IT1[+-A1@(.U?\C.?!GC_X

-W3$OAAQ+-RGK&2CU3

&V
FV2!$(5\60
MS%C@3(19Z
814#(\29Q?P?8Y^\CNB:FUHLBRX*!6#BF+B%6[5JEU[$K;LEX)
M_AG



_ORYYLW]!N6
M'-\T`-^$(7WC__@



YP044R4(458%<4
M%D?B<&:;&1JS;RTQD!D)L@15W9E&Y,3U(`.'^S(9_1<_YL\\<+SZ_`1M#`2

XN?0]FO9F+@:0K_CAC5
):

YI.AGRD3,?SXI+7;6'S5V)QC9:]FWD
MGF;-K7:JW%-(T[CTH7MQ@]EC+N;Q/;Q1['$MET+&^;A\?V?7/TD^HEXB0<JK
M6_`2CX%!+S``K,Z!SUPRE*WUO#A!LJF=2C`Y<NO51E4+<#U=2^*3%S_DEZ:
M/4IF]/U=XW]C
I3]:


M]0(9KTO]^'97`YZU;(7_YJ[VS4FNJPK^=GXC4PF$HYN7L@#IKFB3M$Q$U2
M


D7X

3

+-X'ZLW#/$2/LH;6FG`DO[72H.FV[P33:;:DKC1*=^X

!3


?=[

O#=B8C.DPGI3'HB[L+L#Z
F=



MY0(_[L*+`9N]^'2)8

V#)P7W!KJWMYA:_@#GKG`;D2:`_O1

GL.


MYE


M9$AV9=OI7!W/(-RP&1C!:S*E8?PPQ_0#H5:@$H8J?/7'\PF/:42%R7RN&%BB



\





MNI7
)G/SP#BM\&$`W/.Q@P<V^B+HCU4K&)6M
(8&
W/X
MPK-/?AX(?O54:N]V6E]V3T)CN3??5]71M#:WRLAW5RI&-LLJ$[#(STX?70




J=3[''
M2*LW6#

!5ZN*G9X6F
P*IQ.G\<NX-S`Q7]7J%5E_P'V+_*P0\
MR.-#YT%W_?+LXZ*5]EG%;EFM^4.%V?4?J+/&#VC19SYN2(?.F(=R0XU3/A/6


:R!$
^
M]4/

YQI?&



A\WHAI[QN<O5+\;
M`ZZQONC5A7Y9.*!(N*2;J`::==K-TKM1F1U)T](S:4M%:\F#31;'6L-B?EFH

[%W*(!/
:P6UK0R2

MGJ8H
^TBOI9=I7+_(AHF^K<MR9^_J
M&+C+<A:F4P.7ICAW1KDC#U@DM&JJ$'\9`T/WR($.2


M

GQ'%5A?&F%0B#*G4**YP3N5W\
V!##+\\^FDQ$QI_/
M&$PNKD#PQ1V/V5?WR0\$C$
^XC+(


ZZ(36L3&$D]+AFB.`7




M2;8
]
`?@RI]J^)/M\0)57@FH.1^HV
*`O+LB=9/1/!_F[',\Q\2ZD,]ES*C$'
M_6'N.+/:.$G[+QMU(CZ5@VU%5IYP-^8)YF1,X1.G&,2TC)[+'*N!(!%T%-K#
M2.<81"F9'Q

MQX`F/M0P


Q-)6AVBA6XD-+%I]H






%
M14;$DO5:3AI-@2[*9T5D(YU!S@.::#LI1*1C4XM.K]4A,%RA'5@EB/J&4U


K%UC%[TOQJZRCL
MD]UH=%J-9.[7D0APIS

M.UZEY%C5[V9A:;7JU63RX]%*;
MX_0[6++5C8^U6K;5:9?L]UXZ0;!`J7VE
MH@R;@LPJD83N?%=;+]'1Y#(#_XHR*FBP-D+;\_`*]M[(.-]19T_2636W$9
MY;K*+64FT6JX@0+W%!S_6$\VU4^+)]5CXHG
Q1RM%0AQ[4-&;3AR)(5)F22





M9%B



C/8@MSLI6S)10O\244/
H[OX/(RX=



M@E;Y
&M)RLY[:5QFF^1*HCJC+YR/H?TYP26AD'NNV:T:E[!\*@V8K(OP/0WL


RS9ZP3W6





M1E7AD4+))EX+
;+I&K):4^\8%B!)]YUWPZQ

_-\`:0%T


M?.6:7DP%275ZCQ?



MGHY&.N_OFI^D``JRHL4A4QP!Y$_.;!Y@EL`5V/4!HDJC'YW99W\\Y+E1%DWW
M1JKA%/ALJRKALRTK#WR*1C03$84%P;3_5X*9I%BC]-']]]P=(@FP;IK`W`;6



M7.\


MAQ7SO?&M=)X$@/B[\1W:Q^L_!\^X]








M!3=






`L974O3H

M7OWGX^5M\`ACL$0)34$2P(




CC'\#%[@$&5D4GHH
MPX!*

!RIDD]NK&)R8$
MD^V@3A1E]%#D-F4.+$?EU?T:T


MI3M^RH=S!Z=]#^




AI:K

-`+






T#!&W`437
M`(47R1IL4`JBANKB-&7-4$U9%@R^8L#96`M4V
CT+WJ]9K(@FWD*%WR1!%'&






_K7'G+92G7-
/N(0W:/BG8ZK^]\!
M(8!G91#XA'!&H^T%I1D


DEFLNWB9E/9;O2I=WZ+

MX-^97/-YN!^:+Z=+!;M/7BA*JYQLL=0+*W*`Z4T1223V[$@FS%M2M#ZVLJ:=
MIM06E:?;2$7




BPC5&\V'LP+[/UNPY2?@^A
!73Y=3-C09
M3Y#MWTS2WF'C%Z9AL:5_`T,8YQG[5E=TK#BE^9\&SEEJG_;C)O]::C9E)$P
M2?+X[D5NOU[



(0WK.7$=Q3I$B-E8EV5
6

!L6+[?
VA
O+A47[\X0P0&C/<<=IRF!65U<*ZCG!LB[

M@`5M)?Y-O&=PPQ1$N:D2F1%]5/RS:*YX4!CV(.;TO]!I=5?ER[FQA'^[J'


M=(

HR+0HO(*?CX]/MTUI$K#
ML@&FA%8)P1;M_

_Z]

^H[8A%`Q7$TXU-
8L#73#A<:

F??&
.

T;DGHN'P&#6AMH!1?.E^^N
NU8`)EN623*H]`-S^!CJDX=KU5J


+S


I*
M8LH4F4C=Q:6.I+[&+.9\ZVH$Y]0

-





MQ$2/7$PDD


M5N?EW[Z5Z4]OGZKJ^6_OWW_]^O6[KS]\AXO']Q^___[#^__W^?(V?D+;Z%V:
MEU64Q^CM&T+_M[+Y\1+'4=6(/C^[;[(&(,?WO=U2GH?[UC9._H3^\^?'SW

_JMZPN\H$#Y\;'OKWX2L
MWNLWZP9E%*+745'M[HHH+Z.XP:9%\Y0L#9KY<QT13A5-@WC
#%HRF5:I8_-

MF



#2^(3;*IU5B2\S-:9XB
5U)SZ)M]&C5
M.#$O@X9=DTI04:DP89%JP2
C):XG)CE57J?H2^X0N5UM(O(WU;+G9RC02.)
MW5[4*/GT[1GE=O.VB)-!HZAP-RA&!+MV'29@9(0O_$RZ?D?F&CK
G^GZ]`55

9D;B;XP'5C0U[C+(WM
<,$C-S-
M<.9-4STF=]LAL&$A;?9S6)`:/'W)@#[?W\B[&LP$F)\X.3BT
KI:97+8RK+
M\RF[@RGW)U+.CZ)LEWC+Q=W'J9.'XR9;Z\/2[G!RLN3B2


+AX8

'^@

MM:VL;(_FJ3^SU
S8PH1#L]P6N9&Y-2IO`N:HJ@MT]7!2EVF.2K/SLAD/HX62




]^[

6`&_DLH0Y*[8&@NUYK+=*``

3SR89+'1XM34



,Z`?-1`'MND=.&J3^-:13*U_.C&E^V6
^I;Z5







%&6M5K?8RJ1KAG5.O3

M9JV[JBN:!Y0^M58IF4
JTO2(=!WJ%DMGH/






P



M^OADE*UM.+Z-&`S'OR:#(*%CW1/`^4.SBB`NY04-[\(@6^`
PD$.-#F'-2%-
MHR^


M'&;PG;._Y3AS?#+<U\`FSV'U$XR`:+M.4-`&J7D=^=1*



ISCHGT0\ADGZ4
:Z[K:ZS$TN8X0
M
`P2Q
Y[RO'%A:#*

=)Y:&BFR?7$]`%B1R@%*!






M8YMPOW7]./D6)


MO:\L1KF


TEX^5^'I&%JD6@8+K3








SJ2LN/2'5H9

M5IK&ISC+$-NTCA0*IF=.FVKZT)6L*[*6N@'
P\A1&#^AI
[0U0-/)*YK*+P$


!%(K9J-AI6
M(\+*F/UKQ
K

N'6I26-RV4A:`0&E

P#]
M\XP%.P!(S0


;6N.H(
MY`KB6;7#/N3YLOAB[W[;OH27S

M$KV@3&YL`0K-[2UIH3^#R07OM0-:7=)&A3O?S9L-7D&5964SH+AL$&89!&*B





QU]0%#^M<J@DFXQXP@91.94/#9!T.

(LT$LXW[3)JZ


MT:NBPX24!U!3&U[2U/89OG^#U9LMOM3%3OHWD\/0(:RZZ,(7M'Z]GQB4YV




MQ4]D2]&F34%^T8E9;^+E%&9G)SI@^L(RP('_M*VAVIA'D0L\O5PT


X8`B_=]W!^;X.7:L$
]`SAV40
M_J6GN$F(6
A'MX**!:

`]BYS`$
M]P0(O$^]V_WPTRH4+9%&7[%C9GZ25=^FCWGZD


MI2DGP



$6=:N:7[B0AWI*6;Y7*X]GZQOO$,#+ZM;-



#
,DE=N_Z/?I25T6T]SB\S&)^0%@([=Z92T:[5+(A[2D!
MZXD]2DT$K:QSWI)5$L0D`EU13P9.&X)GZRY8\5SPM5FMW3QRV)&.SB[%@7Q







/^^T

_1Q*M`\A.=J;?^AD&7X(

OR%T8Y`7#!8*Q^$@
MZ/W?`[H`TB#::;]D^Y4;FA0;2F
U
6X()(56PN$P*(;`4C&/8CPTL+F
H.%
M1DNI=GL2N56JPT`%*0F#%8(+VAVV

M5_82FGV4(QY-N
B``54OH5Y3-!T8
(X8IX-CX`4QHH$WJE7=+3AZM476&M

L:

$`*B[;I!01NN
M]G6$!.I:P3*

@




M/^-B08R?2TYB$=[9BH)
D@8F?/L!*!SDG$7(*8A'2;SF7=+'M05_3PXDERA_
M3+[@28Q*Q0(82
0=;0D$[$68&+

XH(*TM;GS73HN


N^TER^[&H.


*H^QKNK@
MT:4GK^8^4\7;4^`4WLS*.6!5D7%UO*IC4J$-EKE''8:QTAQ9)RSU;:+*G[:
MI@+=Y(DP,ZM.D3Z`#J1(\`@QD%S34`=58!LIQ:N1TQASRM7NZJ(P9?\LRXK
M7GQ.+[SE)I`I[^!!Z[
OG1A(IBVQ#2NC2!0P6X'W4_G`HJOD^U0WS8I$R9



MCN[EN+[G\`(


M8/R48$2PX
9`J7



$Z06(?)HS+]C+D&\
M0ANW[02@U1.`5D]6I%6^/+I:/9EHU?&+L0F$\@2BJ3D9?P@.R%:@+Z%4V@-Q



MLNW(GC(/XIZI;_VF+.OM


M!EW@A:6=&H)XCJL;_!%_EQ7Y76![[LQ0+-JCTXTIFA2EYC2%9B-?@!BVT&

M*LL[O6
`]M#!YSC^NA*!5N'732\I!;

MT$&B+[86)D#L+8


%#S#B
B(M?8Z0.+
M]9'L3J





6/.B(;@0'104

H^+\0^8US08T*



M@9^8A
-&W!)3$Y47L^B(TX3K2L28

MZ7(2XPS.:45`

2*1QKJ$86&@(H3


LOB-EF2







=O
M!6]/H1G9D<!^_6A-B#M\,K<'?\E)&_J60YJ+#A-#G&
.`6/(G?]9';X8U2O
MITB.^[:T




M?J


M(`W*&G2HDDE/;QQNGJ(1RF[75'HT*@NX#UVC_FWZPMU]J`0WCL]=Y9N;J'S*
M4%D*0MH:E05M6&=EUXH;4%^XW([.:@HCN$QFYO/#:O;=&Z`':Q-/C?C4(7


ONC-4B9X+%C(KOV\1JD!H:'
M94]EFU6;)CA+:+



/6=;`Q28
(]:90Y
#\NFQGIF`
SN/
`)TDP#8\&#+)@

H_H8JAQ?B_0SUMQ1=1_Y^P[E@IL1T^(3








[Q#:.]
/


MPD;9=7V?I?'5PP.BLQ@`1M)R$B0)RJT23)`^L

OKG8):Z)#


AYW0CB[IH`(.JXT/J9J<_BAEY3<A1470GGB)7



M]([\BO)R\()@BDV'B
\FRU)ZUMBE)2HOLWB<.)Z=RZCHV&&+F&ZI70%\




MB!!Q'(0O'G$*PLHVT.O


MHNY5KJ`.5/
Z

@D2'


M+!'BC%B6YW!`[#`

#`
M*

MG6?`W2=!RD0/&RTI=:##(0]YT[Y=8)D





M%
EE/@?W_)C6EHT_SVT\+_FAFE!F[2Z1F-#2NE6E&32T:\=)`S_^^WJ2!G+%
MX40S5=+)@!)`-%



MA7/`(0A#J6D//T#[_
$-(I52YMDE%U`+
M-ZVD0B_R=)$S02S1'TF3=W6@G3AO&\L8?CXVU*9Z3C#`\L;/M-.2]6D`1\7
MV+L-*G)1?KA?1LF=`]6/Y*&R_0S+C8?/XO'I1W&W5LZ1JVQ)^BE((ZM.X:V

0IC;^WSH:&.UUK9MOY0:N:'80:Z)#

U%&P'-U:#&6X9P
M=SW2FG]H

NQ)W4U#ITUQ':4.FC(
MGWL

18TB*09
MQMUQAXIMV6VR7
T8/)ZVPWW


<6\U\/28_NKYU4
Q$/I

?:




SN'FM8+OP(A*XJIUB<5+J.U))L?;2Y`G-OPEVJ*S49IW




M144GVC:%)9QP6Y47-4VKLH0=P9PX;;0BX;41KVM8.)=IBN!`CY\,13QE^?G
M0PU@054^!OLJN




L_V/7D]./




MCW


M(T#


V#


;&%R!ED_RS+JMF'W*'-TG2-#S*KJ


X&!\=3A#DDB4+<^J$9=(\]!K<2ZJ9P=GBT;WXF

BD



M=7E![(+B`15DA4&_I=7325T2@Z


MIN`YX2HTJY!/7Z5SAI;7D2+?5EP];:

!L;_S_UZ/
MN_-,DI-=O[)Q#BF@Y*$S

M-*;DRYV?@+7.18A4;E)M7PL3)E_QJQ
K_UP4MO&,=EW1'@&Y`$PPQT6W





/C0W7V$7UAUW=354GGQ-U52?O]?RK$)12@_A]XG*ED_L


M]!2P1E_D9)OZWR@JY*:]1GD]P`W+OQ;

V


MX+=W8B/M3U^

M\0(_J=
L(?

F
MM(#D-D:

&Q=@&370(.

KV]!`$C
AZ6
:
MY6
:Y5ZUKRZ-\C%5:=BI2AV/[F/6[%@]7JR9CL.G+



.

M^\71VB&M
(AC$EG#3W'^@HJ273N0OROJ%G9+IL:],U\DG+!P!
`*^58U2W



MP)JCGC*`G7G-#(&.#[G9R?KP.)9LVCY\S\:`X$Y#23^YUY#0KP`SNE*;WF](
M^#/]N\[DU4][YQ&]32&U=G7.)A@5X3[KHI!P!:H&RZD_^L6
F7(7/G'N0QF)
M_!E.=J

M/'^L`I9







M0S'/-!]
/MJ@*^H#UKRNMSD94P=?6

MB&


MEU[.?O(
1FS;E4





M#@``!#D!``#M_7MSY#B6)XC^?\WN=\#-'=O.-%-DI135
U4U
[[F(2FRM*V0


M?_Z%'

S(X5__^J_D'3GZY?`]N7V


M4T2S\^.;IA+H9X][^C__$-M[L-+?_VF-![N9U-DE1F^*_S5_[K'/Y7_NO\

MBB9AO#Z-UNX;WG6%U?B;+$@F@$K?V?@OX+[5DJ9N^)_.V7^U_-)O&8W6=%UZ

=_X]W


M`=1@7X55K=JB^)3D'Q/^.6$A$O,V)C5\;PG[T-;95&B7*]Q8D`?Q*O]IQI




Z$J
)

Q]@




M/86F_HWM^J+-`94&YP/



;A0%,X3!WD
MW`&7Q[0#P/;AYA?UWSW*Y3!`V`\)H\$@#1J#K$KRHC6S1YXKH)GWBK6;O:7
M9$_7YV'`4HPP8S&ROHGAEG[+/K#6_*&(.0.M=
*-M16D2&/IUS;(/-'D+C;

MYF

RCY(S8Y1_Z00=%!ZHG-6`*M.4U
M


`NUI3[-1:4I7VCU]EI
M7;=
OJ?$(*;

+``'J6#KEA;@!G00=(+T6^*@+4B/Q
W/I

[I`




M1
)X'J!WP[1;S^U(/\6W]&&PN(T5HYJX&I&_&[MF22
OPPMN7%


AG


DD=^YZA51GXGGA61W^&W?`$!!*^4/5%C
MYXX=A[V$LS/#)O4


TFST/4?96

M%#GVBB+:/I?SQ=0Q2O+(%!5




Y




M.J;2ATVVW:X#G?.9UBV?:?D#8DU7:E)O:)6HKZ'+Q#VI;7[8AYMU&#U(+TF0

T'?#V7BU)ZKTF/&+RG``)S^M.P[3<TA4`M_4T$2;07)RB
*'@\;@!3_


M
`[MH6GD7,_+!`!TLI8-
M]#L6A(<M%)(@(W?T(8PB\8;-VT&C*FMAB/`C;`B]7:M75F(7$V%H1'FCSC
M@#2$7R?X5`O4R.;=5E:UK[S
*+B)21($M(3UJ4@#6$7?*O
.T_CNYZLF=8V
MH$OGN201HC[F]/WN-Y%
VDD`AE5Z1GYU//A%KI-X&X01A%EM21VM2DD7G
IM





D5*PC3=TS6'_X[]RH]\-_LJWF[CB*0B


MK=A`4[=6=41SB&X_ID-T\;AH]H9:+1G@&


2KOLXB_W-9G?3B5G%U








JR.MCS+:LQG_
VT))VNR[;D

-




M3QR;/QT'3EDD]V7%)9D)&:
J.5]'(A4.=.S2])6!8QU-+=.D7OSAF_2U-ZV0
M


M=)T]SK^$#^AP'8

M9Y/./C*A`*X




=^*&;#E5:BYO5(UWO-Y3G

V=!TF80/811L
M^%^7VW@?9=V='6#Y!B4



5^W(W338Z!
^
M-S:86N2;F.KTGH@:(0DC!KY5\_F?[O6(^RC
9M[T;0TDY:P:ULFZJ;;:@GK^

MA+7OA$%)&R%D@M)(T!9$97S3M*-R@]89G
@]Y47Y%[)F?_*)@M*.55)-U04Z


[L_J(5_CB7A[WW@0/Y)`


*-#_J`KWS8]&$ZHV

CGQ)O\3FW[







M3`6@='#!A/PF&*RHTTL-;-3!D'M:CA#7')ED-%PIN2(%J3P@JIS?AZ8;-?

=^?$&SRIP*



Y4F\




MR=0.##F!/^M%.`@=$J2
.!D8HJ1V!T4H30MGC$]/X9I&Z_0J*6Y^NN'O1A\'
MZ6


U


B2R


MX`$U208ZTQ
88H.?!DSVC+.[X)DU:R/N;V*I[MRWDL
!$`_LHRX)#:IMYH'\
MS
ZV&YH\A2M:[]%L[I&ZX*E(RIJ_%
^.B@O$FY_SS5


;Y%_1*K//+F;2]^)/8!K
M?G





X^U]X\&;976-

7#N^+Y%WY;Z7VPWW1+
MI!8:W2%





M1EM*2Z


=*WM_1AS#BES]]


R*
B@U

M_KKAP)T_K&#BJH5.0I'CQH(F=,V--=Q[IX;:56QYNY7'3.)ED`G0*PBO#K






SYZ$<A?$<+



6O2-MX-&I+B[BC)+Z
U]VHIOZ

WS0R:\
8`/*JT6.*H:/A
[

37
V`#Q
8SW:&;4[%`1ZFPB(F%$=[!`#A7FT9Z+O
MARIA8F09I.)')M<X75#4STD.
&FGT-%VMNG8APJ^BK&H:*IXHRAM1/435QP


-3:5W?
B^Q
OKY)W


MWSJ8CW_-^1C1!UYWT%5#(/Z`7%3H+W[D





O
^I^4W&E^
M


MYB5J

NJBAZ5R`V
@G!37@+P1*-U


1D-I+^Q`O6I['2$RI(3$%A-J8WGJ]4^[+%P*+G9

B/O0FT`T!A#'4V2!BSF!WMMT%


5
+D?X



6G1M+


+AMB%%+#A12%910\14F)Q^BKP86EV'/TX<06!J9P`K&G#R?P%LW&


M1.)I%([4(T-#\+4A#!S2AT+

5)O0LUOKU

XT!K2!P5`&V8



!*3T?*%H5EISC#[I*-\-!U`R\I)(@I<CK@9$IYH[`D1=Q]_<D
MS.A)_+7[;(-:H!MG&P)8O*A
#/C2GUN!]TI6BO..



M!7V
5TV:K#M&$7ZV-/@:4Y-^8V;KZ2VFN


`+D_7:=;+G
MT6W)YM[5#\Z0

TYUK)P'B=_\
M.XA5-834)LT9OP4ZC@;9BH_3A
MA$Q&=[`5';V5!?_\71B]V^42GO`*``#I:@^HAU2K/TIE^7*0P=?\O+O9[W:;
MD
(HIQ7NLDTAC$4TJ7DG'--Y`M%+;6!Q%:S^![Z
$33NE[6$8G8S\HF35
MDY)(XV%6_J09?SDIOW^]W+8M88Y.K,$9N1@6V2&L7FB\6%BB%*U/C40B@_G



M#;OW;




M9U

S]&9L\]NW*2.7



^[SM(!*/Z

M6$S


N;Y?GY'6Q=`@[A[/2AHW8^9'2




M1A.Y]J+^


+V].!82*




M\QT
2DMI/*H#)%X<$<6M3,X;U0V%L7?22H^(&%$
M5FQ&XA-]=+VO9)*A@W2DDJBJ^:7TXPO5^)W-^VSS(Z#)'EF?P303:\CIYQ*





=+
X?Y1@8Z3U!I1G(U\B-7_(E4JKQ_


MY+I*SY
B&'

MH))




MA`BS]P$APF2T%R(NKTZOER\A1$``9@X1PX'A0B-+4(
+;$CR5*W0*D;GD1

M5L5R[4OK7

M)QKC$@R



M9''@*ZG52%MO;L8/Q%.

MQE)891D_T31XTC)3J[NXY;Y)+&[B#XO=A3072'^:F8+&'HXM.Z-#*I5*BSUZ
MNRXAA)?MF;P

MU28(MW/G.H8N5K!$T1]JBC045`3IV?2'2W:JI;NH/*FO`1O8<[DP16+=
X&

MEU4Q_@;15?#




`7`OE;JJ7RZX:I;@QQ@-/9QXM6

MLRX;E+^R!/HMV1[0)99F0_7E_7VXHOHKR[4RQ;=7R(R$M]0J)L)U#G0@5^LM
M\H\:MY&+H6*?1*&XP
Z/:SCU71I;]$`;_5+Q)@$T]EQAQ6Z;K2GMU;H9!)G#
M-X






*DJT[:5CBC@=5*



[BIA*;7[PJ@T[IIW1UF%)S@]I0:Z2Q=KDDN1+UR.$&OCL8H






N






55Z

T9P(LGM_@#*LL\
MS5*M_P$DBY](*SF25!K;F-
[LQL=F4S:B^7Q\?7GTY/J8E5OULH@G1Q;]T:;
M.AJE)F^



M_D`\:2ED-KH9$C*A0Y(*L1(4,F1'\.H^.O,]40@#.(AG=6AEU:OQ3`!T](

_8??(_=+^(O__6_



8Z/G
[90.X1(7R4KT_1$K]5


68$U
M1+R8DHI&?0$Q0^`L/C!25C\,$E8_#`P+'Z0A44_XV*WY6HE_SB.M!_
('^
M@[.X^
%Y7/PP-Y^T,;%#Z\&(:X:`
1+^*BR&QOZ;?L`_/VA[8LUY.2EN`:



MKF/:AM2T[`EQKH+D




M!3%AW:FFJ%I?15:3Q\FPZB27


%W'!\;#U

M;[=Q)%8Q0.F[1%Z;N;?DG21#0].]NS?-KG0%T;'5*EP49D/BLA5B[51=3+


M41OF%DINB+7%


M=.(EE$MQ)5I:;H[I'X@&RLMH)9?'I);
@S-Z:9R!*::TH=G?E=_9&N=:'G%-

M?
DE9[\@@X+!OE_09D8ZT

Z\?R!E[%FW#UK+Z9U4[--!CT
MU%R1LN-HDJ%![G





M[O-!C6-



M]M\U[^G.!T.ZHN$3+W/]'F:/9]O=/J/KLX@-$33-3N_OZ2H+G^@_0KJI_GH=

M-A9W
2H(.M0?9K`5)L:T:3Y2X&4RX]K@B!&'74K$$=G$0422RN9WEFA0X1--



0!(+&#5`KUFI`
SIL:HKQY'YZ;G\@V&UHK&C@H4W3$
MQKZK*7BI]#J$H0ICW4'-ATUU]D`!D%3?A3Z]FU`B*OR/.%=XP#CT%*EP\)
M%8^0'_

)5IE^QT\A4M)3*C*:@Q*J#;8AJ+WI^J?06


MLPZ2%(T;&^HTTY0F74IP^#+N:'M4PQ5S:B*3UW$-3E1F4;,3G0NAB%%Y?Y


P?]\&&?^
CK*@]O@5CP_F8%LP5


'$Z
+U#@/
]7V=PU6UVOQ?!?
MN8_^KG07[W)KCL`MKE5YV`(#@[S*)J6&]
.B/B4!=.Y7V
=BPS%GM:AT)AS

MS&4H&Q#%Z@!6A2ZO8A:\IP&1RMS5'L4GQ0Y@@Y0\7J'M^E78Q9[[J%U8X+I[





:2J%5
M5:-)H4BX)BE4R9?;_

MY%+OJ82.D8C&^T
!)KE:I7LZ;K1

<VS/.DL'50$H2ZQ<-LIQ!8`KBAXW$%T#V8C74_=VCVH]KW
M,8SC(VG3W1]%F4





MD(:L;ZPT0T-*2E#?J3BI5)93TN#+`T;6&WJL+^GX\-R_IL-F0Z$;AYI-AM@.

MO


%%Z)
(E$3Y]2Z&=
G&2
0.:N+OP.\U8\0*F
<+%*E)TR:/Q$W!

13RW9[$#JOJ7@B^BI(LN?&U8BL]:U/


)3*T70DQJ
M:%%#[\A-H`#YA



+\.D9_6/
U/RW5#C)52&5&`2F

@ER:T/%N3


_5



*\






O/&XU&M]V)2A/A%7&YF'M^^A5#B1R:C-3D.V
BR



YZ=^'$



9=M0
V`'-]SNH[O[QQ1#=4GH1/X9J1:JK:A\R?R\I'VY^/

3=SL7NL6


MKAP549K?X^4%V;SUE_?BTW3Y%(0;_J4^QHFXC@$KU@+=C+Z4S^1FMCOX]`WS
M9P
(K*%NKMD#N
[795
2E)^2^S@A(9O.\D

M]N`8Q;I43^\1YPX]R+?R.S,OX4#V,BY8@+.9HTB16Y71%AEJT(([Q]CR&H



M+R*W=7
#AX*_Y<!#1ARC:R<%7
LVSWK/


M&EX)BT:YW^_!R#'\7WLT\J]07%2U]RQS3L+_I.O/?!55S-/R[\774M/6X9!K
M_H.41?'&7HCB=P!EI


M8M64;@SB)X#OZ$

N8G)]%61)&:;@2YT7<3<?E?O`GX%T_




WT]L-`<8F3WY$0M&2ZHA$W*C'ONXC$AJ2N3XBH4?P!$<D





MVU3#&SDJ5`]UN\C70;F`UZ






*OW

SC/T[2$E`V
`+$;H^R[++<RTF6_MW[=H
MD._(R__^

J0D%)^2

M`&


MWV%I1^K1P3KSL!8
K?.H;2ZJ?Y)4L#



E+U/*)`%#8B

!@
M
PZEO@XJ`Y?-]+J`06:R13.YMZE6T1&7S#3V^N-/N83@+X_'K!J8^Q1.ZR%+
M!CK_4Z-XDO4QO7M4

6;C8]G4(:Y;N\__.PKL-O:$K)IF%5D
:




M/_9I)B[EQ\QD5+8Q
IN^[3DSG6YK7%P#Z:!]SA(BJ3_=1J1&UL0MD2C.?)Y_

MG``&('N_)ITV:5Q.59/!GC29C)KF3/[&HM'3)&!O6VQZ&3I)
K;$M^B0S^HL

M^5:XQ$&M83M





M#-\78=DBMU1C*3!+!K:
5E\77'A@V:)-74\3OU(*CREWN.4VU0&Z9)N\%-






L9_8\!W0[K)=,XS9V`7U0!
]#
M]BWW1EY66@2CA4U

C$








MO9

M=.WZ0I'S
*)G&=WV[BDPB



(_

M
K52WI_D#)T:L7M(]B

1MO0?AM=%H74G.+-P+@7)AM*`F
^\F3&D\


4=

P!:6.HS+LFB7`


US


MA)L]^VO^[MOE/DNS(%JS*5TW2@W3+N.8K?98

M%LG5Q!ZL_#7%#T$:K@C3(84E?YY6'(JY&`4('8[;&6I%@2%MF)X`:-.Z@;Z1


E=_MP#&VXHS0C7YY_$=YOP(=\U0\)H
MM1?7&?

M6?'8./]S683D[U[_N&9MX[NEV/C'))YID/!#0
5?N'3$-_=M2+QCF!8W





X8Z(!=X0=K*G9(_


M(IJ--SRZ?61)'4U.M[M-_$RIM$2O$RF^L%QD#'=D%M&S?XT3)3^4.HO\$T*+





*M5T\1IA]*-E@4EWD`L5=%X6(


&167^3_S=?@Z_`MKBG9!4DF3NOS/%@$]J(T&^KS3[E!X9VFV5RP:\,LSG
MLP&GX[FZ_T[<2:A*<7
4W&IXP&C9..UY#6]R_AD^D]LP.!?GRFGE$VL\UT`
M^=!2?@U2?@]2?9'9QQ88-&-[_'09K55LL!G@P#$#L
81D*
QV!?CAQ):)!=\

[\+.+;ARA8HH6H..P(83E`T.
+%ES6+CR&#R3IZ9@=TJ&0'2#]?-:[6$W2+QIPT6V[3]^5C,&SB`5W;)I9)
MLV(8S(5K?.(D@U!/HY#)TL-C#3EZJK_\?S+Q$Z`IL@<49$V

*J'N
M1N'MJ

M8S.GD#`_E9`U$7Z4-4E8O*G%J@X^MCO
T3:_+`KW%*R5?*_CLH]/ESH3R%

M$^]AJAB


M.?3,2.5!22.Y0H,J7PL!0DN)YGRVND?/AWFMNC=C2`=(;W&N12M$*XR@`P,G
MCU:MH-$?5UW2JH/7F1WZV_MAO;WR%%8:A-QJ%7:M^OUHT:OU_SG:V-BPY0W

M(W$CGPH/
-J;&0]NV(QLPJUQCFB$*Q[5%=#+^\;ID?*EB-N8?*`DM\-O=JKW




MC8?(\BNTLUK/D[51.SQUZ;6W2ROI8+,].JL%LXGA33N.JV56SPP-]=WB]'I
MND:ST
-14_&IXE1;5@Z=@QK5_=^YPVXY*_L\%L1Z?HBSBAP%J774DV?5%JH

HDT=ZPA

M4[X6@3P8M*RZC/XR1Q:O133C^S6]I_FAPU4STA?O'?L3Q^4=JWXHPB)2MS0T
M;T0XB



N9P\M#Y!4L*&P$/^=UWP:TP7V'_R(UCIX;CVMXL_TH=.)DF2P


#\C\


F!(R



!U!0T(=ZE*2R?!RDCQN:










MS.+'3(


@!N&T
-?W[82JEW1A?C#S&%+]O/'^M^MC;*&4(6K

N8$-3L#2VQ\`&!;&
M\@])_:DG(6TT
A2!;C`T4





MBDY'W^F$22?EU;VSTVGT5;^CO





BB



.

MN_5]LZ
)$(VZT@AQ-A;+AY('%PM`=T#\:A&H7YC$A#.4J7)^JI(@N?8Z%X





Y%6)QE\.@'E&PVEP8TT#4G[%F



SR#
J


'2G&PH;YNI/`DWY`DR[WGYBD1RU$ZHWC[RX!^5.O
P+4\UE_M=C0/W/
M_EB.)Q##$C$V
R5;[,S_^PY[Y3Y=6*RD^#&U0J


M&*`=-8#6SM7K)
S<?B+%HE
Y;;(NC?,]DJO:/-F5]HLY@.X<;V\AD-P]Y[O+Q2[VF2<)#C@3.T5K
M.UKB^:AB)G:S_2$\SA0OTT349U-)WYSP?#O!+9#WPMC\
H[*(^;*?U8H^-H\XP_*+AH+J%8Q@<4LZ
M-^%#)&[VB++EBL7E-`_HRVA]$J:[.`TVZ07-/L3Q'V59BL7R++V)-]W[-Q`L

MD*8)D6%71@X(
T.X'5*5A7)3A-OZSJ





YO%O@0)Z5%^.`S*P6+:N

G'M*WG9MQ

O3J(




MO





MO[Y


U*==2Y``M/^$?6[)VK

I=_%T\$
(7[C2G
MCD6CB&C00?X_I(S<#<Y<1NS_IZ1H'&&M(WGS&\?J1O(GZ03322\C0<-&]^C
N
M-F9`@7I!KX]8.E;&9L[8BORUT*#!+E*9\-GO



2



M/NKQ^-(
6/NS'.

M?E*Z8/C

MV&&*G


E6K;U.&J(+F[H+DA$

M-Q]B#:P#=?%&WX.H


4AN7XDSF?BB
M^B
BLT_:QMX'<$*?%(#R!V-$T84AFVZ^+#9QU_RO\\<4@9T




M
E=P(H3?CDSXR]*NBH'@X=!QW<:P;SES9X;K'FN<7I







MC[

8:GC.(W^QHT*:RG4^:V5SU6?C


M]*$'[%)]=R'


M(AMX?:704]WDB8V]D4
[S`ELO/]K#KZ(/O!EU5OML`_W.Q*(+$%XLQA4)!?H

?BB//SF22_$YTY.0FWF^!.SZV+J#VF31





MS7
KS7@[384QSG\..9LKM&$]JZMQ/W&W)X7U?A'!K3]'

'

M008K]T!IB


M`1C-B981B
'-X\6!Q+


A2#/O?-SVZ$0



M^/.=/KI5\]GY

M11D'UBL.
A9A^Q03L+_A#[(V/RL`_$6BPM-[MPPP%)=W05WH=\\2.
@HC-





M9
N]W


M=@QEM*;1
PZ(-R5GS


?F22_[O5P4J

4/M-6*^98A




T1G*%@J&=4=K`AY:
-$PY(H?P&L:X8PR8%

KJL#





JZT!L%OR)[G!S]J
N#


Z1J3[OXP::

3'RJV2AQ961.*3Y/+BY%2Y$523RY#@/BLR
&@#[FX:J&(]G63C#P&DXH&D
M-D*]+94YAZ;RT2-'V$0ME5U1AF$6_OC+ALS?7?%<W.7]Z1/[\VU\0N^#_29C
M8F+<ZJ!]H';Y2HRM]JB7$^R<H8\CP_RKGUD88(Z-+&&:;Z8,,[IMO@:XJ\SQ
MV^%WM<'\X!A3P56U[E=KIGKW,_#

*0!$Q
!Z0V:





&C)
M*`_N=36_M2:D;`8XG0S5^&


4M$2&WGG/Z,$5T
M.$/$F"^]/GA/`2SPZG99#3N2'[?W\=.C\$Z2KFB`9=S(Q:Z\KY7!'B'9Q?
MFXV]TI$5#C=5`@Y&@3X'UYI1YN$`YY

M!LXN'2$;=?0Z_4:359C2R_O?@R0)^&W;LH'*)%;\$&JQ
614644?:0R.E$33

MK*!&SQ
V]7@*^*&2\[#837(=;S8?X^1KD*P[8(


MMM$I)\
PG5%3`H@+_
FOA5?U1`!L)']94HCSW8K\U--3L-G3\@C4NJ;;IJ+;

.C
$2#J]=P`

MC*YOXX]!F/S&Q]-J9O(I7H?WX4I(=V^Z0K!4K16
L#2NCCK8L8-UA+%MT51:
5F18)%MT^S<N14=&-<#'5K
MM8.--BJW(QLV([.PUBM&-\(5I\1:1H-*A0E2V"W.96X)?);2:7&&E9^\ZD

='Q+7!'JJ$



QI59;R9$TLX/N(A7=@FHU&UHAS0B7
HXJ1U8%?C0'C8




M:`-;*EYA6F/





M*L]!66A4[ZH#-

X*M51VL7/RDVNU*F.7K/Y?G=`XGV6\F7FJFH3\K]N:9D)\12[GY.+
MYS?*R@[Y^ABS])RF+RQ!-X
IMNKV3AZEU*F3*(-9=TA%RLB-/@9BE.?BXMA!
MB9Q2Q)
B#!IT5#GX6.R
W;BF-8ZY8\WH:"C@2WO41Y
L=+V@04FU'&PLA
MU

MQ4;J6H24
N3L@)R?'WL2:E'!I!BQ4=$O+K^'W%R7+RZG2ZC]7%UV%VS'^G



6./YN]TIZY;B8H_LD4EN

M:J2E1[YP32)49]^V





MW=FWA49G*Z)6`V.+E\:!LVV)9I_&35\F$XV=7YT@&JQ6?$K+HN@]2[D?V$0R


M(':YI^%#)&X-8RIWP8;78U.^-

0=FZG


`M#3G+JAU
M/)@AVE)X70&MU[D]

OZ0X'D4K2/X[81=)P@A[&N:3N$M$+8U]BW`&;7XZ;@


`NQ[T'@[_)IXI:\@_+VRTZ'XZZ



M[6J


RTQ
S(Q$]K&_56#*.G8=@YDHRUKP(NBF1Q)%QP


M8




M[39
Q;-#=\_

M5%BV0AE?]*S^[$G0'-31JI5/FYY&#7B_A7$^


MPW*BF$\$J7CN*-UOLOR-WKHTOBI\BG$J*[RR`:MV6XX]=X7K:I65^Y[]14!

MR3#O.3&5[S5ZR4S4E.2*?4B3A*Z/-VS.PMKT09IEF
2*'TXM-B:8J*RB#^\&
M1TKB:_46E_N

3N
&%&]WF^F$JOE2XIF45,V-]TS$[;[`R8CVVP&4[
MHJ@TJBA-^F*1#B#K



G3A[
!MD^H3/G9S98BH=U=IND`.6*F6!'$T`7)]&R<#86
MMRE6L(0^VH1J,B0'$!P9X$](*8`%EX'`M$ENK\RB^AAP;05PM'1=KB`(ZH





M?&]6L:U
W)C%F-#
DF=.2I'`&Z-#J!UTQMFMH@]&\^9E&$X&B]
.A]PZ;([;


M
`ZW5!PDR3/S_AO/?+15ZLOH)

MR0BM44_31QL7*?6J


UTP=&\-[H<T5
MA4+%`JU!1WC!&1D

MI4'0*-??

M`_Y?)AKP_S)XP/]+=\#_RPL:\`=!!SS@6T$']]:6UI['9;0NSQ?K+X332W?O

MG0/'D$*^




G%7A6@5/$7!U$CV%&^XC%,)OX;@Z:NJ&Z**/:J

X
M-L2G@VQA1#

MR$.:WY;!'?!5O_5_[-.
_T`I^;&UC

@LU/

3'S_40Y#T



MB5
Z\MNW&W/(VYC4A@BW1





M35EYLRNZV=7;G$X

M;/G

M@$Y\\M214\BZB-]G3Y';..VJR]RG3UVTHGG\%+RZ\W;/GKHB-JBN-]_I4V3_



M(CG






IM0%Y-W`

?JWN
MS47%6FD8I5DBOI




B?T1T13/I:]1@P.1FY.R_H+5=9

T@T0UL/.)611'

M5.TI$+]




+9:$M77#R\'\;R3
=Y9Q

G;;0K)+WP$X
MD3

P








8H!?$U

2RHF)_A3A?QX^OMFZ^:^ZUB-:-O12T
M_G)^E:#`0%=
=6S0IYWKF`RI9CNP!DS


MSAE;4#X\

/GV#T7/H^;Z#^J+VF9K4RN6K?$+DY^]$SE[=UELOZ.87

5^'R*^@$0[XAUO*


M4/6`S=L+B&

MQ367USL

`P[HT@
M


=^G

MWH=\ASF'S
P)H`X^
J3KV_B$WF7:AYEUHIT9N%P4(Q62678VE]8X,V8U2MU7^-:R
M%AG=_,74@_(<1:;52T34IEU#W=&JO
R&'3-N64IPW\]+N79$\DH6#+

M34,GT5L[D73[#K(Z&5T$6?T*GCF^__/HM,G1O#+^Q-Z'[XT`&FM5[Q0UCH
MC:$
V`UZZ+;UK*24G2$6U%G
^V7LB,MJAX[!C%H?_'4?Y#O#UF4;KL0!J;/H.$C9)/N*




#+H/Q=&&N=]!!!-R3XI
M)@SLJW34].N8=0=C1S&[YV

MC:



`ZN+SP4C

M70
U/:<
M54Y[+HS%@HZ&J)1NZL_(NB@VB5L!&%M7O!D/M'S.,WAX2.@#/[(4;.,]R^7S
M*,87Y\790(A+Z


']CE20;!M%3%'4#BQ[_TC:^WX=7AR
!D/=$8P&#^N
M3FJ+3NJ)/DP6/*T;3E


B4PVATX*]#8


Y$7:1(Q
7LGGDIHVS+CBKVQ7=-PV#2C
(RRWWEJ
M@[(7Q5/'2^[\-6;I'F6(J'(9OBF*NWI66YY@:;[GS&))K:
KENMWU?T26;BE

M5!MPH

N*P!X0+P!

M;RTR
#$S
3(S

%-TQ3!3=
4W5XP`!!4.```$.0$`


M-3E*O6G7X`D*%YP25PH`+)?NMQB(H%,_)X)3+_]K^^;K(/KZ@H4YS__9L?

MN$C+58;+78$^W.-L5Q$.Y8?;N^7EU?7'#S]]]Y_?_?S=#Q_.\79?I


BRS[4Y.6'`I6H






R]/YEJ5FBRU

MG%2[`BV?SG9EFJ/2[+QLPL-HHB2FLUX6+9_.D_+E



M%?_BFK9?%8DJW*
MJNO!C#JV_/T;G2+D

7[]?H_1[(NA/]`\J\4_?
M_O!CZP#Y'^2G?S8MN$//*:V83
G)!HU$E)&T(O%)AB+TL;`HAN(DQ8IQ)'\.
M@#!UFVPIOM_6(_/;U4N:=1AZ*O!&LU
P2






Z&R`!S0`X$YK(`.7T08H$\XM0/[O.`#2
M6LP[M
4%/42A^\T='R=RTN%1D`:&6I`$ELM:P05M!CZSS@P5/_G$RSS[WS
MQ@%TN!0#Q(PH(@.*3#X;?(SXMK#X2QRPN-T]9NGJ


XYT@*1X4=#

MO:@:+!PZ+EP&=)$1BRK\@
N+


MOWU.DFV#4915)?ME#-;VYW_V_%@NTYRT)R4S+2Y3R:6\3I&VJV%%+


/8QVO.6O?=92'YSDWJ&H5


@QKX=)1VMVV3K-=DZ+61@.(``O[
-G!ZK

MX0KIT


MV!3%L(O



B.$



\W^5

MZ$Y+.HBUJM7
'HY:LAA:2R]CB
M@B:$*P?!N.E)/3Y5`A=@!TN``H&#2UMF'8!!F

M:K7;[.KL;*.$$2V^X`5:74
*!(XO;9EU\`5A[CM6JLL=CG)GH]S1!(\7I4PZ
M^.`Q

M

1]Z#$Y`49#P35@1_TB@.@GK@4);EHX.\#S%
M[AKF
/


%U.PY'*2#AR'4C\&1E%

M2!2PY6CP%$)IG..2K$=:F01SAY2FNU_@TGB6J[9V]SB;7K-QOPYDZ7WUYT\G

M6$P/(3SZ'L@JLV@R2Q9RW\N$T!KY'8O(XS`#%@20J0R\'!`PB]='Y5.!R_*V

F
[?

C;`%%W(S84?3AZ

MR30L&EA3BO'0ZE-$`0VA2/J@Z+.:(^+N4=



30X


M285$1

5GO$Z?


M0T:FG2K
YF5(-7

M5@U;G-

@R'&ST!/$#4'5@4U#%`1T=@;2`IF

[

X<3RUEWEJP(E]+%'\^]5/CUUN<-9=HF+
M+TDQ/FHW+'T(::I7.J!D=I-.%Q$(D]?Y/=TUZC9NE''5P:Y.3?P@XS;F8HN*
M%)

^QD18_Z8OU



YF


ML^SG5-A3*?!$
#0[3B18

MORWK








M`S[K1V9@&4HYV0-=LM2%OY3E20\!N#*/-PRD;6)#(8I[12G@]0MW,].`+S&
MBIG7X8P/Q)]CN1LTP:*L),A=['31%#-S`YB`CSZN-\S
(V_;NF5QRI+RK+W
MZHPN_=$FF62XH`GZ!



M&J-.Z2TDG6;RYI#ZW#G0YMP6F#J:K
_VOY9H?94OB=DG_9H_+U95^EK'C!*H

MAD9T6C_
%G&1%FA%REZB:4!/-64?BB+*MX-'D*X\@5+4-O.M41#GTE2J)%^A

-A`<IKD+6&@&X#^FA<HR=(_T;HW%%&1OA(UO$ZVC4#J



MN%Q`.EFLZA/0DN`)D<7B-JA3A&A)GA%`O+<5W4PUXM<J0:5Y[Z@5KY'.:\V

Y5QF*RO?DT2RV(5@C``6WLR!
+[A1R@VH
W$UQQK99VR3='W1M-.

M\LL=%X^TYF^RX_?`0;ZF'$UO^@6U7T]&.T:

G]`I7219
@`79






(.):H410@8_S8%A0:'G:7P@M
M/S!T


`Y`PY;6]O&
M:;E#JRPI2[0F:]$ZZ_CO:?4RG


@=GIT-^N+/JD@WWZWPIJGW)B$+
M2;1\.MN5:8[*\AMO`=J+YR1OT]R1E4:)LW3=:#=?W_:D73ZU/MU)UG6;Z$FQ








-$$?3'R$8-LR&WJ
M[',*(^LZ)4*N:=K&BV23/!LMD04WK1/6@H&CI&-[/C&=N^OA2277:R24-3L

MBTEK3MVBS(*3QV6I=JO%:U=[5N:Z#
'DN``3=JK(\7K:N'W-HMNF7=&:OF:-
MY


M


P77^7_HJ7\MYQW*Z)KS')=5
M63_1?$Q*M+Y-]C+_=#?

M840KU8WA\HU6&P+.]3I#S#':D7.5DS_10_+5XR%*UP:`9ZZ2LO-6E5!Z]
R=




D6.=K$HZQC6KBG;0TP!9:54OU[T-\%X;&JM#GRBA?`6Y


M!U@9C^X
.GV+S90P]G(`5%E[/

M?O?2@@8)'[;!R+M7;BIR;Z-1U#3U@MJ@I$(=82VUP7V

MHK40][O'$OU[1WA]?/6Z1\W1'0=I2#KTF:*R#QF#1TV27A[I:(3B!C6%;V


$`:
0B=$S:ZT4+ID;5^4B#
MZ]B[6[6*DY.-O;JC0QE

M838@W-RA+2ZH]





')A*\N&'I.66
EC`:_/(VL3BV1#G]N





P-*&A?9Q(:T'%
M[6N!+CX:;)7E;M/\!AT


XH0C.C=]@G&H%'PQ=YN(
M(YC@V:*U+HA8&BX[`'


MGQ-BA7-4#!X1?4:;1U2


M])2ND!Q(4II6IP*:6
`#$=$(-@+&D3L7+785WN#'-*
OMCF($7YG!R33[[$@


QREL'E\4.AM

ZS1'5Q7:@`]5)P54)XJ]`N&)_VN)GG;9=?HT/F#7








^5)
MKX0]UF&[98/W4<UN^6.^#L8+8\X3YOG.)8]X,.U4


$^X8!55#G

MM$N*)*^0

8GI*2OCOT%Z;SO8W




M!'=HE'AVD])



M]DF)H!;7TUX4K/;D@JL7U]=]APM0!?&N]N[0J7U#3'U(KFJDT&O6=#BCT]/
M:$7]1?\G1=FZ'\IX!#]++BROJRF7\&'J1D&:T#6N-#B/=E)]6ET4R9?\`G_)
MV^%WBXK&57'LR@ZC9C[L*NKPP:4GL:(E
R])?H2@(4V=4U:VK3O@=6+S@;
M@T1!Q:(IB*C!P5








`RE:Q4LI8L`
7UPA'
M4O;QG@DMGY[2%9(;&RE-JU
!32S@@8AH!!L!XWA/=^C3V1VQA'+(**B8DY.(
M*A;8P
0T`HZ0]1SQ[D+0





M8[]W;(Y

\90(







^(R\1/3Y.+Q
M:G9'XV40BU'M;Y(-ST]
#++1H0:Q59^-CPJLKZLM`D`+.
M]CUE\!VJ7;`Z7/I9L`H@!)O0YUI&,EE?!N%5W:B]MX;GN\ZJR%C&2R&9QYE5
MTB48+-EX_IPRK?.,9F=1J(2N]&/00.$&Z[$J.)A;+U3<UPSGE`=6G)G$Z]=


MD6%,--F&


M[




03N[OMVB5/J5H_?_NDIS(NJ]=\.DYR9*V$JW)G$CABLYQ








8W

G2@EF82B)]2$PE\R(9P_$_.WH:T2/(27D72WA3R28(3B/EV7$PD$

'RZ-MYE!T1L8)M5P0N#S;

=#DR=7(P@R(6

MIPP.P.''4USL$7?NDOR9MVJ8_

7O/_]@Y?PT_^MMB0#L#*R0:;3
4

9
+V


P\9



UCCMH&?B+_65^0)=M@

]0[E_S9(/);/XG6C
O&RQ:A^X3&3*RU?;:?$C,R7E1

EX:
E-LB%_/A1)7B9U(%KNPREX`28U



M&5PN4(R92@Y!FP9O'RMQP9YLV

M\(JR3KX0M=$L


D!%`@6(@;P0E
#8.K[7


M/_Q[9%'TME`N`R/08S7'0]!CGC$J#Z(PX$!G=%(HXME[M3C@]7Y$.SFB!9X/


&?
MTRPC&KC-=B5K_:*@+ILTT?/X1-JH




-NUU(TD3





M/%.W\CIKV(2ANEU4'5]4WNN4R+&F8_LBV23/J#0/SN8(R8U(+N*NG82QPQ





M.+F&8AWY\.^?7L^R)N!5X'1]
4]]R2+

NK(:



G4
0MN*A)S;1/PTL2`TR(?KC!%6*NW9(P


S=89/
M74YB@


MYDF^2I.L=X#

M



DF+
M.G+.M2!A$HAVLD[BT@8@;V^UP7_2`R&=2
LC#6!LR#H


M#O++)XZ@`B=(6*&1XZ.J4`08
I)?%TW02D)RY!![5HH3I^F44?O0!A$?2Q])
M.M*;`DE11^3G$XY60__\.;;UD
V$-Y%VEBG/X
BCF?(^YOS(:_Z#N4X#M?^:


6X4/7@6HT\6M6H[=TI@(+REHX:/CBB51VA]8[
M7G9SC1)#_T!YB?`AIB^X)J)`%7A




`+JF:M`%J48]#(Y'O41Q`\?;`J\0

M.?8;BB^2MZ@?9DFL


MT4W4
J'S)^.A)3?)AOSY0!8(95)?'W(#Q
$+
*D!!1RF+
RRE*YU%NO7M
1%

M$?FH4%
R7
@H8T$&6%HC;





MHK



6P=VM*ZS
MTL)0)2\E@I.H5PX`DEM!`1YWBC;MV1E5.1TM`ZXEE)2M
=%'%I`H4

M_/3O$3Y@Z#V`NQUD:I:DW%92#])J2ZB#A8R.E##D*#B:AW-R;B^&[Q_;HY$'
M/&QW[_Q$-B$8
AF%RM%E$BBLG.A$8R[2KL@\'-.Q0+BL7E!AB#UY63GD1&7C

NW*0TW6
^+DV@\(%(!(&)@




MCGEI/

[7`,PB@*]3?3F]?P-4[B_9A_/'?+=)L2QJ
MCX#F2(YHHE:#^+A=58+GATJ$0%0]26W.*07UQ!<AH];
FY6Z99-#C3=\&/5



JF7MH

;^<[S9)OF^
G82O/A):EN<4Z$(22CQSCQ.01
MP%939E





N

M-:@BC@`V6O+J(D;%G('%X`+*TTKL\/2G_:R[$!
R@*[#.`PB@)FU7IROPC@5
M
C@&$^NI.\IA_C.UG


KY9@5;'(Q4?-
`[_JW%?`B\RM,J3;+;W6.6KI9/11B<0$@E):3X%!0





MO(X3-V?8#2Z:T7::JS77

ML7_[?J)7
N3^:+YQ/PUTCKY69#5RN)0?:/W/JD@WWZWPIJFW=[M^FR7Y(N^]
X:!8D
MNC)A


.CS-8[4DW-';XS4Z0)EID7K4`RG5*
0`-(_/









MPO6$
ML@U1G.W*M`_]X64Y)\)RTO&%)SU5AC4ZOJX

M41_MGK)EM%&90QNIV0R#H]N0'*`\;:!@![SO6RB1NOQNHH(]J%TUAWCFZU9H

DS/+YGD]=.`\HI
1_5IY@.^2*JQ#FH:
M^KLP:X^?%MCZG=JT(



M3EE)BZCC)U!S

^3A\/P`JWB(04B`)VV





M:/[4^$_E36H%



MCI.@P+




T&N%_K@1MPZMWMIX_]=&R
5MU^[+B=!8PC
M=QU?`XZG$5#0L!._)!







T\YH%F-)'
#%XC-E


P@S26?NC!B$)7!M)G_#&6&3



J

M?/.MRCPI


:[!Z@6M=QEJS91
R\*PX0_4



M_V
KV/AC8/LM-WV(%4J`[)JL6D+73^



E;JZ1Q%CVTZM0-



MD+'5A9#
E@(\`*FGRQA?1!8T577CA2`)Q]W%<I<4+-X6]DSX0+




M=:$7[P&2!3-2_28/H3(674;Q)%4Q$%4^;RBUO$U?S3X]YW]@Y\?;MT''
MTR^6-WTXNGH





M\($*ZFCN:UF;.XV\HN(1A[26NB-Z*5[%*ZC1]PENNN^QX84OF!5..I8M/O[B

M]O

]0(]PE[HEV/9W97+)LN\4-RSC0

0-EV
:1`QWVNFB90W:)+[7$(B

M*RLB?5$N\O4Y6;HB&F&G#ISC^T3B+BW_H*WZE32J($W)JU08:`]$RQYKR&D]

%9P_@OQX'D


MX4@J#%\


M
EV?PO
SF.
/]QA4^09-RIM_!AKK0S0:^SIMGMSZ=OOJ-:5Q23N\\U
^33
J

Z19BW#:B(-R6P;&TT=3'-!OCQW[MT

:LB8[Z@0C)O

TUM8#2H6OI?%=0&)LI
M:5183T==X4#&*1P*V%)!LI&L;




M=9MF=GFIJB+FL!PF[EG8R(%I$DD/7G

MN_X)KNNDM8FR




M`
X!/9%JFE9#NIXVR7KI`1?5#N_*JYRLV4G;R
R#?D^KE[-=29:E)=D3-..@



5JJI)\G13KVP*O
ECZ_5(0._4;$VA'IKJZSE<#K
M2TW:.7/)2`/%@(9\$!3(V07D(?@9%T5:?DJ*)T(J2
HKI6$7XGR:0'L;(A&D
MFP5\0O*22XH__D&
QPLN\H_K+V0!?;])JY=%OB803?*KLDA0QN]U_9(


M

^HBHHD`$

M3-L'TN3OBGH/WA-#7J0TEY8&C










M\G7ZFJYW27;PTF)YU



MXA7]D=SLJB*Y+?`*E25-%BN(B0.B;;6CH`VTPW4DA/2_@E^\P6S?(UUX7@B[








IW
MFISW+KJSY?#A+I?9[.]RVR_T/X]D5B:__/]02P
$%`````@`I7N.1'[V2X5B
M&0``TB(!`!$`'`!Z=&AO+3(P
3
Q
C

M\PGUOAR=GYP=6=BSJ4.\^R]'H7^
?)N0HW_^_)__\=-_'1]?8P\S%&#'NMM8





M3_GK.^3C[;!+\/'(@=(7I^+M%A0Z(HJNB>

/)UT@9I=Z

M5Y/OIOSZ^0RT_MD9K%-)#]F?R'.LJ#LKT]]/I\5.BOV'/G;&WL_B=W$BQZUC
M$%7+PERIWS`OCO)V\=.$`SLRYA*Y?!F9+3$.(D;DGB@)#V07A)\!;7!





M+-K344OH5


MS5IEGJ$X&#8//&0(DLSEVI^@32KI52\U'/A4Y@#8/]]`VPQ`W(7XSZQ)Y[=6
YZ9SW6J<[+X9K!R!N0!#PFZ(RX)MG:^

MFX&.'J_YIR8N\L!&_P4Q!K[J-G96^5Y#?9GKRM6Y-9[PB+
U&79&PI#_I3.=

MSC[0D%KBK`Y&W?%-WYIW?FVIG*'R#?J=LF[H!T!:YH
^$6%*+\CM=NF`--R0
M^*\WG?\93ZWN+:B@F_YT)A2/'.YNT.6-G!6JU(('9
WE#+PNKF?ZW]HE8(?]Q%WV%:7[B\6\KOH[B9JDKW\\;Y_2^B$9
M;IO0TE0XYCRXW4@TXA:O(AB?GBL8T6!;L9#L9&<Y7WRH8NYV_UK+.]7F=\N:
MVKO@64:I051L4^Q]:QG9;N]9:UVDS?+4ODK%2N+6[M:_M78'FZ95G/7)LLZ


ND\F







M`\J5L)J-9/=AJ$N5[6Y4B+YVT=1ES1#7'(*AVL$Q?EJ[R$
\J_D*_JZO+;*]
M]--.%#2+R\F)
6[3`DM9+5VQ





M7-
2J9(ZT^H5Z95&/X0'S0K


MWC]V;HA'5N%*RE0%MFH._A.A?ELB1CV![X/QZHEH23&6PK(7)B&P&]('[Z

M9E$F7H#O

_QT')

:GR@<X:.%UF<\\Y:'?A8WD'889!B?7_;I3OF
M66)L];!O


[
#/
MJ)O;0'I.+Z;LKFDB4%


/7H]^NB)/8IP!2A%6&4-)1WD@0@VQ\`!!*)A




%1#+8HKT/BM?ZC&$T%=_I/)&LN9MYMH-GZ@2?'0)?



H9)\4
MUC!-PK
+H[3I#!K9A^;%1_A5AB+;V\NK.(`(\_N`6DAC(B*:^%;$D'*.2N&Y

:Z


&J&AI#$=V&
M39)/$9\JEXI_?IY43*9G]W0H)
NGY\38#CQY%D8=X$-!O#*;JT[&ET%H:H]Z

;@JF.I1M&K;8@=&AM#F'VNG7FMMN
Z6NSD8@U\``

7P%B9-T-E!`G&_

MI
-JX(S!5Z





U5';39=T&YD7F9VMLDP7!

V6!U.,U
MQ38%-];A.P=7C*XZ]^#!\2*<TH6F%O3!Z$X)BTIJP(R34;3JT._Q0FA`]EV
MBAK


D]%/B?]==N2I

#Z=
M!_N2&[FJ00R+9!4'*KT*I!K&1*OL!MM+Y!';'Q+L\9
]%-H'FR%/NG/*3F\=
M:'


87
E8%


M/3IN:L!'H


W
*&*V0
DF
M4_\)%C(/N=6UJLA3%L*2I?6G%WH+[9)8<Q'YU




M5'!@XON)-A*T*B%-14U26*3XQM2A\VGB$Y_W+Q6PS%O#-EN2
19JN.0TN/R8

KR.US
_D
M;O'*%FG8M0?S=HVC@8\7-R@(6=Z%*K\R;_A)

M^2




M'^;`6UVBASC\MI6#_P-E[F?3@%%'^SZ%8*__@]02P$'@


#$S
3(S
2YX

C`Q
S$R
S%?9&5F
M+GAM;%54!0`#!3=




#$S
3(S
5]P

%-TQ3=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`I7N.
M1'[V2X5B&0``TB(!`!$`&````````0```*2!0O
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLossCarryforwards'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredTaxAssetsValuationAllowance'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DeferredTaxAssetsNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxDisclosureTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PayablesAndAccrualsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SettlementLiabilitiesCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherAccruedLiabilitiesCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccruedLiabilitiesCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquity'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockSharesOutstanding'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_StockReturnedAsResultOfServicesValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_StockReturnedAsResultOfServices'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_StockIssuedDuringPeriodValueWarrantsExercised'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_WarrantsExercised'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_StockIssuedDuringPeriodValueCashlessWarrants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_StockIssuedDuringPeriodSharesCashlessWarrants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_ExercisedCashlessStockOptions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_ExercisedCashlessStockOptionsShares'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_StockIssuedDuringPeriodValueConversionOfPreferredStock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_StockIssuedDuringPeriodSharesConversionOfPreferredStock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProceedsFromNotesPayable'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquityOther'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DividendsPreferredStockCash'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PreferredStockAccretionOfRedemptionDiscount'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_AdjustmentsToAdditionalPaidInCapitalStockIssuedForServicesVested'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_AdjustmentsToAdditionalPaidInCapitalStockToBeIssuedForSettlementLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_StockIssuedDuringPeriodValueUponReclassConvertibleRedeemablePreferredStockToConvertiblePreferredStock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_StockIssuedDuringPeriodSharesUponReclassConvertibleRedeemablePreferredStockToConvertiblePreferredStock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetIncomeLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquity'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockSharesOutstanding'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_StockIssuedDuringPeriodValueWarrantsExercised'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_WarrantsExercised'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_StockIssuedDuringPeriodValueCashlessWarrants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_StockIssuedDuringPeriodSharesCashlessWarrants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_ExercisedCashlessStockOptions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_ExercisedCashlessStockOptionsShares'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_StockIssuedDuringPeriodValueConversionOfPreferredStock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_StockIssuedDuringPeriodSharesConversionOfPreferredStock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_StockIssuedDuringPeriodValueWarrantsExercisedForEquityModification'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquityOther'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DividendsPreferredStockCash'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PreferredStockAccretionOfRedemptionDiscount'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_StockIssuedDuringPeriodValueSettlementLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_StockIssuedDuringPeriodSharesSettlementLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetIncomeLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquity'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockSharesOutstanding'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventoryDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventoryDisclosureTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SubsequentEventsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SubsequentEventsTextBlock'
<div style=font-family: 'Times New Roman'
 Times
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventoryDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventoryRawMaterialsNetOfReserves'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventorySuppliesNetOfReserves'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventoryWorkInProcessNetOfReserves'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventoryNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventoryValuationReserves'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_SettlementLossesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_ztho_SettlementLossesTextBlock'
<div style=font-family: 'Times New Roman'
 Times

